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Management Using Continence 
Products
A. Cottenden
d.Z. Bliss, B. BUCKley, M. FAder, C.GArtley,
d. HAyder, J. ostAsZKiewiCZ, M. wilde 
Not all incontinence can be cured completely and 
even those who are ultimately successfully treated 
may have to live with incontinence for a time, for 
example, whilst they wait for surgery or for pelvic 
floor muscle training to yield its benefits. Still oth-
ers – depending on their frailty, severity of incon-
tinence and personal priorities – may not be can-
didates for treatment or may choose management 
over attempted cure. For all such people, the chal-
lenge is to discover how to deal with their inconti-
nence so as to minimise its impact on their qual-
ity of life. This usually involves using some kind of 
continence product(s) to control or contain leakage 
of urine and / or faeces, and /or to manage urinary 
retention. In short, the possible role of continence 
products should be considered at each stage of 
patient assessment and treatment and, if treatment 
is not available, appropriate, acceptable or (fully) 
successful – subsequent management. Managing 
incontinence successfully with products is often 
referred to as contained incontinence, managed 
incontinence or social continence, in recognition of 
the substantial benefits it can bring to quality of life 
even though cure has not been achieved [1].
This chapter is aimed primarily at healthcare profes-
sionals seeking to make informed decisions as they 
choose – or help their patients to choose - between 
continence product categories and then select a 
specific product within their chosen category. We 
have also aimed to make this information acces-
sible to the user, particularly in the summary and 
recommendation sections. The chapter includes a 
section for each of the major product categories, 
each section reviewing published data and – where 
possible - identifying evidence-based recommenda-
tions for product selection and use. Products de-
signed to deal with skin and odour problems caused 
by incontinence are also addressed.
The sections on the major product categories are 
preceded by two others. The first provides over-
all guidelines for product selection, describing the 
key elements of patient assessment and suggest-
I. INTRODUCTION
ing a classification of people with incontinence into 
a number of broad groups based on gender, age 
(adult or child) and the nature and severity of their 
incontinence. A table is provided for each group 
summarising the user characteristics, priorities and 
contexts which commonly favour or discourage the 
use of each of the major product categories avail-
able to them. Following these overall guidelines and 
preceding the sections on the major product cat-
egories, a review is provided of the methodological 
challenges of conducting continence product evalu-
ations and interpreting the results.
Much of the evidence base for product selection 
and effective use is patchy and so, where there is 
little published data to provide confident evidence-
based advice on an issue commonly raised by pa-
tients and caregivers, an expert opinion is offered 
as the best advice available. The hope is that high-
lighting knowledge gaps in this way will help stimu-
late the research necessary to provide more robust 
evidence-based advice in the future.
To accompany this chapter, the International Con-
sultation on Incontinence and the International 
Continence Society have collaborated to make the 
material more generally available via a new web 
site hosted by the International Continence Society 
at http://www.continenceproductadvisor.org/. The 
hope is that this will help people with incontinence 
and their caregivers to make informed choices in 
selecting appropriate products, and provide them 
with accessible, evidence-based advice on how to 
use them effectively. 
The literature search strategy to identify material 
for this chapter additional to that reviewed for the 
third consultation [2] was conducted as follows. 
MEDLINE and CINAHL databases were searched 
from 2008 – 2011 for English language publications. 
Detailed search strategies were developed for each 
electronic database searched. Consideration was 
given to variations in terms used and spellings of 
terms in different countries so that studies were not 
missed. Relevant abstracts were examined and 
then pertinent articles were retrieved and reviewed, 
and the reference lists searched for further studies. 
1654
For product categories associated with little or no 
research literature, analysis relied on expert opinion 
from clinical practice papers. 
The following main search terms were used: incon-
tinence AND device*, toilet* AND facilities, female, 
male, urinal*, commode*, bedpan*, urin* AND 
sheath, condom AND catheter*, incontinence OR 
absorbent pad*, urinary AND catheter* (in title), 
urinary AND leg bag* OR legbag* OR drainage 
bag, faecal OR fecal AND incontinence AND plug 
OR pouch OR bag OR device, OR manage* sys-
tem, incontinence OR perineal AND dermatitis OR 
inflammation OR skin damage.
Selecting suitable continence products is critical 
for the well-being and quality of life of patients and 
carers. The ability to contain and conceal incon-
tinence enables individuals to protect their pub-
lic identity as a “continent person” and avoid the 
stigma associated with incontinence [3]. Failure to 
do so can result in limited social and professional 
opportunities, place relationships in jeopardy and 
detrimentally affect emotional and mental wellbe-
ing [4]. The ability to contain and conceal incon-
tinence enables carers to feel confident that the 
person(s) they care for will not be embarrassed 
publicly. It reduces the level of care required in re-
lation to maintaining hygiene, skin care and laun-
dry for the person who is dependent upon conti-
nence products [5]. 
Fortunately there is a diverse range of differ-
ent products to choose from. However, without 
comprehensive and current information on the 
products available, this plethora of choice can be 
overwhelming and confusing [5]. Furthermore, the 
range of products actually accessible to users can 
vary enormously between and within countries, de-
pending on the funding available, healthcare policy 
and the logistics of supply [5]. 
The choice of appropriate products for an individu-
al with incontinence is influenced by the resources 
and care available and patient / carer preference, 
as well as assessment of specific client character-
istics and needs [6] [7]. 
The stigma associated with incontinence means that 
another measure by which the success of products 
is judged is their ability to conceal the problem [8]. 
Such concealment may involve compromises: for ex-
ample, in order to prevent leakage from a product, 
those with a larger capacity than strictly necessary 
may be preferred but this can in itself introduce is-
sues to do with discretion when the product is worn. 
The intimate and stigmatised nature of incontinence 
means that issues relating to self-image can affect 
some patients’ preferences. This may be especially 
marked in younger people for whom body-image 
may be particularly important and for whom disrup-
tion to normal social and interpersonal development 
may result in isolation or lack of access to normal 
experiences [9] [10].
1. PRODUCT CATEGORIES
The continence products considered in this chapter 
may be divided into those that are intended to assist 
with toileting and those to manage urinary retention 
and / or contain incontinence (urinary and / or fae-
cal) (Figure II-1).
All toileting products can be useful for dealing with 
urine and / or faeces except for handheld urinals 
which are just for urine. Containment / control prod-
ucts are subdivided into three overlapping classes: 
those for urinary retention, urinary incontinence, and 
faecal incontinence. So, for example, someone with 
urinary retention is most likely to benefit from one of 
the products in the red ellipse, while someone with 
urinary incontinence will most likely benefit from one 
in the blue ellipse. A patient experiencing both prob-
lems will need two products (one from each ellipse) or 
one product from the intersection of the two ellipses.
2. IDENTIFYING THE NEEDS
The algorithms below (Figures II-2 and II-3) are de-
signed to provide guidance for determining broadly 
which product(s) is likely to be of benefit to a par-
ticular patient. There are three main questions:
II. OVERALL GUIDELINES FOR SE-
LECTING CONTINENCE PRODUCTS
Figure II-1: Products for toileting (top) and for man-
aging incontinence and / or urinary retention (bot-
tom). CIC= Clean intermittent catheterisation; IDC= 
Indwelling catheter
Handheld
urinals
Products
for toileting
(urine)
CIC, IDC +
drainage bags/
catheter valves
bodyworn 
urinals
Sheaths
Occlusives
Pads
Products
for urinary
retention
Products for 
urinary
incontinence
Products for
 faecal
incontinence
Rectal pouches
Commodes
Raised toilet seats
Bars and frames Bidets
Bedpans
Products for
toileting
(faeces)
Anal plugs
Rectal tubes,
catheters &
trumpets
Bottom wipers
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Figure II-3: Algorithm to help identify the category(s) of products most likely to help a patient with 
faecal incontinence. (Y = Yes; N = No; U = unsatisfactory ie considered and deemed inappropriate 
or tried and found not to work satisfactorily). * Consideration should be based on assessment of the 
patient’s physical characteristics, cognitive ability and personal preferences, as well as the nature of 
their incontinence.
•  Is there urinary retention (with or without incon-
tinence)?
•  Are there problems with toilet access (e.g. the 
proximity or design of the toilet; mobility or ur-
gency problems for the patient)?
•  Is there urinary incontinence or faecal inconti-
nence or both?
•  Answers to these questions will determine which 
one (or both) of the algorithms is most appro-
priate for an individual and help identify the 
category(s) of products most likely to help.
3. PATIENT ASSESSMENT FACTORS
A careful patient assessment is an important 
part of the process of product selection and 
Table II-1 summarises the key elements to be 
considered. 
The choice of appropriate products for an indi-
vidual with incontinence is dependent upon the 
resources and care available. It must also be in-
fluenced by patient and carer preference as well 
as assessment of specific client characteristics 
and needs [6] [7]. 
Assessment of physical characteristics such as 
anthropometrics, level of independence, mobility 
and dexterity, mental acuity and the nature of the 
incontinence will determine which products may 
be appropriate. In addition to these factors, suc-
cessful product choice and effective use involves 
other practical and psychosocial considerations. 
Product effectiveness depends upon the same 
factors as any assistive device intended to ad-
dress a disability or impairment: patient participa-
tion in device selection [11] provision of adequate 
instructions for use [12] and the need for products 
to fulfil their function reliably and not be difficult to 
use [12] [9] [13].
While Table II-1 provides general guidance on 
patient assessment relating to product selection, 
later sections in the chapter provide further dis-
cussion on assessment issues specifically related 
to the various product categories.
In addition to selection of appropriate and effec-
tive products following patient assessment, edu-
cation and training of users or carers in the cor-
rect use of the devices is of importance if product 
use is to be optimal. This may be a simple matter 
of instruction in the effective fitting and changing 
of absorbent products, or may involve more in-
depth training in the ongoing care of, for example, 
a suprapubic catheter.
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Incontinence is often a long term condition and so 
monitoring and periodic reassessment is essential to 
maintain effective management with products.
4. MAIN USER GROUPS
Although needs, priorities and preferences vary be-
tween people with incontinence it is useful to divide 
patients into major user groups to help identify the 
category(s) of products most likely to benefit an individ-
ual. Seven primary groups are identified in this chapter:
• People with urinary retention. 
• People who need help with toileting / toilet access.
• Females with light urinary incontinence.
• Males with light urinary incontinence.
• Females with moderate / heavy urinary incontinence.
• Males with moderate / heavy urinary incontinence.
• People with faecal incontinence.
An individual may belong to more than one group. 
Each group includes children and young people: the 
products available for them are broadly similar to 
those for adults.
5. CHOOSING BETWEEN PRODUCT CATEGORIES
•  Figures II-4 to II-9 summarise the user characteris-
tics, priorities and contexts which favour or discour-
age the use of each of the categories of products 
available for six of the seven user groups identified 
in section II.4. Assistance with choosing appropri-
ate products for the first group (people with urinary 
retention) is given in the section on catheters (Table 
XII-1) as all the product options for these people are 
in the same category (catheters).
•  The recommendations given in these charts are 
based on the evidence presented in the sec-
tions of the chapter dedicated to different product 
categories and they are intended to help iden-
tify which product category (categories) are most 
likely to help an individual. However, it should be 
remembered that the same product will not suit all 
people, even if they have very similar assessment 
outcomes on the factors summarised in Table II-
1. Different people prefer different products and 
where possible patients should be given access to 
a range with which to experiment to determine the 
most satisfactory product(s) for them. Similarly, 
the balance of priorities varies between users; for 
example, some pad users will opt for a bulky and, 
therefore, less discreet product to achieve an ac-
ceptably low risk of leakage while others will see 
the balance differently. It should also be noted that 
a mix of products from different categories may 
provide the best solution; for example, needs may 
vary between day / night and home / away. Once 
a product category of interest has been identified 
the corresponding chapter section should be con-
sulted for further help.
6. SUMMARY
In conclusion, continence products can play an im-
portant role in enhancing the quality of life and re-
ducing the stigma of incontinence of those who: are 
awaiting treatment; are waiting for treatment to take 
effect; elect not to pursue cure options; are unable 
to be fully cured and are living with an ongoing blad-
der / bowel problem.
7. RECOMMENDATIONS
•  Incontinence should be actively managed with 
products to minimise the impact of incontinence 
on quality of life (Grade of Recommendation C).
•  Patients should be carefully assessed (and reas-
sessed periodically) to select the most appropriate 
products (Grade of Recommendation C).
This section aims to assist those planning clinical 
trials of products. There have been relatively few 
large clinical trials of continence products (with the 
exception of urinary catheters) and for most product 
categories research evidence to guide the selection 
of individual products / designs / features is limited 
and in some cases absent.
Measuring the performance of continence prod-
ucts is methodologically challenging. Manufactur-
ers modify and change their products regularly - in 
terms of both materials and designs - and this limits 
the long-term validity of research results. There are 
also complex issues regarding research questions, 
study design, product representation, blinding and 
sample size [14] which are discussed below.
It is common for practitioners to be asked (by their 
employers or by companies) to do a small evalua-
tion or trial – sometimes to ‘test out’ a new product 
and sometimes to help choose between competing 
brands for bulk-buying. Such trials should be ap-
proached with caution; they can be very demanding 
but their results may be of very limited value, even 
for local use. The methodological challenges identi-
fied below still apply but are compounded by small 
sample size and restricted product selection. These 
studies are likely to be helpful only for identifying 
gross product short-comings or benefits. 
1. RESEARCH QUESTIONS
a) Comparisons
Part of the complexity of product evaluations stems 
from the sheer number and type of products avail-
able, meaning that many different comparisons 
could be made. Table III-1 illustrates the problem 
III. PRODUCT EVALUATION 
METHODOLOGY
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Figure II-4: Products for people who need assistance with toileting.(Grade of recommendation in brackets)
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Figure II-5: Products for females with light urinary incontinence (Grade of recommendation in brackets)
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Figure II-6: Products for males with light urinary incontinence (Grade of recommendation in brackets)
Figure II-7:  Products for females with moderate / heavy urinary incontinence. (Grade of recommendation 
in brackets)
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Figure II-8:  Products for males with moderate / heavy urinary incontinence. (Grade of recommendation in 
brackets)
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Figure II-9: Products for people with faecal incontinence. (Grade of recommendation in brackets)
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using a hierarchy of questions relating to absorbent 
products. So, in this example, once the decision is 
made to choose an absorbent product in response 
to question 1, successive further questions can be 
used to narrow down the choice to a specific prod-
uct brand. Questions at any of these levels may 
form the basis for research projects. 
that patient ‘overall opinion’ scores can vary by as 
much as 70 percentage points between apparently 
similar products [15]. Accordingly, in an evaluation 
to compare different designs, the selection of one 
or more products to represent each design, is cru-
cial. Studies that have purported to compare differ-
ent designs or materials have often included a small 
number (most often just one) of arbitrarily selected 
product(s). Generalizing the results of such studies 
to whole product groups (e.g reusable underpads, 
or disposable bodyworns) is meaningless and mis-
leading. It is perfectly possible to select (either by 
accident or design) a particularly ‘good’ product 
from one group and a particularly ‘poor’ product 
from another. A well-designed study will therefore 
be seriously flawed if there is no clear process or 
pilot study to determine and justify the choice of 
particular products. Even with a systematic process 
of product selection (or preferably a pilot study) it 
is unwise to select a single product to represent a 
whole group of products and selection of a small 
group of products (e.g. three) is preferable. This 
allows for any ‘within group’ differences to be de-
tected and helps to demonstrate the ‘representa-
tiveness’ of the products selected. 
The most controlled method of testing different de-
signs, materials or features of products is to make 
up experimental batches which differ only in the 
aspect of interest (e.g. the material or the feature) 
and a small number of studies have attempted this 
[15] [16]. However, experimentally made products 
are not usually identical to those available on the 
market which impairs the validity of such studies. 
2. RESEARCH DESIGN
A randomized controlled trial is not possible for clini-
cal trials of products in most categories simply be-
cause a ‘control’ product does not usually exist. Nor 
is there a ‘standard or reference’ product to act as 
a control and comparisons with ‘standard practice’ 
(i.e. the product currently in use) are prone to bias. 
Although it is methodologically simpler (and more 
robust) to compare only two different product 
groups, it is more clinically relevant to compare sev-
eral competing groups, using a multiple cross-over 
design, where there are valid comparisons. For ex-
ample, there are four main design groups of dispos-
able bodyworn pads for moderate / heavy inconti-
nence (inserts, diapers, pull-ups and T-shaped). 
Evaluation of all four groups together is much faster 
(and therefore gives more long-lasting results) and 
more cost-effective than several serial studies. 
Cross-over trials are vulnerable to order effects and 
randomization of the order of testing should be car-
ried out using Latin squares [17] to ensure balance.
It is important that clinical trials of single designs of 
products (which aim to enable selection of particular 
product brands) are comprehensive (i.e. cover all the 
available products) because otherwise manufacturers 
Table III-1: Levels of questions
•  Which product category (eg catheter, sheath, ab-
sorbent pad)?
•  Which design of product design (eg pull-up or 
diaper design of pad)?
• Which material type (eg reusable or disposable)?
• Which features (eg with / without elastic gathers)?
• Which product brand? 
In the field of absorbent products the practitioner 
and / or patient wishes to know whether to use an 
underpad or a bodyworn product, a reusable or 
a disposable, a diaper or an insert (if they select 
a bodyworn), a diaper with internal elastication 
(standing gathers) or without and, finally, which of 
the many diaper brands is likely to be most effec-
tive. Attempting to answer this final question is the 
most pertinent question for the practitioner (who 
may already have made decisions about questions 
1-4, Table III-1) but is particularly problematic be-
cause of the high rate of product change. By the 
time the results of a clinical trial of product brands 
are known many of the test products will have been 
modified and the results will have limited value for 
product selection. However, these ‘single design’ 
studies do have value in demonstrating the range 
of performance within the group of product brands, 
and where objective measurements can be made 
(for example, of leakage performance) can allow for 
comparisons between groups of products. Single 
design studies are also helpful in promoting prod-
uct improvement by revealing common problems 
experienced by patients and exposing particularly 
poor products or poor product features which are 
amenable to change by manufacturers.
Basic product designs, features and materials 
change much less frequently and attempting to an-
swer questions 1-4 (Table III-1) is therefore likely to 
lead to more long-lasting results. Such studies have 
been attempted by many researchers, but these 
have frequently been confounded by problems with 
product representation.
b) Product representation
The single greatest (and most frequently over-
looked) threat to the validity of clinical trials of prod-
ucts is the selection of the products entered into the 
study. Evaluations of a number of product variants 
of a similar design (eg different brands) have shown 
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can justifiably claim that although their product may 
be similar to one of those tested even subtle distinc-
tions may lead to clinically important differences. 
A further problem with research design is the blind-
ing of products. Different products have different 
appearances and it is impossible to blind subjects 
or staff to the product in use. Products can be re-
packaged to assist anonymising but this may have 
unwanted effects on the products and is expensive. 
Previous product experience can also affect study 
results, particularly if a substantial proportion of 
subjects are currently using a product included in 
the study. It is therefore important to record which 
products are in current use in order to add this data 
to the model used in the analysis.
a) Sample size and study power
Studies that include more than two products (or two 
small groups of products) will need to be powered 
so that multiple comparisons can be made. As the 
number of products included in the study increases 
the number of possible comparisons of pairs of prod-
ucts rises. This requires a corresponding reduction 
in the significance level (e.g. by using the Bonferroni 
method) for each pair-wise comparison to retain the 
overall level of significance (usually p<0.05). Thus as 
the total number of pair-wise comparisons increases 
the likelihood of a type 2 error (accepting the null hy-
pothesis when it is false) also increases. 
Sample sizes therefore need to be calculated to al-
low for each pair-wise comparison. Sample size re-
quirements rise rapidly if each subject does not test 
each product and the number of products entered 
into a study must therefore be limited by subject fa-
tigue. As an example, a clinical trial of four product 
groups where the primary outcome variable will be 
binarised (e.g. satisfactory / unsatisfactory) will re-
quire a sample size of approximately 80 subjects 
with an alpha of < 0.05 and d (difference) of 20%.
b) Outcome variables
Studies of product performance have most fre-
quently used self-report questionnaires at the end of 
the product test period to assess participant ratings 
of product performance. Diaries of product-related 
events such as leakage, laundry generation and 
product consumption are also commonly included. 
Subjects in some absorbent pad studies have been 
asked to identify and prioritise items of product per-
formance [18] [19] [20] to inform questionnaires and 
Table III-2 shows the most common items of high 
priority to women with light urinary incontinence 
identified by Getliffe and colleagues [19].
Outcome variables in studies designed to compare 
catheterisation strategies and / or catheter materi-
als or other design features commonly encompass 
measures of urinary tract infection, tissue trauma 
and recurrent catheter encrustation leading to 
blockage (see Section XII-2).
Questionnaire items vary depending on the prod-
ucts being tested and for product groups where 
few studies have been carried out it is particularly 
important to tailor questionnaires to patient needs 
by asking study subjects to prioritise items and to 
assess final questionnaires for content and face va-
lidity. One study [21] has measured the test re-test 
reliability of a questionnaire to assess sheath per-
formance and found moderately good Kappa scores 
(around 0.7) when assessing the same sheath twice 
with four weeks between assessment periods.
Skin health, urinary tract infection, pain or discom-
fort are the main physical health consequences of 
containment products and skin health (which can be 
rated by self-report or by skin inspection) has some-
times been used as the primary outcome variable 
(e.g. [22]). Urinary tract infection is an important 
outcome for invasive devices such as catheters. 
Although leakage performance is most frequently 
Daytime:                                    % women  
                                                      (N =99) 
Nightime:                                      % of      
  women 
                                          (N=81) 
    
Hold urine without leaking 83.8  Hold urine without 
leaking 
93.8  
Contain smell 75.8  Stay in place 77.8  
Stay in place 54.5  Contain smell 54.3  
Discreetness 41.1  Comfortable when wet 54.3  
Comfort when wet 40.4  To keep skin dry 48.1  
 
Table III-2. Most common items of high priority to women with light incontinence using absorbent prod-
ucts. Getliffe et al. [19]
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rated as the top priority for users, good leakage per-
formance is not adequate as a sole measure of pa-
tient satisfaction with performance. A single (or mul-
tiple) fatal flaw such as poor comfort, bulkiness, or 
poor fit may cause a product that performs well for 
leakage to be unacceptable to the patient. For this 
reason aggregate measures - which assumes that 
the overall performance of a product can be calcu-
lated using a weighted sum of the scores for specific 
aspects of performance (like comfort and freedom 
from leakage) - are ill-advised. Patient overall opin-
ion or satisfaction with the product should therefore 
be used as the primary outcome variable [21].
There are no quality of life measurement tools spe-
cifically designed for clinical trials of products, but 
there is a need for such tools to measure the im-
pact that good or bad product performance has on 
people’s lives. Existing incontinence-specific quality 
of life tools are designed to measure change after 
interventions to improve incontinence and include 
urinary symptoms. These tools are therefore likely 
to be insensitive to changes in quality of life brought 
about by products which are designed to contain 
incontinence rather than reduce or prevent it. The 
first stage in the development of a quality of life tool 
for absorbent product users has been reported by 
Getliffe et al. [19] and a similar tool for catheter us-
ers is known to be under development.
3. SUMMARY AND RECOMMENDATIONS
There is little published evidence on which to base 
summary and recommendations regarding method-
ology and so the following summary points / recom-
mendations are all Level of Evidence 3 / Grade of 
Recommendation C.
•  Evaluation of continence products is methodologi-
cally complex and many attempts at providing 
robust evidence for product selection have been 
hampered by methodological weaknesses. 
•  Product representation is critical to providing ro-
bust and generalisable data. Selection of products 
for inclusion in a study needs to be transparent 
and systematic and several products should pref-
erably be included to represent a product group. 
In particular, care should be taken not to select a 
particularly good or a particularly poor product to 
represent a whole class of products.
•  Multiple crossover designs are likely to be more 
efficient than randomised controlled trials for many 
products (eg pads) and therefore sample sizes es-
timation needs to take into account the multiple 
comparisons that will be made. 
•  Outcome variables should include patient (or car-
er) questionnaire including items that have been 
established as important to patient users. 
•  Diary data should be included to determine 
leakage performance, skin health, laundry and 
product consumption. 
•  Incidence of urinary tract infection should be in-
cluded when testing invasive devices such as 
catheters, but “significant” UTI/ bacteriuria needs 
to be carefully defined (see Section 12.2.8).
•  The primary outcome variables should be patient 
overall opinion / satisfaction and patient preference.
•  Health economics should be measured alongside 
product performance 
4. RESEARCH PRIORITIES
•  The development of Quality of Life tools for users 
of continence products. 
 
Handheld urinals are portable devices designed to 
allow a person to empty their bladder when access 
to a toilet is not possible or convenient, often due 
to limited mobility, hip abduction or flexibility. They 
can be especially helpful for those suffering from 
frequency and / or urgency.
An effective hand held urinal must enable its user to 
empty his / her bladder in comfort and be confident 
of no spillage. It should not require excessive physi-
cal effort on their part and should be easy to empty 
without spillage.
General guidelines on patient assessment for prod-
uct selection are discussed in Section 2. Aspects 
of patient assessment particularly important for 
handheld urinals are user postures (in bed, on side 
of bed, back in chair, on edge of chair, standing/
crouching/kneeling), leg abduction, approach of 
urinal (from front, side, behind, above), ability to 
initiate void, dexterity and strength to position and 
remove urinal, level and availability of assistance, 
user preference.
There has only been one clinical trial [23] of female 
urinals and there are no published trials of male uri-
nals. However, much helpful guidance and expert 
opinion has been published [24] [25] [26] [27].
1. FEMALE HANDHELD URINALS
Female handheld urinals come in a variety of 
shapes and sizes (Figure IV-1). Most are moulded 
in plastic but they may be made from metal or (for 
single use items) cardboard. Some are designed for 
use in particular postures, like standing, sitting or 
lying down – (see below). Some have handles to 
facilitate grip and positioning. Some are intended to 
empty into a drainage bag during or after use. 
Although female handheld urinals are often de-
scribed and discussed in general nursing articles on 
continence products they have only been the sub-
ject of one published (cross-over) evaluation. Fader 
IV. HANDHELD URINALS
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et al. [23] carried out a multi-centre study in which 
each of 37 community-based women (age range 
33-89y; mean age 61y) was invited to evaluate all 
13 products on the UK market in 1997. No prod-
uct suited everybody but each was successful for 
at least some subjects. The key requirements for 
success were that the user should be able to posi-
tion the urinal easily and feel confident that it would 
catch urine without spilling (Level of Evidence 2). 
Many products were successful when used in the 
standing / crouching position or when sitting on the 
edge of a chair / bed / wheelchair. Fewer worked 
well for users sitting in a chair / wheelchair. Only 
one worked even reasonably well when users were 
lying / semi-lying (Subaseal), In general, subjects 
with higher levels of dependency found fewer uri-
nals to be suitable for their needs.
Recently the development of a powered urinal de-
signed to pump urine into a reservoir has been de-
scribed [28]. The aim of the device was to provide 
active removal of urine without leakage and without 
the need for gravity-assisted drainage. The urinal 
was tested by 80 women from six countries. Al-
though evaluated as ‘good’ or ‘okay’ by more than 
three-quarters of the women, nearly half the women 
found the device ‘poor’ for weight and size. Prob-
lems with reliability of the device were also common 
and the authors concluded that the current device 
needed further refinement but may have potential 
as an alternative to conventional urinals. Although 
this device is not currently on the market, at least 
one other powered device is available. However, 
there are no published reports on efficacy. 
2. MALE HANDHELD URINALS
Most handheld urinals for men are somewhat similar, 
involving a narrowed neck opening into which the pe-
nis is placed. Some products come with a detachable 
or integral non-spill adaptor containing a flutter valve 
to impede back-flow of urine from the urinal. There 
are no published trials of such products. 
A review paper by Vickerman [27] makes recom-
mendations for selecting suitable urinals for men. 
A flat bottom urinal may be more stable (and less 
likely to spill) for those using a urinal in bed. Urinals 
made from soft plastic (jug-style or with a funnel) 
may be easier to grip for those with poor manual 
dexterity. Urinals designed to be attached to a drain-
age bag (for emptying the urinal) may also be help-
ful to men living at home with limited support. 
Vickerman also suggests that home-made devices 
(such as empty wide-mouthed containers with a 
handle and lid (for example, those used for clothes-
washing liquid or conditioner) may be a practical 
(and cheap) option for some men. For those with a 
retracted penis female urinals may be easier to use 
than male products. 
3.  GENERAL POINTS FROM THE LITERA-
TURE, INCLUDING EXPERT OPINION
The literature [24] [25] [26] [27] suggests that suc-
cessful use of urinals depends on many factors 
which are summarised below. 
•  Experimentation is often needed to find the opti-
mum urinal for an individual. A ‘library’ of urinals 
(i.e. a collection of different types of urinals to be 
lent out to users for experimentation) has there-
fore been recommended [26] but rigorous cleaning 
methods are needed (see below).
•  Clothing alterations can aid quick and easy use of 
a urinal. For men, extending the fly opening of trou-
sers or replacing zips with Velcro can be helpful, as 
can boxer shorts. For women drop-front pants may 
be needed, particularly if mobility is limited. 
•  Disposable and reusable ‘travel’ hand-held urinals are 
available for both men and women. These urinals fold 
away to fit into a pocket and may therefore be more 
discreetly portable than conventional urinals.
•  Some disposable urinals include superabsorbent poly-
mer in their reservoirs which turns urine into a gel and 
help to prevent spillage. Sachets of superabsorbent 
polymer may also be added to reusable urinals. 
•  Use of a urinal is not always free from leakage and 
provision of absorbent chair or bedpads to protect 
bedding, clothes and furniture (particularly when 
testing out urinals) may be necessary.
•  The limited range of urinal options in acute set-
tings, where often only bedpans are available, 
has been criticised and the process of introducing 
hand-held urinals to hospital services has been 
described and recommended [29].
•  When used by one individual in the home, urinals 
can be cleaned with soap and water between 
uses. But where urinals are shared (i.e. cleaned 
and used by others), or if a library of urinals is 
used then robust methods are necessary. Some 
urinals can be cleaned in a bedpan washer but 
cleaning methods vary with different designs and 
Figure IV-1: A variety of female handheld urinals.
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materials and compliance with local infection con-
trol procedures will be needed.
4. RECOMMENDATIONS
•  There is a wide range of female urinals and experi-
mentation is likely to be necessary to identify the best 
one for an individual (dependent on their individual 
needs and abilities) (Grade of Recommendation C).
•  A library of female urinals (used with robust clean-
ing methods) will help to facilitate experimentation 
(Grade of Recommendation C). 
•  Male urinals are less varied than female urinals, 
but may be supplemented by use of less conven-
tional receptacles (e.g. jugs, home-made devices); 
experimentation will help to identify best options 
(Grade of Recommendation C).
•  Section IV.3 addresses other more general recom-
mendations regarding urinal use.
5. PRIORITIES FOR RESEARCH
•  Further development of female urinals is encour-
aged, particularly for supine users and those un-
able to move to the edge of a chair.
•  The range of male and travel urinals need to be 
evaluated to provide guidance for users and carers.
 
Toilets can be difficult to use by people with mobility 
problems and other disabilities. Toilet adaptations 
such as raised toilet seats, padded seats, and grab 
rails can be very helpful in enabling individuals to 
access the toilet easily and comfortably. Bottom 
wipers and bidets can also be useful. However, if 
access to the toilet is impossible, commodes and 
other toileting receptacles should be considered.
Commodes are devices that comprise a frame sup-
porting a toilet seat with a pan (disposable or wash-
able) beneath to receive urine and faeces. They are 
used independently of a toilet and may be static or 
mobile. Mostly, they are used by people with re-
duced mobility who find it difficult to access a con-
ventional toilet. Bedpans are portable receptacles 
that may be used for passing urine or faeces while 
in bed or chair. Some female urinals (see section 4) 
may also be used to collect faeces.
General guidelines on patient assessment for prod-
uct selection are discussed in Section II. Aspects of 
assessment that are particularly important regard-
ing commodes and bedpans begin with appropriate 
indications for their use since Matsumoto and In-
oue [30] reported that incontinent elderly persons or 
their caregivers misunderstand indications of com-
mode use for incontinence. Other patient assess-
ment elements include: a) physical characteristics 
of the person with incontinence (e.g. can an obese 
person fit on a commode and use its handrails?); 
b) mental acuity (e.g. will a person with dementia 
recognize a commode or bedpan as a device to be 
used for defecation?); c) need for supervision or 
foot supports whilst on the commode (what is the 
risk of falling?); d) mobility (e.g. does the person 
need a commode or bedpan?), ability to transfer 
and method of transfer to the commode (e.g. hoist, 
carer help, independent with transfer board), need 
for static or mobile commode (particularly when 
considering using commode over a toilet), postural 
stability and need for supportive commode, e) level 
of assistance needed and physical burden to care-
giver involved; and f) personal preferences (e.g. 
comfort of bedpan type) including need for ‘non-
commode-like’ appearance (e.g., particularly when 
used in own room, particularly the living room). 
Patient assessment findings need to be evaluated 
in terms of the safety and stability properties of a 
commode. The proximity of the area for waste dis-
posal, storage facilities (i.e., the location / visibility 
of the commode in the household), the availability of 
privacy during defaecation, and length of time likely 
to remain on the commode (is there a need for a 
pressure-relieving commode cushion?), are addi-
tional factors to be considered.
Commodes (or better still toilets) are preferable to bed-
pans (which are relatively difficult to use and do not 
permit appropriate posture for passing urine/faeces). 
Bedpans are generally reserved for people who are 
confined to bed (e.g. post-operatively) and for whom 
safety (risk of falling) is an important assessment issue.
1. RESULTS
Fader [31] has reviewed the little work that has been 
done to evaluate existing commodes and bedpans 
and to identify the needs of users. An investigation 
of commode design by Nazarko [32] highlighted the 
problem of commodes providing poor trunk support 
for elderly and disabled people. Prolonged periods 
of sitting alone (for privacy) to enable defecation 
resulted in a risk of falls. Nazarko worked with a 
manufacturer to produce a design specification for 
a commode. Consultation with patients indicated 
that many would prefer to use a toilet. As a conse-
quence, attention was focused in designing a show-
er chair which could also be used as a commode or 
could be wheeled over a toilet. 
An evaluation of the four main types of commodes 
(standard; with adjustable height; with removable / 
drop-down arm; with adjustable height and remov-
able / drop-down arm combination) was published 
by the UK Medical Devices Agency [33] [34]. One 
third of the 150 commodes on the UK market at 
the time were found to have backwards instability, 
and most of them scored poorly for aesthetics and 
comfort. A discussion of the results of this evalua-
tion and its application to nursing was subsequently 
published by Ballinger et al. [35]. 
V. COMMODES AND BEDPANS
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The maintenance of hospital commodes can be a 
problem and Gillan [36] complained about the poor 
condition of commodes in wards for elderly people. 
Commode cleaning has also been found to be poor 
[47] and a recent audit by Bucior and Cochrane [37]
showed visible traces of faecal contamination on 
cleaned commodes. The authors concluded that it 
was necessary for ward staff to have clearly defined 
roles and responsibilities for commode cleaning. 
New commodes have been designed to overcome 
such problems by being easier to clean (e.g. de-
sign-bugs-out commode www.designcouncil.org.
uk/our-work/challenges/Health/Design-Bugs-Out/
Case-studies/Commode).
Naylor & Mulley [38] investigated the use of com-
modes in community-dwelling patients and the atti-
tude of carers and users towards them (115 subjects 
and 105 carers). The main reasons for commode use 
were impaired mobility, difficulty climbing stairs and 
urinary incontinence. Main concerns were lack of pri-
vacy and embarrassment about using the commode, 
unpleasant smells and the poor physical appearance 
of the commode. Carers tended to view them nega-
tively, particularly with regard to cleaning. Where 
commodes were used for defecation in a living area 
the authors highlighted the problem of odour that lin-
gered even after a commode had been emptied, and 
recommended the use of a chemical toilet.
Thorough cleaning of commodes or bedpans after 
every use is necessary for hygienic purposes and 
to eliminate odours. Naylor & Mulley [38] report that 
typically a caregiver rather than the commode user 
empties and cleans a commode. No recommen-
dations for cleaning a home commode or bedpan 
were found in the published literature. In institution-
al settings, large sinks with spray hoses or special 
sanitizing equipment are available. The size and 
shape of a bedpan or commode receptacle may 
be difficult to fit under a standard sink basin in the 
home. Whether certain commode cleaning products 
reduce any residual odour more than others is not 
known. Toilet bowl cleaning products are suitable 
for cleaning a commode or bedpan; many contain 
bleach or antibacterial ingredients but their effect 
on reducing odour of commodes or bedpans has 
not been studied. Gel formulations are advertised 
by manufacturers as being better able to cling to 
hard-to-reach surfaces than liquid agents. Use of a 
deodorizer can be considered (Level of evidence 4).
Nelson and colleagues [39] surveyed 147 spinal 
cord injured patients regarding their satisfaction 
and safety with the shower chairs (used for bowel 
care) used in the home. They found that around a 
half of patients were dissatisfied with their chairs 
and concerns expressed related to lack of hand 
access to the perianal area, difficulty in turning 
and rolling the chair and problems with keeping 
the chair clean. One third of patients experienced 
chair related falls and nearly a quarter reported 
pressure ulcers. Two-thirds of subjects felt that 
their safety was compromised.
The same group of researchers evaluated three 
shower chairs using video-taping, photography and 
questionnaires and produced performance criteria 
for the design of an optimal shower chair [40]. Pres-
sure mapping devices were used to measure seat 
pressures on three subjects who tested all three 
bowel / shower chairs to inform seat design [41]. 
These researchers [42] then set about designing 
a more advanced commode-shower chair. It had 
lockable, swing-away armrests and lever activated 
brakes to facilitate transfers. To prevent pressure 
ulcers a chair frame and padding combination was 
designed to facilitate a seating position that distrib-
uted body weight and reduced pressure on pressure 
points. Cupped edgeless footrests were designed to 
reduce the risk of heel ulcers. An adapted version of 
this chair is now commercially available in the USA.
Matsumoto and Inoue [30] examined whether use 
of a commode in the home might prevent or delay 
nursing home admission of elderly people who were 
incontinent. A five-year follow-up of multiple predic-
tors of institutionalization in elderly people in a rural 
town in Japan showed that 40% of incontinent men 
and only 17% of incontinent women used a com-
mode. Use of a commode was not associated with 
institutionalization. The authors suggested several 
possible reasons: misunderstanding of appropriate 
indications for a commode based on the type of in-
continence; physical burden in assisting a care re-
cipient to use a commode that seemed no different 
than for cleansing after an incontinence episode; 
and inadequate muscle strength of the elderly for 
using either a Japanese-style or Western commode. 
Bedpans and other portable receptacles are not 
well described in the literature. Wells and Brink [43] 
describe three general shapes of bedpans: con-
cave, cutaway, and shovel. The concave pan has 
a rounded triangle shape that slopes back to front 
and a curved seat. The cutaway has a rounded tri-
angle shape with a flatter seat and rolled edges that 
allow for handgripping. The shovel shape, common-
ly called a “fracture pan” is a wedge or rectangle 
shape that has a flattened end that goes under the 
individual and a handle at the distal end. Generally 
bedpans are considered to be unsuitable for defeca-
tion for safety and acceptability reasons. However, 
for individuals with specific needs (e.g. frequency 
and urgency of defecation) a portable receptacle 
may be beneficial. Although many portable urinals 
are now available for both men and women, very 
few are recommended for defecation [44] and they 
have yet to be formally evaluated. 
Privacy and dignity need to be given high priority 
when patients need to use a bedpan or commode, 
in particular in institutional settings. Care needs to 
be taken when transporting patients on a shower 
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chair to maintain dignity and avoid revealing the pa-
tient’s bottom.
Bottom wiping and cleaning can be difficult for peo-
ple with disabilities, particularly manual dexterity 
problems, or caregivers. Simple moist wipes may 
be helpful and are widely available. Devices de-
signed to assist with bottom wiping problems are on 
the market and portable bidets are also available, 
however there are no published trials of these prod-
ucts. Bedpans have other disadvantages including 
difficulty removing the bedpan from under an indi-
vidual without spilling (particularly if the individual is 
obese), risk of spilling and odour when transporting 
the contents for disposal since none have lids, and 
lack of privacy during use.
2. SUMMARY
•  There are major defects in most of the current de-
signs of commodes, especially: poor aesthetics; 
poor trunk support; instability (i.e. a tendency to tip 
over easily); poor comfort; difficult to clean; poor 
pressure relief (Level of Evidence 3). 
•  If direct transfer to a toilet is impossible or unsafe 
a sani-chair / shower chair is usually preferable to 
a commode (Level of Evidence 3).
•  The main concerns of users about commodes and 
bedpans are: lack of privacy; embarrassment over 
use; odour; poor aesthetics; poor perineal cleans-
ing accessibility; and inadequate facilities for clean-
ing the devices in the home (Level of Evidence 2).
•  Defecation on a bedpan or other portable recep-
tacle presents problems of safety and unaccept-
ability to users (Level of Evidence 2).
3. RECOMMENDATIONS
•  If at all possible, access to a toilet should be made avail-
able for defecation (Grade of Recommendation C).
•  If direct transfer to a toilet is impossible or unsafe, 
a sani-chair / shower chair should be offered in 
preference to a commode wherever possible 
(Grade of Recommendation C).
•  If a commode is used, care should be taken to 
ensure good trunk support; that the chair is stable; 
and that methods of reducing noise and odour are 
offered (Grade of Recommendation C).
•  With commodes and sani-chairs / shower chairs, 
the user’s bottom should never be visible to others 
and transportation to the toilet and use of the toilet or 
commode should be carried out with due regard to 
privacy and dignity (Grade of Recommendation C).
•  Bedpans and other portable receptacles should 
be avoided for defecation purposes (Grade of 
Recommendation C).
•  Patients vulnerable to pressure ulcers should not sit 
on a commode / sani-chair / shower chair for pro-
longed periods (Grade of Recommendation C).
•  The person should be given a direct method of 
calling for assistance when left on the toilet / 
commode / sani-chair / shower chair (Grade of 
Recommendation C).
•  Cleaning of bedpans and commodes should be 
carried out after each use following local infection 
control policies (in institutional settings) (Grade of 
Recommendation C)
•  There are no evidence-based published guide-
lines regarding frequency of cleaning or type of 
cleaning product. However, thorough cleaning 
after bowel evacuation (to avoid odour and main-
tain aesthetics) is important, together with rins-
ing after urine has been passed. Cleaning needs 
may vary according to personal hygiene stan-
dards and offensiveness of urine/faecal smells 
(Grade of Recommendation C).
4. PRIORITIES FOR RESEARCH
• Studies are needed to determine how to make toi-
lets accessible to as many users as possible. These 
may lead to improved designs for toilets and associ-
ated equipment and / or strategies for toileting.
• Studies are needed to determine which commode 
/ sani-chair / shower chair designs best meet perfor-
mance and safety requirements.
• Development of better commodes designed to 
overcome the limitations identified 
 
1. INTRODUCTION
Absorbent products (commonly known as pads) are 
available in a wide range of sizes and absorbencies 
encompassing light through to very heavy inconti-
nence. Most pads are bodyworn but some are used 
on the bed or chair (underpads, see Section 6.2); 
in this section the term ‘pad’ refers to bodyworn 
absorbent products. Broadly speaking, absorbent 
products can be divided into two main sub-groups: 
those suitable for light incontinence (usually smaller 
products) and those suitable for moderate-heavy in-
continence (usually larger products). Manufacturers 
generally indicate the severity of incontinence that 
each product is designed to accommodate, but see 
the discussion in Section VI.4. Although absorbent 
pads are most commonly used for urinary incon-
tinence they are also used by individuals for both 
faecal and urinary / faecal incontinence; however, 
there have been no published studies which specifi-
cally address this issue.
Incidental findings from evaluations of products in-
dicate that absorption capacity alone does not 
VI. ABSORBENT PRODUCTS
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determine whether a user will choose to use a 
product. Some users may have frequent, low flow-
rate loss of small volumes of urine (“dribble”), whilst 
others may be dry for days but then have a high-
er volume, higher flow-rate incontinence incident 
(“gush” or “flooding”. Both may prefer to use pads 
for light incontinence. Mobile and independent com-
munity-dwelling women of all levels of incontinence 
are reported to generally prefer small pads and are 
often willing to change them frequently rather than 
use larger products and change them less often 
[45]. Conversely, dependent, immobile individuals 
may prefer the security of larger products despite 
relatively low urine volumes due to their depen-
dence on others for pad changing. 
More recently studies have focused on the use of 
pads by men. Teunnissen and Lagro-Jansson [46]
interviewed 56 men with UI of which only nine used 
absorbent pads. They concluded that men use pads 
less frequently than women, have little knowledge 
about purpose-built pads, are more likely to con-
struct their own pads out of absorbent materials 
such as towels and are less satisfied with pads than 
women. Furthermore there are indications that men 
may prefer other devices such as urinary sheaths 
[47] (see Section VII Sheaths).
Studies that have collected and weighed used pads 
to measure urine volume have found overlap be-
tween the quantities contained by pads from differ-
ent sub-groups of users; thus in a study of insert 
pads for moderate-heavy incontinence used by old-
er people in residential care around 15% of insert 
pads for moderate-heavy incontinence contained 
less than 100g of urine [48] and in a study of older 
women with light incontinence living in the commu-
nity about 10% of insert pads for light incontinence 
were found to contain more than 100g of urine [49]. 
It might be speculated that the number of pads used 
per day might be a good measure of degree of uri-
nary incontinence, but this has not been found to be 
the case in nursing home residents in Norway [50]. 
Pads were collected and weighed from residents in 
six homes, but a poor correlation was found between 
the number of pads used and the mass of leaked 
urine measured over 48 hours. The authors conclud-
ed that this was due to pad changes being carried 
out at routine times by healthcare assistants.
It is possible that a proportion of patients are simply 
provided with inappropriate products that exceed 
or fall short of the absorption capacity they require. 
One study investigated this issue [51] and found 
that patients were more satisfied with their prod-
ucts once their urine loss had been determined by 
pad weighing and appropriately absorbent products 
were provided. But many of these patients were 
using inadequate products to start with (such as 
pads comprising tissue paper) and firm conclusions 
could not be drawn. In practice, it is probably hard 
to justify the need for pad weighing to determine 
which absorbents should be provided and if there 
is doubt about which group a patient falls into then 
the patient should be offered small pads for light in-
continence in the first instance and the size of pad 
titrated upwards as necessary.
General guidelines on patient assessment for prod-
uct selection are discussed in Section II. Aspects of 
assessment that are particularly important regarding 
absorbent pads are frequency / severity of leakage, 
day / night incontinence, gender (some products are 
designed for, or are better for, men / women than 
others), ability to change pad independently / need 
for carer, pad changing position (standing / lying), 
laundry / drying facilities, individual priorities (e.g. 
need for discreetness), personal preference for de-
sign / materials (washable / disposable), lifestyle (at 
home / travel / work etc). 
Aspects of absorbent pad performance have been 
identified and prioritised (during interviews) by men 
and women taking part in a series of clinical trials 
of such products [19]. There was considerable con-
sistency across patient groups (light / heavy, men / 
women) with the ability of a product to hold urine with-
out leakage being the top priority, and the following 
aspects also being considered to be of high priority: 
discreetness, containment of smell, ability to stay in 
place, comfort when wet and ability to keep skin dry.
2. ABSORBENT PRODUCT CATEGORIES
Absorbent products may be classified into two 
broad categories - disposable (single-use) and 
washable (reusable) - with each category dividing 
into two sub-categories: bodyworn products (worn 
on the person) or underpads (placed under the per-
son). Within each sub-category are different design 
groups such as diapers and pull-ups which are sub-
divided by size (to fit users of different sizes) and 
/ or absorbency (to cater for different severities of 
incontinence). Some designs are further subdivided 
into those intended for men, women or children. 
This classification is shown in Table VI-1.
•  Bodyworn absorbent products can be divided into 
four main design groups:
•  Inserts (sometimes called liners or, in the case 
of small pads, shields) are held in place by 
close-fitting underwear or stretch mesh briefs 
(Figure VI-1). Some patients experience prob-
lems with keeping pads in place using the com-
monly supplied net pants. As a result, many use 
more robust stretch pants purchased privately 
(e.g. cotton / Lycra, etc). Many disposable in-
serts (Figure VI-2 and Fig VI-3) have an adhe-
sive strip on the back to help secure them and 
may have an indicator that changes colour when 
the pad is wet to signal the need for a change. 
They may have longitudinal, elasticated stand-
ing gathers of hydrophobic material intended to 
impede lateral leakage of urine and faeces. They 
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are sometimes rectangular but are more usually 
shaped to fit the body more snugly. Elastica-
tion at the legs may also be used to enhance fit. 
Washable inserts (Figure VI-4) are usually more 
simply designed than disposable inserts, with no 
elastication and are either shaped or a simple 
rectangle. Inserts are made in a wide range of 
sizes suitable for light through to very heavy uri-
nary incontinence. For light faecal incontinence, 
the liner may be a small cotton gauze dressing 
placed against the anus and held in place by the 
cheeks of the buttocks (Figure VI-5).
•  Diapers (sometimes called all-in-ones or briefs) 
are adult-size versions of babies’ diapers. Dis-
posable diapers (Figures VI-6) usually have 
elasticated waist and legs and self-adhesive tabs 
(usually resealable), and often a wetness indica-
tor and standing gathers. More recently modified 
diapers have been introduced that fasten round 
the waist before the front is pulled into position 
and secured, to enable users to apply the diaper 
whilst standing (Figure VI-7). Washable diapers 
are usually elasticated at the waist and legs and 
are fixed with Velcro or press-studs (Figure VI-
8). Diapers are intended for moderate to very-
heavy incontinence.
•  Pull-ups are similar in construction to trainer 
pants for toddlers. The absorbent material is built 
into a pull-up pant and is either limited to the 
crotch area or distributed throughout the pants 
(Figures VI-9 to VI-11). Disposable pull-ups 
(Figure VI-9) are usually elasticated throughout 
the pants to give a close fit. Both disposable and 
washable pull-ups have versions for different lev-
els of incontinence. Washable pull-ups for light 
incontinence are often known as pants with inte-
gral pad (Figure VI-11). 
Some people use less conventional or home-
made systems either instead of or as well as 
the designs described above. In particular ter-
ry-towelling squares may be used by those with 
heavy incontinence. These may be formed into 
briefs by folding into different configurations 
and fastening with pins and covered with plastic 
pants as a waterproof barrier. It is known that 
such pants may also be worn over more con-
ventional designs in an attempt to reduce leak-
age and / or odour. 
“Body” garments (like vests which have a crotch 
section which opens and closes with snap fasten-
ers, much like those manufactured for babies) may 
be helpful to hold pads in place well and may reduce 
the rustling noise from plastic backing materials.
•  Male pouches (sometimes called shields, 
guards or leaves) are for lightly incontinent men 
and are designed to fit around the penis and 
sometimes the scrotum too (Figures VI-12 and 
VI-13). All are worn with close-fitting underwear 
or stretch mesh briefs. An adhesive strip is often 
provided on the disposable versions to help hold 
them in place.
•  Underpad absorbent products are usually 
simple rectangles of different sizes to be used 
on the bed or chair (Figure VI-14). Washable 
underpads (Figure VI-15) may have a high 
friction backing or have ‘wings’ for tucking be-
neath the mattress of single beds to help keep 
them in place. Underpads vary widely in ab-
sorbency with less absorbent products being 
used as ‘back-up’ with bodyworn absorbents 
and more absorbent products being used as 
sole protection on the bed at night. 
Categories: Disposable (single use) Washable (reusable) 
Sub-
categories:     
Design 
groups* 
Inserts 
Diapers 
Pull-ups 
Pouches 
Bedpads
Chairpads  
Inserts 
Diapers 
Pull-ups 
Pouches  
Bedpads  
Chairpads  
Sub-groups Groups sub-divide according to the severity of incontinence (light or moderate / heavy) and the gender of the intended users (M, F or unisex). 
* The products within a given design group may vary considerably in their features and their 
constituent materials. 
Bodyworns Underpads Bodyworns Underpads
Table VI-1. Classification of absorbent continence products
Table VI-1. Mesh pants with (right) and without (left) 
legs, for securing incontinence pads in position
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Table VI-2. Disposable inserts for light incontinence
Figure VI-3: Disposable inserts with (right) and without 
(left) standing gathers, for moderate / heavy incontinence.
Figure VI-4: Reusable inserts for light (left) and 
moderate / heavy (right) incontinence.
Figure VI-5: Liner for light faecal incontinence. It is 
positioned against the anus and held in place by 
the cheeks of the buttocks
Figure VI-6: Disposable diapers with (right) and 
without (left) standing gathers, for moderate / heavy 
incontinence. Diapers are shown open (top) and 
with the tabs secured (bottom).
Figure VI-7: A modified (T-shaped) diaper. The waist 
band (left) is secured first and then the front pulled 
up and secured in position (right).
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Figure VI-8: A reusable diaper
Figure VI-11: Reusable pull-up pant (also known as 
pants with integral pad) for lightly incontinent men 
(right) and women (left)
Figure VI-8: A disposable pull-up
Figure VI-10: A reusable pull-up for heavy inconti- nence.
Figure VI-12: A disposable pouch for men
Figure VI-13: Reusable pouches for men: side view 
(left) and front view (right).
Figure VI-14: A disposable underpad.
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3. ABSORBENT PRODUCT MATERIALS
Absorbent products – disposable or washable – 
usually comprise three main layers: an absorbent 
core sandwiched between a water-proof backing 
beneath and a water-permeable coverstock (or 
topsheet) next to the wearer’s skin. 
The main component in disposable absorbent 
cores is invariably some kind of fluffed wood 
pulp fibres, but most also contain some pow-
dered superabsorber (sometimes referred to 
as SAP (superabsorbent polymer) or AGM (ab-
sorbent gelling material)), which is often con-
centrated in the crotch region. Superabsorbers 
hold much more urine – weight for weight – than 
fluff pulp and retain it far more tenaciously un-
der pressure. They are usually based on cross-
linked salts of polyacrylic acid whose chemistry 
can be varied according to the balance of prop-
erties such as absorption capacity and absorp-
tion speed desired. Some thermoplastic fibres 
are also sometimes included in absorbent cores 
to reduce core break up and the collapse of the 
structure when wet. It is increasingly common for 
absorbent cores to comprise two or more layers, 
each designed to perform a different function. 
For example, an upper layer might comprise low 
absorbency fibres engineered to receive and 
distribute urine efficiently and maintain a dry 
layer next to the skin, while lower layers provide 
absorption capacity. Some disposable products 
have ‘breathable’ plastic backings designed to 
reduce skin occlusion. 
Washable absorbent cores are usually made 
from a needlefelt or knitted fabric compris-
ing rayon and / or polyester fibres. A variety of 
polymers are used for the water-proofing. In 
general, the thicker, stiffer materials are more 
durable (the durability of the plastic backing of-
ten determines the lifetime of the product) but 
less comfortable. Topsheets are usually made 
from either cotton – which is hydrophilic and in-
tended to have good dry comfort – or polyester 
– which is hydrophobic and intended to have 
good wet comfort.
Concern for the environment and also for control-
ling costs has led to an increase in the number 
of washable products available on the market. 
An important consideration in the comparison of 
washable and disposable designs is the relative 
environmental cost, particularly disposal (landfill) 
costs of disposable designs and energy costs as-
sociated with laundering the washables. A recent 
report on baby diapers concluded that there was 
no significant difference in environmental impact 
between three diaper systems (disposables, 
home and commercial laundered washables) al-
though the types of impacts did vary [52].
4. ABSORBENT PRODUCT CAPACITY AND 
USER REQUIREMENTS
Pads come in a range of absorbencies to cater 
for users with different levels of urinary inconti-
nence and, understandably, purchasers wish to 
know how much urine available pads will hold. 
But there is no simple answer: a pad does not 
have a volume of urine below which it is guar-
anteed not to leak; rather, the probability of suc-
cess decreases as the volume of the urine in-
creases. However, for higher absorbency pads 
the performance falls away more slowly with 
increasing urine volume than it does for lower 
absorbency products.
This is a complex concept to communicate in 
sales literature and product packaging and so 
companies commonly quote a simple absorption 
capacity figure. Some use the volume of fluid 
a pad will hold in a laboratory test - usually in-
ternational standard ISO 11948-1[53] - but this 
figure can be very misleading. Although it has 
been show to correlate well with the leakage 
performance of pads for some groups of users 
(see Section VI.7.2), the volume of urine which 
a pad will hold when tested with ISO 11948-1 
is enormous compared with how much it will 
hold in real use. For this reason, some compa-
nies prefer to quote a “working capacity”, which 
might be calculated as some proportion (com-
panies vary in the proportion they use) of the 
capacity in the laboratory. However, this is still 
misleading as it implies that the pad will not leak 
until the working capacity is exceeded. A simple, 
valid and widely accepted solution to this prob-
lem has yet to be devised. 
It is equally difficult to determine the needs of us-
ers in terms of the volume of urine they need their 
pads to hold. Not only can different users leak 
widely differing volumes from each other but also 
a given user may leak widely differing volumes 
on different occasions. This means that, like 
pad performance, users’ needs cannot be easily 
quantified. However, a number of studies have 
been published on work with pad users described 
as being lightly incontinent of urine in which the 
median and 90th percentile urine volumes in 
used pads have been of the order of 15ml and 
100ml, respectively [54]. Similarly, a number of 
studies of pad users described as having mod-
erate-heavy urinary incontinence have yielded 
corresponding figures of about 250ml and 600ml 
[54]. Accordingly, in this chapter the material 
is divided – somewhat simplistically – into that 
which relates to light incontinence and that which 
relates to moderate-heavy. 
But the published work also makes it clear that 
some products work better for users whose inconti-
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nence is towards the lighter or the heavier end of the 
spectrum within each of these two groups and so, 
where necessary in the text and tables that follow, 
these distinctions are made by dividing light incon-
tinence into “light LIGHT” and “heavy LIGHT”; and 
moderate-heavy incontinence into “light HEAVY” 
and heavy HEAVY”. 
5.  ABSORBENT PRODUCTS FOR WOMEN 
WITH LIGHT URINARY INCONTINENCE
There are four main product designs for women with 
light incontinence (Table VI-2). In addition menstru-
al pads are known to be frequently used for light 
urinary incontinence. The disposable pull-up group 
are relatively expensive, single-use items and are 
seldom used for light incontinence except as ‘emer-
gency’ items. Underpads are not commonly used for 
light incontinence.(Figure VI-16)
Aspects of assessment that are particularly impor-
tant regarding pads for women with light inconti-
nence include frequency / severity of leakage, day / 
night incontinence individual priorities (e.g. need for 
discreetness), personal preference for washables / 
disposables, lifestyle (home / travel / work).
a) Quality of data
A small number of robust comparative evaluations of 
absorbent pads for lightly incontinent women have 
been published and there has been a Cochrane re-
view [55]. A recent study has compared the most 
common designs: disposable inserts, menstrual 
pads, washable inserts and washable pants with 
integral pad. One study has compared a range of 
disposable inserts and menstrual pads and there 
have been comprehensive single group studies of 
disposable inserts and washable pants with integral 
pads. A further study has compared specially made 
experimental products that have differed from one 
another in carefully controlled ways enabling more 
specific questions about product materials and de-
sign to be addressed.
b) Results
Using a crossover design, Fader et al [54] com-
pared disposable inserts, menstrual pads, wash-
able pants with integral pad, and washable inserts. 
Three products were selected (based on previous 
study results) to represent each design and each 
product was tested for one week (three weeks for 
each design block, total 12 weeks). Order was ran-
domised. Product performance was characterised 
using a validated questionnaire to evaluate pad 
performance (leakage, discreetness etc) with a five 
point scale (very good – very poor) at the end of 
each week of product testing. A pad change and 
leakage diary was used to record severity of leak-
age from pads (three-point scale: a lot, a little, or no 
leakage), and numbers of laundry items and pads 
used were recorded to estimate costs. Skin health 
changes were recorded weekly. At a final interview 
preferences were ranked (with and without costs), 
acceptability of the design recorded (highly accept-
able – totally unacceptable) and overall opinion 
marked on a visual analogue scale (VAS) of 0-100 
points (worst design – best design). This VAS score 
was used to estimate cost-effectiveness. 
Eighty-five women (mean age 60) completed the 
study and 8691 used pads were weighed. The dis-
posable insert was significantly better than the other 
designs on most variables except for discreetness. 
For leakage prevention, overall acceptability and 
preference, disposable inserts were found to be 
significantly better than menstrual pads, which were 
better than washable pants with integral pad, which 
were better than washable inserts. There was no 
clear benefit for skin health using either washable 
or disposable designs. Most women preferred the 
disposable insert pad but some preferred the other 
cheaper designs (6/85 preferred menstrual pads; 
Figure VI-15: A reusable underpad.
Table VI-2: Bodyworn absorbent products for women with light urinary incontinence
 Disposable Washable 
Design 
groups  
Inserts (Fig VI-2) Inserts (Fig VI-4) 
Pull-ups ie pants with integral 
pad (Fig VI-8) 
Pull-ups ie pants with integral 
pad (Fig VI-10) 
Menstrual pads   
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Figure VI-16: Designs of pads for women with light urinary incontinence. For definitions of light LIGHT and 
heavy LIGHT, see Section VI.4. (Grade of recommendation in brackets)
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13/85 preferred washable pants), both of which 
were >50% cheaper to use than disposable inserts. 
Washable inserts were significantly worse than the 
other designs (72/85 found them unacceptable). 
Overall there were generally more practical prob-
lems with washables, particularly when away from 
the home (Level of Evidence 1).
The authors concluded that allowing women to choose 
their preferred design of absorbent product (or combi-
nation of different designs for different circumstances) 
would be more cost-effective and provide better pa-
tient satisfaction than provision of disposable insert 
pads (the most expensive product) alone.
Clarke-O’Neill et al. [18] compared the range (12 
products) of disposable inserts for lightly inconti-
nent women available in the UK in 2000. Products 
were tested by 60 community-based women aged 
50 years or older who currently used products 
similar to those to be evaluated. Products were 
evaluated using a pad performance questionnaire 
and a pad leakage diary. As a group, the products 
performed well in terms of their ability to hold urine 
without leakage. However, the ‘overall opinion’ 
scores of the testers showed large differences 
between products with 88% of subjects scoring 
the most successful insert as Good or OK com-
pared with 51% for the least successful product 
(p<0.001) (Level of Evidence 2).
A similar study by the same research group [56] 
compared all 10 washable pants with integral pad 
for lightly incontinent women available in the UK in 
1999. Seventy-two community-based women who 
usually used absorbent products for light incon-
tinence tested each product for one week each. 
Leakage performance was found to be disappoint-
ing with 69% (CI: 59-78) of the best performing 
product not leaking at all with 10g of urine, com-
pared to 40% (CI: 29-51) for the least successful 
product. Again subjects’ ‘overall opinion’ scores 
showed wide differences between products with the 
best performing product scoring 85% Good or OK 
compared with 34% for the least successful product 
(Level of Evidence 2).
Baker and Norton [57] evaluated six small dispos-
able inserts and two menstrual pads (available in the 
USA in 1991) with 65 community dwelling women. 
The products were rated using an evaluation ques-
tionnaire and daily diary of pad use. The two men-
strual pads (which were the least expensive pads 
in the study) scored significantly higher than many 
of the incontinence products although neither was 
the most popular pad. The authors concluded that 
women should try a ‘maxi’ menstrual pad first and 
then move onto a higher capacity (incontinence) 
pad if this was inadequate. However, this study was 
carried out more than 10 years ago and products 
have changed considerably since then (Level of 
Evidence 2).
Thornburn et al. [16] studied ‘wet comfort’ using 
small disposable pads that had been experimen-
tally made using different combinations of materi-
als in an attempt to reduce ‘wetback’ (the tendency 
of pads to allow urine to escape back on to the 
wearer’s skin). Twenty women tested the pads. 
Whenever differences in wet comfort, absorbency 
or overall performance were found they were in the 
expected order but differences were small and few 
reached statistical significance. The clinical value 
of including technically superior materials was not 
strongly supported. However, this was a small study 
and may have had insufficient power to detect sig-
nificant differences (Level of Evidence 2).
More recently Erekson and colleagues [58] mea-
sured the wet-back performance of a range of 10 
different branded products. This was a laboratory 
experiment involving two patients (of different BMIs) 
sitting on pre-wetted pads. Results showed that nei-
ther size nor price of the pads had any effect on the 
measured product performance. However it is dif-
ficult to determine how much such measurements 
reflect clinical performance.
c) Summary
There is robust evidence that disposable inserts 
are more effective in terms of leakage and more ac-
ceptable than menstrual pads, washable pants and 
washable inserts (Level of Evidence 1). Menstrual 
pads are cheaper and washable pants cheaper still 
(on a per-use basis) and are acceptable to many, 
particularly those with lighter incontinence and par-
ticularly when used at home. Washable inserts are 
not acceptable to most women. The user charac-
teristics, priorities and contexts which favour or dis-
courage the use of the different product designs are 
summarised in Figure VI-16. 
d) Recommendations
•  Disposable inserts are recommended as the most ef-
fective and preferred absorbent product for women with 
light incontinence (Grade of Recommendation B).
•  Menstrual pads or washable pants may be suffi-
cient for some patients with very light incontinence 
and are cheaper (Grade of Recommendation B).
•  Washable inserts are not recommended (Grade of 
Recommendation B).
•  Combinations of designs for different situations (e.g. 
disposable inserts for going out, washable pants with 
integral pad for staying at home) are likely to provide 
optimum management in terms of patient needs and 
cost-effectiveness, and product advice and provision 
(where purchased by institutions / services) should 
reflect this (Grade of Recommendation B).
•  See also the general recommendations relating 
to pad selection in Section VI.11 and to washable 
pads in Section VI.12. 
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e) Research priorities
•  Because the performance of washables is gener-
ally poor (particularly for leakage) compared to 
disposables, the development of better washable 
products is a priority.
•  The use of combinations of designs for different 
situations needs to be evaluated.
6.  ABSORBENT PRODUCTS FOR MEN WITH 
LIGHT URINARY INCONTINENCE
There are five main product designs for men with 
light urinary incontinence (Table VI-4). However, dis-
posable and washable insert pads are often unap-
pealing to men as they are frequently marketed spe-
cifically at women and bear a strong resemblance 
to menstrual pads. Anatomical differences are also 
likely to mean that they are less effective for men. 
Pouch, shield and leaf products (Figures VI-11 and 
VI-12) are designed to be more suitable for men by 
containing the penis or penis and scrotum. 
Aspects of assessment that are particularly impor-
tant regarding pads for men with light incontinence 
include frequency / severity of leakage, day / night 
incontinence, retraction of penis, individual priori-
ties (e.g. need for discreetness), personal prefer-
ence for washables / disposables, and lifestyle 
(home / travel / work).
Only one study has been published which has 
evaluated absorbent products for men with light uri-
nary incontinence (59]. It compared the four main 
absorbent designs of products available in the UK 
in 2003: disposable insert pads, pouches and leafs 
and washable pants with integral pad. All six leaf 
products (five disposable and one washable) and 
all six pouches (all disposable) on the UK market in 
2003 were evaluated, together with a selected dis-
posable insert pad and a selected washable pant 
with integral pouch (chosen to represent their re-
spective designs). Seventy men with light urinary in-
continence completed the 14 week study and filled 
out product performance questionnaires at the end 
of testing each product for a week. Products were 
supplied in random order within their design group 
and the design group order was also randomised. 
Pad leakage diaries were used to record product 
performance and used pad weight. At the end of 
testing each design a design performance question-
naire was completed. ‘Overall opinion’ was used as 
the primary outcome variable. Results showed that 
the pouch design performed significantly worse than 
the leaf and the insert design. The most common 
problems with the pouch were staying in place and 
difficulties re-inserting the penis in the pouch once 
the pouch was wet. The leaf designs had the best 
leakage scores, but one product was significantly 
better than the other leafs (Tena). The disposable 
insert was also effective for leakage prevention and 
was substantially cheaper than the leaf designs. 
The washable leaf was the least successful of the 
leaf designs. The washable pants with integral pad 
received polarised overall opinion scores (loved 
or hated) and scored well for staying in place but 
poorly for leakage (Level of evidence 2). The user 
characteristics, priorities and contexts which favour 
or discourage the use of the different product de-
signs are summarised in Figure VI-17. 
a) Recommendations
•  Disposable leafs are recommended as the most 
acceptable and effective design for men with 
light incontinence, but some men prefer other de-
signs which should be considered as alternatives 
(Grade of Recommendation B).
•  Simple insert pads are cheaper and may be accept-
able to some men (Grade of Recommendation B).
•  Washable pants with integral pad are likely to be 
most suitable for men with very light incontinence 
who have difficulties keeping an insert or pouch in 
place (Grade of Recommendation B).
•  See also the general recommendations relating 
to pad selection in Section VI.11 and to washable 
pads in Section VI.12.
b) Research priorities
Because the performance of washables was gen-
erally poor (particularly for leakage) compared to 
disposables, the development of better washable 
products is a priority.
7.  ABSORBENT PRODUCTS FOR MEN AND 
WOMEN WITH MODERATE-HEAVY URI-
NARY INCONTINENCE 
There are at least 12 absorbent product designs for 
men and women with moderate-heavy urinary in-
continence (Table VI-5). The most commonly used 
products are disposable bodyworn inserts and dia-
pers (Figures VI-3 and VI-6). More recently, modi-
fied diapers (T-shaped diapers, Figure VI-7) have 
been introduced which can be applied by the wearer 
whilst standing. Pull-ups are also a relatively new 
innovation and comprise an absorbent pad integrat-
ed into a disposable elasticated pant (Figure VI-9). 
Washable counterparts to most disposable body-
worn designs are available but they have a much 
smaller market, where they are available. They are 
made from a variety of natural and synthetic mate-
rials. Disposable and washable bedpads are used 
on the bed at night with or without the support of a 
bodyworn product. Disposable and washable chair-
pads are used either without a bodyworn product 
(in which case the individual must sit directly on the 
pad with no underpants on) or in combination with 
bodyworn products to protect chairs from any leak-
age from the bodyworn. Both practices place an un-
derpad on display and mark the individual as being 
incontinent and are therefore to be discouraged.
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 Disposable Washable 
Design 
groups 
Inserts (Fig VI-2) Inserts (Fig VI-4)  
Pouch (Fig VI-11) Pouch (Fig VI-12) 
 Pull-ups ie pants with integral   
pad (Fig VI-10) 
 
Table VI-4: Bodyworn absorbent products for lightly incontinent men
Figure VI-17: Designs of pads for men with light urinary incontinence. For definitions of light LIGHT and 
heavy LIGHT, see Section VI.4. (Grade of recommendation in brackets)
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Aspects of assessment that are particularly impor-
tant regarding absorbent pads for moderate / heavy 
UI are frequency / severity of leakage, day / night 
incontinence, gender (some products are better for 
men/women than others), ability to change pad in-
dependently / need for carer, pad changing position 
(standing / lying), laundry / drying facilities, individ-
ual priorities (e.g. need for discreetness), personal 
preference for design / materials (washable / dis-
posable) and lifestyle (at home / travel / work etc).
a) Quality of data
There have been two recent clinical trials comparing 
the main designs of disposable bodyworn pads (one 
also included washable designs) which are included 
in a Cochrane review [55]. There have been no trials 
of underpads for the last 15 years. There have also 
been a large number of comparative studies of ab-
sorbent products for moderate-heavy incontinence 
but most are more than 10 years old and evaluated 
products that are no longer available. Furthermore, 
changes in materials and design features mean that 
it is impossible to generalise any particular find-
ings to products of today. Brink [60] identified 30 
studies of absorbent products published between 
1965-1990. Some robust multi-centre international 
studies have examined the correlation between 
laboratory testing and the leakage performance of 
products clinically.
b) Results
1.  EVALUATIONS COMPARING DIFFERENT DESIGNS OF DISPOS-
ABLE AND / OR WASHABLE BODYWORN ABSORBENT PROD-
UCTS FOR URINARY INCONTINENCE
Fader et al. [54] carried out two clinical trials of absor-
bent products for moderate-heavy incontinence; one 
involving subjects in the community and the other 
subjects in nursing homes. In the community-based 
trial 85 moderate / heavily incontinent adults (urinary 
or urinary / faecal) living in their own homes [49 men 
and 36 women) were enrolled, and tested three (or 
two) products from each of five design categories (to-
tal of 14 test products): disposable inserts (with mesh 
pants); disposable diapers; disposable pull-ups; dis-
posable T-shape diapers; and washable diapers. All 
products were provided in a daytime and a (mostly 
more absorbent) night-time variant. Products were 
selected based on having similar scores for absor-
bency across the designs (Rothwell scores, [53] see 
below) and performance data from pilot studies. In 
the nursing-home-based trial 100 moderate / heav-
ily incontinent adults (urinary or urinary / faecal) liv-
ing in a total of 10 nursing homes (27 men and 73 
women) evaluated one product from each of the four 
disposable design categories above. Products were 
selected on the basis of product performance from 
the community-based trial and, again, day and night-
time variants were provided. 
Product performance was characterised using vali-
dated questionnaires which asked the participants 
(in the community-based trial) or carers (in the nurs-
ing home based trial) to evaluate various aspects 
of pad performance (leakage, ease of putting on, 
discreetness etc) using a five point scale (very good 
– very poor) at the end of the week (or two weeks 
for the nursing-home-based trial) of product testing. 
In addition, participants / carers were asked to save 
individual used pads in bags for weighing and to in-
dicate the severity of any leakage from them on a 
three-point scale (none, a little, a lot). These data 
were used to determine differences in leakage per-
formance. Numbers of laundry items and pads used 
were recorded to estimate costs, and skin health 
changes were recorded by the participant or by the 
researchers. At the end of testing participants were 
interviewed and ranked their preferences (with and 
without costs), stated the acceptability of the design 
(highly acceptable – totally unacceptable) and re-
corded their overall opinion on a visual analogues 
scale (VAS) of 0-100 points (worst design – best 
design). A pad changing experiment was conducted 
with 12 women from the nursing home based trial 
to determine any differences between product de-
signs. Under idealised conditions the different de-
signs were applied (by the same carers) in random 
order for each patient and the speed of pad chang-
ing was timed using a stop-watch.
Findings from the community-based and nursing 
home trials were broadly similar. The leakage per-
formance for the disposable inserts was worse than 
the other designs for day and night and disposable 
pull-ups were preferred over inserts for the daytime. 
The new T-shape diaper was not better overall than 
the traditional disposable diaper. But there were im-
portant differences in performance and preference 
findings between men and women from both trials 
 Disposable (single use) Washable (reusable) 
Ty
pe  
Bodyworns Underpads
 
Bodyworns  Underpads
De
sig
n 
gr
ou
ps  
Inserts 
Diapers 
T shaped 
diapers 
Pull-ups 
Bedpads  
Chairpads  
Inserts 
Diapers 
T shaped 
diapers 
Pull-ups 
 
Bedpads  
Chairpads  
 
Table VI-5: Absorbent products for moderate-heavy adult incontinence
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and the men (in the community) had more severe 
urinary incontinence than the women - mean day-
time urine mass in a pad 375 g for men and 215g for 
women (difference148g, CI: 80, 218). 
Pull-ups (the most expensive design) were better 
overall than the other designs for women during the 
day and for community-dwelling women during the 
night too. Although disposable diapers were bet-
ter for leakage than disposable inserts (the cheap-
est), women did not prefer them, but for men (in 
the nursing homes and the community) the diapers 
were better both overall and for leakage and were 
the most cost-effective design. No firm conclusions 
could be drawn about the performance of designs 
for faecal incontinence and there was no firm evi-
dence that there were differences in skin health 
problems between designs (Level of Evidence 1).
In the nursing home trial the carers found pull-
ups and inserts significantly easier to apply (in the 
standing position) and significantly quicker in the 
pad change experiment (mean time 35.2 and 37.9 
seconds for inserts and pull-ups respectively and 
53.2 and 62 seconds for diapers and T-shaped dia-
pers respectively) and ability to stand was associ-
ated with preference for pull-ups or inserts. Despite 
being designed for ease of changing the T-shape 
diaper was not found to be easier or quicker to 
change than the diaper.
The washable products (used in the community-
based trial) gave diverse results. Two of the prod-
ucts were made from cotton terry-towelling (one a 
simple square, folded and pinned in a diaper shape; 
the other a shaped diaper-like design, both worn 
with plastic pants) while the third product had a felt 
absorbent core, with an integral plastic backing and 
was fixed by poppers. This third product performed 
significantly worse for leakage than the other two 
washables and was therefore excluded from the 
final data analysis. The terry-towelling washables 
were better for leakage at night than the disposable 
designs, but were less popular overall for daytime 
use than the disposable designs. Three quarters of 
the women (27/36) found them unacceptable, but 
nearly two thirds of men (31/49) found them highly 
acceptable at night. Findings from the community-
based trial showed that there were many practical 
problems dealing with washable products particu-
larly when out of the house, but that they were more 
acceptable at home. 
Macaulay et al, [20] carried out a pilot study of 19 
washable products with 14 community dwelling sub-
jects. The products included a mixture of washable 
insert and brief designs and two disposable body-
worn products. Product performances varied widely: 
the most popular was rated as good (for overall per-
formance) by 78% of testers, while the least popular 
scored 22%. Although most of the washable prod-
ucts performed poorly for leakage, one washable 
product made of cotton towelling (used with plastic 
pants), scored better than both the other washable 
and disposable products (Level of Evidence 3).
Eight older trials have compared disposable with 
washable bodyworn products for moderate-heavy 
incontinence [61] [62] [63] [64] [65] [66] [67] [68]. 
The trials varied in size and design from a large 
controlled trial with 276 subjects [61] to a small trial 
of eleven subjects [64]. In addition some trials have 
compared disposable and washable bedpads and 
body-worns. Brown [22] [69] undertook a large trial 
of this kind. The fact that no systematic method of 
product selection was used for these studies limits 
the utility of the results since particularly good or 
poor products may have been selected to represent 
the disposable or washable groups.
Skin condition was used as an outcome measure in 
five of the above trials. However, only three used an 
experimental design and statistical methods of anal-
ysis. Beber [61] and Grant [62] both reported that 
they did not find statistically significant differences 
between their washable and disposable products in 
terms of an adverse change in skin condition. But 
Hu et al. [70] reported a statistically significant im-
provement in the skin condition of their disposable 
product users as compared to their users of wash-
able products (See Section XIV).
Other parameters frequently investigated in these 
studies were staff preference, product leakage and 
laundry. Overall, the disposables in the studies were 
considered to have performed better than the wash-
able products in terms of preventing leakage (often 
measured by quantity of laundry) and staff preference.
Four studies attempted to measure costs [63] [62] 
[71] and [69]. Of these, three used statistical meth-
ods of analysis. Hu et al. [71] and Brown [69] report-
ed that although there were no statistically signifi-
cantly differences in terms of per-day product costs 
of washable and disposable products, the laundry 
costs associated with the disposable product (ie for 
laundering soiled bed linen and clothes) were signif-
icantly lower than those associated with the wash-
able product (ie for laundering the products as well 
as soiled bed linen and clothes). Brown [69) found 
no significant differences between daily costs of the 
washable and disposable products. However, sta-
tistically significant differences were found between 
the groups in terms of incontinence-related laundry, 
with the disposable group producing less laundry 
than the washable group. Grant [62] reported that 
the cost of washable products was significantly low-
er than that of disposables, but laundry costs were 
not taken into account. 
2. DISPOSABLE ABSORBENT PRODUCTS FOR URINARY INCONTI-
NENCE: STUDIES OF SINGLE DESIGNS, LABORATORY TESTS AND 
STUDIES OF MATERIALS
Clancy and Malone-Lee [15] compared versions of the 
same pad experimentally engineered to have differ-
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ent combinations of fluff pulp and topsheet materials. 
Forty-five heavily incontinent older adults participated. 
The main valuable finding from this study was that 
pads were more likely to leak if they were not held in 
place by pants (p<0.0001) and that, if there was any 
leakage from a pad, this tended to be less severe if the 
supplied mesh pants were worn than if normal pants 
were worn (p<0.05) (Level of Evidence 2). The mesh 
pants probably held pads more firmly to the body.
There have been two single design group studies of 
bodyworn products for moderate-heavy incontinence 
[72] [73], both carried out in nursing homes. A study 
of shaped insert pads involved 228 subjects from 33 
nursing / residential homes who tested 20 ranges 
of insert pads [74 products in total). A similar study 
of diapers involved 192 subjects from 37 nursing / 
residential homes who tested a total of 36 products. 
These studies showed the wide range of product per-
formance that can exist within single product groups. 
For example, the least successful diaper (based on 
‘overall opinion’) was found to be unacceptable to 
100% of the test subjects while the most successful 
was unacceptable to only 6% (Level of Evidence 2).
In addition, there have been a number of studies on 
the impact of wet pads on skin health and these are 
reviewed in Section XIV.
Because clinical evaluations are expensive and 
time-consuming, laboratory evaluation procedures 
are in widespread use. Few have been clinically 
validated but there is a clinically-validated Interna-
tional Standard (ISO 11948-1) relating to the leak-
age performance of disposable bodyworn pads for 
moderate-heavily incontinent adults in institutions 
[53]. It describes a simple method for measuring the 
absorption capacity of pads in the laboratory that 
was shown to correlate well with the leakage per-
formance of 18 different products evaluated in an 
international multi-centre clinical study involving 112 
heavily incontinent adults [74]. The strength of the 
correlation between technical and clinical data data 
depended on the exact parameters being compared, 
but typically r = 0.9 (Level of Evidence 2). This labo-
ratory test (the Rothwell method) is now in common 
use in the UK, Sweden and other countries and pro-
vides a basis for selecting similar products with which 
to make direct comparisons (for cost purposes) or to 
select promising pads for inclusion in clinical trials. 
The ability of ISO 11948-1 to predict the leakage 
performance of more recent bodyworn pads (138 
diapers and inserts) for heavy incontinence was 
investigated by Cottenden et al. [75]. Correlations 
were poorer than in the original 1993 study (r<0.87 
compared with r<0.95) but still strong enough to 
make the method useful. For a given Rothwell ca-
pacity, the leakage performance of diapers was far 
superior to inserts, but no evidence was found for 
any other design feature of the test products (in-
serts and diapers) having a significant impact on 
their leakage performance (Level of Evidence 2).
The repeatability and reproducibility of the ISO 
11948-1 was investigated by Cottenden and co-
workers [76] in three laboratories (UK, Spain and 
Sweden). Repeatability (precision between repeats 
in the same laboratory) was found to be very good 
with the co-efficient of variation for five repeats rarely 
exceeding 5%. However, the reproducibility (preci-
sion between laboratories) was poorer, revealing 
systematic differences: results from the Swedish and 
Spanish laboratories typically exceeded those from 
the English laboratory by 13% and 8%, respectively. 
Efforts to identify the source(s) of this poor reproduc-
ibility have so far been unsuccessful but it seems 
likely that minor variations in interpretation of the 
standard when constructing the apparatus and / or 
executing the test are to blame (Level of Evidence 2).
c) Summary
Results from these studies indicate that there is 
no single best design (i.e one design that is sig-
nificantly better than all other designs for all users) 
(Level of Evidence 1).
There is evidence that different designs are better 
for men and women, and that men leak substan-
tially higher volumes of urine than women (Level 
of Evidence 1).
Of the disposable designs, the more expensive pull-up 
and T-shaped diaper designs are not better overall than 
the cheaper diaper for men, indicating that the diaper 
is the most cost-effective design for men. For women 
pull-ups are better overall than the other designs (ex-
cept for night-use in those living in nursing homes), but 
they are expensive (Level of Evidence 1).
Unlike men, women in the community do not favour 
diapers over insert pads and of these cheaper de-
signs, inserts may be preferred for women. There is 
also evidence that the leakage performance of inserts 
is worse than other designs, but that they leak signifi-
cantly less if they are held in place by mesh pants than 
by ordinary pants, and using no pants at all is associ-
ated with significantly more leakage than if either kind 
of pant is worn (Level of Evidence 3). 
There is evidence that pads containing superabsorber 
leak less, are more comfortable, and keep the skin 
drier than those without (Level of Evidence 2).
The leakage performance of inserts and diapers for 
heavy incontinence can be predicted with reasonable 
precision using an international standard laboratory 
tests (Level of evidence 2).
This test has been shown to have very good repeatabil-
ity and adequate reproducibility (Level of Evidence 2).
Washable products are very varied in design and ma-
terials, and also in performance. There is evidence 
that terry-towelling products (used with plastic pants) 
have good leakage performance, however they have 
limited acceptability - confined mainly to some men at 
night. There is no firm evidence regarding the perfor-
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mance of different designs for faecal incontinence and 
no firm evidence that any particular design or type of 
material (washable or disposable) is better or worse 
for skin health.
The user characteristics, priorities and contexts 
which favour or discourage the use of the different 
product designs are summarised in Figure VI-18. 
d) Recommendations
•  Gender should be considered when products are 
prescribed / purchased for users. As men often 
have substantially higher incontinent urine volumes 
than women, men may require more products and / 
or more absorbent products than women (Grade of 
Recommendation B).
•  Gender should also be considered when products 
are prescribed / purchased for users because men 
and women are likely to prefer different designs. 
Men generally prefer disposable diapers to inserts 
(Grade of Recommendation B).
•  Women generally prefer disposable pull-ups to 
other designs, but these are expensive. Disposable 
inserts are a cost-effective alternative (Grade of 
Recommendation B).
•  Caution is recommended if washable designs are 
being considered. Heavy bulk confines their use 
mainly to the night-time (where they may be par-
ticularly useful for users who lie on their side). They 
are unacceptable for most people during the day-
time and for most women at any time and for this 
reason a blanket policy of health services providing 
washables alone is not recommended. If washables 
are being considered refer to points below (Grade 
of Recommendation B).
•  Freedom from leakage: Where possible, interna-
tional standard laboratory tests should be used to 
rank the likely leakage performance of different 
pads for heavy and light incontinence (Grade of 
Recommendation B). In general, diapers should be 
selected in preference to inserts to minimise leak-
age (Grade of Recommendation B). 
•  Carer application: When products are applied by a 
carer to a patient who can stand for pad changing, 
disposable inserts or pull-ups are easier and quicker 
to change than diapers or T-shaped diapers. If the 
patient is lying down (e.g. at night) pull-ups should 
be avoided (Grade of Recommendation B). 
•  Combinations of designs for different situations 
(e.g. disposable inserts for staying in, disposable 
pull-ups for going out, washable diapers at night) 
are likely to provide optimum management in terms 
of patient needs and cost-effectiveness (Grade of 
Recommendation B).
•  See also the general recommendations relating to 
pad selection in Section VI.12 and recommenda-
tions specific to washable pads in Section VI.13. 
e) Research priorities
•  Comparison of absorbent products (disposable and 
washable) when used by carer-dependent users in 
the community.
•  Development of more effective and aesthetically ac-
ceptable washable products, particularly for night-
time use and for women.
•  Development of more effective and acceptable dis-
posable designs specifically for men.
8. DISPOSABLE UNDERPADS
There have been no published studies examining the 
use of bedpads during the last 15 years. This prob-
ably reflects the recognition of their limited role in 
long-term management of incontinence. Disposable 
underpads on chairs declare their user to be inconti-
nent and require clothes to be pulled up (or absent) 
which is unacceptable for dignity. In the bed dispos-
able underpads easily become displaced, folded and 
creased under the patient which inhibits their perfor-
mance and comfort, and may potentially be a threat 
to skin health. Large disposable underpads with 
wings to tuck into the bed may have a role as bed 
protection ‘back-up’ to bodyworn pads. The main role 
of disposable underpads should be confined to tem-
porary bed or chair protection such as during clinical 
procedures (e.g. enemas) or when using a urinal. 
Published trials comparing different disposable 
bedpads are few [77] [78] [22] and it is not pos-
sible to draw firm conclusions from them on the 
effectiveness of different product design features 
and materials. Some useful work has been done 
to highlight the risks of infection from disposable 
bedpads and to validate clinically some laboratory 
tests to assist with product selection by predicting 
pad leakage performance. 
Bedpads are generally supplied as non-sterile items 
and Bradbury [79] has drawn attention to the risk of 
infection, particularly from products containing re-
cycled paper. Leigh and Petch [80] and Sprott et 
al. [81] have conducted microbiological tests on a 
range of products. Both studies identified low lev-
els of bacterial contamination but concluded that 
the risk to patients was minimal unless they were 
immunocompromised in some way. More recently, 
Stansfield and Caudle [82] reported an outbreak of 
wound colonization on a surgical orthopaedic hos-
pital ward which they attributed to the use of dispos-
able underpads containing virgin wood pulp.
Due to the paucity of published clinical data many 
technical tests have been devised to evaluate prod-
ucts in the laboratory. The only tests with published 
clinical validations are described by Cottenden et al. 
[74] who subjected six different bedpads to a vari-
ety of laboratory tests and to a multi-centre clinical 
evaluation in which 95 incontinent subjects tested 
each product in turn for a week, in random order. 
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Figure VI-18: Designs of pads for adults with moderate-heavy urinary incontinence. For definitions of light 
HEAVY and heavy HEAVY, see Section VI.4. (Grade of recommendation in brackets)
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A combination of two laboratory tests (one to mea-
sure the absorption capacity and the other the ab-
sorption time of bedpads) gave a strong correlation 
with the percentage of subjects finding the leakage 
performance of a product acceptable when used 
as their sole protection (r = 0.94) and predicted the 
acceptability scores of all six products accurate to 
within ± eight percentage points. A different absorp-
tion capacity test produced a strong correlation for 
the leakage performance of bedpads used as back-
up to bodyworn products (r = 0.96) and predicted 
the acceptability scores of all six products to within 
± five percentage points. 
a) Summary
No robust data are available on the effectiveness 
of current disposable bedpads or of their various 
design features or constituent materials. There is a 
risk of infection from bedpads made from recycled 
paper for immunocompromised users (Level of 
evidence 2). The leakage performance of bedpads 
(used alone or as back up to bodyworn pads) can be 
predicted with reasonable precision using clinically-
validated laboratory tests (Level of Evidence 2).
b) Recommendations
•  Disposable underpads should not be used for 
long-term management of incontinence, but have 
a useful role as temporary protection for chairs 
and beds during clinical procedures (Grade of 
Recommendation C). 
•  Immunocompromised people should not use bed-
pads made from recycled paper because of the 
risk of infection (Grade of Recommendation B). 
•  Where possible, clinically-validated laboratory tests 
should be used to rank the likely leakage performance 
of different products (Grade of Recommendation B).
c) Research priorities
Disposable underpads have a limited role in con-
tinence management but are known to be widely 
used. An exploration of patient views regarding their 
use may help demonstrate their limitations.
9. WASHABLE UNDERPADS
Aspects of assessment that are particularly important 
regarding washable underpads are patient accept-
ability and preference, particularly with regard to will-
ingness to be naked below the waist (if sole use in-
tended) and availability of laundry and drying facilities.
Cottenden [83] has reviewed comparative evalu-
ations of different washable bedpads up to about 
1990. Leiby and Shanahan[84] have since pub-
lished a study. Some evaluations have found sig-
nificant differences between products relating, for 
example, to leakage performance and impact on 
skin health but none of the products evaluated is 
still available in the variant tested. In addition, com-
pared products always differed from one another in 
many respects making it impossible to draw reliable 
generic conclusions relating to the products now 
available. However, the choice of topsheet material 
and the presence or absence of features like tuck-
in flaps and integral water-proofing appear to be, 
primarily, matters of personal preference.
In institutional settings washable bedpads are com-
monly used by multiple patients and questions are 
often asked about the risk of cross-infection. Cot-
tenden et al. [85] assessed the risk by determining 
the microbial content of 145 bedpads of five differ-
ent designs after a night’s use by incontinent adults, 
followed by laundering using a standard foul wash 
procedure which included heat disinfection at 71oC 
for three minutes. Laundering destroyed all known 
pathogenic organisms, although some commensal 
flora were isolated in small numbers. It was con-
cluded that foul wash laundry had left bedpads safe 
for multiple patient reuse with no demonstrable risk 
of cross-infection.
a) Summary
The literature contains insufficient robust data on 
which to base guidelines for choosing between 
washable bedpads. Choice of topsheet material and 
the presence/absence of design features like tuck-
in flaps and integral/separate water-proof backing 
appear to be, primarily, matters of personal prefer-
ence (Level of evidence 3). Provided an approved 
foul wash procedure is used, the risk of cross-infec-
tion between different users of a bedpads is very 
low (Level of Evidence 2). 
b) Recommendations
•  If considering using washable underpads for sole 
use (ie without a bodyworn product) the patient will 
need to be naked below the waist. Patient con-
sultation and approval will therefore be needed 
(Grade of Recommendation C). 
•  Personal preferences of users with regard to top-
sheet material, tuck-in flaps and integral waterproof 
backing should be considered in making product 
selections (Grade of Recommendation C). 
•  Provided an adequate foul laundry wash cycle is used, 
the risk of cross-infection between successive users of 
washable bedpads is low and not a contra-indication 
for their use (Grade of Recommendation B).
c) Research priorities
•  Comparison of washable underpads with body-
worn products when used at night.
10.  ABSORBENT PADS FOR CHILDREN WITH 
URINARY AND / OR FAECAL INCONTINENCE
Most children are expected to achieve daytime 
dryness by the age of three [86]. However, some 
children take longer to become dry and some (e.g. 
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children with learning and physical disabilities) may 
never reach this goal. These children usually re-
quire absorbent products to contain leakage. 
Aspects of assessment that are particularly impor-
tant regarding bodyworn products for children are 
presence of faecal incontinence, day / night inconti-
nence, level of independence with toileting, and use 
of aids (e.g. callipers).
To date there has been only one study of absor-
bent products for children and this has compared 
the diaper design with the newer pull-up design 
[87]. Sixty-one children with physical and / or learn-
ing disabilities tested five diaper products and five 
pull-up products, each testing each product for one 
week. The children were randomised to receive ei-
ther the pull-up or diaper group first and individual 
products were tested in random order within each 
design arm. Parents completed a product perfor-
mance questionnaire and a pad leakage diary to 
record wet weights and severity of leakage. Parents 
were asked to state their preference for a design for 
day and night use. 
Findings indicated that generally, the diaper prod-
ucts performed similarly to each other and so did 
the pull-up products, although there were some sta-
tistically significant differences between products 
within each of the two design groups. Overall dia-
pers were preferred for night-time use by the major-
ity of parents. By contrast, 40% of parents preferred 
pull-ups for daytime use and these were found to be 
particularly appropriate for older children and those 
who were attempting independent toileting, provid-
ed they did not have faecal incontinence and did not 
wear callipers or adapted footwear. Diapers were 
more suitable for children who were dependent on 
carers and / or had faecal incontinence, and wore 
callipers or adapted footwear. The authors recom-
mended that both diapers and pull-ups should be 
supplied for children, with pull-ups (which are about 
50% more expensive than diapers) being provided 
for selected children during the daytime.
a) Summary and recommendations
Diapers and pull-ups meet different needs of chil-
dren and both should be made available to children 
with disabilities, dependent on assessment (Level 
of Evidence 3 / Grade of Recommendation C).
b) Research priorities
Comparison of washable and disposable body-
worn products.
11. PADS FOR FAECAL INCONTINENCE
Most absorbent products are designed for urinary 
incontinence. No studies comparing available ab-
sorbent products for faecal incontinence were 
found. Bliss et al. [88] reported preliminary findings 
of a survey of the use and evaluation and suggest-
ed modifications of absorbent products for faecal 
incontinence by 188 community-living persons with 
the problem. Forty-five percent of persons used an 
absorbent product for FI. Ninety-eight percent of 
those with UI and FI used the same type of prod-
uct for both. Suggested improvements in product 
designs included having better odour control, fit, 
and ability to stay in place; a clearer distinction 
between the front and back of a pantiliner or pad; 
adding wings for greater absorbency; and making 
them flushable, cooler feeling, wider and longer in 
the rear and more absorbent but less bulky. For 
mild faecal incontinence, especially when faeces 
remain between the buttocks without soiling under-
wear, persons have used a small disposable gauze 
surgical dressing placed between the buttocks. This 
product was more acceptable than a pantiliner or 
pad to some men [88] (Level of Evidence 2).
a) Recommendations
•  A disposable gauze dressing that can be placed 
between the buttocks maybe acceptable for 
men with light faecal incontinence (Level of 
Recommendation C).
b) Research priorities
• Better designs of products are needed for light and 
moderate FI (with and without UI).
12.  GENERAL RECOMMENDATIONS ON PAD 
SELECTION
•  individuality: No study has ever identified one 
product that worked best for all testers: needs and 
priorities vary. Accordingly, users are advised to 
try a variety of products when possible (Grade of 
Recommendation B).
•  Brand differences: The individual product brands with-
in a design group often exhibit a wide range of perfor-
mance and acceptability for individuals, and it cannot 
therefore be assumed that pads of different brands 
but broadly similar design will be equally acceptable 
or effective (Grade of Recommendation B).
•  Combinations of designs: Absorbent products vary 
greatly in price and performance and suitability for 
individual needs. Users may therefore find combi-
nations of designs preferable and cost-effective. 
For example, women might use pull-ups (expen-
sive, but discreet and good for leakage) for going 
out, and inserts (cheap, less good for leakage) for 
staying at home. Men might use disposable diapers 
for daytime, and washable terry-towelling products 
for night-time (Grade of Recommendation B).
•  Freedom from leakage: In general, pads contain-
ing superabsorber should be selected in prefer-
ence to those without (Grade of Recommen-
dation B). Nobody wants their pad to leak but 
compromises have to be made: the pad needed 
to contain a person’s most severe accident may 
be substantially more bulky and expensive than is 
needed most of the time. Some users choose to 
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tolerate a higher risk of pad leakage in exchange 
for being able to use cheaper, smaller (more dis-
crete) pads. The balance of priorities for a given 
user should be investigated in making product 
selections (Grade of Recommendation C).
•  Comfort and skin health: In general, pads contain-
ing superabsorber should be selected in preference 
to those without (Grade of Recommendation B). 
Shaped pads should usually be selected in prefer-
ence to unshaped (Grade of Recommendation C).
•  staying in place: No product is effective if it slips 
from position. Inserts should be used with pants, 
preferably mesh pants (Grade of Recommenda-
tion B). Robust, stretch (e.g. cotton / lycra) pants 
may also help to provide a snug fit and minimise 
leakage. Shaped pads are preferable to rectangu-
lar (Grade of Recommendation C).
•  ease of putting on and taking off: The ease of put-
ting pads on and taking them off should be consid-
ered, especially for caregivers and for incontinent 
users with reduced mobility or dexterity (Grade of 
Recommendation C). 
•  Aesthetics and discretion: A possible preference for 
small, more discrete pads (even if they are more 
likely to leak) should be considered, especially for 
those wishing to wear close fitting clothing (Grade 
of Recommendation C). The possibility of plastic 
backing materials rustling noisily should be con-
sidered (Grade of Recommendation C).
•  independence and lifestyle: The ability of a user 
to change his / her own pad should be consid-
ered (Grade of Recommendation C): those able 
to change their own pad can often manage with a 
smaller (less absorbent) one than those reliant on a 
caregiver. Users who travel should consider in their 
choice of product(s) the practicalities of carrying a 
supply of pads, disposing of used ones, and dealing 
with laundry (Grade of Recommendation C).
•  Costs: Cost issues should be approached with 
caution (Grade of Recommendation C). Ex-
pensive pads do not necessarily work better than 
cheaper ones. Cheaper pads do not necessarily 
save money. If pads leak more they may have 
to be changed more frequently and / or lead to 
higher laundry costs. More pad changes will mean 
increased caregiver workload. However, more ab-
sorbent pads will not necessarily reduce pad con-
sumption rates: pads are often changed according 
to ward or personal routine. 
13.  RECOMMENDATIONS RELATING TO 
WASHABLE PADS
•  Laundry issues: Access to good, reliable wash-
ing and drying facilities should be checked before 
washable products are introduced (Grade of Rec-
ommendation B). Laundry – especially of bedpads 
– can be heavy work, beyond the capability of frail 
incontinent people or their caregivers. The number 
of washable products needed per user depends on 
laundry turn-around times. Drying times for wash-
ables can be long and expensive, especially for 
bodyworns for heavy incontinence and for bedpads.
•  Personal preferences: Personal preferences (of 
both users and caregivers) with regard to choos-
ing between washable and disposable products 
should be taken into account carefully (Grade 
of Recommendation C). Some users prefer the 
chore of laundering washables to anxiety over 
whether their next consignment of disposables 
will be delivered on time. Washables generally 
require less storage space than disposables. 
Discreet disposal of disposables can be a chal-
lenge. The possibility of using a mix of dispos-
able and washable products should be consid-
ered (Grade of Recommendation C). Some 
users who choose disposables when at home 
prefer washables when travelling because of the 
space that disposables occupy in luggage and 
the possible inconvenience of disposal. Others 
use washables at home and disposables when 
away as they see the balance of disadvantages 
and advantages differently. 
•  Personalisation of products: In institutions, the 
chore of personalizing washable products and 
sorting them after each laundry cycle should be 
considered before they are introduced (Grade 
of Recommendation C). Washable bodyworns 
are often personalised to particular users. In in-
stitutions this means marking products with users’ 
names and sorting them after laundry, an extra 
task for caregivers. Washable bedpads are not 
usually personalised. 
•  staining: Washable products should not usually be 
used by those with faecal incontinence – beyond 
occasional light smearing – because of staining 
(Grade of Recommendation C). Skin sprays and 
ointments may stain washables too.
•  Costs: Cost comparisons between washable and 
disposable products should be made with cau-
tion (Grade of Recommendation C). Key fac-
tors are: local arrangements (mostly laundry and 
transport costs); the durability of the products 
(which depends on how carefully they are used 
and the criteria for deciding when they should be 
replaced); the costs of ordering, transporting and 
disposing of disposables; and product purchase 
costs. Much of the cost of washables is encoun-
tered with the initial capital outlay for stock. This 
also represents a commitment to use the prod-
ucts for an extended period and so expensive 
mistakes can be made if it transpires that a better 
product was / has become available. It will usu-
ally be wise to experiment with samples of a va-
riety of alternative products before committing to 
major purchases.
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Close-fitting penile sheaths (sometimes called con-
dom catheters, uridomes or external catheters) are 
commonly used male incontinence devices and 
they are used in combination with a urine drainage 
bag. They are suitable for males who are experi-
encing moderate to heavy urine loss, or have lim-
ited mobility and are experiencing frequency and 
urgency and may even be considered in combina-
tion with intermittent catheterisation (IC) for males 
who are leaking urine as a consequence of bladder 
emptying problems. Sheaths may not be suitable 
for males who are experiencing confusion, consid-
ered psychologically vulnerable or have decreased 
sensation through spinal cord injury [89], [90], [91]). 
There is strong opinion expressed in the literature 
that suggests assessment, selection and use of pe-
nile sheaths and the accompanying urine drainage 
systems needs to be undertaken with the guidance, 
education and monitoring of health professionals 
who have a knowledge of continence products. Fail-
ure to do so, according to this expert opinion [[90], 
[92], [91]], may result in serious penile trauma, im-
paired penile skin integrity and leakageof urine.
General guidelines on patient assessment for prod-
uct selection are discussed in Section II. Aspects of 
assessment that are particularly important in rela-
tion to sheaths include: physical, mental, cultural, 
gender and socio-economic factors. This incorpo-
rates assessment of the cognitive and dexterous 
ability of the male or carer to apply the sheath and 
empty the drainage bag, the integrity of the penile 
skin, length and circumference of the penis and 
whether it is retracted, or retracts on sitting or bend-
ing down, history of latex or adhesive allergy and, 
most importantly, recognition that the assessment 
from the health professional needs to be ongoing. 
It is also important to assess factors known to en-
courage or discourage sheath usage. Expert opin-
ion [[93], [90], [94]] suggests factors that encour-
age usage include: level of reimbursement, cultural 
expectation, resonance with masculine image, and 
ability to keep urine off the skin when the skin integ-
rity is at risk because of incontinence. Factors which 
they suggest discourage usage include: ignorance 
of product efficacy by professionals and consumers 
and embarrassment between carer and client.
An effective sheath is one that stays securely in 
place for an acceptable period of time, is leak-free, 
comfortable to wear, easy to apply and remove, 
avoids skin damage and channels the urine effec-
tively into a urine drainage bag.
1. PRODUCT CATEGORIES AND FEATURES
Sheaths come with a variety of features (Figure VII-
1) of which the following are the most important to 
consider in making selections:
•  Material: sheaths may be made from latex, silicone 
rubber or other synthetic polymers. Some men will 
be allergic to latex.
•  Size: most sheaths are supplied in a range of 
lengths and sizes. Most companies supply them 
with diameters in the range of about 20 – 40 mm, 
in 5-10 mm increments. 
•  Adhesive: the adhesive may be integral to the 
sheath (one-piece systems) or come as a sepa-
rate strip or spray (two-piece systems). Some men 
will be allergic to some adhesives.
•  Applicator: some sheaths come with an applicator in-
tended to help users and carers to put the sheath on.
•  Anti-kinking / twisting features: some sheaths 
come with features intended to improve drainage 
by reducing kinking and twisting at the distal end, 
near the connection to the drainage bag tube.
•  Anti-blow-off features: some sheaths come with 
features intended to reduce the likelihood of the 
sheath blowing off at high urine flow rates, for ex-
ample, at the beginning of a void (eg the distal end 
of the sheath may be thickened and bulbous to 
stop the internal walls sticking to one another be-
tween voids). 
•  Connection to the drainage bag: some sheaths 
come with features intended to increase the ease 
and security of connection to the drainage tube (eg 
a push ring or ridge at the end of the outlet tubing)
•  Retracted penis features: with or without specific 
features intended to accommodate a retracted pe-
nis (eg a shorter sheath or a wider adhesive seal).
•  Durability: some sheaths are intended for use over 
a limited time period (eg 24 h) while other (generally, 
more robust) designs are intended for extended wear.
•  Transparency: some sheaths are transparent al-
lowing for observation of the condition of the skin 
along the shaft and glans of the penis.
2. QUALITY OF DATA
Some controlled comparative evaluations of differ-
ent sheaths have been performed; one extensive 
market survey to identify the needs and priorities of 
sheath users; and two studies comparing sheaths 
with other product categories (versus indwelling 
urethral catheter, and versus absorbent pads). Oth-
er studies report on the problems encountered by 
various groups of sheath users. 
3. RESULTS
Although many men use sheaths successfully, 
problems have been reported in the literature. In 
a study on an unspecified number of spinal cord 
injured men, Golji [95] found that 15% experienced 
side effects or complications when using sheaths. 
These were irritative, allergic or compressive in 
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nature. Jayachandran et al. [96] reported similar 
experiences with six incontinent men of widely 
varying aetiology and highlighted the importance 
of ensuring that the sheath does not become twist-
ed near the distal end to avoid stagnation of urine 
and the risk of UTI. They also stressed the impor-
tance of good genital hygiene to avoid problems 
with infections. In a study of 94 men on medical / 
surgical wards, Hirsh et al. [97] found that none of 
the 79 who were judged as co-operative and able 
to manage their sheaths properly developed UTI 
(mean period of use, 21.2 days). By contrast, eight 
of 15 patients who tended to tug and kink the drain-
age tube attached to their sheath developed UTI 
within a mean of 9.6 days. In a retrospective study, 
Johnson et al. [98] compared the frequency of UTI 
in users (mean period of use, 35 months) and non-
users of sheaths amongst 64 elderly men on an 
extended care unit. He found that 63% of users 
but only 14% of non-users developed UTI. No dif-
ference was found between men who did and did 
not tug and kink their tubing. Ouslander et al. [99] 
reported that 40% of 30 nursing home sheath us-
ers (mean period of use, 35.9 months) developed 
at least one UTI. The need for proper fitting of the 
sheath and regular monitoring of the skin integ-
rity of the penile shaft, glans penis and prepuce 
of males who are regular sheath users has been 
highlighted in two articles that report a combined 
total of eight cases of fibropithelial polyps of the 
glans penis and prepuce of which six had a history 
of long term sheath use [92] [100].
A trial to compare sheaths and indwelling catheters 
in terms of infection, risk and patient satisfaction 
has been reported by Saint et al [101]. This was 
a prospective, randomised, unblinded, controlled 
trial which compared one type of sheath drainage 
with one type of indwelling urethral catheter using 
a small group of participants (N=75) across sev-
eral locations in one hospital. There are important 
limitations of the study, including the low numbers 
drawn from a specific population, and the lack of 
comment on the changing / care routines associ-
ated with the sheaths and catheters. After making 
adjustments for age, mental score, history of UTI 
and history of catheterisation the conclusions of 
the study were that for males without dementia the 
use of sheaths has the potential to reduce infection 
compared to indwelling catheters and is more ac-
ceptable to patients in terms of comfort and pain. 
For males with dementia no significant difference 
in infection rates was found.
There has also been a cross-over trial [47] compar-
ing sheaths with absorbent pads when used by men 
with moderate to severe UI (N=61). Products were 
used for two weeks each and the Kings Health 
Figure VII-1: A variety of sheaths (top left and bottom right), a sheath applicator (top right) and an external 
fixation strip (bottom left).
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Questionnaire was used as the primary outcome 
measure. Scores for the sheath system were sig-
nificantly better than for the pads on most domains 
and the number of men preferring sheaths was sig-
nificantly higher than for pads. 
Nichols and Balis [102] reported the results of a sur-
vey undertaken for marketing purposes of an interna-
tional cohort of 216 men who had used sheaths for at 
least three years, and their carers. Their responses 
to 19 brands of sheath were gathered using a ques-
tionnaire in the form of a Likert scale. It was found 
that catheter security (presumed to mean staying in 
place and freedom from leakage) was the most im-
portant issue for both wearers and carers, followed 
by comfort and ease of application and removal.
There have been a number of comparative evalua-
tions of different sheaths. Peifer and Hanover [103]
reported on an evaluation in which 20 men compared 
a new branded sheath system that consisted of three 
ed parts: a tubular sheath impervious to urine with 
a drainage tube connection at one end and a ring 
at the other; an undergarment with a frontal opening 
through which the penis is extended; and a ring-like 
collar which is used to keep the sheath and penis 
in the correct position, with the variety of external 
sheaths they had previously been using. The partici-
pants were a convenience sample identified through 
pharmacy medication files. In all, 32 men were ap-
proached and 20 consented, all experienced users 
of urinary sheaths. A questionnaire was developed 
to test the participants pre and post intervention. The 
new sheath – which was used for a week - proved 
more popular with the participants: it was judged 
to provide superior security (13/20 experienced in-
creased dryness by day; 10/20 by night), and con-
sidered easier to apply (19/20) and remove (20/20). 
In a multi-centre study involving 35 men (age 
range 22-87y; mean age, 54y; 34 living in their own 
homes), the UK Medical Devices Agency [104] com-
pared four latex sheaths: two with integral adhesive; 
and two in which the adhesive was supplied as a 
separate strip. They found the products with inte-
gral adhesive to be more successful in both overall 
performance and ease of application. Fader et al. 
[21] conducted a multi-centre study to compare all 
six sheaths with integral adhesive on the UK mar-
ket in 1998. Five were made from latex, one from 
silicone rubber. Four were supplied with an applica-
tor, two without. Fifty-eight men (age range 26-88y; 
mean age 53y) were given the opportunity to try 
each sheath in turn for one week. The silicone rub-
ber sheath was found to be significantly better than 
four of the other sheaths in overall performance 
(p<0.01). The ease with which a sheath could be 
put on was found to be the best predictor of overall 
performance. Surprisingly, sheaths with an applica-
tor were found to be unacceptable to a significantly 
higher proportion of subjects than sheaths without 
an applicator (p<0.0001). Subjects found that the 
silicone sheath fell off / blew off significantly less 
frequently than two of the other products (p<0.01). 
Pemberton et al [94] report a randomised prospec-
tive open crossover design trial to test user prefer-
ence for an established one-piece silicone rubber 
self-adhesive sheath with a new one-piece silicone 
rubber self-adhesive sheath in a study sponsored 
by the distributor of both products. To be included 
the males had to be currently using at least one, 
one-piece urinary sheath, per day. Fifty three males 
from seven centres participated in the trial and were 
each given 10 sheaths of each product. Data from 
the 44 participants who had evaluated at least three 
of each product were analysed. No reason was giv-
en for why nine males did not complete the trial. The 
data shows that there were some problems with 
both products, however, it is difficult to understand 
why the new product was preferred, as the report 
does not mention any differences in the features of 
the two products.
Watson & Kuhn [105] describe a crossover study 
with six male participants that found the choice of 
leg bags may influence the performance of penile 
sheaths. Goldyn, Buck and Chenelly [106] con-
ducted an exploratory study on 10 patients in an 
extended care hospital to consider the efficacy of 
a brand name external sheath and a hospital con-
structed sheath. The brand name sheath was found 
to be more secure and the preferred nursing choice 
but it was recognised that the hospital-constructed 
sheath was useful for patients with fragile skin and 
limited mobility. A study by Saint et al. [107] provid-
ed further evidence (although low level) to support 
the importance of security and comfort to sheath 
users. Using questionnaires, they interviewed a 
convenience sample of 104 older men (response 
rate = 90%) and surveyed 99 nurses (response rate 
= 92%) about the relative merits and problems of 
sheaths and indwelling catheters. The study popu-
lation was drawn from a university-affiliated Veter-
ans Affairs Medical Centre in the USA. The patients 
using the sheaths were more likely to believe their 
product was comfortable (p = 0.04) and less likely to 
believe it was restrictive (p = 0.002) or painful (p = 
0.008) than those using an indwelling catheter. This 
viewpoint was supported by the nurses surveyed, 
the majority of whom (no numbers given) believed 
that sheaths were more comfortable and less re-
strictive than indwelling urinary catheters for male 
users, but required more care time because they 
fell off or leaked.
4. SUMMARY
For incontinent males, sheath drainage can provide 
a good alternative to pads. However, the increased 
risk for complications such as local skin breakdown, 
bacteriuria and infection - especially in the frail con-
fused elderly male – should be borne in mind (Level 
of Evidence 2). Also, there is the risk of urinary re-
tention if the condom twists or the external band is 
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too tight, leading to poor drainage to the urine bag 
(Level of Evidence 3). Sheaths with integral adhe-
sive are more popular with users and easier to apply 
than those with separate adhesive strip (Level of ev-
idence 2/3). Secure fixation and the ease with which 
a sheath can be put on are the best indicators of its 
overall performance (Level of Evidence 2). Sheath 
applicators are often ineffective and unpopular (Lev-
el of Evidence 2). There can be considerable differ-
ences in performance between products with some-
what similar designs (Level of Evidence 2).
5.  GENERAL POINTS FROM THE LITERA-
TURE, INCLUDING EXPERT OPINION
•  Prior to applying the sheath, ensure any remain-
ing adhesive or barrier cream is removed from the 
penis and that it is thoroughly washed with soap 
and water and thoroughly dried. 
•  Trim long pubic hairs to prevent them being caught 
up in the adhesive. 
•  Protective skin wipes can be used to protect the 
skin, but make sure the skin has dried properly be-
fore applying the sheath.
•  Leave a gap at the end of the sheath between the 
glans penis and the drainage tube to avoid trauma 
to the glans / prepuce. However, make sure the 
gap is not too large such as to cause kinking or 
twisting of the sheath [108].
•  After the sheath has been applied, snip any rein-
forced ring or unrolled section of sheath sitting at 
the bottom of the shaft of the penis. 
•  Penile sheath removal should not be rushed and 
is made easier by gently rolling it off while bathing 
the penis in warm soapy water.
6. RECOMMENDATIONS
•  Since there can be considerable differences in 
performance between products of similar design, 
men should be given the opportunity to experi-
ment with different products before making a final 
selection (Grade of Recommendation B).
•  The key performance characteristics which should 
be considered in selecting products are: security 
(ie ability to keep a leak-proof seal and channel 
urine to the drainage bag without leakage) and 
ease of putting the sheath on and taking it off 
(Grade of Recommendation B).
•  In general, sheaths with integral adhesive 
(one-piece systems) should be selected rather 
than those in which the adhesive is supplied 
separately (two-piece systems) (Grade of 
Recommendation C).
•  It should not be assumed that a sheath applicator 
will make sheath application easier: often it does 
not (Grade of Recommendation B).
•  Potential sheath users should be asked if they 
have an allergy history and regular users should be 
routinely checked as their latex allergy status can 
change over time and with continued use. (Some 
health settings are moving to reduce or eliminate 
latex usage whenever possible and some manu-
facturers have moved to offer non-latex sheaths) 
(Grade of Recommendation C).
•  Sheath users should be monitored for skin health, tis-
sue damage and UTI (Grade of Recommendation C).
•  When possible the external sheath rather than indwell-
ing urethral catheter should be the urinary collection 
device of choice. (Grade of recommendation B).
7. PRIORITIES FOR RESEARCH
•  Although products are continually being devel-
oped, changed, withdrawn and released, compari-
son studies that are controlled and use multiple 
sites to achieve larger numbers are recommended 
to further evaluate the effectiveness of the variety 
of sheaths available. 
•  More comparative studies of the risks of complica-
tions between the use of sheaths, pads and cath-
eters are required.
•  Since leg bag features may influence the perfor-
mance of the sheath, further evaluation of design 
features claimed to reduce twisting and kinking at the 
drainage bag connection site and increase ease and 
security of connection to drainage bags is required. 
•  Well designed studies to generate and validate 
procedures to help identify the type of sheath most 
likely to suit an individual are needed.
Urinary drainage bags are attached to an indwelling 
catheter or penile sheath to collect and store urine. 
Features of effective drainage bag systems include 
ease of operation of all components (connectors, taps, 
and support devices), comfort and discreetness.
General guidelines on patient assessment for prod-
uct selection are discussed in Section II. Aspects of 
assessment that are particularly important regard-
ing urine drainage bags are patient / carer dexter-
ity [90] [109], and eyesight. Both are necessary to 
manage the urinary drainage bag system, including 
using the outlet tap to empty the drainage bag. It is 
also important to assess the patient’s preferred and 
usual mode of dress [90] [109]; for example, a male 
whose preferred mode of dress is shorts will want a 
drainage system that is not visible and allows easy 
access for emptying,
1. PRODUCT CATEGORIES AND FEATURES
Urine drainage bags fall into two major categories: 
VIII. URINE DRAINAGE BAGS AND 
ACCESSORIES
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leg / body worn bags for day-time usage; and large 
capacity body-free bags for night-time use (night 
drainage bag) which are suspended from a stand 
or bed hook. 
Leg / body worn bags come with a variety of fea-
tures of which the following are the most important 
to consider in making selections: 
•  Volume: most bags have a volume in the range of 
350-750 ml, but some are bigger. 
•  Material: most bags are made from transparent 
PVC (polyvinyl chloride) but PVDF (polyvinylidene 
fluoride, less noise from rustling), polyethylene or 
rubber / latex may be used.
•  Sterility: bags may or may not be supplied sterile.
•  Wear position: bags may be designed for wearing 
over the knee, across or down the thigh, down the 
calf, or against the abdomen.
•  Attachment / suspension system: most leg bags 
are attached to the leg with straps, which are usu-
ally made from latex or a (usually elasticated) fab-
ric. A variety of hooks, loops, buttons / button holes 
and Velcro may be used to secure straps and to 
attach bags to straps. Some bags are designed 
to be suspended around the waist. Some straps 
and suspension devices can be bought separately 
from bags, but they are generally not suitable for 
use with all bags (Figure VIII-1).
•  Connecting tube: bags come with a variety of con-
necting tube lengths (eg the length required for 
wearing a bag on the calf will be greater than that 
for the thigh). With some products the tube can be 
cut to the preferred length. 
•  Drainage tap: Drainable bags come with a variety 
of drainage tap designs (Figure VIII-2).
•  Sampling port: bags may or may not have a 
sampling port in the drainage tubing for taking 
urine specimens.
•  Comfort features: some bags come with features 
intended to increase comfort – most commonly, a 
fabric backing against the skin to reduce sweating.
•  Discretion features: some bags come with features 
intended to increase discretion – most commonly, 
internal welds between the front and back faces to 
reduce bulging and / or sounds caused by a large 
volume of liquid moving about as the user mobilises.
•  Anti-kinking / twisting features: some bags come 
with features intended to improve drainage by re-
ducing kinking and twisting in the connecting tube.
•  Infection reduction features: some bags come with 
features intended to reduce the risk of infection for 
the self-carer and cross-infection between bag us-
ers by care givers. Such features may include; a
non-return flap valve, designed to help reduce re-
flux of urine up the tubing when the bag is moved 
by users or carers, a sampling port and / or a tap 
with an outlet sleeve which allows the overnight bag 
to be connected to the body worn bag. This linkage 
provides a mechanism to maintain a closed catheter 
drainage system designed to minimise the risk of 
cross-infection by reducing the handling of the cath-
eter. Having connected the night bag to the leg bag 
sleeve, the leg bag tap is opened and urine flows 
freely from the sheath or catheter through the leg bag 
into the night drainage bag. Pre-sealed drainage sys-
tems to prevent breaking the closed system are also 
available, and these could be beneficial in reducing 
time to bacteriuria [110].
Night drainage bags are usually held on a suspen-
sion system away from the body. They may be con-
nected directly to the catheter or sheath or they may 
be connected to the drainage tap of the leg / body 
worn bag to avoid the need for repeated connec-
tions and disconnections with the catheter or sheath 
(Figure VIII-3) ie a closed-link system. They usually 
have a capacity of 2000-4000 ml and come with a 
variety of design features many of which are similar 
to those for leg / body worn bags. Night drainage 
bags are available as non-drainable bags (NDB) i.e. 
without a tap for single use as well as with a vari-
ety of drainage tap designs for emptying and reuse. 
Glass bottles are also available for high volume or 
overnight urine drainage. It has been suggested 
that current standard drainage tubing / bag designs 
evacuate the bladder sub-optimally, leading to re-
tention of residual urine. Outflow obstruction can 
be caused by the development of air-locks in the 
dependent curls of tubing. A new drainage tubing 
design which incorporates a coiled downward-spi-
ral-shaped configuration has been reported to elimi-
nate air-lock obstruction [111] in experimental and 
clinical studies. However the importance of this in 
relation to infection requires further study.
2. QUALITY OF DATA
Several controlled comparative evaluations of urine 
drainage bags and suspension systems have been 
performed, as well as a small number of studies ad-
dressing infection and cross-infection issues There 
are also two case-controlled studies which have in-
vestigated the purple urinary bag syndrome.
3. RESULTS
a) Evaluations of urine drainage bags
A randomized cross-over design compared use 
of a standard latex drainage bag with a cloth cov-
ered bag in 42 men with post prostatectomy in-
continence [112]. Each bag was tested for about 
4-5 days, and complete data were provided by 30 
individuals. People with known latex allergy were 
excluded. Measures included adapted question-
naires for Leg Bag Evaluation and Skin Health. A 
statistically significant preference was found for the 
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Figure VIII-3: A night urine drainage bag on a stand.
cloth covered bag with a main effect (F= 36.614, 
df = 1.28, p<0.01) as well as an effect related to 
the order provided (F= 8.398, df = 1.28, p<0.01). 
That is, those who used the cloth bag first had a 
stronger preference for it than those allocated to 
the latex bag first. The cloth backed bag seemed 
to have several positive features, including comfort 
under the bag and cloth straps, flexible adjustable 
tubing, and taps that did not cause urine spillage 
on fingers. But these bags had a tendency to slip 
down and pull on the catheter. Two persons using 
the latex bags had minor skin irritation, one a rash 
related to the straps pulling on hairs on the leg 
and the other minor redness and swelling which 
resolved within 24 hours.
Figure VIII-1: Body worn urine drainage bags held in place using leg straps (left) and a waist band suspen- 
sion system (right).
Figure VIII-2: A variety of urine drainage bag tap designs.
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Kennedy et al. [113] tested the performance of 
ten different drainage bags in a simulation study 
involving 40 subjects (mostly health-care staff) 
which focused particularly on taps. Significant 
differences (p<0.05) were found between many 
pairs of bags with regard to each of the perfor-
mance aspects studied: ease of tap opening and 
closing, ability to empty the bag without urine 
wetting fingers; and how easy the tap mecha-
nism was to understand. Taps comprising caps 
or bungs were found to be particularly fiddly and 
messy to use.
In a study which focused primarily on the cross-
infection risks associated with leg bags, Wilson 
and Coates [114] evaluated four leg bags. Each of 
ten long-term catheterised patients was invited to 
try each bag for a week in turn. The authors con-
cluded that no one bag suited every patient; rath-
er, each was liked by some users. The popularity 
(or otherwise) of many features was a matter of 
personal preference. Adverse comments mostly 
related to the tap (difficult to operate, opened ac-
cidentally, causing leakage) and the straps.
The UK Medical Devices Agency [115] evaluated 
all 14 sterile 500 ml leg bags on the UK market 
in 1995 in a multi-centre study involving 83 test 
subjects (58 men, 25 women). About half (44) 
lived in their own homes and almost all the rest 
in nursing / residential homes. Subjects were di-
vided into pairs matched for sex, mobility, manual 
dexterity and dependency and each pair was of-
fered each of the 14 bags (seven each) to try for 
a week in turn. Preferences varied but the main 
concerns of users consistently focused on taps 
(many subjects found many taps difficult to op-
erate), straps (discomfort was common) and the 
minimisation of leakage (through faults in bags 
and / or connectors; onto the fingers when emp-
tying; or by the tap accidentally opening in use). 
The most popular bags tended to perform well in 
these three respects. 
In a multi-centre study involving 34 men (age 
range 27-84y; mean age 55y; all sheath users) 
Fader et al. [116] evaluated all seven non-sterile 
500-700 ml leg bags on the UK market in 1997. 
Twenty-five of the men lived in their own homes 
and the rest in residential/nursing homes or long 
stay wards. Conclusions were substantially simi-
lar to those for the earlier MDA study.
Some international standards have been devel-
oped which provide general advice on bag perfor-
mance and test methods [53]. These standards 
can be useful to laboratories asked to advise on 
bulk buying choices.
b) Urine drainage bag suspension systems
Little research has been undertaken on urinary 
drainage bag suspensions apart from a study by 
Thelwell et al. [117]. Thelwell et al. conducted a 
cross-over study using 52 subjects (20 men, 32 
women). This study compared four suspension 
systems for fastening leg bags with the leg straps 
they had used prior to the study. Each subject 
evaluated each product for a week in turn and re-
corded their findings on a weekly questionnaire. 
Again, difficulty of application, comfort, discrete-
ness and cost were key issues. However, there is 
suggestion in the literature that urinary drainage 
bag suspensions have an important role to play 
not only in the comfort and security of the wearer 
but in the prevention of urinary tract infection re-
gardless of whether the drainage system is con-
nected to a sheath or an indwelling catheter.
Munnings and Cawood [118] report the findings 
of a pilot study designed to evaluate the use of a 
belly bag of 1,000ml capacity and worn 24 hours 
a day, thus eliminating the need to use two sepa-
rate bags and reducing the number of times the 
closed system is broken, Twenty-nine patients 
from a variety of areas from within an acute care 
setting who were using continuous catheter drain-
age systems were invited to participate, with 27 of 
the participants completing the study. All agreed 
to wear and then compare the belly bag with their 
previous leg and night drainage bag system. Worn 
around the waist, the belly bag is not positioned 
below the bladder: the manufacturers claim that 
the pressure of the bladder muscles is sufficient to 
ensure that urine flows through the catheter from 
the bladder into the bag. The residual pressure 
of the bladder is reported to be around 10-25cm 
H2O, while the manufacturer asserts that a pres-
sure of only 6cm H2O is necessary to ensure the 
urine drains into the bag. Following education of 
how to use the drainage bag, users were given 
a questionnaire designed to facilitate comparison 
between the previous drainage system used and 
the belly bag. This was followed up with a tele-
phone call. All agreed the belly bag was an im-
provement over their previous system of leg and 
overnight drainage bags, and found it more con-
venient, comfortable and less likely to cause pain 
with movement. 
It has been suggested that current standard drain-
age tubing / bag designs evacuate the bladder 
sub-optimally, leading to retention of residual 
urine. Outflow obstruction can be caused by the 
development of air-locks in the dependent curls 
of tubing. A new drainage tubing design which in-
corporates a coiled downward spiral shaped con-
figuration has been reported to eliminate air-lock 
obstruction [119] in experimental and clinical stud-
ies. However the importance of this in relation to 
infection requires further study.
There is opinion in the literature that positioning 
standard drainage bags below the bladder in a 
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manner that averts kinking will prevent reflux of 
urine, and associated infection [120], [121], [122].
When doing so care must be taken not to increase 
traction or friction [109]. This can be achieved 
with the use of supports specially designed to di-
vert accidental pulling on the catheter or sheath. 
When using these support systems allowance 
should be made for penile erection and tumes-
cence [109]. 
The drainage system for indwelling catheters 
should be positioned off the floor to reduce the risk 
of cross infection [120], [121], [122]. Some sterile 
and unsterile leg bags come with a variety of tub-
ing lengths or tubing that can be cut according to 
the needs of the individual, and leg straps that can 
be adjusted to allow positioning of the bag on the 
thigh or calf. Night bags - even if the tubing can be 
cut - rely on uniform stands or hangers to ensure 
that they are off the floor. Roe et al [123]) raised 
the issue of poorly designed support systems for 
night bags. Expert opinion suggests that this still 
remains an issue. 
c) Infection and cross-infection issues for man-
agement of urine drainage systems for indwell-
ing catheters. 
Usage of urinary catheters and their drainage sys-
tems increases the risk of urinary tract infection 
and cross infection (See Section XII.2.h). There 
is evidence to suggest that catheter associated 
infections are reduced with the use of closed uri-
nary drainage systems. A randomised controlled 
trial was reported by Platt et al [124]. This trial 
compared the incidence of infection (measured as 
105 cfu/ml in catheter urine or drainage bag urine) 
between patients who were catheterised using 
sealed junction catheters (i.e. catheters pre-con-
nected to a drainage bag using a sealed junction), 
and those catheterised using unsealed junction 
catheters (i.e. unconnected catheters and drain-
age bags), in a hospital setting with a median pe-
riod of catheterisation of three days. For subjects 
not taking antibiotics, sealed junctions showed 
less infection than unsealed (p=<0.01). For sub-
jects taking antibiotics there was no difference 
in infection rates between sealed junctions and 
unsealed junctions. The infection rate appeared 
to be consistently lower in the subjects taking 
antibiotics than the ones not taking antibiotic but 
no statistical significance tests of this effect were 
reported.
Maintaining a ‘closed’ system has since become 
an important tenet for avoidance of urine infection 
both particularly in acute care but also in long-term 
care. This has led to the introduction of products 
designed to maintain a ‘closed’ system. In the UK 
the ‘link’ system is advocated whereby legbags 
are designed with a connector to attach to a night 
drainage bag, thereby obviating the need to dis-
connect the legbag from the catheter in order to 
connect a night bag. Use of non-drainable (single-
use) night bags is also recommended in the UK 
(RCN 2008) presumably to reduce the cost of us-
ing a new (and more expensive) drainable night 
bag every night and also to avoid the practice of 
cleaning and re-attaching drainable night-time 
bags. However it should be noted that this ‘link’ 
system is not completely ‘closed’ (because the 
night bags are still disconnected and reconnected 
every night – albeit at the legbag tap rather than at 
the catheter) and the legbag may still be discon-
nected at the catheter junction for other purposes 
such as bladder instillations.
If a ‘link’ system is not in use then whenever a legbag 
needs to be changed to a nightbag the bag will need 
to be disconnected at the catheter junction. The bag 
(leg or night) may then be replaced (or more com-
monly) will be cleaned and reused. As yet there have 
been no studies to compare the use of the ‘link’ sys-
tem with a conventional disconnection system. 
The number of days that a legbag may be safely 
(or acceptably) left in place before it is replaced 
is unknown. There is little research to support the 
common practice of changing drainage bags every 
five to seven days (or any other particular change 
regime). The practice appears to be based upon 
expert opinion, anecdotal evidence and manufac-
turers’ recommendations. The five to seven day 
practice seems to be challenged by a study by Rog-
ers et al. (1996) [125],of biofilm progression,which 
showed that it took only four days for colonization in 
the bladder model to extend all the way to the drain-
age bag (Royal College of Nursing, 2008).
A prospective study of catheter use in the US, of 
43 long-term catheter users, indicated that drain-
age bags were changed less often than either com-
monly reported, or Rogers et al. suggest. In that 
study, drainage bags were replaced an average of 
every 23.5 (95% CI 21.1-25.9) days, during their six 
months’ participation in the study [126].
Of interest is the study outlined by Keerasunton-
pong et al. [127] which was a randomized controlled 
study that compared the incidence of catheter-re-
lated urinary tract infections in a group of 79 hos-
pitalised patients whose catheter bag was changed 
every three days with that for a group of 74 patients 
who had their bag changed at the time of the cath-
eter change or if the bag became faulty. A urine 
sample for culture was obtained for each participant 
every seven days, on the day the catheter was re-
moved or on the day the participant was suspected 
of having an infection. The findings suggest that 
urinary drainage bags could be left for longer than 
three days but the authors were reluctant to define 
how long as the sample size was considered too 
small to rule out a false-negative result. They rec-
ommended additional study.
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Single use drainage bags, including non-drainable 
urine bags (NDB), were recommended in England’s 
Royal College of Nursing Catheter Guidelines 
(2008) for all sites of care (hospital based and com-
munity living patients). Only one study was found of 
this product. Hardyck and Perrinovich (1998) [128] 
described a retrospective home care trial of a NDB 
in 63 elderly patients, comparing with the same per-
sons who had used a typical drainable bag (DB) in 
the previous months. The non-drainable bag was 
replaced when full, but no information was given 
about the capacity of the bags, the mean number 
of bags used per day or how often they were re-
placed. Fewer UTIs (and hospitalizations) were re-
ported with the NDB, 71 (2) versus 1395 (27) in the 
DB. Unfortunately the methodology was flawed in 
several ways. Counts of UTIs were reported though 
the timeframes were vastly different, with a mean of 
44.4 months for DB prior to the intervention period 
and a mean of 8.8 months for NDB. UTI diagno-
sis was determined by mailed questionnaires to 82 
home care patients and information from nurses, 
physicians, and patients as well as chart information 
reviewed by the physicians. Comprehensiveness or 
completeness of the chart data extraction was not 
described. Additional analysis comparing matched 
timeframes of 16 months for a subsample of 15 (and 
5 more within 2 months either direction) indicated 
that the mean number of UTI related hospitaliza-
tions in the NDB group was significantly higher: 12.1 
(SD 8.87) as compared with 2.8 (SD 4.74) in the DB 
group (Wilcoxan rank test p<0.005). The matched 
pairs were selected based on whether the NBD was 
used for at least a month and chart data were avail-
able. Given questions on the methodology, it seems 
that a well designed randomized trial is needed, but 
no such study was found. 
There is no evidence to support the practice of adding 
in situ antiseptic agents to drainage bags to reduce 
catheter-associated infection. A paper by Thompson 
et al. [129] which was primarily looking at the effec-
tiveness of hydrogen peroxide instilled into closed 
drainage bags in reducing infection in drainage bags 
and in catheters also raises the question of whether 
catheters are infected primarily via drainage bags or 
vice versa. This prospective randomised study in a 
hospital setting involved daily sampling for bacteri-
uria (See Section XII.2.h for further discussion of out-
come measures for catheter-associated infection) in 
catheters (>=105 cfu/ml) and drainage bags (>= 103 
cfu/ml) and identifying the infecting bacteria species. 
In a sample size of 688, infection was found in 68 
catheters and 78 bags. Although bag contamination 
was 8% in the H2O2 group and 16% in the control 
group (p<0.001) there was no significant difference 
in catheter bacteriuria (11% and 9%, respectively). 
One of the reasons given in the paper for questioning 
whether the drainage bag is the main source of cath-
eter infection was that 77 % of the bags in this study 
were contaminated later than the catheters.
Best practice guidelines to prevent infections asso-
ciated with short term indwelling urethral catheters 
are available. The most recent of these, the EPIC 
2 guidelines, were revised in 2005 and reported by 
Pratt et al. [122]. Designed to prevent short term, 
indwelling urethral catheter associated infection in 
NHS Hospitals in England, the guidelines are based 
upon a series of systematic reviews that include 
the best available evidence (experimental and non-
experimental research as well as expert opinion). 
These guidelines recommend a closed catheter 
system where drainage bags are changed accord-
ing to the manufacturer’s recommendations (5-7 
days) or the patient’s clinical need. The guidelines 
also recommend that antiseptic or antimicrobial so-
lutions are not added to urinary drainage bags.
Recommendations for acute care settings were is-
sued by the Society for Healthcare Epidemiology 
of America (SHEA) in 2008[130]addressing system 
wide infrastructure preventive activities. These in-
clude use of written guidelines, complete documen-
tation, surveillance for catheter–associated UTI 
(CAUTI), education and training of personnel related 
to catheter insertion and management, and appro-
priate insertion technique. The authors noted that 
decreasing catheter use and duration are central 
to preventing bacteriuria and CAUTI. Suggestions 
were given for organization-wide strategies, such as 
reminder systems for review of catheter continua-
tion, automatic stop order processes, ward rounds 
to enhance communication and review, catheter 
related protocols like post operative duration, and 
systems for data reporting. Guidelines from SHEA 
for preventing infection in long-term care facilities 
were updated also in 2008 [131].
d)  Long-term management of urine drainage 
systems and reuse of components
The quandary for health professionals involved in 
the education and support of clients, who are self-
managing and often financing their long term indwell-
ing catheter drainage systems while living at home, 
is that they are aware that many of them are leaving 
the bags on for much longer than the manufactur-
ers recommend and are often washing the bags out 
with a variety of solutions and reattaching the bags 
directly to the indwelling catheter. The reuse of drain-
age bags is often not a matter of choice but necessity 
in developing countries. In a survey of 28 continence 
nurses who were members of ICS, a majority (68%) 
said they advised their community dwelling patients 
to reuse drainage bags [132]. A number of reasons 
were given, such as cost of bags, evaluation of risk 
in the patient, policies, guidelines, and ability to do 
the procedure. While advice varied, most suggested 
a solution of water mixed with vinegar, household 
bleach, or dishwashing detergent. 
There is a paucity of studies that have explored 
long-term self-management of urinary catheter 
drainage systems in a community setting. Moreover, 
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practices may vary considerably in parts of the world 
where catheter supplies are not routinely provided 
by prescription, as in the UK, or in developing na-
tions where supplies are scarce. More research 
in this area is needed to provide guidance to cli-
nicians. Implications involve cost, aesthetics, and 
environmental waste, particularly when single use 
non-drainable bags are used.
Madigan & Neff [133] undertook a literature review (50 
studies) that explored the complications and long term 
management of long term indwelling catheters used 
for urinary retention and incontinence. Their recom-
mendation in relation to management of drainage bags 
was that closed drainage systems were preferred best 
practice. However they also indicated that leg and bed 
bags may be used for up to four weeks if the system 
is broken daily to allow daily bag decontamination with 
a diluted (1:10) bleach solution This recommendation 
appears to be based on the following two trials, one of 
which involved 54 participants sampled from an acute 
care rehabilitation centre and one involving 14 com-
munity dwelling participants.
Dille et al [134] report a randomised group paral-
lel study with a pre-test and multiple post-tests uti-
lised to determine the safety of a four week re-use 
of vinyl leg and bed bags compared to the usual 
practice of one week when de-contaminated daily 
with a procedure that utilised dilute bleach (sodium 
hypochlorite, 1:10 bleach to water). This study was 
based on previous research in which daily decon-
tamination of drainage bags was done as compared 
with replacing with new sterile bags each day [135]. 
Set in an acute rehabilitation unit, 54 participants 
(18 female and 36 males) completed the four week 
data collection period. Randomised by the flip of a 
coin, 28 participants were in the experimental group 
and 26 in the control group. All participants had an 
indwelling catheter and were using a leg bag dur-
ing the day and a bed bag at night. Both groups 
received identical daily bag decontamination and 
weekly bag and urine cultures. A standard of 0 to 
100 cfu/mL was used to measure bag decontamina-
tion effectiveness and the urine cultures were pro-
cessed by the Associated Regional and University 
Pathologists Inc. No significant differences were 
found between groups and the authors concluded 
that it is safe and cost effective to reuse vinyl bags 
for four weeks as opposed to the previous practice 
of one week, if the protocol for daily decontamina-
tion described is used. This study does not compare 
the practice of washing out the drainage bags with 
the chlorine solution either weekly or for a period of 
four weeks with a closed urinary catheter system to 
determine if that would result in fewer UTI’s.
Rooney [136] reported a study of 14 people with 
neurogenic bladders living at home. They changed 
from using daily sterile leg bags to non-sterile leg 
bags which were washed out after use each day 
with a dilute chlorine solution. Nine participants 
were on Foley catheter drainage and five were us-
ing sheaths. Bedside urine collection bags were 
used by all participants at night and there was no 
change made to the standard practice of rinsing the 
overnight bag with water each morning and recap-
ping the drainage tubing. While the steps of the pro-
cedure were described, no information was given 
on who did the decontaminating, i.e., patients/care-
givers or both. The study ran for three months in-
cluding a preliminary baseline phase of one month. 
No comment was made on whether the non sterile 
bags were changed. There were no symptomatic 
UTI infections during the study and urine samples 
with bacteriuria (>105 cfu/ml) did not increase. 
However the sample was very small and no statisti-
cal tests were applied to the results. 
e)  Urinary drainage bag features intended to re-
duce the risk of cross infection
The cross-infection risks of leg bags (particularly 
via the tap or sampling port) have been studied by 
Glenister [137] and by Wilson and Coates [114]. In 
her study Glenister [137] concluded that designs in 
which the tap and outlet spouts were most widely 
separated were most effective at preventing contami-
nation of the hands with urine. Wilson and Coates 
[114] studied sampling ports and contamination of 
leg bag spouts. They suggested that the night con-
nector tubing attached to the taps on the four leg 
bags in their study made decontamination difficult.
A small comparative study of two sets of closed sys-
tem bags with a double non-return valve and two set 
of bags with a single non-return valve - all inoculated 
with Escherichia Coli and using simulated laboratory 
conditions in two separate microbiological laborato-
ries blinded to each other - found that the colonisa-
tion of a simulated bladder was significantly delayed 
when the double non return valve was used [138].
f) Purple urine bag syndrome
There are occasional reports in the literature of pur-
ple discolouration in urine drainage bags – termed, 
purple urine bag syndrome (PUBS) – and there is 
considerable debate and diversity of opinion over 
the cause and significance of the phenomenon. Two 
case controlled studies were found.Tsumura et al. 
(2008) [139] compared five persons with PUBS to10 
without it.Urine sugar, serum amino acids, and leu-
kocytes were similar, but the PUBS group differed 
in having a high alkaline urine in combination with 
bacteriuria. An earlier study had showed similar 
results with a high urinary pH. Mantani et al [140] 
conducted a case controlled study on 26 patients 
in three long-term wards. Fourteen (two men and 
12 women) had exhibited PUBS while 12 (four men 
and eight women) had not. The clinical, microbio-
logical and bacteriological backgrounds of the sub-
jects in the two groups were compared to identify 
possible causes of PUBS. The findings of both stud-
ies suggest that urine that is alkaline and has a high 
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bacterial yield are most likely to exhibit PUBS. There 
is no evidence to suggest detrimental effects on pa-
tients’ health or functioning of the drainage system. 
However, the smell can be very distressing.
Studies which have compared leg bags and cath-
eter valves are reviewed in Section 12.
4. SUMMARY
Taken together, published studies agree that the 
main factors to consider in selecting leg bags are 
the ease of tap operation, the comfort of suspension 
systems and the minimisation of leakage (Level of 
Evidence 2). Bags in which the tap and outlet spout 
are widely separated are most likely to be effective 
at preventing contamination of the hands with urine 
and cross-infection (Level of Evidence 3). There is 
high level evidence from studies – predominantly in 
acute care settings - to support the use of closed 
urinary drainage systems (Level of Evidence 2).
5.  GENERAL POINTS FROM THE LITERA-
TURE, INCLUDING EXPERT OPINION
Provision of clearly presented information based on 
the best evidence available is needed for clinicians, 
carers and patients as many aspects of caring for a 
urinary drainage bag system are supported by scant 
or conflicting evidence or by custom.
There is agreement that the hands must be cleansed 
and clean non-sterile gloves put on prior to caring for 
the urinary drainage bag system and that, on com-
pletion of handling the system, the gloves must be 
discarded and the hands cleansed again [141], [122]. 
There is also mention of confusion arising for cli-
nician, patient and carer because of the many 
different designs of urinary drainage bag taps, 
and the regularity with which such features are 
changed [142]. Manufacturers should ensure 
that the instructions and accompanying literature 
that they develop for their urinary drainage bag 
systems are clearly presented and easily under-
stood [142] in a format which is convenient to 
retain and refer to.
6. RECOMMENDATIONS
In making urinary drainage bag selections particular 
attention should be focused on: the ability of the user 
to operate the tap; comfort (especially of the straps); 
freedom from leakage (especially from the welds and 
the tap); and discretion (especially visibility beneath 
clothing) (Grade of Recommendation B).
The patient’s individual needs and personal prefer-
ences should determine the use of leg / suspension 
/ attachments and position of where the bag is worn 
(Grade of Recommendation C) 
Maintain closed urinary drainage system for indwelling 
urinary catheterisation where the system is only bro-
ken to change the sterile bag according to manufac-
turer’s recommendation or in a shorter period of time 
if clinically indicated. (Grade of recommendation A).
7. PRIORITIES FOR RESEARCH
Jones, et al [141] identify many of the issues con-
cerning the handling of urinary drainage bag sys-
tems that require further research, including the 
issue that has already been discussed above, of 
how long a closed urinary drainage system can be 
left unbroken before the urinary drainage bag is 
changed. Jones et al [141] also suggest research 
is needed into:
•  How often and how drainage bags should be emptied? 
•  If a closed urinary drainage bag link system is used, 
does the night bag that is connected to the leg bag 
need to be sterile or can it be a reusable one?
•  If a reusable night urinary drainage bag can be 
used, how should it be cared for when not in use?
•  What is a reasonable method to dry reusable bags 
after they have been washed?
•  Establishing whether the incidence of UTI is in-
creased in hospital, community or residential aged 
care settings when urinary drainage bags in closed 
drainage systems are changed at different intervals 
(eg the time of catheter change rather than weekly).
•  Determining in own home settings whether a 
closed catheter drainage system is more effective 
at preventing urinary tract infections than reusable 
non-sterile urinary drainage.
•  Determining which method of cleaning non-sterile 
urinary drainage systems is most effective and ac-
ceptable to patients. 
1. FEMALE BODYWORN URINALS
Pieper [143] has reviewed the many attempts to de-
sign bodyworn urine collection devices for women. 
The major challenge is in achieving a comfortable 
and aesthetically acceptable leak-proof seal with 
the body. Various designs have sought to achieve 
this by holding a collection device over the urethral 
meatus with the help of suction, straps, adhesive 
or close-fitting underwear. While none have found 
widespread success and usage, they are available 
commercially in some countries.
2.  MALE BODYWORN URINALS AND DRIB-
BLE CONTAINERS
The urine collection devices most commonly used 
by men are sheaths (see Section VIII) but a variety 
of other products such as pubic pressure urinals are 
available. They comprise a ring-shaped opening or 
cone-shaped component which is worn around the 
IX. BODYWORN URINALS
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Figure IX-2: A dribble pouch
penis (and held firmly against the pubis by means of a 
belt and straps) and channels urine to an integral col-
lection bag (Figure IX-1). Such devices are not widely 
used but they can be effective for individuals whose 
penis is too retracted for a sheath to be suitable. There 
are no published evaluations of these products.
They should be fitted by a specialist: a good fit is 
crucial for comfort and to avoid leakage. It is also 
important that the wearer / carer understands how 
 X. MECHANICAL DEVICES FOR
WOMEN WITH URINARY INCONTINENCE
Figure IX-1: A variety of pubic pressure bodyworn urinals for men.
to use the device and the importance of skin care, 
The wearer / carer will need good manual dexterity 
to manage the device. Several urinals will be need-
ed to use in rotation, allowing each to be properly 
washed and dried between periods of use.
Dribble pouches are also available for light incon-
tinence (Figure IX-2) but there are no published 
evaluations of these products.
3. PRIORITIES FOR RESEARCH
There is a need for leak-free, comfortable and aes-
thetically acceptable body-worn urine collection de-
vices for women and improved (in these respects) 
products for men.
 
Female mechanical devices are designed to pre-
vent urinary leakage in different ways and fall into 
three main categories: those that are applied over 
the urethra at the external meatus; those that are 
placed within the urethra (intraurethral devices) and 
those that are inserted into the vagina (intravaginal 
devices). Both designs of urethral device are in-
tended to occlude the urethra and the intravaginal 
devices are intended to provide some support to the 
bladder neck and possibly some compression to the 
urethra. These devices are also known as occlu-
sive devices and are primarily used by women with 
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stress incontinence. There is a recently updated 
Cochrane review of these devices [144].
General guidelines on patient assessment for prod-
uct selection are discussed in Section II. Aspects of 
assessment that are particularly important regard-
ing mechanical devices are high levels of motiva-
tion and acceptability of the concept of use, good 
cognition and good manual dexterity. They should 
probably be avoided by those with skin sensitivity 
or if avoidance of urinary tract infection is a priority.
1.  DEVICES THAT OCCLUDE AT THE EXTER-
NAL MEATUS
Urethral occlusion devices have been developed to 
block urinary leakage at the external urethral me-
atus (Figure X-1). Several devices have utilized ei-
ther adhesive or mild suction to achieve occlusion. 
In addition to the simple barrier effect, compression 
of the wall of the distal urethra has been hypoth-
esized to contribute to continence.
Miniguard (Uromed Inc., but no longer available) 
is an angularly shaped foam device which utilizes 
an adhesive hydrogel to adhere to the peri-meatal 
area. The device is single use, removed prior to 
voiding, and disposable. FemAssist (InsightTM 
Medical Corp., but no longer available) is a hat-
shaped silicone device, which adheres by applying 
an adhesive gel to the edge of the device, squeez-
ing the central dome and creating a vacuum. The 
device is then placed over the urethral meatus and, 
upon release, the meatal mucosa is drawn up into 
the device and the urethral lumen is occluded. It 
may be worn for up to four hours or until voiding, 
after which the device is washed in hot soapy wa-
ter and reapplied. The device was reusable for one 
week. CapSure (CR Bard Inc., no longer available) 
was applied and retained by suction. A petroleum 
based lubricant is applied prior to device use. The 
device is removed for voiding and re-utilized for up 
to two weeks.
a) Quality of data and results
Miniguard: Eckford et al. [145] studied the ef-
ficacy of a single application of this device dur-
ing a one hour pad test and reported that 25% 
of patients were continent, 50% were improved, 
but 25% had worse incontinence. Brubaker et al. 
[146] enrolled 411 women to their study; 390 used 
the device, and 346 completed the study. Results 
showed significant improvement in symptoms. 
The incontinence impact scores significantly de-
creased from a mean of 41.0 (out of 300 – high 
scores worse) to a mean of 10.5 at 17 weeks. 
Twelve hour pad test showed mean urine loss 
decreased significantly from 15.8 to 6.9 ml and 
incontinence episodes from 14.2 episodes per 
week to 4.9 episodes at week 17. Symptoms of 
vulvar irritation or lower urinary tract discomfort 
occurred in a small percentage of subjects but it 
was generally transient, and only three women 
discontinued using the device for this reason. 
There were no statistically significant differences 
in the proportion of subjects reporting urinary 
tract infection during device use compared to be-
forehand. The authors concluded that the device 
was safe and effective (Level of Evidence 3).
Fem Assist: Versi et al. [147] studied 155 women 
with stress or mixed incontinence, of whom 133 at-
tempted to use FemAssist and 96 enrolled in a four-
week study. Their mean pad test loss fell from 27 g 
to 9.4 g (p<0.001) and 49% were dry. Symptomatic 
cure was more likely in those with mild incontinence. 
Of the nine women who had a positive pad test (>2 
g) without the device, five were dry (<2 g) with the 
device (p<0.05). VAS scores showed a significant 
improvement for the symptom of stress inconti-
nence (p<0.05). QoL scores improved significantly 
by 38% (p<0.05) for the IIQ and 29% (p<0.01) for 
UDI (Level of Evidence 3).
Moore et al. [148] reported on 57/100 recruited 
women who completed a one-month trial. Reduc-
tion of incontinence was statistically significant on 
pad testing, which revealed that 47% of the patients 
became continent and 33% had more than 50% 
benefit compared to baseline, while 9% had worse 
leakage. Those with severe baseline leakage were 
as likely to respond as those with mild or moder-
ate pad test loss. Women with stress, urgency or 
mixed incontinence appeared to respond equally 
well. Dropouts included 13% who were unwilling to 
utilize the device (Level of Evidence 3).
Tincello et al. [149] in a 3-month prospective study 
involving 27 women with urodynamic stress incon-
tinence found the median (range) loss with and 
without the device was 4.9 (0-65) ml and 21 (1-
94) ml respectively (p<0.01); and 20 patients were 
Figure X-1: A female occlusive device that occludes 
at the external meatus.
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less wet when using the device. Discomfort was 
greater among the women with a greater loss. The 
acceptability correlated negatively with discomfort 
(r = -0.53) and negatively with embarrassment (r 
=-0.39); 15 patients (56%) reported that they would 
use the device in the long-term (Level of Evidence 
3). Tincello et al. [150] later reported on 41 women 
recruited to use the device over a three month pe-
riod, but 10 declined to participate, six withdrew be-
fore two weeks, 10 failed to attend two week follow-
up and 11 did not attend three month follow-up. Only 
two completed the study. There was no difference in 
pad test or voiding diary grades. The authors con-
cluded that the device had low acceptability and 
was ineffective, and could not be recommended for 
non-surgical management of stress incontinence 
(Level of Evidence 3).
CapSure: Bellin et al. [151] reported on 88/100 com-
pleters after 12 weeks, with 82% elimination of leak-
age on pad test, 91% continent on provocative stress 
test (single cough assessment of leakage), and 48% 
dry and 40% improved on urinary diaries. Pad test 
leakage decreased from 6.67 g (range 0.55-25.95 g) 
to 0.19 g (range, 0-2.5 g) by week 12. Five patients 
withdrew secondary to vaginal irritation and three 
due to poor device fit (Level of Evidence 3).
Shinopulos et al. [152] carried out a multi-centre 
study enrolling 100 women with stress incontinence 
who wore the device for 12 weeks. Eighty-four wom-
en completed the study. Mean pad weights reduced 
from 6.7g at baseline to 0.19 by week 12. Compli-
cations affected seven patients, including urethral 
/ vaginal swelling and vulval abrasion, but none of 
the affected patients withdrew from the study. The 
IQOL tool showed significant mean improvement 
from 62.3 to 90.4.
b) Summary
External urethral occlusive devices were found to 
be of varying efficacy, with minimal morbidity. Effi-
cacy of the combined studies reveals a continence 
rate of approximately 50% dry and two-thirds of pa-
tients improved, but this data is from open studies 
(typically pre-test / post-test with no control group) 
and there have been no randomised controlled tri-
als. Devices achieve occlusion either by blocking at 
the meatus or compressing the distal urethral lumen 
and adherence to the peri-meatal area is essen-
tial to success. However, the method and degree 
of adherence is also the determining factor for the 
type and severity of local irritation. Patient selec-
tion based on motivation, appropriate anatomy, and 
manual dexterity, in combination with efficacy and 
morbidity will determine overall satisfaction. There 
is no data which compares one extra-urethral de-
vice to another, or to other categories of products. 
Cost comparisons for disposable versus short-term 
reusable devices are not available. Efficacy for dif-
ferent grades of incontinence has not been estab-
lished. The objective degree of continence improve-
ment in the clinical laboratory (pad and stress tests) 
is greater than in community use (diaries). The de-
vices tested in these studies are no longer available 
and there are no external urethral devices currently 
on the market.
c) Recommendations
Although these devices have proved effective for 
some women (limited mainly to those with high mo-
tivation, manual dexterity and cognitive function), it 
appears that they have failed to find popularity with 
users and clinicians. They are no longer commer-
cially available and so no recommendation on their 
use can be made.
d) Priorities for research
Further research on the development and role of 
devices which block urinary leakage at the exter-
nal urinary meatus, with a focus on improving pa-
tient acceptability is recommended. One half of 
patients utilizing these devices in monitored stud-
ies were dry and two-thirds of the patients were 
improved with minimal morbidity. These devices 
may have a future role in the algorithm of con-
servative treatment based on patient acceptance, 
availability and cost, especially in those patients 
with mild or moderate stress incontinence, for oc-
casional or intermittent use and/or for those who 
prefer to avoid pads or surgery.
2. INTRAURETHRAL DEVICES
Urethral inserts are silicone cylinders that are self-
inserted or removed at the patient‘s discretion. They 
are intended for day-time use, especially during vig-
orous physical exercise. While some women manage 
exercise incontinence by limiting fluid intake before 
or during exercise, by choosing sports that allow fre-
quent bathroom access, or wearing absorbent pads, 
20% to 40% of women cope with leakage by ceasing 
exercise [153]. These devices have external retain-
ers or flanges to prevent intravesical migration and 
proximal balloons to hold the device in place. They 
act by causing occlusion either in the urethra itself 
or at the external urethral meatus [154]. (Figure X-2)
The FemSoft (Rochester Medical Corporation) 
is the only urethral insert currently distributed. It 
has a soft, compressible, mineral oil-filled silicone 
layer with an insertion probe. Before insertion, the 
fluid distends the proximal end of the cylinder, as 
the user pushes the device (guided by the inser-
tion probe) into the urethra, fluid transfers auto-
matically to the distal end, allowing the device to 
pass through the urethra. Once in place, fluid flows 
back to the proximal end to hold the device in place. 
None of these devices are recommended for reuse 
after removal. The FemSoft Insert is currently pack-
aged in a box of 28 inserts and each box is priced 
at $49.95. The Viva [155], Reliance and other intra-
urethral devices mentioned in this sub-section, are 
not currently marketed. 
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a) Quality of data and results
The objective efficacy measurements utilized were 
the one-hour pad test, voiding diary and quality of 
life questionnaires. There have been no random-
ized control trials. 
Nielsen et al. [155] [156] and Peschers [157] stud-
ied the Viva device. Peschers et al. screened 53 
patients with USI and 21 patients accepted treat-
ment with the two sphere device. During a four 
month study, the investigators analyzed subjective 
improvement and performed pad-weight and cough 
tests. The authors reported that 67% of patients had 
improvement in symptoms. Nielsen et al. [155] stud-
ied forty women who tested two variants of the de-
vice (with one or two spheres) each for two weeks in 
a cross-over study. They then continued with what 
they judged to be the better plug in period three (two 
months). Only 45% (18/40) completed this period 
but almost all (17/18) were reported to be subjec-
tively and objectively continent or improved. Six 
women developed urinary tract infections and two 
of these had retained a plug in the bladder.
Staskin [158] reported on a four month study of 135 
of 215 patients who utilized a disposable balloon 
tipped urethral insert made from thermoplastic elas-
tomer, inflated with an applicator on insertion and 
deflated by pulling a string at the meatal plate for re-
moval during voiding (Reliance, Uromed Corp., but 
no longer available). Eighty subjects discontinued 
the device prematurely, mostly because of discom-
fort and inability or unwillingness to use the device. 
Miller et al [159] and Sand et al [160] then reported 
on 63 of the 135 patients from the above cohort who 
utilized the device for one year.
The Reliance device provided 72% complete dryness 
with 17% improvement on diary, and 80% complete 
dryness and 15% improvement on pad weight testing 
in the study by Staskin et al. [158], and 79% complete 
dryness and 16% significant improvement on objec-
tive pad weight studies consistent with the improve-
ment in subjective diaries (p<0.0001) for Miller et al. 
[159]. In the Miller study the patients reported im-
proved comfort and ease of use over time. Sensation 
of device presence decreased from 35% at week one 
to 7% at 12 months. The volume of urine lost during 
exercise decreased from a median of 20g (range 4.9-
80.2g) without the insert to 2.6g (1.3-6.8g) when the 
insert was worn (p=0.03). On a 5-point scale, in which 
1 represented very comfortable and 5 very uncomfort-
able, subjects rated the mean comfort for the sessions 
performed with the insert in place as 2.1.
Treatment for positive urine cultures was undertaken 
in 20% of’ symptomatic and 11% of asymptomatic 
patients, 39% of patients had positive cultures which 
were not treated and 30% had negative cultures at 
all monthly intervals for the four month study. The 
main reason for drop-out was discomfort [158]. One 
or more episodes of gross haematuria (24%), cysto-
scopic findings of mucosal irritation at four or at 12 
months (9%) and asymptomatic bacteruria (30%) on 
monthly cultures were also documented [159]. 
Robinson et al [161] carried out a small randomised 
controlled trial comparing the NEAT device (intra-
urethral device with expandable tip) with the Reli-
ance device. Twenty-four women (mean age 51 
years) entered the study and there were eight 
withdrawals. Devices were randomly allocated and 
tested for four months. Improvement was reported 
for 6/8 women (NEAT) and 5/8 women (Reliance) 
when compared to baseline. There were no signifi-
cant differences in the number of women improved, 
in mean reduction in urine loss, or in leakage scores 
between the two groups. 
Boos et al. [162] reported in an abstract, a random-
ized prospective parallel group trial comparing the 
Reliance intra-urethral insert with the FemAssist 
external meatal occlusive device. Assessments at 
baseline, one month, and three months included 
subjective efficacy, seven day diary, and pad test 
(1 hour). Fifty-three females were randomized 
to the FemAssist and 49 to the Reliance device. 
There were some initial problems with sizing the 
Reliance. Once this was corrected, 40.8% (20) of 
women were subjectively dry and the remainder im-
proved on completing the trial. Of women using the 
FemAssist, 28.3% [15] were dry, 60.4% [32] were 
improved, 9.4% [5] were no better and only one 
subject was made worse with device use. Problems 
experienced were few and minor with no serious ad-
verse events. The conclusion was that both devices 
are efficacious, the FemAssist was more comfort-
able, but required a greater degree of user skill to 
achieve control of leakage (Level of Evidence 2).
Figure X-2: A female intraurethral occlusive device.
1704
Recent studies have investigated the efficacy of 
the FemSoft which is the only intra-urethral device 
which is currently available. Dunn et al. [153] mea-
sured pad weights during four standardized aero-
bics sessions during which six subjects were ran-
domly assigned to exercise twice with the insert and 
twice without it. The medians of the averaged pad 
weights for the two different types of’ sessions were 
compared. Median urine loss during standardized 
exercise sessions decreased from 20g (range, 4.9 
to 80.2g) without the device to 2.6g (range, 1.3 to 
6.8g) with the device (p=0.03). Five women used 
the device at home during unsupervised exercise; 
one subject had urinary tract infection. At the end of 
three months, satisfaction and comfort were rated 
high on a 5-point scale. The conclusion was that the 
FemSoft urethral device is an effective, safe, and 
comfortable treatment for exercise incontinence in 
women (Level of Evidence 3).
Results from a prospective three-year study, (FDA 
post-approval device safety data submitted by Roch-
ester Medical Corporation, 2002 unpublished), for 
evaluation of the long term effect of the device in-
volved 41 subjects. Of the group, nine women were 
65 years or older (22%, 9/41); 80% were post-meno-
pausal with 24 women (59%) being on hormone re-
placement. Thirty-eight, (93%) used absorbent prod-
ucts to contain urine leakage prior to enrolment. A 
total of 66 follow-up visits took place with an average 
participation period of 4.2 years. Seven patients with-
drew in the third year, three due to non-study related 
health problems and one because of dissatisfaction 
due to urge symptoms. Two were lost to follow up. 
There was a significant difference in the rates of in-
continence at the three-year follow-up between us-
ers and non-users of the device: 0.83 versus 2.64 
episodes per day, according to voiding diaries. The 
difference in urine loss during pad weighing tests 
was also significant. There were 24 reported adverse 
events in the 41 subjects enrolled. None of these 
events required medical intervention except for an-
tibiotic prescription in cases of urinary tract infection. 
The 24 events included: bacteriuria (11); symptomat-
ic UTI (3); urinary symptoms (3); device performance 
problems (2); irritation (2); and migration (1). 
In 33 women a total of 38 cystoscopies were per-
formed at three years. Only one patient was report-
ed to have an abnormal finding, but this was due to 
mucosal irritation produced by an indwelling Foley 
catheter during one hospitalization for a problem 
unrelated to the device. Patient satisfaction had 
not changed over the follow-up time interval. The 
Quality of Life questionnaire (I-QoL) scores at three 
years were compared to those at 12 months and 
there was improvement from the baseline of 60.6 to 
74.0. No safety concerns concerning urethral integ-
rity were identified after the three years of continu-
ous use. The incidence of urinary tract infections, 
given the high number of insertions and removals, 
was considered low risk (Level of Evidence 3).
b) Summary
Intraurethral devices have demonstrated high effica-
cy, but have been associated with urinary tract infec-
tion, hematuria and discomfort. Bacteruria, without 
symptomatic infection, was similar to extraurethral 
device use, which approaches screening urinalysis 
data [146] or may be similar to the rates seen with 
self catheterization. Device migration into the blad-
der, which requires endoscopic removal is the most 
serious reported problem. Long-term results are lim-
ited. Patient and clinician acceptance of this form of 
therapy has also been limited and there is currently 
only one intraurethral device on the market. High 
cost is also a factor that probably precludes more 
widespread application but ‘occasional’ use, for ex-
ample during exercise may be helpful and affordable 
for some patients. Good hand dexterity is necessary 
to use the device (Level of Evidence 3).
c) Recommendations
Intraurethral occlusive devices may be considered 
for women with stress incontinence but they are in-
vasive devices with high cost and have had limited 
evaluation. They may be most appropriate for inter-
mittent and occasional use (such as during vigorous 
exercise) (Grade of Recommendation C).
d) Priorities for research
It is important that new devices - particularly inva-
sive ones - are evaluated by randomized trials and 
comparing to control approved devices. Long-term 
follow-up results are needed to demonstrate the ef-
fects of such devices on the urethra and / or bladder 
and will determine the real value and safety of devic-
es that initially have been adopted enthusiastically. 
Further development and study of the use of intra-
urethral devices for the treatment of urinary inconti-
nence is recommended. In particular assessment of 
their cost-effectiveness and effects on quality of life, 
when used intermittently or for particular activities, 
is recommended.
3. INTRAVAGINAL DEVICES
Support of the bladder neck to correct urinary stress 
incontinence has been achieved, with varying suc-
cess, utilizing traditional tampons, pessaries and 
contraceptive diaphragms, and intravaginal devices 
specifically designed to support the bladder neck.
a) Quality of data and results
1. TAMPONS / PESSARIES 
Nygaard [163] performed a prospective, random-
ized, single blind, and laboratory based study test-
ing 18 patients (age 33-73) with three 40 minute 
standardized aerobics sessions, utilizing a Hodge 
pessary, a super tampon, or no device. Urine loss 
was determined by a change in the weight of the 
pad worn while exercising. Statistical analysis of 
the log of urine loss revealed that women lost 
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significantly less urine when exercising with ei-
ther the pessary or the tampon than when exer-
cising with no device. Continence rates were 6/14 
cured and 2/14 improved with tampons, 4/10 im-
proved with a diaphragm (Level of Evidence 2).
2. DIAPHRAGMS / PESSARIES
Realini et al, [164] analyzed the benefit for one 
week, in 10 selected patients of a coil-type dia-
phragm ring, which was softer than a pessary, utiliz-
ing diaries and a two hour pad test. They also gave 
an overall subjective evaluation of their experience. 
Urodynamic findings were essentially unchanged 
by wearing diaphragm rings. Four of the 10 women 
experienced clinically significant improvement in 
the amount of urine lost during pad tests, number of 
leaks per week, and overall assessment response 
(Level of Evidence 3).
Suarez et al. [165] included urodynamic testing in 
his evaluation of a contraceptive diaphragm in 12 
patients. Complete resolution of SUI was achieved 
in eleven of twelve patients (91%) but two of them 
withdrew from the study because of associated dis-
comfort from the diaphragm, therefore, complete 
resolution of SUI was achieved in 9/12 patients 
(75%) (Level of Evidence 3).
Bhatia et al. [166] reported on the urodynamic ef-
fects of the Hodge pessary on 30 women aged 29 
to 71 with a history of UI. With the pessary, 24 of the 
30 patients became continent when tested in supine 
position with a full bladder, three of the 24 patients 
lost urine with coughing in the standing position and 
demonstrated a positive cough profile despite the 
presence of the vaginal pessary. Uroflowmetry data 
show that the vaginal pessary did not produce any 
obstruction to the free flow of urine and suggested 
this is a modality to predict the outcome for bladder 
neck support surgery.
Richter et al (2010) [167] compared use of a pes-
sary (ring or dish) with behavioural therapy (pelvic 
floor muscle training plus strategies for active use 
of muscles to prevent stress and urgency incon-
tinence), compared with combined treatment in a 
randomized controlled trial of 446 women with stress 
incontinence. Outcomes were measured at 3, 6 and 
12 months. There were small differences between 
groups at 3 months with slightly better results in 
terms of bothersome incontinence symptoms for the 
behavioural therapy group than the pessary group. 
Combined treatment was not significantly better than 
behavioural therapy alone and difference between 
groups were not sustained at 12 months. 
The long-term discontinuation rates of ring pessa-
ries (including the Introl device – see below) was in-
vestigated by Sarma et al (2009) [168]. A retrospec-
tive review of the notes of 273 women was carried 
out and found a surprisingly high rate of complica-
tions (93 (56%) of the 167 women who were suc-
cessfully using a pessary at 4 weeks subsequently 
developed problems such as bleeding, extrusion, 
discharge and pain). The majority of women dis-
continued use of the pessary over time. It is there-
fore important that further studies of pessary use 
should include long-term follow-up results. Gorti et 
al (2009) [169] surveyed clinicians about use and 
follow-up of pessary placement and concluded that 
patients should be followed up at 6-12 monthly in-
tervals.
3. INTRA-VAGINAL DEVICES DESIGNED SPECIFICALLY TO SUP-
PORT THE BLADDER NECK
Included in this category are:
1.  Removable reusable intra-vaginal ring, composed 
of silastic, and constructed with two prongs which 
are placed behind the symphysis to support the 
bladder neck (Introl, no current distributor).
2.  Single-use disposable devices: (i) A clam-type 
device composed of polyurethane foam, which is 
folded up upon its long axis and placed into the 
sagittal plane in the vagina, and when moistened, 
its dimensions expand by 30% and create a sup-
portive cushion under the urethrovesical junction 
(originally called the Conveen Continence Guard, 
now known as Contrelle Activgard); (ii) A version 
of the expanding polyurethane design, with simi-
larities to a tampon, (Conveen Continence Tam-
pon, Coloplast, Denmark (no longer available) 
(Figure X-3); (iii) An expanding polyvinyl alcohol 
sponge (Ladycon, Home Care Engros, Norway); 
(iv) a simple surgical foam cylinder with draw-
string e.g. Rocket stress incontinence device 
(Rocket Medical PLC)
Figure X-3: A female intravaginal occlusive device.
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4. REUSABLE INTRA-VAGINAL RING (INTROL)
A pilot laboratory study was carried out by Biswas 
[170], the developer of the device, employed a 
straining cystogram. Eighty-six percent of the pa-
tients were continent with the device in place on 
cystogram. Following this study, the number of de-
vice sizes was increased from eight to 25. Evalua-
tion studies followed examining efficacy, safety and 
satisfaction. Davila [171] initially demonstrated that 
83% of patients were dry on pad weight test. Later 
[171] the researchers enrolled seventy women (53 
completed) aged 24-76, 29 with stress, and 24 with 
mixed incontinence in a one month study. A statisti-
cally significant reduction in incontinence was noted 
on pad testing (stress mean 46.6-16.6g; mixed, 
mean 31.9-6.8 g) and in bladder diary (stress, mean 
28.6-7.8 losses per week; mixed, mean 30.2-15 
losses per week). QoL scores (I-QoL) improved in 
both groups. With the device in place, urodynamic 
testing indicated normalization of urethral function 
without evidence of outflow obstruction. Subjects 
found the device comfortable, easy to use and con-
venient. Side effects included five urinary tract in-
fections and 23 cases of vaginal soreness or mild 
irritation (Level of Evidence 3).
Moore et al. [148] detailed problems with both siz-
ing and efficacy. Of the 80 recruits, four could not be 
fitted, and 11 did not satisfy all entry criteria. Of the 
65 participants, 39 (60%) withdrew; 20 for distorted 
vaginal anatomy which made fitting difficult, five for 
lack of efficacy, four for constipation, and ten for un-
related patient events. In the remaining 26 patients, 
pad test weights decreased from a baseline median 
of 19g to 2g (p<0.001), 62% were continent, and 15% 
were >50% improved, and wished no further therapy. 
Moore et al. commented that the device was difficult 
to fit in women who have had multiple vaginal surger-
ies or were oestrogen deficient. Long-term follow-up 
showed that 18 of 26 (from the original 65) continued 
to wear the device at six months (interim dropouts 
being due to concurrent illness in half, the remainder 
had declining efficacy). Of these, 78% continued to 
wear the device for a minimum follow-up of two years 
(Level of Evidence 3).
In a separate study of patients with mixed inconti-
nence by Moore et al. [148], five of 21 recruits never 
wore the device home, leaving 16 participants. A 
further two did not reach week four, because of poor 
efficacy or inability to fit the device. In the 14 who 
reached week four, the median number of leaks/
day declined from 4.3 to 1.0 (p=0.002). Median pad 
weight loss fell from 53g to 7g. (p=0.012). Cystom-
etry showed an increase in maximum bladder ca-
pacity (p<0.05) and a modest reduction in severity 
of detrusor overactivity, with no evidence of outflow 
obstruction. Three women discontinued because of 
poor efficacy or a poorly fitting device, leaving 11 of 
16 participants (69%) at week eight, when median 
pad weight decreased to 2 g (Level of Evidence 3).
Kondo,et al. [172] found no urinary flow obstruction 
with the device in place. Urine loss decreased from 
20.6 to 4.8 g per hour (p<0.001) on the 60-minute 
pad weight test. Twenty two patients (29%), re-
ported complete continence, and 39 (51 %) had 
decreased severity of incontinence by more than 
50%. Minor adverse effects occurred in 26% of the 
patients. According to the global usefulness rating 
which was employed, 62 patients (81%) had some 
or maximum benefit (Level of Evidence 3).
5. REUSABLE INTRAVAGINAL HOLLOW TAMPON (CONTIFORM)
The Contiform intravaginal device was first tested 
in 2003 and although significant benefit was shown 
only 20% of participants were completely dry on 24 
hour pad test [173]. In 2007 Allen et al [174] enrolled 
65 women to test the device and fitted 52 devices. 
37 women completed the protocol (4 weeks test-
ing). Urine loss on pad testing was significantly re-
duced from a median of 6.6g to 2.2g and there were 
significant improvements on the Incontinence Im-
pact Questionnaire and Urinary Distress Inventory. 
Seven patients were unable to insert the device and 
two were shown to have residual urine over 100ml, 
but overall the authors concluded that the device 
was well tolerated.
6. DISPOSABLE INTRA-VAGINAL DEVICES
Thyssen et al. [175] tested the Continence Guard in 
26 women with stress incontinence before and after 
one month’s use: four women discontinued the treat-
ment because of discomfort or difficulties in using the 
device 9 (41%) were subjectively cured of inconti-
nence, 10 (45%) improved while three (14%) claimed 
unchanged incontinence. With the device in place all 
had decreased leakage at the 24-hour pad weighing 
test and unchanged urodynamic tests. No vaginal or 
urinary infections were found (Level of Evidence 3).
Thyssen et al. [176] reported on 19/22 women with 
stress incontinence, subjectively and objectively 
cured or improved in a short-term study, and who 
then continued the treatment with the device for 
one year. All 19 completed the study, 13 (68%) were 
subjectively dry, (26%) were improved and one (5%) 
reported unchanged incontinence. All but one had 
decreased leakage at the 24h pad test, and 67% 
a greater than 50% decrease. Subjectively cure 
was 41%, and 36% were dry on 24 hour pad test. 
Overall reduced leakage was statistically significant 
(p<0.0005) No significant changes were found in 
the other urodynamic measurements, specifically, 
urinary flow rate.
Sander et al. [177] found subjective cure in 11/55 
women (20%) and improvement in 27/55 (49%) 
was reported. Results of the 24-hour pad test and 
mean leakage and epi-sodes in the voiding diary 
significantly decreased. After three months, 58% 
of the 55 patients desired to continue device us-
age. There was a highly significant improvement in 
QoL scores using the IIQ, as well as two additional 
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incontinence-related quality of life questionnaires. 
Responses to the SF-36 general health question-
naire showed no significant changes
Hahnet al. [178] reported on 121 women, in a four 
week study. Patients dropped out because of vagi-
nal irritation (25%), other product-related reasons 
(6%), lack of time (6%), or failure to complete a 
user questionnaire. Of the remaining 90 (mean 
age 47.5), 85 performed a 24 hour pad test, which 
showed that baseline leakage of 42 ml/24h de-
creased to 14 ml/24h (p <0.001). Of these, 39 (46%) 
were continent. The device was considered un-
pleasant by 8%, and caused some local discomfort 
in 62% on direct questioning: 75% of these wished 
to continue using the device. The authors noted that 
older women (age 56-65) tolerated the device and 
appeared more motivated to continue. Coexistent 
atrophic vaginitis and the use of topical oestrogen 
was not discussed
Thyssen et al. [179] reported on 94 women re-
cruited in a cross-over study, which compared two 
versions of the same device; the Conveen Conti-
nence Guard (CCG) and the Contrelle Continence 
Tampon CCT. 62 women (66%) completed the 
study with withdrawals mainly due to discomfort or 
for unknown reasons. Both devices reduced leak-
age significantly but the CCT was significantly bet-
ter than the CCG. Few side-effects were reported. 
Thirty-two women continued the treatment for one 
year or more with 63% preferring the “tampon” type 
design for its ease of use. 
The report on the polyvinyl sponge by Glavind 
[180] was an acute laboratory study of only six 
women utilizing a pad test measurement during 
30 minutes of aerobic exercise Without the vaginal 
sponge the patients had a mean loss of 7g (range 
2-18g) during exercise. With the vaginal sponge in 
situ there was no leakage.
Two papers have been published recently on the 
Tipi device (ConTIPI Ltd. Israel) [181] [182]. This 
device has a resin core with support ‘poles’ covered 
with a soft nylon mesh that stretches between the 
arms of the poles to act as a suburethral sling. Ziv 
et al. [183] recruited 60 women with severe stress 
incontinence to test the product. A seven day ‘con-
trol’ period was followed by a 28 day device usage 
period. There was no control arm or comparison 
product. Pre-weighed pads were used during the 
test period and the primary end point was the per-
centage of women achieving at least a 70% reduc-
tion in pad weight gain from the control period to the 
last 14 days of usage. Ten women withdrew from 
the study during the test period, four for device re-
lated reasons. Using intention to treat analysis 85% 
of women achieved at least 70% reduction in pad 
weight gain. The most common adverse events re-
ported were mild and included genital tract discom-
fort, pain and spotting with blood; the only report of 
a moderate event was of candidiasis. The authors 
conclude that the device is easy to use, well-toler-
ated and effective. 
Farage et al (2011) used a similar evaluation design 
with 57 women who had at least seven episodes of 
SUI per week. After a baseline period the women 
identified the best TIPI among a selection of three 
device sizes. The fitting period was followed by 
14 days of device usage for up to 12 hours daily. 
The results of the 57 intention to treat population 
shows that 75% of the patients had at least a 60% 
reduction in SUI episodes, the subjective perspec-
tive of patients with regard to the severity of their 
incontinence improved and the results show also 
an improvement in the quality of life (statistically 
significant for: feeling frustrated, impact on social 
activities and impact on recreational activities). The 
authors stated that the device is safety in daily use 
and a nonsurgical alternative in the therapy for SUI.
b) Summary
Support of the bladder neck resulting in improved 
continence is possible with intravaginal devices 
without evidence that they cause significant lower 
urinary tract obstruction or morbidity, but the evi-
dence is limited (Level of Evidence 3).
Studies performed in the acute setting, regardless 
of the device type, demonstrate better performance 
than diary based studies performed over time. Ef-
ficacy appears to be higher in patients with minimal 
to moderate urinary leakage. 
Relatively high drop-out rates in monitored studies, 
during which patient support is provided, indicates 
the need for proper patient selection’ and patient and 
provider education, but may also indicate limitations in 
product efficacy, difficulties in application or other fac-
tors such as discomfort (Level of Evidence 3).
c) Recommendations
Intra-vaginal support devices may be considered 
as a treatment option when managing women with 
stress urinary incontinence, dependent upon the 
availability of product, patient ability to manage the 
product (particularly manual dexterity) patient ac-
ceptance, and cost (Grade of Recommendation C).
d) Priorities for research
Long-term results are not available and studies 
comparing these therapies to other forms of conser-
vative therapy or surgery are needed
4.  OVERVIEW OF MECHANICAL DEVICES 
FOR WOMEN
a) Overall summary
The recently updated Cochrane review of mechani-
cal devices for urinary incontinence in women [144]
review found seven trials that met their criteria and 
concluded that the role of such devices is question-
able. The authors state that there are indications 
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that using mechanical devices might be better than 
no treatment but that the evidence was weak and 
that there was insufficient evidence to recommend 
any specific device or to show that mechanical de-
vices are better than other forms of treatment. 
In this section we have attempted to review all 
available evidence including many trials that did 
not meet Cochrane criteria. Most trials were open 
pre-test post-test trials with no comparators and 
the strength of this evidence is relatively weak. Al-
though most trials showed positive effects on symp-
toms, this was often combined with relatively high 
drop-out rates and unwanted effects, such as dis-
comfort, skin irritation or urinary tract infection.
Although many products have appeared on the 
commercial market, few have stood the test of 
time and are currently marketed – there are no 
external urethral devices available and there is 
only one intra-urethral device. There are at least 
two intra-vaginal devices available on the market 
and these may have potential to be more accept-
able to women because of their similarities to fa-
miliar tampons. The relative lack of market suc-
cess for these products may indicate low efficacy 
and unwanted effects, but may also reflect their 
relatively high cost compared to pads which are 
the main alternative.
b) Overall recommendations
It is possible that some of the mechanical devices 
currently marketed are effective and acceptable to a 
minority of women and, given that they are relative-
ly non-invasive (with the exception of intra-urethral 
devices), they may be suggested to patients for 
consideration and testing, particularly for short-term 
or occasional use.
c) Overall priorities for research
The substantial withdrawal rate and the frequency 
of unwanted events indicates that that there is a 
need to establish efficacy of these devices (com-
pared to no treatment) over longer time periods 
(more than a year), with careful identification of 
unwanted effects. 
There is also a need to compare devices with 
simple, cheap devices. The Cochrane review 
recommends an intravaginal tampon as a suit-
able comparator.
There are indications that the devices may best 
be used occasionally or intermittently for specific 
activities and there is a need for this type of use 
to be tested, possibly compared to the most com-
mon alternative - an absorbent pad.
As these devices aim to prevent urine leakage 
there is also potential for testing their efficacy 
compared to other treatments such as pelvic-floor 
exercises or surgery.
 
Male mechanical devices aim to prevent urine leak-
age by compressing the penis. A variety of designs 
are available but occlusion is usually achieved with ei-
ther a clamp or a peri-penile strap (Figure XI-1). Such 
devices have the potential advantages of low cost 
and simplicity compared with a sheath and drainage 
bag. However there is potential for tissue damage and 
these devices should be used with caution.
Careful assessment is necessary for use of these 
devices because there is potential for damage to 
the penis from ischaemia (restriction of blood to the 
penis). Such devices should be fitted by a trained 
health professional and subject to regular review. 
Use should be limited to men who are assessed as 
being cognitively intact, are aware of bladder fill-
ing, have normal genital sensation and intact penile 
skin, have sufficient manual dexterity to open and 
close the device (Moore 2004) and are motivated 
and willing to use such a device.
XI. MECHANICAL DEVICES FOR MEN 
WITH URINARY INCONTINENCE
Figure XI-1: A penile clamp.
1. QUALITY OF DATA
The use of penile compression devices is described 
only rarely in the literature [184] [185] and is usually 
referred to as a last resort where other forms of man-
agement have failed or been judged inappropriate. 
There has only been one published evaluation [186].
2. RESULTS
Moore et al. [186] evaluated three different devices 
(Timms C3 penile compression device; Cunning-
ham clamp; and U-Tex male adjustable tension 
band) in a cross-over study in which twelve men 
with stress urinary incontinence following radical 
prostatectomy tried each device in turn. Each of the 
devices significantly (p<0.05) reduced mean urine 
loss (measured using a 4h pad tests) compared 
with baseline measurements. There was some ob-
jective or subjective improvement in continence for 
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each of the 12 men with at least one of the devices, 
although none completely eliminated urine loss 
when applied at a comfortable pressure. 
Ten of the 12 men rated the Cunningham clamp 
positively; two, the C3; and none, the U-Tex. How-
ever, the C3 and U-Tex allowed good cavernosal 
artery blood flow while the Cunningham clamp sig-
nificantly reduced it. Overall Moore et al. concluded 
that, used correctly, the Cunningham clamp can be 
an effective method of controlling urinary inconti-
nence (although it should be noted that complete 
control i.e. no leakage, was not achieved) in men 
with stress urinary incontinence who are cognitively 
intact and aware of bladder filling, and have normal 
genital sensation, intact penile skin and sufficient 
manual dexterity to open and close the device.
Expert opinion and anecdote suggest that penile 
clamps may be more successful when used for 
short periods, for example when undertaking ac-
tivities such as swimming or jogging. Such activities 
may not only exacerbate incontinence but also pre-
clude the use of bulky and / or absorbent products.
3. SUMMARY
Male mechanical devices can partially control urinary 
leakage (but not eliminate it at comfortable levels of 
use) but are likely to lead to reduced cavernosal artery 
blood flow and therefore care must be taken to ensure 
regular removal or release (Level of Evidence 2).
4. RECOMMENDATIONS
•  Male mechanical devices may be considered for 
selected men with stress urinary incontinence who 
are cognitively intact and aware of bladder filling, 
and have normal genital sensation, intact penile 
skin and sufficient manual dexterity to open and 
close the device (B).
•  The devices should be fitted by a trained health 
professional and reviewed regularly (Grade of 
Recommendation C).
•  The devices may be considered for short-term 
use when undertaking sport or other activities, as 
an adjunct to management with other products 
(Grade of Recommendation C).
5. PRIORITIES FOR RESEARCH
• There is a need for mechanical devices for men 
which are discreet, easy to use and which prevent 
leakage without risk of tissue damage.
 
Urinary catheters can provide an effective way of 
draining the bladder in either the short-term or long-
term, by intermittent or indwelling catheterisation, 
where alternative strategies are unsuitable or unsat-
isfactory. However, indwelling catheters are rarely 
completely trouble-free and the risk of catheter-relat-
ed complications is high, with substantial detrimental 
impact on patients, carers and healthcare services. 
It is generally agreed that catheter use should be 
avoided wherever possible and only adopted for 
those for whom alternative strategies are unsuitable 
or unsatisfactory, after careful assessment of the pa-
tient and their particular problem [187]. 
This section examines the characteristics of uri-
nary catheters, and provides a critical review of 
existing evidence to guide decision-making on 
choice of catheters, equipment and management 
strategies to minimise associated risks. Specific 
issues relating to short-term catheterisation are 
addressed, but the main focus of the section is on 
long-term management of bladder dysfunction, by 
intermittent catheterisation (least invasive) or in-
dwelling catheterisation (most invasive). An over-
view of factors influencing choices of catheterisa-
tion strategy is provided in Table XII-1. Detailed 
discussion of key issues is provided under the 
following headings: user characteristics, catheter 
characteristics, associated risks / problems, cath-
eter management. 
The bulk of research evidence on catheter use 
relates to short-term catheterisation. In particular 
there are numerous trials which focus on catheter-
associated urinary tract infection since this is well 
recognised as a major source of healthcare associ-
ated infection. The quality of data is very variable 
and many studies are limited by being underpow-
ered and by other design issues, including poorly 
defined outcome criteria and highly selected study 
populations. Much less research has addressed in-
termittent or long-term indwelling catheter-related 
issues and guidance to healthcare practitioners re-
mains largely based on expert opinion. Some of the 
difficulties in conducting research on use of conti-
nence products are discussed in Section III. Further 
discussion related specifically to catheters is pro-
vided within the following sections.
1. INTERMITTENT CATHETERISATION
Intermittent catheterisation (IC) is the act of pass-
ing a catheter into the bladder to drain urine via 
the urethra, or a catheterisable channel such as 
a Mitrofanoff diversion. The urine can be drained 
into a toilet, urinal, plastic bag, or other reservoir. 
The catheter is removed immediately after drain-
age. This technique avoids many of the problems 
associated with indwelling catheters. Intermittent 
catheterisation may be carried out using a sterile 
technique in some care settings, but clean intermit-
tent catheterisation (CIC) or clean intermittent self-
catheterisation CISC [188] is widely accepted as a 
safe technique for people who are self-caring in their 
own homes. Since some studies do not distinguish 
between CIC and CISC, the term CIC has been ad-
opted to cover both throughout the following sec-
tion. CIC provides much greater convenience than 
urethral catheterisation, without unacceptable 
XII. CATHETERS
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increases in infection rate, and has become a 
method of choice for management of bladder drain-
age for neurogenic and non-neurogenic bladder 
dysfunctions where urinary retention is a significant 
symptom and not easily remedied by other relatively 
simple means, eg TURP for prostatic obstruction. 
CIC can be taught to people of all ages, including 
the very elderly and children as young as four years 
old, with parental supervision [189] [190]. CIC can 
also be taught to carers, where this is an acceptable 
procedure to both patient and carer.
a) Quality of data
The majority of research evidence on intermittent 
catheterisation relates to catheter-associated uri-
nary tract infection (CAUTI) and catheter materials 
and coatings. The most frequent complication of 
CIC is urinary tract infection (UTI) but it is unclear 
which catheter types, techniques or strategies, af-
fect its incidence. There is wide variation in practice 
and important cost implications for using different 
catheters, techniques or strategies. Two relevant 
Cochrane reviews were identified; ‘long-term blad-
der management by intermittent catheters in adults 
and children’ [191]; and ‘urinary catheter policies for 
long-term bladder drainage’ [192]. The objective of 
the first review was to examine which intermittent 
catheter types, techniques or strategies, affect the 
incidence of UTI. Fourteen trials were included but 
sample sizes were small and attrition of participants 
was problematic. Definitions of outcome variables 
and follow-up periods differed, making it difficult to 
draw clinically useful conclusions. Several of the tri-
als were more than 10 years old and were typically 
less rigorous in design and analysis. The authors 
concluded there is insufficient evidence to state that 
incidence of UTI is affected by use of sterile or clean 
technique, coated or uncoated catheters, single 
(sterile) or multiple use (clean) catheters, self-cath-
eterisation or catheterisation by others, or by any 
other strategy. The objectives of the second review 
[193] were to determine if certain catheter policies 
are better than others in terms of effectiveness, 
complications, quality of life and economics. Com-
parisons included type of catheterisation (intermit-
tent, indwelling urethral and indwelling supra-pubic) 
and antibiotic prophylaxis. Seven trials were includ-
ed but all were small and confidence intervals were 
wide. There was limited evidence which indicated 
that prophylactic antibiotic therapy was associated 
with reduced episodes of bacteriuria (asymptom-
atic and symptomatic) in subjects using intermittent 
catheterisation. In both reviews, the trials which met 
the inclusion criteria were limited by small sample 
sizes and methodological weaknesses. A third re-
view on ‘catheter policies for management of long-
term voiding problems in patients with neurogenic 
bladder’ [194], which aimed to assess the effects 
of different types of urinary catheter (IC): in man-
aging the neurogenic bladder, found there were no 
trials that met the inclusion criteria. Other research 
in this area is dominated by retrospective reviews 
of bladder management outcomes of patient co-
horts. Long-term follow-up studies are almost ex-
clusively of patient groups with neurogenic bladder 
disorders. Small scale, comparative studies of new 
products are common and are often industry-spon-
sored. Quality of life issues are vitally important 
for continence product users but studies are often 
limited by outcome measures predominantly based 
on user satisfaction, in the absence of clear criteria. 
Few studies have directly compared CIC with other 
methods of bladder drainage.
b) User characteristics:
CIC is a commonly recommended procedure for 
people with incomplete bladder emptying not sat-
isfactorily managed by other methods. CIC can be 
appropriate for post-void residual urine volumes of 
100ml or more in:
•  Patients with neurological disorders that result 
in urinary retention problems, including failure to 
empty the bladder, incomplete emptying, detrusor 
sphincter dyssynergia.
•  Patients with difficulty emptying the bladder after 
surgical procedures, if outflow obstruction occurs 
either in the short or long-term.
•  Patients who accumulate a build up of residual 
urine caused by detrusor overactivity and inad-
equate bladder emptying. 
• Acute urinary retention (most commonly in men).
• Management of urethral stricture.
•  Emptying the bladder following continent urinary 
diversions such as a Mitrofanoff diversion.
CIC may be a practical option for patients who are:
•  Sufficiently motivated to manage their bladder 
drainage by this technique.
•  Sufficiently dexterous to perform the technique. An 
appropriate level of manual dexterity is essential 
but generally if people can write and feed them-
selves they have sufficient dexterity [195].
•  Sufficiently cognitively aware to adhere to a re-
gime and empty the bladder at appropriate time 
intervals to prevent bladder over-distension and 
preserve upper urinary tract function. 
•  Unable to perform the technique themselves but 
willing to accept the procedure from a caregiver.
Most men require some form of lubrication to aid 
catheterisation, which can be on the catheter surface 
or instilled into the urethra [196] (Level of Evidence 
3). For those with preserved urethral sensation, a 
local anaesthetic gel may be needed. Many female 
patients also use a catheter lubricant / anaesthetic 
gel although some choose not to. In developing 
1712
countries, where resources are limited (or some-
times through patient choice), patients sometimes 
use plain water as lubricant [197] (Level of evidence 
4). Some may benefit from adaptive equipment. An 
occupational therapist reported [198] on how a spe-
cially constructed penile trough (to hold the penis in 
a fixed position) allowed catheterisation with just one 
hand in a person with multiple brain injuries.
Regular bladder drainage is important to avoid po-
tential damage to the upper urinary tract from urine 
reflux and raised intravesical pressure from build 
up of residual urine. Patients require individualised 
care plans to help identify appropriate catheterisation 
frequency, based on discussion of voiding dysfunc-
tion and impact on quality of life, frequency-volume 
charts, functional bladder capacity, and ultrasound 
bladder scans for residual urine. Some people need 
to catheterise several times per day, others less fre-
quently. Catheterising frequently enough to avoid 
residual urine greater than 500ml is a general rule 
for adults but further guidance is also provided by 
urodynamic findings, detrusor pressures on filling, 
presence of reflux, and renal function. Disabilities 
such as blindness, lack of perineal sensation, tremor, 
mental disability and paraplegia do not necessarily 
preclude individuals from mastering the technique if 
they have sufficient manual dexterity [195]. Learning 
the technique may require more sessions for people 
with physical disability, such as MS, and cognitive im-
pairment can contribute to less adherence over time 
[199]. Lack of motivation is the most common rea-
son for failure, often linked to difficulty managing the 
technique or adhering to the required regime.
Children at school need a multi-professional as-
sessment which may include a continence advi-
sor, paediatric community nurse or school nurse, 
the child’s consultant, the child and parents. With 
adequate training, suitable facilities and supportive 
teaching staff many children are able to carry out 
CIC themselves either on a toilet or from a wheel-
chair. CIC has been shown to be a viable therapeu-
tic option for children with a large post-void residual 
urine volume in the absence of any neurological ab-
normality [200]. Intermittent catheterisation has also 
been shown to be an effective technique for elderly 
patients with post-void residuals more than 50% of 
the bladder capacity, resistant to other treatment 
[201]. In a group of 21 patients (mean age 76.5 
years), 12 mastered the technique of CIC, with the 
remainder catheterised by their partners or nurses. 
Urinary continence was restored, urgency, frequen-
cy and nocturia decreased and UTI rate diminished, 
resulting in improved quality of life.
In a study in a 110-bed hospital, a bladder scanner 
was introduced to decrease unnecessary catheter-
izations using either a straight catheter (in-out) or an 
indwelling catheter [202]. Staff members were edu-
cated on the use of the new scanner in conjunction 
with an algorithm to guide decisions on treatment. 
Fourteen per cent (11) of the 79 scans resulted in 
catheterization, and there was an 80% decrease in 
catheterizations in 47 persons unable to void, based 
on clinical observation during a one month period. 
Most of those who required catheterization were sur-
gical patients. There were three in-out catheteriza-
tions and eight indwelling catheters were inserted, 
more were female (73%), and over age 75 (p=0.035).
Advantages of intermittent over indwelling catheter-
isation include:
•  Greater opportunity for individuals for self-care 
and independence.
•  Reduced risk of common indwelling catheter-asso-
ciated complications.
•  Better protection of the upper urinary tract from reflux.
•  Reduced need for equipment and appliances e.g. 
drainage bags.
• Greater freedom for expression of sexuality.
• Potential for improved continence between.
c) Catheter characteristics
Types and characteristics of catheters used in inter-
mittent catheterisation vary considerably so evalu-
ation and selection of products is complex [191]. 
Plain uncoated catheters, typically clear plastic 
polyvinyl chloride (PVC), are packed singly in sterile 
packaging. As per industry standards, all disposable 
catheters are intended for one time use, but PVC 
catheters are frequently cleaned and reused by 
individual users because of cost or concern about 
environmental issues. Recently, to address environ-
mental concerns related to single use catheters, a 
new PVC-free catheter was created and evaluated 
by 173 persons in comparison to the standard PVC 
one [203]. Both catheters had a hydrophilic coating. 
No significant differences were found. Some health 
care professionals make a distinction between ‘sin-
gle-use’ (i.e disposed of after insertion) and ‘single 
patient use’ (cleaned and re-used by the same pa-
tient for a limited period of time, such as one week). 
Where products are used in ways which differ from 
manufacturers’ guidance, both patients and health 
care professionals should recognise their personal, 
professional / legal responsibilities. In some coun-
tries, including the US, there are very clear govern-
mental directives that catheters identified as single-
use devices should not be re-used in any setting. 
US patients should be provided with an adequate 
number of catheters to use a sterile catheter for 
each catheterisation, and patients and carers must 
be informed that catheters are identified for single 
use only. However, not everyone in the US using 
IC has the federal insurance program (Medicare), 
which began paying for single use catheters on April 
1, 2008 at the rate of up to 200/month [204] [205]. In 
one US study of 34 IC users [206], many said they 
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did not have adequate insurance reimbursement for 
single use catheters, and 35% cleaned and reused 
catheters.
Most uncoated intermittent catheters are used with 
separate lubricant, although this is a matter of per-
sonal choice. Cleansing for re-use (where this oc-
curs) varies from being washed with soap and wa-
ter, boiled, soaked in disinfectants, or microwaved. 
Cleaned catheters are air dried and then stored in a 
convenient container (often plastic containers / Zip 
loc bags or paper bags). Metal catheters made from 
silver or stainless steel can be sterilized by heat or 
chemicals and may be used repeatedly for longer 
periods than other reusable materials.
Coated catheters are single use only (they are not 
currently suitable to be cleaned and reused) and are 
designed to improve catheter lubrication, ease of 
insertion and convenience. Coated catheters may 
reduce urethral trauma and CAUTI although good 
quality research evidence remains limited. The most 
common coatings are hydrophilic (which require the 
addition of water to the catheter to form a lubricious 
layer) or pre-lubricated (whereby the catheter is 
supplied pre-packed with a coating of water soluble 
gel). There are also several pre-lubricated products 
with an integrated collection bag (all-in-one) which 
gives flexibility for the user and are efficient for hos-
pital use. Not all CIC users like this type of bag; thus 
trying several types of catheters for various activi-
ties, such as when home or when away, can help 
in decisions about what is best for the person [206].
Intermittent catheters range in size from 6-20 Ch, 
with most common sizes being 10-12 for females 
and 12-16 for males (Figure XII -1). Intermittent 
catheters are generally around 40cm long (male 
length) and are more rigid than indwelling catheters 
to aid insertion. A variety of aids to assist catheteri-
sation are available (Figure XII -2).
Some women find a stiffer catheter easier to handle 
and some designs are slightly curved and made 
only in female length (around 18cm) to accommo-
date their requirements. A new compact catheter of 
7cm was as effective in 23 of 24 women in removing 
residual urine as 20cm catheters [207]. Some man-
ufacturers produce conveniently packaged ‘cathe-
ter-sets’ where the catheter is already attached to a 
urine containment pouch inside the pack and a non-
touch, clean technique is facilitated by holding the 
catheter inside the bag and gradually advancing it 
from the bag during insertion. Catheter designs may 
include a protective tip to help reduce the transfer of 
bacteria from the distal region of the urethra further 
into the bladder. Patients should have the opportu-
nity to try different catheters and choose which best 
suits their needs and lifestyle. Different catheters 
/ packs may be appropriate at different times e.g. 
when added convenience for quick and efficient use 
and disposal is important, such as going to work or 
on holiday. 
An effective intermittent catheter should have the 
following characteristics:
•  Smooth for comfort, but sufficiently firm for easy 
insertion and maintenance of lumen patency.
• Minimal friction on insertion or removal.
•  Smooth edges to catheter eyes to avoid tissue 
trauma on frequent catheterisation. 
•  Shaped for easy passage through urethral contours.
•  Easy to hold and manipulate for those with lim-
ited dexterity.
•  Easy to identify correct end for insertion and for 
drainage, for those with visual impairment.
Although there is an increasing range of intermittent 
catheter types on the market - including many pre-
lubricated products with integrated collection bags 
- the quality of evidence for clinical benefit is poor. 
De Ridder et al [208] conducted a prospective, ran-
domised, parallel, comparative trial of a hydrophilic 
coated catheter with an uncoated PVC catheter with 
Figure XII-1: Examples of catheters for intermittent 
catheterisation: Scott (top) and Nelaton (bottom).
Figure XII-2: Examples of catheters for intermittent 
catheterisation: Scott (top) and Nelaton (bottom).
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123 male spinal cord injured (SCI) patients. Only 57 
completed the 12 month study but fewer patients 
with the coated catheter experienced one or more 
symptomatic UTIs (p=0.02). There was no differ-
ence in haematuria, leukocyturia and bacteriuria. 
However a recent Cochrane Review [191], conclud-
ed that overall current research evidence is weak, 
most studies are underpowered and conclusions 
are limited by serious design issues. A recent re-
view indicated that hydrophilic catheters are benefi-
cial for men with SCI, in relation to safety (prevent-
ing urethral damage and associated complications) 
and quality of life (comfort) [47].However research 
is limited in women, MS, and spina bifida. An earlier 
literature review [209] also indicated the wide vari-
ety of materials and techniques used for intermittent 
catheterisation. It concluded that there was no one 
best technique or material and that choice of both 
depend greatly on the patient’s individual anatomic, 
social and economic status.
d) Associated risks / problems
Urinary tract infection is well-recognised as the most 
frequent complication of intermittent catheterisation 
[191]. The accumulation of urine in the bladder pro-
vides a reservoir for infection, but it has also been 
proposed that the increased intravesical pressure 
reduces the vascular supply to the bladder tissue 
rendering it more susceptible to bacterial invasion 
[210]. A post-void residual urine volume of 150ml 
has been demonstrated to be an independent risk 
factor for the development of UTI, in stroke patients 
[211] (Level of Evidence 2). In Wyndaele’s review of 
complications of intermittent catheterisation (82 stud-
ies), prostatitis was identified as a risk in men but 
epididymitis and urethritis were relatively rare [209]. 
Trauma from catheterisation, measured by haema-
turia, was noted to occur regularly but lasting effects 
were more limited. The prevalence of urethral stric-
tures and false passages increased with longer use 
of CIC but the review concluded that the most impor-
tant preventative measures are good education of all 
involved in CIC, good patient compliance, use of an 
appropriate catheter material, good catheterisation 
technique and the avoidance of bladder over-filling. 
Similar findings were reported by Campbell [212] in a 
follow up of children with spina bifida who had used 
intermittent catheterisation with uncoated PVC cath-
eters for at least five years. The incidence of urethri-
tis, false passage, or epididymitis was very low whilst 
adherence to the protocol was excellent. However, 
Ku et al [213] found a higher incidence of epididy-
mitis in their cohort review of 140 male, SCI patients 
followed over 16 years.
A study of medical and social complications of US 
data in 24,762 persons with SCI [214] who were 
evaluated every five years for 30 years, has been 
published (see section XII.1.g below for report on 
bladder management changes over time). Bladder 
management comparisons were done for indwelling 
(IC), CIC, condom, and spontaneous voiding. While 
there was some variation at different time points, 
medical complications were higher in persons with 
indwelling catheters, for pressure ulcers and days in 
the hospital, and kidney stones, though infrequent, 
were higher at times. Psychosocial outcomes also 
did not favour IC users, and each measure (satis-
faction with life, perceived health status, and partici-
pation in society) was lower than the other groups, 
though not significantly so. The authors said that bet-
ter understanding of psychosocial issues could be 
attained though prospective studies, as other factors 
than bladder management might affect quality of life.
1. URINARY TRACT INFECTION 
It is difficult to know the prevalence of UTI asso-
ciated with intermittent catheterisation as reports 
vary widely and definitions of UTI are inconsistent, 
sometimes based on bacteriuria alone (asymptom-
atic) and sometimes on symptomatic UTI (with or 
without clearly defined criteria). In a study of 41 Eu-
ropean centres serving children with spina bifida, 
although most centres had established protocols 
for diagnosis and treatment of UTI, no consensus 
was identified for common protocols [215]. Other 
variations found included methods of evaluation, 
catheterisation techniques, frequency of urinalysis 
/ culture, administration or not of prophylactic an-
tibiotics, and the patient group studied (including 
gender, functional ability, behavioural and personal 
hygiene factors).
In a prospective study of 128 SCI patients, where 
the incidence of UTI was calculated as the number 
of episodes per 100 person-days, the overall inci-
dence of UTI was 0.68. The rate for males using 
CIC was 0.41, compared to 2.72 for those using 
an indwelling catheter [216]. Biering-Sorensen et 
al. [217] studied 77 SCI patients on CIC after five 
years and found that 81% had been treated for at 
least one UTI, 22% had two-three UTIs/year and 
12% had four or more per year. The technique of 
intermittent catheterisation used does not seem to 
be a risk factor and despite different catheterisation 
techniques used, the number of episodes of clini-
cally significant nosocomial urinary infections and 
the mean species turnover remains similar [218] 
(Level of Evidence 2).
In the Cochrane review cited above [191], the pri-
mary outcome measure was catheter-associated in-
fection (definition of infection as used in the trial re-
ports). Fourteen trials met the inclusion criteria but 
too little data could be entered into a metanalysis 
to produce meaningful data summaries. Based on 
the available data, the authors concluded that there 
appeared to be no clear difference between various 
methods of catheterisation (sterile catheterisation 
techniques, clean catheterisation with a single-use 
sterile catheter, or clean catheterisation with a clean 
reused catheter). Whilst the outcomes of this review 
raise questions over efficacy and cost-effectiveness 
of expensive coated catheters it is clear that further 
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robust research is needed. All sample sizes in the 
trials were small and only two included statistical 
power calculations, although they were unable to 
achieve their predicted sample sizes. Most studies 
suffered from high attrition rates and several reports 
were more than 10 years old. The challenges of ob-
taining sound data in this clinical area continue to 
hinder the accumulation of evidence to help guide 
healthcare practitioners. A common difficulty is in 
the establishment of robust outcome measures. 
UTI remains the most clinically important primary 
outcome variable but bacteriuria/ positive urine cul-
ture is not clinically relevant unless accompanied 
by symptoms. Symptoms themselves may pres-
ent in vague and imprecise ways, especially in el-
derly and/or SCI patients where symptoms can be 
masked or unclear.
Since the Cochrane review two further studies have 
compared hydrophilic versus plastic IC catheters and 
examined the effect on UTI [219]. In a community 
study of patients with spinal cord injury (45 partici-
pants completed) Cardenas and Hoffman found no 
differences in the incidence of symptomatic UTI be-
tween the groups, although the number of antibiotic 
treated UTIs was significantly smaller in those using 
hydrophilic catheters. Regression analysis showed 
that women were more likely to have UTIs than men 
and it is noteworthy that there were twice the number 
of women in the control (plastic catheter) group com-
pared to the hydrophilic group (N=11 versus N=5). 
Cardenas and other co-workers also carried out a 
randomized trial of hydrophilic or plastic ICcatheters 
in SCI patients in hospital. This study demonstrated 
benefit from the hydrophilic catheter during initial 
early rehabilitation with a delay in the first symptom-
atic UTI [220]. Fifteen North American SCI centres 
took part, and 224 patients were randomized to the 
catheter type within 10 days of beginning IC, and 
were followed either in the hospital or rehabilitation 
then, when discharged to the community, for up to 
3 months more, for a total of up to 6 months. This 
delay in first UTI resulted in a daily risk reduction 
of 33% and during the initial institutional time the 
UTI rate decreased by 21% (p<0.05) in the hydro-
philic group. However, no differences were found 
between the two groups in the incidence of UTI over 
the whole study period.
A Cochrane review on urinary catheter policies for 
long-term bladder drainage [221] reported limited ev-
idence that prophylactic antibiotic therapy was asso-
ciated with reduced episodes of bacteriuria (asymp-
tomatic and symptomatic) but all trials were small 
and confidence intervals were wide. The authors 
caution that possible benefits from prophylaxis must 
be balanced against possible adverse effects such 
as the development of antibiotic resistant bacteria.
In order to improve rigorous clinical evaluation of cur-
rent and innovative products for CIC, more epidemio-
logical data on user populations and characteristics 
of catheter use is needed. A recent Canadian na-
tional survey of intermittent catheterisation practices 
following SCI [222], reported on 912 responses to a 
36-item self-report postal questionnaire. Fifty five per 
cent of respondents used intermittent catheterisation 
regularly, with users forming a significantly younger 
group than non-users (p=0.001). The majority of us-
ers (73%) used a clean technique. The remaining 
27% reported using a sterile technique. Uncoated 
catheters were used most commonly; 74% only used 
uncoated catheters; 15% used hydrophilic coated 
catheters; and 11% reported using both types. These 
notable differences may be partially related to pa-
tient education, costs to patients and health insur-
ance funding constraints. The majority of uncoated 
catheter users used their catheter only once (53%) 
but a further 30% used their catheter more than 
nine times. The mean frequency of self-reported 
CAUTIs in the past 12 months (symptomatic but not 
necessarily confirmed by laboratory evidence) was 
2.6, with females experiences significantly more in-
fections than males (p=0.003). Although the use of 
hydrophilic coated catheters was associated with a 
lower rate of CAUTI (2.46 versus 2.62 for those using 
uncoated catheters), this difference was not reported 
as statistically significant. However UTI rates are 
multi-factorial and are unlikely to be fully accounted 
for by the variables investigated. A significant rela-
tionship between number of catheterisations per day 
and CAUTI rates was identified, with those who cath-
eterised only once a day having the highest rate of 
infections (p=0.03). This is consistent with previous 
suggestions that increasing the time that colonised 
urine is present in the bladder is associated with in-
creased infection rates [208]. It is interesting to note 
that, while extra fluid intake was positively related to 
reduced rate of CAUTI (p<0.001), catheter re-use, 
catheter disinfection and antibiotic prophylaxis were 
not significantly associated with CAUTI rate. Clearly 
there are potential limitations in this study as with 
any which employs self-report methodology. These 
include self-selection of respondents, accuracy of 
recall and quality of information provided, but the 
large number of respondents and the degree of inter-
nal consistency reported by the researchers provide 
creditability to these results. 
Several studies have sought to determine whether 
the antibacterial effects of cranberry extract will re-
duce or eliminate bacteriuria and pyuria in patients 
using intermittent catheterisation, particularly in SCI 
populations [223] [224]. In a randomised, double-
blind, placebo-controlled study of 48 SCI patients 
living in the community and using intermittent cathe-
terisation or external urine collection device, partici-
pants ingested 2g concentrated cranberry extract in 
capsule form or placebo daily for 6 months [224]. 
There were no differences between groups with re-
spect to number of urine specimens with bacterial 
counts >104 cfu/ml, types and numbers of different 
bacterial species, numbers of urinary leukocytes, 
urinary pH, or episodes of symptomatic infection.
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2. TISSUE TRAUMA, STRICTURES AND OTHER COMPLICATIONS
Long-term follow-up studies have examined other 
complications associated with intermittent cathe-
terisation and found urethral trauma to be common 
[225] [226]. Urethral bleeding is frequent in new pa-
tients and has been noted to continue to occur in up 
to 30% on a long-term basis [226] [227], however 
risks of tissue trauma may be reduced with newer 
catheter products which are designed to reduce fric-
tion. Consequently the outcomes of older studies 
need to be considered with caution. The withdrawal 
frictional force was compared between two hydro-
philic coated catheters and one uncoated catheter 
in a prospective, randomised, participant-blinded, 
crossover trial by Stensballe et al [228]. Forty par-
ticipants completed the study and it was interesting 
to note that while one coated catheter (SpeediCath) 
exerted a lower mean withdrawal force than the 
other catheters, the second coated catheter (LoFric) 
exerted a significantly higher mean friction force 
than both the other catheters. Both hydrophilic coat-
ed catheters were associated with less microscopic 
haematuria than the uncoated catheter. Similarly, 
there was a lower incidence of microscopic haema-
turia reported in two of the coated catheter groups 
compared to uncoated catheters in trials included in 
the Cochrane review [191]; 0.31versus 0.65 [229]; 
6/14 (43%) v 11/14 (78%) [230]. Trauma of the ure-
thra, especially in men, can cause false passages. 
Treatment for false passages in SCI patients by six 
weeks indwelling catheter use and five days antibi-
otics, has been reported to be effective [231] (Level 
of Evidence 3). The false passages had disap-
peared on cystoscopy and CIC could be restarted. 
It has been claimed that the long term risk of ure-
thral stricture formation may be less when hydro-
philic coated catheters are used [232]. The degree 
of urethral inflammation, measured by urethral 
cytology in two groups using CIC (one using ordi-
nary PVC catheters with lubricant; the other using 
hydrophilic coated catheters), showed significantly 
less urethral inflammation in the hydrophilic coated 
catheter group. Although this data suggests some 
benefit in using hydrophilic coated catheters to 
minimise stricture formation in the long-term com-
parative studies are limited. One recent follow-up 
study of 31 females with spina bifida, using CIC for 
a median of 15 years, examined risk of urethral le-
sions. There were few problems reported (only on 
20 occasions in a total of 459 patient-years), de-
spite long-treatment periods and use of non-coated 
PVC catheters [233]. 
The relative importance and cost-effectiveness 
of hydrophilic catheter coatings has not been ad-
equately addressed in large scale studies to date. 
Hedlund et al. [234] in their review of 28 CIC stud-
ies, called for a prospective, randomized, long-term, 
multi-centre study to address clinical benefit and 
cost effectiveness. Data on patient characteristics 
should include age; gender; diagnosis of bladder 
dysfunction; reason for CIC; physical and mental 
disability; manual dexterity; and previous treat-
ments. Effect parameters should include number of 
catheterisations; urinary tract infection (symptom-
atic or asymptomatic); early and long-term urethral 
complications; patient satisfaction, preferences; 
and drop-out rates. Robust studies of this nature 
are still awaited.
3. OTHER COMPLICATIONS 
Formation of bladder stones has been found to be 
associated with long-term use of CIC in a number 
of studies [235] (Level of Evidence 2). Barroso et al. 
[236] reported an increased risk of developing blad-
der calculi in children performing CIC based on the 
records of 403 children. Stones were diagnosed in 28 
patients. The incidence was slightly higher in those 
with a Mitrofanoff conduit but was not influenced by 
bladder augmentation (Level of Evidence 3). A retro-
spective study of 140 SCI patients, followed up from 
1987 to 2003, identified 27.9% of patients diagnosed 
with epididymo-orchiditis. This problem was more 
common in patients using CIC compared to indwell-
ing catheterisation (42.2% v 8.3%, P= 0.03). Multi-
variate analysis showed CIC to be an independent 
risk factor for epididymo-orchiditis, with SCI patients 
in this study subject to a 7-fold higher risk (OD 6.96; 
95%CI, 1.26-38.53) [213]. While the risk of cancer 
in long-term indwelling catheter users is known, (see 
section 12.2.10 below) squamous cell cancer in per-
sons with intermittent catheters has been reported 
also in at least eight cases. A number of factors may 
be involved including leukoplakia, bacteriuria, trau-
ma from the catheter and squamous metaplasia, a 
premalignant change [237]. 
e) Catheter management
1. EDUCATION, SUPPORT AND QUALITY OF LIFE (QOL)
Good education of all involved in CIC, good patient 
compliance, use of an appropriate catheter mate-
rial, and good catheterisation technique have been 
identified as the most important measures to pre-
vent adverse complications [209]. Factors affecting 
adherence to self-catheterisation procedures have 
been explored, addressing both initial mastery of 
technique and both short-term adherence and long-
term adherence [238] [239]. Time taken to build 
confidence is variable and may range from days 
to years [239]. General determinants of adherence 
related to knowledge, complexity of the procedure, 
misconceptions, fears, shame, motivation, quality 
and continuity of professional care. 
CIC may affect both sexuality and sexual activity 
[240] and sensitive support and teaching are need-
ed. An emotionally negative response can occur, 
which requires individualized teaching in a relaxed, 
supportive environment [240]. Adequate informa-
tion combined with thorough teaching and good 
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communication can help new CIC users gain initial 
acceptance and adherence to the procedure [239]. 
Some women are not able to locate the urinary me-
atus, and they may not be comfortable in learning 
and thus require additional coaching, encourage-
ment, practice and support [241] [206] [240]. Other 
anatomical issues need to be considered as well, 
such as redundant prepuce in some males, false 
urethral passages, and bladder spasms [242]. In 
addition, lack of adequate bathroom accessibility, 
especially in public places, can be a major barrier 
to adherence [242] [206].
Integration of the CIC regime into everyday life was 
a recognised difficulty and for younger patients, in 
particular, availability of materials, physical impair-
ments and resistance to ‘sickness role’ were factors 
which could also compromise adherence. Qualitative 
research studies using a grounded theory approach 
have identified similar factors influencing variations 
in quality of life (see also section XII.4). These in-
clude sex; lifestyle; frequency of duration of carrying 
out CIC; technical difficulties; type of catheter; co-
morbidities; and individual predispositions [241].
In the large scale Canadian survey above [222] 
71% reported that CAUTIs had negatively impacted 
on their QoL score (a 10-point scale). Several sig-
nificant variables associated with CAUTI and QoL 
were determined. Interestingly, time lost from social 
activities was more strongly associated with compro-
mised QoL than actual number of infections or days 
lost from work. In another study in 41 persons with 
SCI, treatment success correlated positively with the 
Qualiveen QoL measure. Success criteria involved 
clinical symptoms of continence, lack of autonomic 
dysregulation (dysreflexia), and urodynamic testing 
for adequate bladder storage capacity (> 360 mL) 
and detrusor pressure (< 40cm water) [243].
Twenty two teenagers and young adults with my-
elomeningocele were interviewed about psychoso-
cial factors related to CIC [244]. Deciding when to 
disclose CIC use was important in relation to peer 
support and friendships, and many wished they had 
done so at an earlier age, with the help of an adult. 
In fact everyone in a group needed to appreciate the 
need to avoid gossip. Those not in wheelchairs found 
it harder to convince others of their need to use CIC. 
In healthcare settings, many wanted to perform self-
catheterisation instead of staff doing it. Information 
about sexual function was desired by many.
An Internet based qualitative study in the US aimed 
at discovering issues and problems in long-term 
CIC users [206] found key concerns related to use 
of bathrooms that were dirty and inaccessible and a 
lack of knowledge of options in supplies and/or insur-
ance coverage. Other themes involved knowing the 
body, practising intermittent catheterization, hassles, 
and adjustment in making intermittent catheterization 
a part of life. Experienced CIC users explained how 
they made adjustments to include CIC in daily life by 
paying attention to their routines. 
More education may be provided to catheter users 
through the Internet in the future. In a study us-
ing 18 articles written for persons with spinal cord 
injury (based on suggestions from patients and 
rehabilitation nurses), consumers were satisfied 
with the information and scored this approach as 
8.02 on a 1-10 scale with 10 as being most sat-
isfied [245]. Information was available in English 
and Spanish. Utilization during the 13 month study, 
scored as “hits” on the website, was far more fre-
quent in the Spanish language materials (n=811, 
70% ) than “hits” for the English materials (n=351, 
30%). Examples of article content in both languag-
es included cranberry juice and UTIs, cleaning the 
drainage bag, types of urinary management and 
only in English, latex allergies and catheter use, 
autonomic dysreflexia, and sexuality.
2. CATHETER CLEANING FOR RE-USE
Where catheters are cleaned for re-use they may 
continue to be used many times, up to weeks or 
even months. However, health professionals and 
users need to recognise their personal responsibili-
ties and liabilities in supporting this approach since 
manufacturers’ guidance will normally relate to sin-
gle use only (see also Section XII.1.c). Questions 
over how long the same catheter may be safely re-
used require further examination, and may be par-
ticularly important in developing countries, where 
access to new supplies may be limited [246]. Meth-
ods of cleaning or re-sterilising include soaking in 
a variety of antiseptic solutions or boiling water or 
microwave sterilisation. In a study which compared 
three home cleaning methods used by patients 
performing CIC, all of the following were found to 
be effective: 0.6% hydrogen peroxide; bleach in a 
1:4 solution with tap water; and betadine in a 1:2 
solution with tap water [247]. None of the cleaned 
catheters showed detectable bacterial growth for 
48 hours after the cleaning procedure was per-
formed (Level of evidence 4). Lavallee et al. [248] 
also compared the effectiveness of hydrogen perox-
ide, vinegar, dishwashing detergent, and tap water 
alone to clean catheters contaminated with Pseu-
domonas aeruginosa and Escherichia coli. They 
also examined the effect of immediate rinsing and 
drying before cleaning. Results indicated that rins-
ing and drying immediately after use was the most 
effective at reducing bacteria to near zero (Level of 
evidence 4). Microwave sterilization has been advo-
cated by some, but has not been adequately evalu-
ated. A study by Sherbondy, et al. [249] showed that 
even where standardized instructions (both verbal 
and written) were provided, microwave steriliza-
tion techniques by patients performing CIC varied 
considerably. Many patients surveyed did not fol-
low the study instructions recommending sterilizing 
used catheters on a daily basis, cleaning with soap 
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and water and air drying before inserting into a mi-
crowave oven on a paper towel. Microwaving on a 
high setting for six minutes on a rotation table was 
recommended together with a heat sink – a cup of 
water in a microwave-safe container placed in the mi-
crowave to absorb extra heat. Catheter melting was 
reported by 63% and was significantly associated 
with the absence of a rotation table. If microwaving is 
to be accepted as an appropriate sterilization meth-
od then users must be provided with a standardised, 
evidence-based, protocol to follow. A recent study 
reported the development of titanium dioxide-coated 
catheters for CIC which were easily sterilized under 
certain light sources and were shown to be safe in 
experimental studies [250]. Preliminary clinical anal-
ysis with 18 volunteers was also promising.
f) Comparisons between intermittent and in-
dwelling catheterisation
A systematic review of risk factors for UTI in adults 
with SCI reported evidence of fewer infections in pa-
tients using intermittent catheterisation compared to 
indwelling catheterisation [251]. Twenty two studies 
met the inclusion criteria for evaluation but the au-
thors noted that many had important methodologi-
cal deficiencies. Intermittent catheterisation has 
also been shown to be associated with fewer UTIs 
compared to indwelling catheterisation in elderly 
patients after surgical repair of hip fractures [252]
and in a comparative study of patients at a hospital 
department of urology [253].
g) Catheter use over time in persons with SCI
Bladder management methods in 24,762 patients 
were tracked for over 30 years, using the US Na-
tional Spinal Cord Injury Database, yielding the 
results summarsied in Table XII-3 [168]. Surveys 
were completed every five years to evaluate cathe-
ter use at discharge from rehabilitation. In addition, 
continued use in the same individuals was evalu-
ated 30 years later in follow up data with 12,984 to 
determine changes in use over time. 
Patient education & support: 
• Discussion of individual bladder dysfunction and reasons for CIC. 
• Personal anatomy and identification of urethral orifice. 
• CIC technique – comfortable position, frequency, observation of patient’s technique. 
• Hygiene. 
• Discussion of any psycho-sexual anxieties (body image, sexual function etc). 
• Single use versus reusable catheters (cleaning, storing, re-use, disposal). NB including 
awareness of personal / legal issues. 
• Difficulties and what to do. 
• Dietary advice and avoidance of constipation. 
• Obtaining supplies. 
• Follow-up visits and consultations. 
 
Guidance for common problems: 
• Catheter will not go in at first attempt – relax for a while and try again a bit later; lubricate 
catheter (eg dipping in water or gel); if necessary seek professional guidance. 
• Catheter inserted into vagina by mistake – withdraw, wash and re-insert. 
• Catheter will not come out – leave for a few minutes, relax and try to ‘let go’, cough gently 
and withdraw catheter. 
• UTI – report changes in urine (eg blood, sediment, smell). Know how to recognise signs 
of symptomatic infection and seek treatment and review of CIC technique. 
 
Table XII-2: Intermittent catheterisation 
Table XII-2 provides some guidance on patient education and troubleshooting for CIC.
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At discharge from rehabilitation, condom catheter 
use decreased gradually (35% in 1972 to 1.5% in 
2001) while clean intermittent catheterization in-
creased from 13% in 1972, peaked in 1991 at 56%, 
and fell slightly to 50% in 2001. Indwelling catheter 
use initially decreased during this time (33% in 1972 
to 17% in 1991) but increased somewhat to 23% in 
2001. In follow up data, the great majority of those 
originally using an indwelling catheter stayed with it, 
i.e., 71% after 30 years. However, most persons us-
ing CIC or condom drainage did not continue to use 
them, and only 20% and 35%, respectively, did so 
after 30 years. This indicates that despite CIC being 
the bladder drainage method of choice, individuals 
with SCI might use indwelling catheters if not able to 
manage CIC (Level of Evidence 3).
Patel et al. [254] examined the outcomes of different 
forms of urinary drainage for men with acute urinary 
retention. After a short period of indwelling urinary 
catheterisation patients were taught to use CIC (34 
men). Patients who failed this were re-catheterised 
and taught to manage a valve or failing this a leg 
bag (16 men) and then discharged home. The CIC 
group had a higher rate of spontaneous voiding (56% 
v 25%) and a lower incidence of UTI (32% v 75%). At 
TURP 20% in the CIC group had a UTI compared to 
69% in the indwelling catheter group. Patients using 
CIC preferred it and had fewer complications. The 
authors concluded that CIC was well accepted by 
those patients who were able to manage the tech-
nique, resulted in fewer UTIs and should be consid-
ered in patients presenting with acute retention. 
In a recent 2-week prospective study of intermittent 
catheterisation versus indwelling urethral catheteri-
sation in older female patients in a rehabilitation set-
ting, 81 females >65 years with post-voiding residu-
al volume persistently >300 ml were randomized to 
one of two groups [255]. Both groups demonstrated 
similar success in regaining bladder function and 
similar rates of bacteriuria. The authors conclud-
ed that intermittent catheterisation was justified in 
managing this patient group, particularly since in-
dwelling catheters were deemed to hinder rehabili-
tation and adversely affected quality of life.
An RCT of 72 women post-urogyncological surgery 
(stress UI or pelvic organ prolapse) compared in-
termittent catheterization (CIC) with supra-pubic 
catheterization (SPC) [256]. The length of hospital 
stay was decreased significantly (Mann-Whitney 
p=0.003) with CIC (median 5 days, range 2-19) as 
compared with SPC (median 6 days, range 2-15). 
The days of catheterization also decreased signifi-
cantly (Mann-Whitney p=0.01) with CIC (mean 4, 
SD 26, median 2) as compared with SPC (mean 5, 
SD 36, median 4), but the differences were viewed 
as limited clinically. Post-op UTIs were higher in the 
CIC group (13 versus nine in the SPC group), but 
not significantly (Fishers’ exact p=0.44). Of note, 
the CIC group had the opportunity to void much 
sooner than the SPC group because the latter were 
on straight drainage for 48 hours post-operatively 
as hospital policy, and this may have had an impact 
on the results and clinical relevance.
In a prospective RCT of CIC versus supra-pubic 
catheterisation (SPC) for post-operative bladder 
care following hysterectomy in 40 women there 
was no significant difference in the length of blad-
der care between the two groups [257]. Bacteri-
uria was higher in the CIC group at days 3 and 5 
(p=0.05 and 0.004, respectively) although it is un-
clear whether there was evidence of symptomatic 
infection. However, there was a higher incidence 
of symptoms / problems arising from the SPC 
site, of which 23% were shown to have a positive 
wound swab. The authors concluded that despite 
a higher rate of bacteriuria, the high incidence of 
site problems with SPC could be avoided by CIC. 
The technique of CIC was seen to be more accept-
able to patients (p=0.009); allowing fewer distur-
bances at night (p=0.006); greater freedom to lead 
a normal life during the day (p=0.000); and less 
anxiety / embarrassment (p=0.005) compared to 
SPC. However, in a study of 43 persons with tet-
raplegia who were on artificial ventilation compar-
ing IC and SPC, SPC users had significantly fewer 
urological complications and better quality of life, 
as measured by the ICIQ-SF (3 items), but not sig-
nificantly better [258].
h) Summary
CIC is the preferred method of urinary drainage in 
patients with neurogenic bladder dysfunction and 
others with problems of bladder emptying who are 
 
Bladder 
management 
Use (%) 
1972 
Use (%) 
1991 
Use (%) 
2001 
Continued use at
30 years (n= 12,984) 
CIC 13 56  50  20  
Indwelling 
catheter 
33  17 23 71  
Sheath 35 4.7  1.5 35 
 
Table XII-3: From US data base of SCI, surveys of bladder management every five years for 30 years. (Cam-
eron et al, 2010)[168). N=24,762.
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capable of performing the procedure and who find 
it acceptable. It can be taught to patients of all ages 
who have sufficient manual dexterity and motivation 
to manage the technique. Urinary tract infection is 
the most frequent complication and the most impor-
tant preventative measures for all complications are 
good education of all involved in CIC management, 
good patient compliance and support, use of an ap-
propriate catheter material and good catheterisation 
technique. Difficulties in carrying out the procedure 
such as physical and technical difficulties, embar-
rassment, time involved and lack of appropriate 
public facilities may deter users from adhering to 
the regime. Hydrophilic-coated catheters confer 
benefits in terms of comfort and minimised tissue 
trauma compared to non-coated catheters (Level of 
evidence 2/3) but evidence of benefit in relation to 
urinary tract infection is less clear. 
The available data on intermittent catheterisation 
does not provide convincing evidence that any 
specific technique (sterile or clean), catheter type 
(coated or uncoated); method (single use or mul-
tiple use), person (self or other), or strategy is better 
than any other for all clinical settings. This reflects 
lack of reliable evidence rather than evidence of 
no difference. Currently clinicians will need to base 
decisions about which technique and type of cath-
eter to use on clinical judgment, in conjunction with 
patients. Differential costs of catheters / techniques 
may also inform decision making.
In particular, CIC has been shown to have benefits 
over indwelling catheterisation in the following ways:
•  Avoidance of common problems associated with 
LTC use such as catheter leakage and / or practi-
cal management of drainage systems
•  Avoidance of complications linked to bacterial 
biofilm formation, including catheter encrustation 
and blockage. Strong evidence for reduced risk of 
CAUTI is less clear. 
•  Maintenance of some level of bladder capacity and 
muscle tone by allowing the bladder to fill periodical-
ly, compared to free drainage by indwelling catheter.
•  Less urethral inflammation (measured by cytology) 
than urethral indwelling catheterisation (Level of 
evidence 2/3).
•  Lower incidence of bladder calculi than indwelling 
catheterisation (Level of evidence 2/3).
2. INDWELLING CATHETERISATION
Indwelling catheters (Figure XII-3) may be used in 
the short-term to manage an acute need for con-
trolled bladder drainage or as part of a long-term 
management strategy (Table XII-1). 
Catheters may be inserted into the bladder urethral-
ly (UC) or suprapubically (SPC) through an incision 
in the abdominal wall. The continued requirement 
for indwelling catheterization should be reviewed at 
regular intervals and the catheter removed promptly 
if no longer necessary, since catheter use is associ-
ated with a number of risks. The major complica-
tion associated with short-term, indwelling catheters 
used in acute care, is nosocomial (healthcare ac-
quired) catheter-associated urinary tract infection 
(CAUTI), which can lead to life-threatening bacte-
raemia in vulnerable groups and may also contrib-
ute to reservoirs of antibiotic resistant microorgan-
isms [187] [122] [259], Long-term catheters (LTC) 
are also associated with increased risk of CAUTI 
and a further range of problems including: recurrent 
blockage due to encrustation by mineral deposits; 
meatal tissue damage - often caused by excessive 
weight from heavy drainage bags; frequent bladder 
spasm with potential expulsion of the catheter; for-
mation of bladder calculi; and potential for long-term 
neoplastic changes in the bladder (although further 
long-term studies are needed to establish this risk). 
Although for some patients an LTC catheter can 
provide satisfactory management of bladder prob-
lems and greater independence, others experience 
pain and discomfort with a catheter in situ and / or, 
are distressed by the impact of a catheter on their 
body image and sexuality. Intermittent catheterisa-
tion (See Section XII.1) is less invasive and is gen-
erally associated with fewer risks. 
a) Quality of Data
Nine Cochrane reviews relating to short and long-
term indwelling catheter use were identified. Five 
reviews on short-term (<14 days or other temporary 
Figure XII-3: A Foley catheter (left) and a suprapu- 
bic catheter with a sharp trocar for introducing the 
catheter (right).
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short-term use as defined by triallists) catheter issues 
included: types of urethral catheters for manage-
ment of short-term voiding problems in hospitalised 
adults [260]; policies for bladder management[192]; 
the role of prophylactic antibiotics [221]; use of 
alpha blockers for acute retention prior to a trial 
without a catheter [261] and policies for removal of 
short-term indwelling catheters [262]. The objective 
of the first review [260] was to determine the effect 
of type of indwelling urethral catheter on the risk of 
UTI. Twenty-three trials - comparing different types 
of standard catheters or a standard catheter with an 
antiseptic catheter (silver alloy or impregnated with 
silver oxide), or an antibiotic impregnated catheter 
(either minocycline and rifampicin, or nitrofurazone) 
- met the criteria. The reviewers concluded that cur-
rently available evidence suggests that silver alloy 
catheters prevent asymptomatic bacteriuria in the 
short-term catheterised patient, although trials are 
generally of poor quality (Level of evidence 2/3). 
They also recommended that further economic 
evaluation is required to confirm that reduction of 
infection compensates for the increased cost of the 
silver alloy catheters. Catheters impregnated with 
antibiotics were also beneficial in reducing bacteri-
uria in hospitalised adults catheterised for less than 
a week but data were too few for those catheter-
ised longer. However, it is important to note that 
although bacteriuria is a commonly used outcome 
measure in CAUTI studies there is much debate 
over the clinical utility of this measure. Many stud-
ies fail to distinguish between asymptomatic bacte-
riuria and symptomatic infection. This is discussed 
further in Section  XII.2.h.3. 
The second review [192] included 14 trials which 
reported on comparisons between SPC and UC 
for short term (up to 14 days). Higher relative risks 
scores were found for UC related to more bacte-
riuria (RR 2.60; 95% CI 2.12 to 3.18), more fre-
quent re-catheterization (RR 4.12; 95% CI 2.94 
to7.56) and increased discomfort (RR 2.98; 95% 
CI 2.31 to 3.85) (Level of Evidence 1). The third 
review [221] included six parallel group RCTs and 
reported weak evidence that antibiotic prophylaxis 
reduced the rate of symptomatic UTI in female sur-
gical patients, compared to antibiotics given when 
clinically indicated. The review of policies for cath-
eter removal [262] reported suggestive, but incon-
clusive, evidence of benefit from midnight removal 
of the catheter (larger volumes at first void) and 
shorter hospital stay after early rather than de-
layed removal. 
In the fifth Cochrane review [261] use of alpha 
blockers prior to a trial without a catheter for acute 
retention was evaluated. This treatment is believed 
to relax smooth muscle in the prostate which would 
improve urine flow and decrease the need for recath-
eterisation. Five clinical trials were involved, in four 
trials ranging from 24-72 hours prior to catheter re-
moval in most persons (up to eight days in one trial). 
In the other study, the drug was given for eight days. 
Results overall were mixed, with two trials favouring 
the treatment and two favouring placebo, and thus 
there was limited but positive evidence that this was 
helpful. There were some side effects, such as hy-
potension and headache, but this was similar in the 
placebo groups. Further research was suggested.
Of the four Cochrane reviews relating to long-term 
catheter use, a review of 400 articles for comparative 
methods of using catheters for neurogenic bladder 
management, updated in 2011 [194] failed to find any 
trial that met the inclusion criteria. A second review 
[263] to compare types of indwelling catheter for long-
term use (defined as >30 days) found only three trials 
which met the inclusion criteria. One trial compared 
antiseptic impregnated catheters with standard cath-
eters and two compared different types of standard 
catheter. The authors reported ‘an astonishing lack 
of evidence for this clinically highly relevant prob-
lem’. Since the included studies were very small and 
showed methodological weakness, the authors con-
cluded that the available evidence was insufficient 
as a reliable basis for practice and catheter choice 
remains largely based on clinical experience. In the 
third Cochrane review on ‘urinary catheter policies 
for long-term bladder drainage’ [264], seven trials 
met the inclusion criteria. All were small, with wide 
confidence intervals. No appropriate trials addressed 
comparisons between: indwelling UC and SPC; UC 
and intermittent catheterisation; or SPC and intermit-
tent catheterisation. Evidence pertaining to whether 
antibiotic prophylaxis is better than antibiotics given 
when clinically indicated, was insufficient as a basis 
for clinical practice.
A fourth new Cochrane review for long-term catheter 
care involved washout policies for the management 
of long-term catheters in adults [265] which examined 
five trials, four of which were poorly reported or de-
signed. Two crossovers compared group differences 
not sequential treatments in individuals, and two 
parallel groups provided limited value. One trial with 
a strong methodology had a small sample size. No 
differences were found in three studies in which so-
lutions were compared: saline, acidic, and antibiotic. 
Unfortunately, there was not enough evidence overall 
to conclude that washouts were of benefit. Larger size 
samples in full randomized trials are needed. 
There was little research to judge the value of 
catheter clamping prior to removal, and one (non-
Cochrane) systematic review [266] of postopera-
tive clamping in three clinical trials in 224 surgical 
patients (mostly women) was inconclusive. In two 
studies, clamping in comparison with free drainage 
was not effective in reducing UTI (not defined) or 
retention post removal. Time to first void decreased 
in one study. Recatheterisation and length of stay 
were measured in one study each, and were not 
different between groups. More recently in a trial 
in Sweden, 113 persons >50 years with short term 
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catheters post hip fracture were randomized to 
clamping or free drainage [267]. The primary out-
come was the time to normal voiding, with a median 
of 6 hours (Q14-Q38) in the group with clamping 
and four hours (Q13–Q37. 25) in the group with free 
drainage. This difference was not significant, nor 
were groups different related to recatheterization or 
length of hospital stay. 
Overall long-term catheter care practices remain 
poorly supported by research evidence. This is at 
least partially due to difficulties in conducting trials 
in long-term catheterised populations for a variety of 
reasons, many of which have been discussed in ear-
lier sections (See Sections XII, XII.1 and  XII.1.d).
The impact of long-term catheters on users’ qual-
ity of life (QoL) is a very important issue which has 
not been studied adequately. No Cochrane reviews 
have dealt with this topic directly, although several 
reviews have included issues with an impact on QoL 
such as catheter related complications and comfort. 
One RCT addressed education needs of catheter 
users. Other studies include a small number of pro-
spective cohort studies, with the remainder being 
retrospective studies and case series reports, pro-
viding evidence at Level 3. Much relevant research 
uses qualitative research methodologies, aimed at 
understanding the nature of long-term catheter-re-
lated issues and patient concerns. Measures of QoL 
used commonly rely on a single question of quality of 
life or satisfaction on a 3- or 10-point scale. Validated 
QoL instruments, such as SF 36 are not only infre-
quently used, but are likely to lack sensitivity for the 
specific issues which concern catheter users. There 
is one device-specific measure for long-term catheter 
users [268], recently validated in two small samples 
for internal consistency reliability and content validity 
(expert review) [269]. Factor analysis yielded three 
subscales related to management, interpersonal, and 
psychosocial issues. Work in this area is continuing. 
b) Prevalence of indwelling catheters use
1. DECREASING ACUTE CARE USE
Short-term catheterisation is common in acute care 
settings, with up to 25% of patients receiving a cath-
eter during their hospital stay [270] [187]. Recently 
a change in the US, whereby CAUTI will not be re-
imbursed during hospital stays [271], has triggered 
a number of studies designed to reduce the use and 
duration of indwelling catheters in acute care, and 
subsequently the number of associated infections. 
A popular approach is a “bundle” in which several 
evidence-based strategies are grouped and imple-
mented in a system-wide approach. Analysis of 
cause and effect are incorporated into the bundled 
activities, and checklists are often used to address 
the issues in methods (procedures), people, envi-
ronment, and equipment [272].
In one study [273], in a community hospital’s 22 bed 
intensive care unit (ICU), a bundled approach was 
used to decrease catheter use with a checklist, a 
decision algorithm and criteria based guidelines. A 
fishbone diagram helped the nurses to identify the 
(historical) reasons for extended catheter device 
days (duration of use) and to plan the intervention. 
The device days decreased significantly from 4.72 
(SD 7.67) in 124 persons to 2.98 (SD 3.17) in 83 
persons, p=0.38, t= -2.10, df 176, n=83). Similar 
results were found in an inner city ICU with 21 
beds [274] with duration of catheter use decreas-
ing from 312 days/month to 239 days/month. 
CAUTI events decreased as well, from 4.7/month 
in the 11 previous months, to zero during the six 
months’ intervention. Also, a multidisciplinary team 
was successful in using a bundled approach and 
decreased catheter use by 56% and the duration 
of device days by 71% [275]. In a hospital in Bra-
zil [276], the CAUTI rate went from 10 to 3.3/1000 
catheter days after an intervention that bundled 
several activities in the previous year. Settings in 
rehabilitation [277] [278] and in an emergency de-
partment [279] have also been able to decrease 
catheter use and CAUTI by effective surveillance 
and an interdisciplinary approach. 
Requiring documentation for the reason for catheter 
placement is critical to reducing unnecessary use. 
In one study with emergency room physicians [280]
education and guidelines for placement contributed 
to an increase in appropriate indications for catheter 
use (72.6% to 82.2% post intervention), and un-
necessary catheterizations decreased significantly 
from16.4% to 13% (p=0.018). Inappropriate cath-
eter use (30%) in a hospital study in Italy with 461 
patients [281] was linked with older age, not hav-
ing had surgery, conscious state, comorbidities, the 
length of time the catheter had been used, and the 
hospital ward. In the only randomized (and patient 
blinded) trial related to interventions to decrease 
catheter use in acute care [282], automatic stop 
orders for inappropriate catheter indications were 
successful in decreasing catheter duration in 392 
patients. For those randomized to stop orders, cath-
eter duration was lower at 3.7 days, compared with 
5.0 in usual care (mean difference -1.3; 95% CI= 
-2.1, -0.6). Likewise, inappropriate catheterizations 
were lower in the stop orders group at 2.2 versus 
3.9 in usual care (mean difference -1.7; 95% CI= 
-2.2,-1.2). CAUTI and recatheterisation rates did 
not differ. 
Simple approaches such as checklists and stop 
reminders have also been effective in decreasing 
catheter use. In one study testing a checklist [283]
catheter duration decreased significantly in five 
acute care hospital units from 402 to 380 pre/post 
intervention (p=0.047), and CAUTI went down from 
2.88 to 1.46/1000 catheter days (NS). Compliance 
with the checklist varied from 50-100% but provider 
surveys indicated most viewed the checklists as rel-
evant, easy to use, and were satisfied with them. An 
educational intervention on issues related to infec-
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tions and notification of the continued catheter pres-
ence [284] also successfully decreased catheter 
use and the CAUTI rate. A simple chart reminder 
sticker related to removing the catheter when not 
needed [285], resulted in a significant increase in 
appropriate indications and a decrease in CAUTI in 
a hospital setting. 
In a study of an educational strategy to use remind-
ers with or without structured education, Gokula and 
colleagues (2007) [286] reported a 14% reduction in 
the number of inappropriately catheterized elderly 
patients in emergency departments, following a staff 
education program and the use of an indications 
checklist attached to each catheter kit. The interven-
tion also enhanced documentation about catheter 
use. In another study, the total duration of catheter 
use and number of days of inappropriate catheter 
use was significantly less for patients randomized 
to an intervention that required staff in three hospi-
tals in Canada to remove the patient’s catheter if six 
criteria for appropriate catheterization were not met 
[282]. Saint and colleagues (2005) [287] reported 
a similar outcome from a simple reminder to assist 
hospital staff to remember which patients had cath-
eters. Using a pretest-posttest design, two of the four 
wards were assigned to the intervention group, and 
two served as controls. The researchers found that 
of 5,678 patients, the average duration of catheter 
use decreased by 7.6% in the intervention group and 
increased by 15.1% in the control group (p=0.007). 
Similarly, Voss (2009) [288] reported a reduction 
from 33% catheter use to 15.3% (p=0.0006) in acute 
care older patients after the implementation of a pro-
tocol designed to enhance clinicians awareness of 
the appropriate use of catheters and the parameters 
for catheter removal.
A systematic review of reminders and stop orders 
for catheter use in acute care settings [289] indi-
cated a benefit in the rate of CAUTI, which was re-
duced by 52% (p=0.001), duration of use decreased 
by 37%, and 2.61 fewer catheter days’ use in treat-
ment versus control groups. Stop orders were more 
effective than reminders. 
Empowering nurses to remove catheters when not 
indicated was also successful in a quality improve-
ment project [290]. Daily prevalence of catheter use 
decreased from 24% to 17%. However, in an anon-
ymous survey of 164 nurses [291] 54% said they 
were not comfortable removing a catheter without 
a physician’s order, but 74% remind the physician 
daily of the presence of the catheter. 
2. PREVALENCE OF CATHETERS AND CAUTI
Despite the increase in research in preventing 
CAUTI, many hospitals do not have systems in 
place for prevention. Based on a large survey to 
600 non-governmental hospitals and 119 VA hos-
pitals in the US [292], only about 1/3 of the respon-
dents stated that they use antimicrobial catheters 
or bladder scanners, and surveillance data were 
not tracked for catheter placement by 56%, nor 
duration of use by 74%. Catheter reminders were 
used by only 10%.
The prevalence of LTC use in home care or com-
munity care settings varies widely and can be more 
difficult to determine. A large scale survey of 4010 
older people (>65 years) receiving home care in 11 
European countries, found a mean prevalence of 
LTC use of 5.4%, ranging from 0% in the Nether-
lands to 23% in Italy [228]. In another large study of 
1004 frail older women living in the community the 
reported LTC prevalence rate was 38.1% [229]. Du-
ration of use can be for many years. In a US sample 
of 43 community dwelling long-term catheter users, 
who each provided data over a six months’ period, 
mean use was 11.7 years (ranging in months from 
1-589; median 8.8 years). Twenty persons had used 
it over 10 years [126].
There is evidence that older patients aged 65 years 
or more are often catheterised inappropriately [293] 
[294] [295]. Gokula et al. [294] surveyed a 10% 
random sample of patient charts from 2845 elderly 
patients who received an indwelling catheter during 
hospital admission in one year. Less than half the 
selected charts recorded an appropriate indication 
for catheterisation. An explicit reason for catheter 
insertion was documented in only 13% of charts and 
there was no written order for catheterisation in 33% 
of the charts. Only 18% had documented care plans 
for catheter removal. Expert opinion and experi-
ence suggests that even when there is an appropri-
ate clinical reason for initial catheterisation, patients 
may remain catheterised unnecessarily if medical 
and nursing staff fail to review ongoing need (Level 
of Evidence 3). Problems of inappropriate catheter 
use may be compounded when patients are trans-
ferred from one clinical setting to another without 
adequate information on why the person was cath-
eterised [296]. Wald et al [297] reported that 32% 
of patients catheterised during treatment for hip 
fracture in their study were discharged to nursing 
homes with the catheter still in place.
The prevalence of catheterized patients in nursing 
homes is generally higher than in people living at 
home and has been reported to be around 9% in the 
UK [298], but there may be considerable variation 
between homes [299]. In nursing homes in the US, 
it has been estimated that between 7-10% of the 
residents have an LTC [300], although figures vary 
from state to state. More recent data from analysis 
of a US National Nursing Home Survey [301] and a 
point prevalence study of nursing home-associated 
infections in the Department of Veterans Affairs 
nursing home care units [302] demonstrated simi-
lar prevalence. Tsan et al. [302] reported a preva-
lence of 10.7% for indwelling urethral catheters and 
2.46% for suprapubic catheters amongst a nursing 
home population of 11,475 in 133 care home units. 
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There is some evidence of decreasing rates of uri-
nary catheterisation in some places. A retrospective 
cohort study of the use of urine collection devices 
in skilled nursing facilities (SNFs) in five US states 
examined the characteristics of 57,302 patients 
who remained in an SNF for one year in 2003 [303]. 
The prevalence of indwelling catheterisation was 
12.6% at admission and 4.5% at annual assess-
ment (p<0.001). Paraplegia, quadriplegia, multiple 
sclerosis and comatose state were strongly associ-
ated with LTC use. Male residents were more likely 
to use a catheter at every assessment, as were 
obese patients; individuals with diabetes mellitus, 
renal failure, skin conditions, deep vein thrombo-
sis, aphasia or end-stage disease; and those taking 
multiple medications.
A qualitative study of catheter use in 14 UK care 
homes (skilled nursing) [304] found that catheter 
use was higher in homes which were task-cen-
tred rather than patient-centred, and / or where 
patients were inappropriately given residential 
care when skilled nursing was actually needed. In 
contrast, the homes with lower rates of catheter 
use (6% or < versus 9% or >) were more proactive 
related to catheter removal (many of which had 
been “inherited from the hospital”), and they ac-
tively promoted toileting and mobility. Both groups 
had similar staffing and believed their approaches 
enhanced patient dignity. 
Duration of catheter use in home settings varies 
widely, with a median of 3-4 years and some indi-
viduals using them over 20 years [305] [306]. Man-
agement regimes for continence problems in older 
people continue to demonstrate a predominance of 
containment strategies, using pads and catheters 
[307] and consequently unwarranted use of LTCs 
for incontinence continues in many places despite 
known catheter-associated risks.
In view of the considerable cost, and morbidity 
and mortality associated with the use of catheters, 
health services should consider adopting similar 
successful strategies, incorporate such informa-
tion into their policies and ensure that education on 
catheters forms part of staff’s continuing education.
c) User characteristics
Short-term catheterisation (usually defined as up to 
14 days) is most commonly used:
•  During surgical procedures and post-operative care.
•  For accurate monitoring of urine output in acute illness.
• Instillation of medication directly into the bladder. 
• For relief of acute or chronic urinary retention. 
Long-term indwelling catheters - routinely changed 
and replaced, often over many months or years - 
may be required to aid those who have difficulty 
emptying their bladder due to obstruction or neuro-
logical disorders, where intermittent catheterisation 
is not a satisfactory option. LTCs may also be used 
to provide supportive care for those with severe in-
continence who cannot manage otherwise, are ter-
minally ill, or need treatment to heal skin lesions or 
surgical wounds affected by the presence of urine.
Long-term catheterisation is most commonly used 
to help manage:
•  Bladder outlet obstruction (BOO), where patients 
are unsuitable for - or waiting for - surgical relief.
•  Chronic retention, often as a result of neurological 
injury or disease (where intermittent catheterisa-
tion is not possible).
•  Debilitated, paralysed or comatose patients (in pres-
ence of skin breakdown and infected pressure ulcers).
Intractable urinary incontinence where catheterisa-
tion enhances the patient’s quality of life (as a last 
resort when alternative non-invasive approaches 
are unsatisfactory or unsuccessful). 
d) Routes of catheter insertion
For some patients the insertion of an indwelling cath-
eter suprapubically (SPC) into the bladder, through 
the abdominal wall, offers advantages over the ure-
thral route (UC). SPC may be necessary following 
urethral or pelvic trauma but also offers advantages 
in acute and long-term care. In frail elderly men, and 
/ or those prone to infection e.g. diabetes mellitus, 
SPC can be preferable to a urethral insertion to avoid 
urethritis, orchidoepidydimitis and prostatitis [107]. 
Strategies to support the SPC may be required (e.g 
anchoring to the abdominal wall with a BioDerm tube 
holder) to prevent traction and potential displace-
ment of the catheter or balloon [308]. 
Advantages of SPC compared to UC are:
•  Avoidance of risk of urethra trauma to men and 
women during catheter insertion and withdrawal.
•  Avoidance of risk of urethral destruction / necro-
sis from pressure caused by the weight of poorly 
supported catheter bags, expulsion of the catheter 
(particularly in neurologically impaired women), or 
sitting on the catheter in wheelchair bound women.
•  Ease of access to entry site in patients with re-
duced mobility, who are wheelchair bound, have 
restricted hip mobility, or experience urethral pain.
•  Facilitation of post-surgical trial of voiding (by tem-
porarily clamping the drainage tubing).
•  Greater freedom for expression of sexuality, al-
though this may be counteracted by perceptions 
of altered body image.
•  Reduced risk of contamination where faecal incon-
tinence is a problem. 
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SPC insertion is generally contra-indicated in pa-
tients with haematuria of unknown origin, bladder 
tumour, or small contracted or fibrotic bladders which 
may have resulted from long-term urethral cath-
eterisation on free drainage. In obese or immobile 
patients the traditional SPC stoma site may become 
concealed by an apron of excess anterior abdomi-
nal wall fatty tissue which can lead to sub-optimal 
care by both patient and carer. SPC is an effective 
and well-tolerated method of bladder management 
for many SCI patients [309] [310] [311]. In Sheriff et 
al’s study [309] the general level of satisfaction with 
SPC was very high with 70% of patients awarding a 
satisfaction score of 9/10 and 95% awarding 7/10 or 
more. It is of interest to note that in 18% of cases, an 
SPC was inserted following the request of the pa-
tient, having heard about this form of bladder man-
agement from others. A review of current literature on 
SPC in the neuropathic bladder, by Feifer & Corcos 
[311] identified some notable differences between 
early studies and more recent reports. Problems and 
complications of SPC identified in earlier studies of 
SCI patients were less common in the more recent 
investigations, in which patients were managed with 
anti-cholinergics, frequent catheter changes and vol-
ume maintenance procedures. 
Recent studies demonstrated similar morbidity pro-
files to clean intermittent catheterisation. In one ret-
rospective study from 2010 [312] comparing 85 per-
sons with neurogenic bladder prior to SPC use, and 
after a mean of 65.3 ( ± 48.0) months with SPC, an-
ti-cholinergic medicine and bladder clamping (with 
a valve) did not seem to be needed to preserve 
detrusor compliance nor renal function. Bladder ca-
pacity did decrease significantly, though, and renal 
function deteriorated in three persons, two of whom 
were on anticholinergics and none used clamping. 
Complications were reported by 62.6%, including 
recurrent blockage (19.2%), surgery for bladder 
stones (12.1%), and CAUTI (28%). 3.6% had septi-
caemia or were hospitalized for CAUTI. In another 
retrospective study of 179 men with SCI comparing 
indwelling urethral catheters (UC) and suprapubic 
catheters (SP) [313] complication rates were similar 
for UTIs, recurrent bladder/renal calculi and cancer. 
However, those with UC had higher urethral and 
scrotal complications and SP users suffered from 
leakage from the urethra and/or SP tube site. Indi-
vidualizing care management was suggested.
Although SPC has gained wide acceptance for 
bladder drainage and many regard SPC insertion 
as a simple procedure, it is not without risks. The 
initial insertion of the SPC requires a minor surgical 
procedure which presents a potential risk of injury 
to adjacent structures to the bladder, especially the 
small and large intestines with resultant peritonitis 
[314] [309]. Other complications of initial SPC in-
sertion include misplacement [315] [316] [317], dis-
placement to the peritoneal cavity and sepsis, [318] 
and incisional hernia [319] [320]. There are a num-
ber of SPC techniques for insertion described in the 
literature and training models have been developed 
to facilitate teaching [321]. Some modern catheter 
insertion kits employ the initial introduction of a 
guide wire into the bladder, to facilitate accurate po-
sitioning of the catheter introducer. However, where 
patients are at high risk of bowel injury (eg previous 
abdominal surgery or small fibrotic bladders which 
do not expand well at cystoscopy), some authorities 
recommend introduction of the SPC by percutane-
ous technique using intraoperative ultrasonography 
combined with flexible cystoscopy [322] [323]. In 
low risk patients nurse specialists may undertake 
first insertion of an SPC, according to agreed policy 
and protocols [324]. Subsequent SPC changes can 
be competently managed by skilled nurses [325].
e) Catheter characteristics
An effective indwelling catheter should have the fol-
lowing design characteristics:
•  Retained in the bladder effectively, yet easily re-
movable without trauma to tissue.
•  Soft ‘tip’ within the bladder to avoid pressure dam-
age to the mucosa. 
•  Effective drainage while minimising risk of bladder 
mucosa being ‘sucked’ into drainage channel.
• Conforms to shape of urethra. 
Despite some notable efforts to improve catheter 
design, the original Foley design has changed very 
little over the years and remains the most common. 
However traditional drainage systems may fail to 
drain the bladder to completion, due to potential 
outflow obstruction caused by air-locks within the 
curled, redundant drainage tubing segments. A 
novel, spiral-shaped, drainage tubing design has 
recently been reported which appears to optimize 
flow and minimize residual urine [119]. Adding more 
eyeholes has been suggested to reduce residual 
urine [326] and in a case report, leakage [327]. Fur-
ther evidence of efficacy is awaited.
f) Catheter materials
An ideal catheter material requires the following 
properties: 
• Soft for comfort.
• Causing minimal tissue reaction or friction.
•  Sufficiently firm for easy insertion and mainte-
nance of lumen patency in situ.
•  Elastic recoil so that an inflated balloon can deflate 
to almost its original size.
•  Resistant to colonisation by micro-organisms and 
to encrustation by mineral deposits. 
Catheters are made of a variety of materials includ-
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ing polyvinyl chloride (PVC) or other plastic, latex 
rubber with or without a coating, silicone or metal. 
Plastic catheters are relatively cheap to manufac-
ture, have a thin wall and relatively large lumen, 
and are designed for short-term use (in situ up to 14 
days). Latex catheters are restricted to short-term 
indwelling use (and commonly avoided where pos-
sible) because of potential discomfort due to high 
surface friction, vulnerability to rapid encrustation 
by mineral deposits from the urine and the implica-
tion of latex allergic reactions in the development 
of urethritis and urethral stricture [328] [329] [330] 
[331] [332] [333] or anaphylaxis [334]. 
Attempts to minimise friction during catheterisa-
tion and to reduce tissue reactions have led to the 
coating of latex catheters with tightly bonded ma-
terials designed to provide a smoother, less irritant 
surface which also minimizes absorption of water 
by the latex (and subsequent changes in internal 
and external catheter diameters). Polytetrafluoro-
ethylene (PTFE or teflon) coated latex catheters 
are sometimes used for medium-term use (catheter 
can remain in situ up to 28 days) but the materials 
known to cause least friction and tissue reaction are 
silicone elastomer and hydrophilic polymer-coated 
catheters, or all-silicone catheters [335] (Table XII-
4). These materials are therefore recommended for 
long-term use (i.e. expected to remain in situ for 14 
days or more, and changed regularly for a new cath-
eter as part of a long-term strategy of care). LTC 
materials are also less vulnerable to rapid coloni-
sation by bacteria and encrusting by mineral de-
posits than short-term catheter materials. There is 
evidence that silver-alloy coated catheters can help 
to reduce risks of CAUTI in the short-term (where 
bacteriuria is used as the outcome measure) (See 
Section  XII.3.a), but no currently available material 
or surface coating is completely immune to micro-
bial colonisation.
Inflation of silicone catheters with water can some-
times lead to water loss from the balloon over time, 
[336] with an associated risk of the catheter falling out 
[337]. Consequently some manufacturers recommend 
filling the balloon with a 10% aqueous glycerine solu-
tion, or to fill the balloon with the full 10mL, knowing 
that 1/4 to 1/2 could be lost over time [336].
Most catheter materials are suitable for either UC 
or SPC, however not all UC catheters are also li-
censed for SPC. Suprapubic catheter removal is 
sometimes associated with trauma of tracts or sto-
ma site where overgranulation has occurred, with 
bleeding and patient discomfort [338] [325]. This 
can be a particular problem with catheter materials 
such as all-silicone, which are prone to hysteresis, 
leading to balloon cuffing on deflation. This problem 
may also occur with hydrophilic coated catheters 
but is less common [339] [340]. Management of this 
and other catheter-related problems is considered 
below in Section XII.2.k.
The main finding of a recent Cochrane Review of 
types of indwelling urinary catheters for long-term 
bladder drainage in adults [263] was a remarkable 
lack of evidence for this clinically, highly relevant 
problem. Despite consideration of 11,000 abstracts 
and 74 full papers, only three trials met the inclusion 
criteria. Since these were very small and showed 
methodological weakness, the authors concluded 
that there was insufficient evidence to provide a reli-
able basis for clinical decision-making and catheter 
choice remains largely based on clinical experience.
g) Catheter size – catheter gauge, length and 
balloon size
Indwelling catheters are formed either by building 
up layers through dipping and coating on a shaped 
‘former’ or by a process of extrusion of a single 
material. Catheter size is measured in Charrière 
(Ch) – also called French gauge (Fr) - which re-
fers to the circumference of the catheter shaft in 
millimetres. Internal diameter varies depending on 
the manufacturing method, with the extrusion pro-
cess resulting in a catheter with relatively thinner 
Duration of catheterisation Catheter material 
Intermittent Removed immediately after urine drainage. 
Plastic: with or without hydrophilic polymer coating. 
Metal (silver, stainless steel). 
Indwelling, 
short term use 
Catheter expected to be in situ for 
< 14 days. 
Latex or plastic 
PTFE-coated latex. 
Silver-alloy coated 
(catheter materials  recommended for long-term use 
may also be selected).  
Indwelling LTC 
Catheter expected to be in situ for 
14 days or more (recommended 
time between catheter changes 
depends on local catheter policy - 
may be up to 12 weeks). 
Silicone elastomer-coated latex. 
Hydrophilic polymer-coated latex. 
All silicone 
 
Table XII-4: Catheter materials 
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walls and a larger lumen for the same Charrière 
size. A size 12Ch catheter made by dipping and 
coating will have an external diameter of around 
4mm and an internal diameter of around 2mm or 
less. Urinary flow rate is related to the internal 
diameter of the catheter but 12 -16 Ch catheters 
(usual sizes for adults) easily drain normal quan-
tities of urine, including larger volumes produced 
by diuresis [341]. Although larger sizes may be 
needed following urological procedures where 
blood clots and other debris are a problem, large 
catheters are generally associated with increased 
bladder irritability and spasm [113], and with po-
tential blockage of para-urethral glands and tissue 
damage, including urethral strictures. Therefore 
large catheter sizes should be avoided wherever 
possible. It is not known whether large catheters 
contribute to CAUTI, but the smallest size to main-
tain good drainage and prevent urethral and blad-
der neck trauma is recommended [342] further re-
search may be needed to determine best practices 
[343]. Small balloon sizes are recommended for all 
patients (10ml for adults and 2.5-5ml for children) 
to minimise the risk of discomfort and bladder ir-
ritation. Larger balloons tend to sit higher in the 
bladder with potential for increased residual urine 
volumes to collect below the catheter eyes. Larger 
balloons are also associated with increased risk of 
meatal tissue damage caused by bladder spasm 
and possible expulsion of the catheter with a fully 
inflated balloon. 
The most common sizes of SPC catheters for 
adults are also 12-16Ch. Some SPC kits provide 
a specific catheter in the kit and therefore dictate 
the sizes available; others allow the insertion of 
a range of Foley catheters. Since the catheter is 
inserted into the bladder via an artificial stoma it 
is possible that slightly larger sizes may be better 
tolerated than for UC although there is no research 
evidence to support this. 
The standard male length catheter (41-45cm) is 
available to males and females but a shorter female 
length (25cm) can be more comfortable and dis-
crete for some women. The female length catheter 
should not be used for males as inflation of the bal-
loon within the urethra can result in severe trauma. 
In one case series report [344] six boys, aged < 1 
month to 16 years suffered damage to the bulbar or 
prostatic urethra due to inflation within the urethra. 
Three required suprapubic catheters, and all healed 
without further complications. Insertion to the bifur-
cation of the catheter – that is, until only the inflation 
and drainage ports were visible - was advised to 
prevent this. Paediatric catheters are usually ap-
proximately 30cm long.
h) LTC–associated risks / problems: catheter-
associated urinary tract infection (CAUTI)
The urinary tract is recognised as the commonest 
site for nosocomial infection in hospitals and nurs-
ing homes, accounting for between 21% and 45% 
of all healthcare-associated infections [345] [346] 
[65] [347] [302] [348]. National nosocomial infection 
surveillance systems monitor CAUTIs and provide 
guidance for benchmarking [349]. The presence of 
an indwelling catheter is a key risk factor in around 
80% of nosocomial UTIs. The risk of bacteriuria in-
creases by 5-8% per day of catheterisation [350] 
[351] [352] and virtually all LTC patients are likely 
to be bacteriuric within four weeks [342]. A major-
ity of microorganisms derive from the patient’s 
own colonic and perineal flora or from the hands of 
health-care personnel during catheter insertion or 
management [187]. Access is gained in two ways: 
(1) extraluminally during catheter insertion or via 
the periurethral space; (2) intraluminally following 
breaks in the closed system or contamination of 
urine in the drainage bag. The comparative impor-
tance of these routes is difficult to determine, but 
animal models have demonstrated rapid colonisa-
tion via the intraluminal route following a break in 
the closed system, compared to the extraluminal 
route (32-48 hours v 72-168 hours respectively) 
[353]. However, clinical studies have shown that 
colonisation will occur even when strict infection 
control practices are adhered to [354]. 
Indwelling catheters rapidly become colonised by 
micro-organisms which form a strongly adherent 
biofilm on catheter and drainage equipment sur-
faces. Biofilm formation begins by deposition of a 
conditioning layer of proteins, electrolytes and other 
organic molecules from the urine [355] which may 
then mask catheter surface properties designed 
to inhibit colonisation. Micro-organisms attached 
to catheter surfaces divide to form micro-colonies, 
ultimately developing a complex three-dimentional 
structure, including fluid filled channels through 
which the biofilm members receive nutrients, diffuse 
away wastes and send chemical signals to each 
other [356]. Catheter biofilms commonly comprise 
mixed communities of micro-organisms embedded 
in a matrix of host proteins and microbial exopoly-
saccharides [357], [358] (Figures XII-4, XII-5 and 
XII-6). Microorganisms growing as a biofilm are less 
susceptible to antimicrobial therapies than free-liv-
ing organisms and are a major source of resistant, 
nosocomial pathogens [187] [359] [259]. Decreased 
susceptibility arises from multiple factors including; 
physical impairment of diffusion of antimicrobial 
agents, reduced bacterial growth rates; and local 
alterations of the micro-environment that may im-
pair activity of the antimicrobial agent [356]. The 
close proximity of cells within a biofilm can facilitate 
plasmid exchange and the spread of antimicrobial 
resistance [355].
1. ANTIBIOTIC USE
Hospitalized patients are likely to be on antibiotics 
for other causes than an indwelling catheter, which 
also might be present. In one study in an acute care 
setting, [360] catheterized patients on antibiotics 
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antibiotics use, in particular with fluoroquinolone. 
The researchers’ model predicted that decreasing 
CAUTI in hospitals with high rates (75th percentile 
or >) could reduce antibiotic use by 2.1% and 0.4% 
for fluoroquinolone.
2. PREVALENCE OF CAUTI
The majority of research on the risks of CAUTI has 
been conducted in acute care settings where cath-
eters usually remain in place for less than 14 days 
and many patients’ health is already compromised by 
co-morbidities [362]. A series of reports from the In-
ternational Nosocomial Infection Control Consortium 
(INICC) provided rates of CAUTI in intensive care 
unit (ICU), using the methodology of the US National 
Nosocomial Infections Surveillance system. The 
rates per 1000 catheter days were: Brazil 9.6 [363] 
and Peru 5.1 [364]. Overall, in 13 limited resource 
countries implementing INICC infection control guide-
lines for education and surveillance (Argentina, Bra-
zil, Colombia, Costa Rica, Cuba, El Salvador,India, 
Macedonia, Mexico, Morocco, Philippines,Peru, and 
Turkey) the CAUTI rates dropped from 8.2 to 6.9 per 
1000 catheter days [365]. A later report in ICUs in 
Cyrus, Greece gave a rate of 2.8/1000 catheter days 
[366]. From the U.S. National Healthcare Safety Net-
work (NHSN) [367] from January 2006 through De-
cember 2008, the pooled mean CAUTI rate in ICUs 
ranged from 3.1 to 7.4 /1000 catheter days, depend-
ing on the type of specialty unit. Surveillance was 
suggested for a minimum of three months, based on 
a pilot study describing the protocol and surveillance 
tool used in six hospitals caring for elderly people in 
Scotland [368].
Less is known about the prevalence of CAUTI in 
long-term and home care settings or about the po-
tential for reduction of CAUTI and improved cost 
benefits in the LTC population [352]. Encourag-
ingly, in a recent U.S. study in North Carolina home 
health and hospice populations, [369] the CAUTI 
rates have decreased over 11 years of surveillance. 
The rate of catheter-associated UTI decreased in 
home health from 4.2/1000 catheter days in 1998 to 
0 in 2008, and in hospice patients from 2.35/1000 
catheter days in 1999 to 0 in 2008. Infection control 
specialists trained the persons collecting data, and 
presumably the rates reflect symptomatic CAUTI. 
However, in a hospital study of U.S. Veterans with 
spinal cord injury and disorder, [348] the rate was 
higher (8.9/1000 catheter days), reflecting greater 
risk. In a similar population of 100 inpatient and out-
patient veterans with chronic catheters, candiduria 
was present in 17%, and all but one had an indwell-
ing catheter. This was of concern due to the likeli-
hood of reoccurrence of this microorganism [370].
In the multi-national survey of 4010 older people 
(>65 years) receiving home care in 11 European 
countries, the risk of a UTI was found to be 6.5 times 
greater for catheterised individuals than for non-
catheterised [371]. Prevalence of a UTI amongst 
Figure XII-4: Biofilm - ‘pillars, mushrooms and water 
channels’ (Reproduced with the permission of Mon-
tana University Centre for Biofilm Engineering).
Figure XII-5: Scanning electron micrograph of biofilm.
Figure XII-6: SEM of bacteria colonising catheter sur-
face – Proteus mirabilis, Enterococcus faecalis, lacto-
bacillus sp.
for a shorter period of time (< 5 days) were more 
likely to develop CAUTI than those taking antibiotics 
longer, and the former should be evaluated for this 
risk. In a prevalence study in France of antibiotics 
used to treat hospital acquired infections, [361] uri-
nary tract infection had the highest association with 
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1004 frail older women living in the community was 
21% in catheterized women compared to 10% in 
non-catheterized subjects (p>0.001) [372]. Further-
more, catheterised subjects were more likely to die 
within a year (RR1.44; 95% CI 1.01-2.07). Tsan et 
al’s point prevalence survey [302] of Nursing Home 
acquired infections found 13.2% of 11,475 residents 
had an indwelling urinary catheter. Of those, 13% of 
residents with a UC and 9.5% of those with a SPC 
had a UTI. In catheterised SCI populations the over-
all rate of urinary tract infection has been quoted as 
about 2.5 episodes per patient per year [373]. Al-
though randomized trials are lacking there is some 
evidence of reduced rates of bacteriuria and CAUTI 
with SPC, condom catheters and intermittent cath-
eterisation compared to UC [373] [374] [302].
Bacteraemia resulting from CAUTI invariably rep-
resents a serious complication which may occur in 
approximately 4% of catheterised patients with bac-
teriuria in acute care settings [375] [376] [377]. In 
their review, Saint et al. [375] statistically pooled re-
sults from several prospective studies on short-term 
indwelling catheterization (in which the definition of 
bacteriuria varied between studies, ranging from 
>103 cfu/ml to >105 cfu/ml) and estimated (Level of 
Evidence 2) that:
•  26% of patients (not receiving systemic antibiotics) 
with a short-term, standard non-coated indwelling 
catheter in situ for between two and 10 days will 
develop bacteriuria. 
•  72% of patients developing bacteriuria will remain 
asymptomatic and not require treatment.
•  24% of those developing bacteriuria will develop a 
symptomatic UTI without bacteraemia.
•  4% with bacteriuria will develop bacteraemia.
This data is interesting since it provides supporting 
evidence that bacteriuria remains asymptomatic in 
a majority of catheterised patients. However, it can 
be difficult to generalize such data from acute care 
contexts to other practice settings. Unfortunately, 
few epidemiological studies or comparative cath-
eter evaluations are conducted on long-term cath-
eterised patients in community settings. 
3. OUTCOME MEASURES AND CRITERIA FOR CAUTI
Interpretation of the literature on CAUTI is often con-
fused by the range of definitions and outcome mea-
sures used. In this chapter, the terms symptomatic 
infection and asymptomatic bacteriuria have been 
employed to distinguish as clearly as possible be-
tween symptomatic and asymptomatic conditions. 
However many studies make little or no distinction 
between these states, referring to both as infection. 
This can be particularly confusing when attempt-
ing to interpret results in terms of the magnitude of 
infection-related problems, clinical importance and 
implications for services and individuals.
Bacteriuria is commonly used as a surrogate out-
come measure for the clinically more important 
outcomes of symptomatic UTI. Although symp-
tomatic infection is far less common than asymp-
tomatic bacteriuria, the frequency of catheter use 
produces considerable overall morbidity and mor-
tality [378]for patients and high costs to health-
care services [377], often including unnecessary 
antibiotic drug therapy which may then become a 
major source of antibiotic resistant pathogens. As-
ymptomatic bacteriuria can lead on to symptomatic 
infection, but not necessarily. Questions about the 
significance of long-term asymptomatic bacteriuria 
in its own right (e.g. effects of chronic tissue in-
flammation) are currently unanswered.
In non-catheterised patients the criterion for ‘signifi-
cant’ bacteriuria is commonly accepted to be >105 
cfu/ml but since growth of micro-organisms in cath-
eterised patients is rapid, many authorities consider 
>102 or 103 cfu/ml in a urine sample collected from 
the sampling port of the catheter, to be indicative 
[187] [342] [110]. Most definitions of symptomatic 
UTI [379] are based on those used for non-catheter-
ised patients and include significant bacteriuria. For 
catheterised patients, these include presence of py-
uria (>10wbc/mm3) plus one or more clinical signs 
and symptoms for which no other aetiology is ap-
parent: fever, suprapubic or flank discomfort, blad-
der spasm haematuria, changes in mental state, or 
malaise / lethargy. Pyuria alone is not diagnostic of 
UTI. [110]. For SCI patients signs and symptoms 
may also include increasing spasticity and / or wors-
ening autonomic dysreflexia (usually manifested by 
increase in blood pressure, headache, sweating 
above the SCI lesion, flushing below the SCI lesion) 
[380] or a “sense of unease” [110]. Elderly persons 
may have atypical or generalized symptoms [284]. 
In a study of the validity, accuracy and predictive 
value of UTI signs and symptoms in person with SCI 
using intermittent catheters, [381] cloudy urine had 
the highest accuracy (83.1%) and leukocytes in the 
urine was the most sensitive (82.8%). Fever was 
the most specific (99%) but least sensitive (6.9%) 
symptom. Moreover, patients might be better at 
identifying when they do not have UTI, as positive 
predictive value was 32.6% and negative predictive 
value was 82.8%.
However, commonly used criteria for symptomatic 
urinary infection have been questioned by Tambyah 
and Maki [362] in a prospective study of 1497 newly 
catheterised patients. No significant difference in 
reported symptoms of pain, urgency, dysuria and fe-
ver was found between patients with a catheter-as-
sociated infection and those without, nor was there 
statistical evidence that peripheral leukocytosis was 
predictive of infection (p=0.14) (Level of Evidence 
2). The criterion for bacteriuria (catheter-associated 
infection) in this study was >= 103 colony form-
ing units (cfu)/ml urine). This finding raises further 
questions over the selection of the most appropri-
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ate outcome measures in studies of CAUTI. Indeed 
concerns have also been raised over current UTI 
criteria for non-catheterised populations, particu-
larly for elderly groups, including nursing home resi-
dents. Consensus criteria (e.g. Loeb criteria 2001) 
have been found to be limited in terms of sensitivity, 
specificity and predictive value by Juthani-Mehta et 
al. [382] and these authors have called for clearer 
identification and evaluation of evidence-based clin-
ical criteria associated with laboratory evidence of 
UTI. A further complication to difficulties in confirm-
ing ‘best criteria’ for UTI and CAUTI is the variation 
in the clinical and scientific definitions required for 
specific populations, for research purposes or to 
meet stipulations for reimbursement from govern-
ments and medical agencies. Asymptomatic bacte-
riuria might be treated inappropriately, as described 
in a study in which 32% were treated (53 of 164 
episodes of bacteriuria) [383] further confound-
ing the definitions of CAUTI that include treatment 
with antibiotics. It is important that efforts to resolve 
these issues are progressed as quickly as possible 
to provide greater clarity in the interpretation of ex-
isting research, the design of new studies and the 
application of clinically important findings.
4. REDUCING THE RISK OF CAUTI
Risk factors which are independently predictive of 
increased risk for CAUTI have been identified in a 
number of large prospective studies of short-term 
catheterised patients [187] (Table XII-5). There is 
evidence that females have a substantially higher 
risk than males (relative risk: RR 2.5-3.7), and 1.3-
2.2, p=0.001 in an ICU setting [384]. But the greatest 
risk is associated with prolonged catheterisation > 
six days (RR 5.1-6.8). A recent retrospective cohort 
study of 35,904 undergoing major surgery reported 
that 86% of patients had a perioperative indwelling 
catheter [385]. Multivariate analysis showed that 
postoperative catheterisation for longer than two 
days was associated with increased risk of UTI.
Use of a preconnected drainage bag may be of 
value in preventing CAUTI in acute care settings. A 
prospective study in the UK of 205 patients in three 
medical wards over two periods, each of about six 
months’ surveillance, [386] compared use of precon-
nected bags with the usual bags. The CAUTI rate 
was 41% lower in the group with the preconnected 
bags, with rates of 37.8/1000 catheter days for the 
usual bags, compared with 22.4/1000 catheter days 
in the intervention group (RR 0.59 (0.35–0.99) 0.04. 
In Japan, a prospective observational study in five 
hospitals evaluated risks in persons with catheters 
3> days, using a Cox proportional hazards model 
[387]. Risks were significantly associated with two 
practices in this study of 555 inpatients, not using 
a pre-connected closed system (RR 2.35, 95% CI 
1.20–4.60, p=0.013) and the lack of daily cleaning of 
the perineum (RR 2.49, 95% CI 1.32–4.69, p=0.005).
Although there is some evidence to suggest there 
may be a reduced risk of CAUTI when SPC is em-
ployed compared to UC, the data is limited, stud-
ies are often small and most catheterisations are 
for post-operative care in acute care settings. 
One large scale point prevalence study of nurs-
ing home acquired infections in >11,000 residents 
[302] reported that 9.5% of residents with a SPC 
had a UTI compared to 13% of those with a UC. 
These data just fail to demonstrate a statistically 
significant difference between UC and SPC (one-
sided, Fisher’s exact test; p=0.066). A review of five 
published RCTs comparing SPC with urethral catheters 
Risk factor Relative risk 
Prolonged catheterisation  >6 days 5.1-6.8 
Female 2.5-3.7 
Catheter insertion outside the operating room 2.0-5.3 
Other active sites of infection 2.3-2.4 
Diabetes 2.2-2.3 
Malnutrition 2.4 
Ureteral stent  2.5 
Renal insufficiency (creatinine > 2.0mg/dL) 2.1-2.6 
Using a catheter to measure urine output 2.0 
Improper position of drainage tube (above 
bladder or sagging below drainage bag) 
1.9 
Table XII-5: Risk factors for catheter-associated infection based on prospective studies and use of multi-
variate statistical modelling (adapted from Maki & Tambyah 2001)[187].
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following colorectal surgery [388] reported that sample 
sizes were small, catheters were used short-term 
and there was no apparent difference in the dura-
tion of catheterisation between the two techniques. 
Significant UTI was defined in different papers as 
bacteriuria with either >104 or 105 organisms or cfu/
ml. Frequency of UTI was less in the SPC group in 
three of the studies, with no significant difference in 
the other two. The SPC groups reported less pain 
and discomfort than the urethral groups and SPC 
was preferred by those patients who experienced 
both. The authors concluded that the results fa-
voured SPC over urethral catheterisation as UTIs 
are reduced, particularly in females, and the ability 
to attempt normal voiding is facilitated, particularly 
in males (Level of Evidence 2). 
Much of the recent research on reduction of risk of 
CAUTI has centered on the development of cath-
eters with antimicrobial surfaces, such as silver. 
Silver ions are bactericidal [389], non-toxic to hu-
mans when applied topically, and have been used 
successfully in other areas of infection control such 
as burn wounds. Silver is also purported to have 
broad spectrum activity against Gram-positive, 
Gram-negative, aerobic and anaerobic organisms. 
Early silver-coatings incorporated silver oxide into 
the external surface of the catheter material only, 
but efficacy against CAUTI was limited [390]. Sub-
sequently, silver-alloy coatings were developed to 
provide an integral coating on both internal and ex-
ternal surfaces and promote a slow release of sil-
ver ions. Other developments have been directed 
towards impregnation of catheter materials with 
antibiotic or antiseptic agents such as nitrofurazone 
[391] [392] [393] [394]; minocycline and rifampicin 
[395]; chlorhexidine, silver sulfadiazine, triclosan 
[396] and others. Although a large number of stud-
ies (both laboratory models and clinical studies) 
have attempted to examine the potential benefits of 
antimicrobial catheters, most have used bacteriuria 
- rather than symptomatic UTI - as a surrogate end-
point. Most reports were either prospective cross-
over studies [397] or prospective surveillance of 
outcomes associated with introduction of new cath-
eter types, in comparison with historical or baseline 
outcomes associated with previously used catheter 
types [398] [399] [400]. Almost all have examined 
short-term catheter use in acute care settings. 
A recent Cochrane review [260], designed to de-
termine the effect of type of indwelling urethral 
catheter on the risk of UTI, examined 23 trials, 
comparing different types of standard catheters or 
a standard catheter with an antiseptic catheter (sil-
ver alloy or impregnated with silver oxide); or an 
antibiotic impregnated catheter (either minocycline 
and rifampicin, or nitrofurazone). The reviewers 
commented that trials were generally of poor qual-
ity but concluded that current evidence suggests 
silver alloy catheters prevent asymptomatic bacte-
riuria in the short-term catheterised patient (Level 
of Evidence 1). They recommended that further 
economic evaluation is necessary to confirm the 
extent to which reduction of clinically important in-
fection compensates for the increased cost of the 
silver alloy catheters. Catheters impregnated with 
antibiotics were also found to be beneficial in re-
ducing bacteriuria in hospitalised adults catheter-
ised for less than a week, but data were too few for 
patients catheterised longer.
An earlier systematic review of antimicrobial urinary 
catheters to prevent CAUTI in hospitalized patients 
[401] identified 12 randomised or quasi-randomised 
trials of silver-alloy coated (n=9) or nitrofurazone-
coated catheters (n=3) compared to standard 
silicone or latex catheters. Pre-post study designs 
were excluded. No study addressed symptomatic 
UTI and therefore analysis was based on bacteri-
uria. Although all studies indicated some benefit in 
prevention or delay of onset of bacteriuria the effect 
size varied substantially between studies. Varia-
tions were related to catheter type, patient charac-
teristics, control group bacteriuria rate and year of 
publication (i.e prevailing clinical conditions at the 
time of the study). Post enrolment exclusions, ab-
sence of intention to treat analysis, highly selected 
study samples and lack of data on clinically mean-
ingful end-points, all limited the ability to draw defin-
itive conclusions on efficacy. The authors concluded 
that, according to fair-quality evidence, antimicrobial 
catheters can prevent bacteriuria in hospitalized pa-
tients during short-term catheterisation (Level of Ev-
idence 1), but trial results are highly context depen-
dent. The relevance of results to other institutions or 
patient groups depends on the similarities between 
settings with respect to a range of variables, includ-
ing: background bacteriuria rate, baseline catheter 
type, local catheter use and maintenance practices, 
patient groups and patterns of antimicrobial usage. 
The authors cautioned that older data may lack cur-
rent relevance, particularly where background rates 
of bacteriuria have changed notably in the interven-
ing period. Although there is evidence that antimi-
crobial-coated catheters prevent bacteriuria during 
short-term catheterisation, there is a lack of corre-
sponding data to demonstrate clinical benefit [402]. 
Further well-designed and adequately powered 
randomised trials, with clinically relevant endpoints 
are needed to clarify comparative clinical utility and 
economic value.
In contrast to the majority of trials of silver-coated 
latex catheters Srinivasan et al [403] found no signif-
icant reduction in bacteriuria with silver-impregnat-
ed, silicone catheters despite similar performances 
in vitro. However, outcomes may have been affect-
ed by notable differences in the study groups in this 
prospective, cross-over study. The authors drew 
attention to the fact that not all silver products are 
the same and clinical trials of new products remain 
critically important. Any potential advantages of sil-
ver alloy catheters (or other antimicrobial catheters) 
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for LTC patients remain uncertain, although clinical 
experience suggests some benefits for individu-
als with frequent symptomatic infections. It is not 
known whether argyria (deposition of silver in the 
skin) may be a potential problem for long-term care 
patients or whether silver-resistant mutants may be 
selected by repeated exposure [404] [405].
A common concern over the use of antimicrobial im-
pregnated catheters is that elution of sub-inhibitory 
levels of the antimicrobial agent into the urine may 
induce resistance in resident organisms with pro-
longed catheter use [406]. Antiseptic agents are 
generally considered more likely to confer resistance 
to surface colonization than antibiotics and not to 
select for infection with antimicrobial drug resistant 
bacteria. Alternative approaches to inhibiting biofilm 
development include development of catheter sur-
faces which reduce protein absorption [407]; inflation 
of the balloon with a biocide solution, such triclosan, 
which then diffuses throughout the catheter mate-
rial and into the surrounding area [408] [409]; or ef-
forts to disrupt matrix or glycocalyx components with 
agents such as heparin [410], and colonization with 
a competing benign organism. Bacterial interference 
with E. coli 83972 was attempted in 13 CIC users 
with SCI, [411] [110], and eight were successfully 
colonized in 19 three-day attempts. Monthly urine 
cultures (until colonization was lost in the urine) indi-
cated a reduction in symptomatic UTI rate per year, 
0.77 per patient year as compared with 2.27 per pa-
tient year prior to the study.
Relatively few studies have examined the cost ben-
efits of different catheters. Those that have tend 
to rely heavily on assumptions that a certain pro-
portion of patients with bacteriuria will develop the 
clinically important outcomes of symptomatic UTI or 
bacteraemia. The focus of economic studies gener-
ally falls on acute care settings and, as discussed 
earlier, it can be difficult to generalise results from 
one practice setting to another. Practitioners and/or 
institutions who are considering introducing a new 
product (e.g. catheter type) for a majority of their 
patients on the basis of claims of improved cost-
effectiveness from clinical research studies, are ad-
vised to look carefully at the similarities and differ-
ences between their own local practice (and patient 
groups) compared to that described in the research. 
Economic studies are frequently required to make 
assumptions about certain data (e.g. increased 
length of hospital stay for CAUTI) which is then ap-
plied to an economic model. (?Cross ref to econom-
ics chapter). Such assumptions may or may not be 
applicable in local settings.
Numerous trials of oral antibiotics, antimicrobial 
bladder washes, drainage bag solutions and topical 
disinfectants all lead to the common conclusion that 
bacteriuria and UTI may be suppressed temporarily 
at best, but resistant organisms are highly likely to 
emerge [357]. The application of devices to secure 
catheters in place, to prevent a ‘to and fro’ pistoning 
effect that could favour invasion of catheter tracts 
by microorganisms, has been shown to reduce the 
incidence of catheter-related blood stream infection 
in central venous catheters. Only one prospective, 
randomised trial has examined a similar device for 
urinary catheters (StatLock) [380]. Although the 
study in 118 SCI patients failed to achieve statisti-
cally significant results the authors reported a clini-
cally important reduction in the rate of symptomatic 
UTI of 45% and called for further larger scale trials. 
They also noted the polymicrobial nature of infec-
tions including the presence of a Candida species 
in more than 20% of infections.
5. TREATING CAUTI: ANTIBIOTIC USE 
Some studies have suggested that methenamine 
hippurate may have a beneficial effect in prevent-
ing bacteriuria in patients requiring short-term cath-
eterisation during and post-surgery. However, a Co-
chrane review [393] designed to address this issue 
concluded there is not enough reliable evidence to 
conclusively support its use for urinary prophylaxis 
and identified a range of methodological limitations 
in existing studies. Caution is needed in translating 
research on reducing CAUTIs in short-term cath-
eters to LTCs but treatment of asymptomatic bacte-
riuria is not recommended in either for either group. 
Urine cultures should be obtained before initiating 
treatment to permit selection of specific therapy 
for the infecting organism and the extensive use of 
broad spectrum therapy should be avoided [412].
Studies of LTC patients can be difficult given the 
relatively high proportion of disabled or elderly pa-
tients, many of whom are very frail. However, rou-
tine use of prophylactic antibiotics in LTC patients is 
not supported by research evidence and has been 
shown to favour the emergence of resistant organ-
isms [110]. In a double-blind, cross-over study of 34 
elderly nursing home patients with urethral catheters 
[413] subjects were randomised to receive antibiotic 
prophylaxis (200mg/day norfloxacin ) or placebo for 
three months, followed by cross-over. Urine cultures 
were obtained once monthly. Episodes of UTI, cath-
eter-related complications (obstruction, encrusta-
tion, leakage, suprapubic pain, inflammation of me-
atus, haematuria and side effects of treatment were 
monitored weekly. Symptomatic UTI was defined as 
bacteriuria >105 cfu/ml and (i) a temp>38.5oC for 
two days in the absence of other clinical sources 
of infection or (ii) flank pain or unexplained mental 
disturbance or abdominal discomfort. Only 23 pa-
tients completed the study and although norfloxa-
cin failed to reduce asymptomatic bacteriuria, there 
was a significant reduction in symptomatic UTIs (1 v 
12, p<0.02) and a decrease in catheter-associated 
complications of obstruction and leakage (p<0.05). 
Of the 11 patients who did not complete the study, 
six died (of non-infectious causes), one died of septic 
shock and four were withdrawn. However, norfloxacin 
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treatment was also strongly associated with the ac-
quisition of gram-positive norfloxacin resistant flora 
(RR 4.66, 95% CI 2.47-8.80), and there was a rapid 
recolonisation by norfloxacin-sensitive, gram-nega-
tive bacteria on cessation of treatment. Overall the 
study concluded that norfloxacin failed to prevent 
bacteriuria in long-term catheterised patients and 
favoured the emergence of quinalone-resistent or-
ganisms, although there were some clinically ob-
servable benefits in some patients. 
Similarly there is little strong evidence of benefit in 
prophylactic antibiotics prior to re-catheterisationand 
it is not routinely recommended [110]. One RCT in 
which 70 residents in a long-term care home were 
allocated to a treatment group (1gm IV meropenem 
given 30 minutes before re-catheterisation) or con-
trol group (no antibiotics) showed no significant dif-
ferences in urine cultures at 3, 7, 14 or 28 days [414]. 
When catheterised patients are prescribed a course 
of antibiotics for symptomatic infection a common 
question from healthcare practitioners is whether the 
catheter should be changed to a new one prior to 
starting antibiotics. There are concerns that this may 
allow time for a new biofilm to become established 
on the catheter within a few hours (and provide a 
source of re-infection) before the antibiotics have 
taken effect. In contrast, the 2009 International Clini-
cal Practice Guidelines from the Infectious Diseases 
Society of America suggest a catheter change if the 
catheter had been in place for at least two weeks and 
was still needed. The rationale was that this would 
facilitate resolution of symptoms and decrease risk of 
bacteriuria and CAUTI [110]. There is little research 
to guide practice but in one RCT of 54 nursing home 
residents managed by long-term catheterisation, 
subjects were randomised to undergo catheter re-
placement, or no catheter replacement, before anti-
biotic intervention for clinical diagnosis of UTI [216]. 
Clinical outcomes (reduction in polymicrobial counts, 
time to achieve afebrile status and clinical status at 
72 hours) were significantly better among subjects 
randomised to catheter change immediately before 
institution of antibiotics (Level of Evidence 2). Re-
placement of the catheter, in patients suspected of 
having a UTI, prior to collecting a urine sample for 
culture and sensitivity testing has also been shown 
to reduce the number of pathogens identified, the 
number of antimicrobials prescribed and laboratory 
costs [415]. There is evidence that certain bacterial 
strains may be particularly difficult to eradicate. In a 
prospective study of infection in catheterised nursing 
home patients a single genotype of P.mirabilis was 
shown to persist in the urinary tract despite many 
changes of catheter, periods of non-catheterisation 
and antibiotic therapy [416].
Cranberry juice has long been advocated as a 
treatment for urinary tract infection and there is 
some evidence of decreased symptomatic infec-
tions in some study populations, but not in cath-
eterized persons [417]. However current evidence 
to date is limited to non-catheterised patients and 
caution needs to be applied in extrapolating results 
to catheterised patients.
i) LTC-associated risks and problems: recurrent 
catheter blockage
Recurrent catheter encrustation by mineral depos-
its, leading to catheter blockage occurs in up to 
50% of LTC users, with resultant increased costs to 
services and patients [418] [419] [420] [421]. Heavy 
encrustation on external surfaces of the catheter tip 
and balloon can also cause painful tissue trauma 
on catheter removal. The major components of en-
crustation are calcium phosphates and magnesium 
ammonium phosphate (struvite) (Figures XII-7 and 
XII-8) which precipitate from the urine, most com-
monly under alkaline conditions.
The precipitation of different ionic species (ie Ca++, 
Mg++, and phosphates) is influenced by their ionic 
concentrations in the urine. In addition, the urinary 
pH at which different ions precipitate from the urine 
varies, not only for different ions, but also between 
individuals and at different times [422] [423]. These 
factors contribute, at least in part, to individual vari-
ability in terms of susceptibility to catheter encrusta-
tion and time to blockage. Catheterised patients can 
usually be classified into ‘blockers’ or ‘non-blockers’ 
[418] [424] where ‘blockers’ are those individuals 
who experience recurrent catheter blockage within 
a few days to a few weeks. Early recognition of re-
current ‘blockers’ facilitates proactive care through 
appropriate catheter change regimes [424]. Urine 
from recurrent blockers tends to have a very narrow 
‘safety margin’ between ‘voided’ urinary pH and the 
pH at which crystallisation (or nucleation) occurs. 
This margin is much wider in non-blockers [425]. 
Precipitates occur most commonly under alkaline 
conditions caused by the presence of urea-splitting 
micro-organisms such as Proteus mirabilis, in the 
catheter biofilm [426] [424] [427] [425].
1. REDUCING CATHETER ENCRUSTATION – CATHETER MATERIALS
The majority of research on catheter encrustation 
comprises experimental, laboratory-based studies 
addressing current and / or potential catheter mate-
rial surface properties in relation to bacterial adhe-
sion and encrustation. Encrustation may sometimes 
take place in the absence of infection [428] and is 
influenced by catheter surface properties, includ-
ing roughness and irregularity, hydrophobicity and 
wetability, charge, polymer chemistry and coatings. 
None of the currently available long-term catheter 
materials is resistant to biofilm formation and encrus-
tation. In a series of laboratory studies of 18 types of 
catheter materials, using a model of the catheterised 
bladder, none resisted biofilm formation by a clini-
cal strain of P.mirabilis [429] [430]. Relative times to 
catheter blockage were: silver-coated latex 17.7h; 
hydrogel-coated latex 34h; silicone-coated latex 38h; 
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all-silicone 47h. However, the authors note that the 
internal diameter of the coated latex catheters was 
much smaller than for the silicone catheters (1.5mm 
compared to 2.5mm). 
This finding was confirmed [409] in tests with five 
types of catheters (pure silicone, silicone-coated 
latex, hydrogel-coated latex, hydrogel/silver-coated 
latex, and nitrofurazone silicone) colonized with P. 
mirabilis 108 cfu/mL and a urine pH of 8.5 All had 
heavy encrustation by 18 h. and were blocked with-
in 40 h. There are implications for coated catheters, 
such as silver, because the bacteria can continue to 
grow even when attached to the crystalline biofilm, 
which shields them from the silver. To keep the pH 
from rising, antimicrobials need to get into the urine.
Targeting P. mirabilis infection for treatment as soon 
as it is introduced into the urinary tract may be 
beneficial in preventing recurrent encrustation and 
blockage [431]. While this organism, which is har-
boured in the intestines, may not cause problems 
in the urinary tract of a healthy person, it has many 
characteristics that negatively impact the bladder of 
a catheterized person who has an already inflam-
matory process taking place. These include: four 
adhesins that help make it stick to the bladder and 
catheter, a protective capsule, several secretions 
that promote extraction of host nutrients, quick mi-
gration capacity, and a powerful urease [431]. The 
ability of P.mirabilis to evade the host’s immune re-
sponse make it a very difficult organism to treat. For 
example, a structure in the membrane called LPS 
contributes to virulence and can cause hypotension, 
fever, DIC and shock. Another component (migra-
tion factor Cmf] improves swarming [432].
Although it is not possible to examine the effects 
of polymer surface properties on microbial adhe-
sion and formation of catheter encrustation in de-
tail here, recent studies have shown that strongly 
electron donating surfaces are less prone to adher-
ence by P.mirabilis than more hydrophobic materi-
als [433]. Some copolymer, polyurethane blends 
are associated with less microbial adherence and 
improved resistance to encrustation in an artificial 
bladder model [434]. The effect of iontophoresis 
produced by passing an electric current through sil-
ver electrodes attached to catheters has also been 
shown to inhibit bacterial growth [435]. Another po-
tentially promising innovation is the use of the anti-
septic agent triclosan in the catheter balloon [408] 
[436] [437]. In laboratory models of the catheterised 
bladder infected with P.mirabilis, silicone and latex-
based catheters, with balloons inflated with triclo-
san, drained freely for seven days compared to 24h 
for controls inflated with water. Triclosan became 
impregnated throughout the silicone catheter mate-
rial and strongly inhibited the formation of the crys-
talline biofilm. However, latex-based catheters re-
quired a higher concentration of triclosan (>1mg/ml) 
than silicone catheters to produce similar inhibitory 
effects on P. mirabilis. Diffusion through the latex 
balloon occurred but the latex-based catheter did 
not become impregnated with triclosan throughout. 
The potential benefits of triclosan in catheter bal-
loons now needs to be tested in clinical trials but it is 
also important to note that not all microbial species 
responsible for CAUTIs are sensitive to this biocide 
and emergence of resistant strains is a common 
concern [437].
2.  REDUCING CATHETER ENCRUSTATION – INTERVENTIONS
A number of studies have employed in vitro models 
of the catheterised bladder to examine the influence 
of urinary composition on bacteria growth and en-
crustation, and the ability of acidic irrigations to re-
duce encrustation build up. There is good evidence 
from laboratory studies that increased fluid con-
sumption (leading to lower concentration of encrus-
tation components) increases the time to catheter 
Figure XII-7: Section of catheter showing encrusta- 
tion and blockage.
Figure XII-8: SEM of encrusting material - struvite 
and calcium phosphate.
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blockage [438]. Increasing citrate concentration in 
fluid intake and urinary output (eg through drinking 
orange juice or other fruit juices such as lemon or 
lime) has also been shown to increase time to cath-
eter blockage (see below). Cranberry juice has fre-
quently been advocated to reduce UTIs, microbial 
adherence and biofilm development but an in vitro 
study by Morris and Stickler [439] drinking cranber-
ry juice did not produce urine which was inhibitory to 
the development of P.mirabilis biofims and catheter 
blockage, although increased fluid intake was bene-
ficial. Although some studies have claimed drinking 
cranberry juice can decrease urinary pH in healthy 
volunteers [440], this is unlikely to be accomplished 
in catheterised patients, in the presence of contin-
ued ammonia production by the action of urease-
producing micro-organisms [441]. 
Urease inhibitors, including acetohydroxamic acid 
(1.0mg/ml) and fluorofamide (1.0microg/ml), have 
been shown to restrict the increase in urinary pH of 
P.mirabilis infected urine from 9.1 to 7.6, in a simple 
physical model of the catheterised bladder [430]. 
Significant reductions in precipitation of calcium and 
magnesium salts were also noted but the impact of 
possible side-effects remains unclear, and therefore 
clinical potential is uncertain. Clinical studies on the 
prevention or management of catheter encrustation 
are extremely limited and only two relevant studies 
addressing the use of urease-inhibitors were identi-
fied. One early clinical study [442] examined oral ad-
ministration of a urease inhibitor (acetohydroxamic 
acid) to five patients who required frequent catheter 
changes (>1 every 2 weeks) due to encrustation and 
blockage. The dose was based on body weight (eg. 
250mg three times daily for patients between 50-
70kg). The degree of encrustation decreased sig-
nificantly during therapy (p<0.05) and the authors 
reported minimal adverse side effects experienced 
by patients, but acknowledged the potential for more 
severe side effects to occur. A subsequent double-
blind, RCT of acetohydroxamic acid in the palliative 
treatment of infection-induced urinary calculi, dem-
onstrated lowered urinary pH in urine infected with 
P.mirabilis but the side effects were unacceptable to 
patients [443] (Level of Evidence 1). 
An alternative approach to reducing catheter en-
crustation, aimed at increasing the ‘safety margin’ 
between urinary pH and the nucleation pH (pHn) (i.e. 
the pH at which crystals of calcium and magnesium 
are formed in the urine) warrants further clinical in-
vestigation. In laboratory studies using models of 
the catheterised bladder, the pHn of the urine was 
shown to increase when urine concentration was de-
creased and also by addition of citrate to the urine 
[438]. In models supplied with urine containing citrate 
at 1.5mg/ml or above, catheter drained freely for the 
seven day experimental period. Drinking 500ml pure 
orange juice per day can achieve concentrations of 
citrate of up to 1.2mg/ml urine [423] and further clini-
cal evaluation of the effects of increasing a patient’s 
fluid intake with citrate containing drinks is awaited. 
Viable cell counts of P.mirabilis in the model suggest 
that results were unlikely to be due to direct effects 
of citrate on the growth of metabolism of P.mirabilis 
in the catheter biofilm, but rather on the process of 
mineral crystallization. 
Recent research provides more evidence. In a re-
cent randomized six week crossover trial of citrated 
drinks in 24 persons with catheter blockage [444], it 
was demonstrated that the pHn could be significant-
ly increased. The highest level of change was with 
lemon juice, with a “safety margin” of 0.84 (95% 
CI 0.63, 1.04), followed by fluid intake 0.57 (95% 
CI 0.37, 0.78), and potassium citrate 0.41 (95% CI 
0.20, 0.61). Overall, the safety margin for the drinks 
was significant (p<0.001) when controlling for the 
three groups. Each participant, who had experi-
enced at least three blockages within four weeks 
previously, received all three drinks. Baseline 24 
hour urines were obtained after each week, allowing 
for a washout period between the one week drink 
consumption for each arm of the study. The lemon 
juice concentration was 60mL/1 litre of water, potas-
sium citrate was 6 g/1 litre, and the fluid intake was 
also 1 litre additional. Participants were instructed 
to consume the drinks each day in addition to their 
usual fluid intake and they tracked their intake and 
output during the study. This study provides addi-
tional evidence that optimal and consistent levels 
of fluid intake could minimize catheter blockage or 
increase the interval between changes, in persons 
with persistent encrustation and blockage. 
The reduction of encrustation and corresponding 
extension of ‘catheter life’ by regular instillation of 
an acidic catheter maintenance solution into the 
catheter has been advocated by some researchers, 
particularly where frequent catheter changes for 
recurrent blockage are difficult and / or unaccept-
able to patients. Solution G (Suby G) and Solution 
R (Table XII-5) have been shown to be effective in in 
vitro models of the catheterised bladder [445] [446] 
[447] and in vitro models of struvite stone chemoly-
sis [448]. In response to concerns over potential 
damage to the bladder mucosa from acidic catheter 
maintenance solutions, Getliffe et al. [446] advocate 
the use of small volumes of solution so that less 
enters the bladder. Under controlled laboratory con-
ditions smaller volumes of acidic solutions (Suby G) 
(50ml), retained in the catheter for 15 minutes, were 
shown to be as effective as the commonly available 
commercial standard of 100ml. Getliffe et al. also 
showed that two sequential washouts with 50ml 
were more effective than a single washout.
There is relatively little clinical evidence to draw 
on in this area and outcomes remain to be tested 
in well-controlled clinical trials. Most clinical stud-
ies are small-scale and descriptive although both 
Getliffe [424] and Kunin et al. [418] compared 
groups of ‘blockers’ and non-blockers’ to identify 
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characteristics of recurrent ‘blockers’. One small-
scale, comparative trial of Suby G, Solution R and 
saline catheter ‘washouts’ in 14 older female pa-
tients [449] reported a higher incidence of red-cells 
in the retrieved washout fluid with Suby G com-
pared to saline (mean incidence of 28% and 14%, 
respectively. However, increased shedding of uro-
epithelial cells was present in the retrieved wash-
out from all three solutions suggesting this was at 
least partially related to the physical process of 
administration. This issue was previously raised by 
Elliot et al. [450] who also demonstrated increased 
uroepithelial shedding following washouts with up 
to 60ml saline 0.9%; chlorhexidine 0.02% or noxy-
thiolin 2.5%.
A more recent RCT with 73 community dwelling 
individuals, which aimed to compare weekly cath-
eter flushes with saline or an acidic solution, with 
no flushes, reported the mean time until catheter 
removal was very similar between groups. Im-
portantly, there was no evidence of detrimental 
effects, such as increased risk of symptomatic 
infection, from breaking the closed system in 
order to apply catheter flushes. Urinary pH did 
not change over the study time; at baseline the 
mean was 6.3 (SD 1.04), range 5-8.5. However 
the study was underpowered and subjects were 
only followed for a maximum of eight weeks, or 
until the catheter was changed three times, or a 
symptomatic UTI developed. There were consid-
erable difficulties with recruitment of patients and 
target numbers fell short within each group (Level 
of Evidence 2) [358). A sample of 400 per group, 
1200 in total, was estimated posthoc, as giving 
sufficient power for future research in this area 
[451]. Other clinical studies have focused on che-
molysis of infection stones (principally composed 
of struvite). Stronger acidic solutions such as So-
lution R have been shown to dissolve fragments 
of struvite renal calculi following lithotripsy [452] 
but potential benefits may be outweighed by the 
greater risk of inflammatory tissue reactions when 
used as a catheter maintenance solution. Renaci-
din solution is approved for kidney stone disinte-
gration in the US but although it may be effective 
for recurrent catheter blockers, there is no pub-
lished research evidence of its use in this group. 
Overall, methodological issues make it difficult to 
draw robust conclusions on the effectiveness of 
acidic solutions in managing catheter blockage. It 
is unlikely that any currently available strategies 
will completely prevent catheter encrustation and 
a more practical aim is to extend catheter life to a 
period which is acceptable to users and manage-
able by healthcare professionals. Early detection 
of impending blockage by determination of usual 
length of catheter-life [424] or by application of 
a sensor device designed to detect early stages 
of P. mirabilis biofilm formation [453] are likely to 
remain the main stays of management.
j) LTC-associated risks and problems: urethral 
trauma, bladder calculi and bladder cancer
1. URETHRAL TRAUMA
Urethral trauma and discomfort can occur during 
catheterisation but may be minimised by using a 
sterile lubricant or anaesthetic gel [454], however 
clinical practice remains variable. More studies 
have considered the use of lubricants for male cath-
eterisation but few have considered the procedure 
for women or for supra-pubic catheterisation [455]. 
A recent randomised, double-blind study with 62 
alert, cooperative females requiring urethral cath-
eterisation, demonstrated that the group receiving 
lignocaine gel had a significantly lower median pro-
cedural pain score compared to the group receiving 
a water-based lubricating gel [456]. It is not clear 
whether cleaning the urinary meatus prior to inser-
tion is needed, based on two small trials (Level of 
Evidence II). In one study, 0.05% chlorhexidine glu-
conate or sterile water was tested in a home care 
sample (N=20), with four urine specimens cultured 
over two weeks. No difference was found, and no 
one developed a symptomatic CAUTI [457].In the 
other study of 60 women receiving outpatient gyn-
aecological surgery,[458] povidone-iodine was 
compared with water. No significant differences in 
bacteriuria or symptomatic CAUTI were found in 
comparing urine samples just prior to insertion and 
24 hours later. 
2. BLADDER CALCULI 
Most long-term follow up studies of LTC use have 
addressed SCI populations. Indwelling catheters 
(UC and SPC) have been significantly associated 
with increased risk of bladder calculi formation in 
SCI patients, compared to intermittent catheterisa-
tion [460] [235]. In a retrospective cohort study of 
457 patients, controlled for variable follow up times 
by regression analysis, both UC and SPC were sig-
nificantly associated with increased risk of bladder 
calculi formation compared to intermittent catheteri-
sation IC (hazard ratio 10.5; p<0.0005 and 12.8; 
p<0.0005) respectively [461]. This increased risk 
was independent of age, sex, level and degree of 
injury but calculi were no more likely to form with 
SPC than UC (hazard ratio 1.2, p=0.6). Another 
case series of SPC in 118 patients with neurogenic 
bladders [462] found common complications were 
bladder calculi (25%), (particularly associated with 
high urinary pH) and urethral leakage (10%). Blad-
der calculi-free rates at five and 10 years were 77% 
and 64% respectively, falling to 50% at 20 years. 
Where SPC has been compared to CIC the main 
difference appears to be in a lower incidence of 
bladder calculi in the CIC group. A prospective com-
parison of long-term outcomes between 34 quad-
riplegic patients managed by SPC (mean period 
8.6 years) and 27 paraplegic patients managed with 
CIC (mean period 9.9 years) reported no significant 
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difference between groups in respect of symptomatic 
UTI, renal stone, degree of bother and overall satis-
faction [310] but there was a significantly increased 
incidence of bladder stones in the SPC group. How-
ever a recent review of current literature [311] (56 
studies), concluded there were variations between 
older and more recent studies. More recent studies 
showed morbidity profiles to be similar for SPC and 
CIC, where patients were managed by anticholiner-
gic medications, frequent catheter changes and vol-
ume maintenance procedures. A dedicated catheter 
clinic established to aid the management of patients 
having problems with LTC, reported the majority 
of patients were elderly with chronic disabilities. 
A significant proportion of those with catheter en-
crustation and blockage (45% of 147 patients) were 
shown to have formed bladder calculi [463].
3. BLADDER CANCER
A number of retrospective, cohort reports of SCI 
patients have linked bladder cancer with long-term 
indwelling catheterisation [464] [465] [466]. The re-
ported incidence of squamous cell and transitional 
cell carcinoma associated with chronic indwelling 
catheterisation varies widely between studies but 
Groah et al. [466] in their follow-up of 3670 subjects, 
calculated that patients with SCI and an indwelling 
catheter were 25 times more likely to develop blad-
der cancer than the general population (Level of 
Evidence 3). For SCI patients without an indwelling 
catheter, the risk of bladder cancer was 15 times 
that of the general population. Since SCI patients 
are already at increased risk of developing bladder 
cancer compared to non-SCI groups, the influence 
of an indwelling catheter on bladder cancer requires 
further clarification, including the potential relation-
ship between duration of catheterisation and cancer 
development. Bladder calculi have been identified 
as an independent risk factor for bladder cancer by 
some authors (464]. 
Most reports have grouped UC and SPC togeth-
er as indwelling catheters but a small number of 
case study reports have drawn attention to long-
term risks of carcinoma within the cystostomy tract 
with SPC, with or without further extension into the 
bladder [467] [468] [469]. However, in a retrospec-
tive analysis of screening biopsies for bladder ma-
lignancy in 36 patients with SPC for more than 12 
years, Hamid et al. [470] found no tumours in the 
screened group although histological findings were 
frequently abnormal (Level of Evidence 2). These 
authors raise concerns over the interpretation of 
screening cystoscopy and biopsy in this popula-
tion and note the importance of the distinguishing 
between histological changes and confirmed can-
cers when interpreting study results. Recently pub-
lished guidance on management and prevention of 
catheter-associated urinary tract infection, based 
on an extensive survey of the literature, includes 
a recommendation that patients with urethral 
catheters in place for 10 years or more should be 
screened annually for bladder cancer [471] (Grade 
of Recommendation C). 
k) Catheter management strategies
Although guidelines and protocols for catheter-care 
practices are abundant, relatively few practices are 
supported by research evidence and even fewer by 
evidence from randomized controlled trials. For ex-
ample, in the ‘Guidelines for prevention of health-
care associated infections in primary and communi-
ty care’ commissioned by the UK’s National Institute 
for Clinical Excellence [472], of 29 recommenda-
tions relating to urinary catheterisation only six 
were Grade A (directly based on Level 1 evidence); 
with one each at Grades B and C. The remaining 
21 were all grade D, being based on evidence from 
expert groups or clinical opinion. 
1. GUIDELINES
In 2009, the U.S. Healthcare Infection Control 
Practices Advisory Committee issued through the 
Centers for Disease Control and Prevention (CDC) 
updated Guideline for Prevention of Catheter As-
sociated Urinary Tract Infections [342]. This guide-
line, which updated the 1982 Guideline, expanded 
information about catheter related issues, including 
intermittent, condom, suprapubic, and chronically 
catheterised long-term users. The recommenda-
tions made by this committee for preventing cath-
eter-associated urinary tract infections, based on 
systematic review of the best available evidence, 
address the following issues:
 •  who should receive an indwelling urinary catheter
 • catheter insertion
 • catheter maintenance
 •  quality improvement programs to achieve appro-
priate placement, care, and removal of cath-
eters
 • administrative infrastructure required 
 • surveillance strategies 
This new guideline recommended selected practices 
at grade B based on level of evidence of 1 or 2. There-
fore, many topics were judged as “no recommenda-
tion/unresolved issue” due to a lack of evidence.
2. QUALITY INDICATORS AND REGULATOR INITIATIVES
It is well established that guidelines alone do not 
change practice. Further efforts should be directed 
to disseminating evidence-based guidelines about 
catheter care through education and the use of 
quality indicators and regulatory initiatives. 
Regulation that is accompanied by the use of evi-
dence based quality indicators has a powerful influ-
ence on the quality of care. Quality indicators are de-
fined as quantitative measures reflecting a professional 
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care standard which are used as guides to monitor 
and evaluate the quality of important patient care 
and support service activities. The ACOVE (Assess-
ing Care of Vulnerable Elders) suite of quality indi-
cators has been designed to measure the quality of 
care for vulnerable elders [473]. It incorporates one 
quality indicator to guide measurement of the qual-
ity of care related to catheter use. 
“IF a VE has clinically significant urinary retention, 
and a long-term (> 1 month) urethral catheter is 
placed, THEN there should be documentation of 
justification for its use, BECAUSE treatment of cer-
tain underlying causes(s) of urinaryretention (e.g., 
treatment of constipation or bladder outlet obstruc-
tion) may carry less risk than long-term urinary cath-
eterization” [473].
Another attempt to ensure the appropriate use of 
catheters is the use of assessment protocols. For 
example, regulation for long-term care settings in 
the USA mandates that all newly admitted Medi-
care/Medicaid funded residents receive an assess-
ment using a standardized form called the Minimum 
Data Set (MDS). A further level of assessment is 
triggered when/if a resident is newly incontinent and 
the Resident Assessment Instrument Minimum Data 
Set is completed (RAI-MDS). This assessment in-
formation in turn, acts as a prompt for staff to design 
an individualized care plan based on direct contact 
with residents, appropriate staff, and through use 
of observation, interviews and record reviews. The 
MDS and RAI are now used in a number of other 
countries, including Canada and Iceland, and other 
countries have developed their own assessment 
instruments. Ideally, these assessment instruments 
should prompt staff to enquire about whether the 
residents’ catheter is medically warranted, and to 
identify catheter related problems, and care plans 
should contain information about an individualized 
catheter care plan (including the frequency of cath-
eter changes and ongoing maintenance). This as-
sessment process is strengthened in the USA by its 
link to quality indicators. Specifically, long-term care 
facilities are required to use information from the 
residents’ comprehensive assessment to provide 
assurances that:
 •  Catheters are used for only medically valid 
reasons; 
 •  Catheters are removed as soon as clinically 
warranted;
 •  Efforts are applied to restore or improve blad-
der function as much as possible; and
 •  Efforts are made to prevent infection while the 
catheter is inserted (U.S Dept of Health and 
Human Services, 2004).
It remains to be seen if these measures will reduce 
catheter rates in long-term care, and how they will 
impact day-to-day catheter use and catheter care. 
However, similar regulatory approaches should be 
considered by government and health agencies in 
other countries.
3. CATHETER CHANGE PROCEDURES AND CATHETER COMFORT
Indwelling catheters can cause substantial patient 
discomfort but although anecdotal information on 
the discomfort experienced by many catheterised 
patients is readily available, there is a general lack 
of published evidence from research studies. Further 
investigation and guidance to practitioners is need-
ed. Catheter-related pain or discomfort can occur as 
the catheter is passed, in situ and on removal. Lo-
cal anaesthetic lubricant gels are commonly used to 
aid the insertion of indwelling catheters in males and 
protect the sensitive urothelium from trauma [474]. 
Similar use of anaesthetic gels is generally recom-
mended for females although the procedure may be 
less consistent in some places and where only small 
amounts of lubricant are applied to the catheter tip 
this may be insufficient to coat the urethra adequate-
ly. There is little research evidence to underpin clini-
cal practice in this area although the NICE guidelines 
on infection control [472] recommend: ’an appropri-
ate lubricant from a single–use container should be 
used during catheterisation to minimise trauma and 
infection’. The choice of lubricating gel is usually left 
to practitioners but not all gels containing anaesthetic 
agents (eg lidocaine) are suitable for both urethral 
and suprapubic use. One prospective, randomized, 
double-blind, controlled trial of plain lubricant versus 
lidocaine gel prior to female catheterisation in an ac-
cident and emergency department found no signifi-
cant differences in pain ratings, based on lubricant 
type or catheter size amongst 100 women recruited 
to the trial [475]. Anaesthetic gels may be contraindi-
cated in patients with damaged or bleeding urethral 
membranes and should be used with caution in those 
with cardiac conditions, hepatic insufficiency and epi-
lepsy [476]. Lubricants which contain chlorhexidine 
have been reported to trigger anaphylaxis in a small 
number of patients during catheter insertion and con-
sequently a careful history is required to screen for 
sensitivities [477] [96]. 
In a study with 45 infants (2-24 months) who need-
ed urethral catheterization, random assignment was 
made to either a topical lubricant (control), topical 
and intraurethral lubricants, or topical and intraure-
thral lidocaines [478].Infants with the lidocaine had 
less distress, but the lidocaine did not eliminate the 
distress totally. 
Catheterization in males can be difficult at times, 
and different approaches can be used, including a 
Coude catheter, various guide wires or filiform cath-
eters, and other techniques performed by urolo-
gists. Research in this area is needed to compare 
different practices and associated risks [479].
Catheters can be painful when in situ. In one study 
at a US Veterans Affairs Medical Centre, 42% of 
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catheterised patients reported it was uncomfort-
able, with 48% complaining it was painful, and 61% 
stated it restricted their activities of daily living [107]. 
In one small sample of 43 community dwelling per-
sons with long-term catheters, pain was reported 
by 24 (54%) [126]. Causes of pain were bladder 
spasms, position of the catheter, or related to cath-
eter changes. Three had pain all the time, but 21 of 
24 persons had it intermittently. If bladder spasm 
is the cause of pain when a catheter is in situ a 
low dose of an anticholinergic medication can help 
[480]. Other helpful approaches include treating 
constipation if present, ensuring that the catheter 
is the smallest size to provide adequate drainage, 
and ensuring that the drainage bag is well support-
ed to prevent dragging on the catheter. Attention to 
the catheter position is needed to prevent kinks or 
twists in tubing and ensurethat the catheter straps 
are not blocking urine flow [481]. Blockage in urine 
flow can cause bladder distension resulting in in-
creases in hydrostatic pressure and bleeding points 
which open the way to bacteria, already present, to 
cause a symptomatic infection [210].
Bladder discomfort related to an indwelling catheter 
can exacerbate post-operative pain by mimicking 
overactive bladder syndrome that is resistant to 
conventional opioid therapy. Sub-lingual oxybutinin 
has been shown to be an effective treatment for 
pain after radical retropubic prostatectomy, with sig-
nificant reduction in other pain relief requirements 
[482]. Cuffing of the catheter material on balloon 
deflation (see below) and / or encrustation of the 
catheter by mineral deposits may cause pain during 
catheter removal. Encrustation is discussed further 
in Section 12.2.9 and management of these prob-
lems is also discussed below. 
4. EDUCATION OF HEALTHCARE PROVIDERS
Educational approaches should ensure that all 
healthcare practitioners have the necessary knowl-
edge and skills to care for individuals with a catheter. 
Some research however, points to gaps in health-
care practitioners’ knowledge about what catheter 
to select, and how to minimize and manage ongo-
ing problems[483]. Mody and colleagues (2010) 
[484] assessed nursing home healthcare workers’ 
knowledge and awareness of recommended cath-
eter care practices, and found significant discrepan-
cies between their knowledge and research-based 
recommendations. Respondents were drawn from 
seven community-based nursing homes in the USA 
and included nurses and nurse aides 
Twin surveys were sent to healthcare providers in 
Minnesota to determine their level of knowledge 
about catheter use. The physicians (N=635) reflect-
ed awareness of the indications for catheter use, 
and about 1/3 said they remove them sooner. How-
ever, about 30% were unsure about how to prevent 
UTI [485]. Nurses (N=370) were aware of catheter 
indications, but some were likely to approve of cath-
eter use in the ICU (for whatever reason) and of 
the value of silver coatings on catheters [485].Both 
studies had low response rates, of 9% and 4% phy-
sicians and nurses, respectively. Another survey to 
333 persons, (70% RNs and 27% unlicensed assis-
tants) indicated that there was a need for more edu-
cation related to catheters [486]. Incorrect practices 
involved not securing the catheter (75%) and not 
knowing when to replace the catheter (74%). The 
response rate was 54%, and about half of those 
surveyed had less than two years work experience. 
An audit of education given to nursing students in 
Greece indicated that there was a need to upgrade 
teaching methods [487]. Proficiency was impaired 
by a lack of attention to preparing the patient (in-
cluding emotional and practical aspects), old text-
books, outworn traditions, little or no instruction on 
troubleshooting and a lack of sophisticated methods 
for teaching (e.g. DVDs showing the procedure). 
An audit of adherence to standards of nursing care 
in one UK Trust related to catheter practices in 
patients’ homes [488]. All nurses surveyed (N=25) 
indicated they would change the catheter every 12 
weeks unless there was a reason to do this more 
often; no data were provided on the percentage 
with 12 week changes. Though a closed system 
was advocated by all nurses, washouts were per-
formed by 75% and sampling ports for urine sam-
ples were used by 28%, and the rest used a clean 
drainage bag. A similar audit was conducted in a 
hospital setting [489]. Continuing catheter care 
was well documented at 98%, but 11% were miss-
ing details on insertion.
5. CATHETER CHANGE FREQUENCY
Protocols on indwelling catheter change frequency 
vary widely from monthly to up to three months if the 
catheter is trouble-free. In the absence of clear sup-
porting evidence this remains an area of controversy 
amongst clinicians with advocates of early change 
believing this to reduce the incidence of complica-
tions while others argue that frequent changes in-
crease the risk of infection, trauma and long-term 
histological changes. However, very sparse evi-
dence suggests that CAUTI might be less when the 
catheter is changed every 4-6 weeks, rather than 
only when it blocks, or with planned changes of ev-
ery two weeks [490].
SPC changes can be competently managed by 
skilled nurses [325], often in the patient’s own home, 
but the new catheter should be inserted as quickly as 
possible whilst the track is still easy to follow. A delay 
of only a few minutes can result in partial oblitera-
tion of the tract [491]. It is also possible to insert the 
new catheter too far through the bladder so it enters 
the urethra with resultant trauma when attempts to 
inflate the balloon are made. Careful observation of 
the length of catheter external to the abdomen and 
the angle of protrusion prior to catheter change can 
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help to ensure correct positioning of the new catheter 
[492]. Dressings around the stoma site are not nor-
mally required unless there is excessive discharge, 
causing staining and / or sticking to clothing.
While nurses do not usually order catheter inser-
tions, and there may be times when delay in a clini-
cally appropriate catheterisation is harmful to certain 
patients. A new protocol and algorithm was thus de-
veloped by nurses, physicians and other key stake-
holders in an orthopaedic unit of a large urban hos-
pital to facilitate catheter insertion in certain defined 
situations [493]. Indications, such as spinal column 
injury, and contraindications were depicted in a dia-
gram to identify when to stop, consider the issues 
(e.g., neutropenia), and when to insert the catheter.
Urinary catheter ‘deflation cuff’ formation can be a 
problem in both SPC and UC, causing difficulty in 
removal and great discomfort to patients. Evidence 
suggests deflation cuff formation can be a particu-
lar problem for all-silicone SPCs. A retrospective 
study of 113 patients cared for by community nurses 
showed that 30% of nurses had experienced prob-
lems changing catheters in the previous 12 months 
[494]. In vitro studies have confirmed increased re-
tention force and resistance to withdrawal caused 
by cuff formation and although cuffs can form with 
other catheter materials (eg hydrogel coated-latex) 
the retention force is less than with all-silicone mate-
rial [339]. It has been suggested that slow deflation 
may enhance the probability of the silicone balloon 
returning to its pre-inflation shape [340]. Alterna-
tively, reinsertion of 0.5-1ml water is sufficient to fill 
the catheter inflation lumen and eliminate the bal-
loon cuff. Subsequent use of lubrication with gentle 
removal of the catheter has been well-tolerated by 
patients and produced virtually no trauma.
6. PERSONAL HYGIENE AND INFECTION CONTROL
Meatal cleansing by simple washing with soap and 
water during routine bathing or showering is rec-
ommended (Level of Evidence 1) [495] [496]. No 
consistent reduction in bacteriuria has been dem-
onstrated by any other meatal cleansing regimes, 
using povidone-iodine solution or cream, chlorehex-
idine, polymicrobial creams, 1% silver sulfadiazine 
or antiseptic lubricating gels, compared to routine 
bathing or showering [374] [122]. Effective hand-
washing by healthcare professionals, carers and 
patients, before and after handling catheters and 
drainage equipment is generally accepted to be the 
most important component of any infection control 
strategy. Healthcare professionals and formal car-
ers should also wear gloves. Catheters and drain-
age equipment are commonly supported in position 
by tapes, Velcro and other securing devices (eg 
CathSecure, StatLock)
More securement devices are now on the market 
providing choices for long-term users, in particu-
lar. Consideration should be given to usual activ-
ity, clothing, size of the person (e.g. thighs) and the 
weight of the bag it would support. All, but especial-
ly those using adhesives, need to be comfortable, 
easy to use, and gentle to the skin [497].These se-
curement devices are designed to control post-op-
erative bleeding, maintain surgical anastomoses in 
the lower urinary tract, and prevent urethral erosion 
or trauma and accidental dislodgement from trac-
tion [498]. The importance of these in reducing risks 
of CAUTI and the mechanism involved are not well-
established [380] (See also section XII.2.h).
7. URINE COLLECTION – CATHETER VALVES
Urine may drain continuously from the bladder into 
a drainage bag attached to the catheter (See Sec-
tion XIII) or intermittently via a catheter valve. The 
valve is a small device connected to the catheter 
outlet in place of a bag. Closure and opening the 
valve allows bladder filling and intermittent drainage 
rather than continuous drainage into a bag. Valves 
are available in a variety of designs (Figure XII-9) 
ranging from simple inexpensive types used for up 
to a week, to more expensive, complex, forms which 
last longer and which may permit one handed ac-
tion. However, valves are not available or licensed 
in all countries.
Figure XII-9: Example catheter valves.
Most valve designs can be attached to a drainage 
bag at night to allow free drainage while the patient 
sleeps. A valve can provide a discreet alternative 
to conventional urine drainage bags and may offer 
improved maintenance of bladder tone and capac-
ity for appropriate patients. A spigot is not a suitable 
alternative to a valve since it must be removed from 
the catheter to allow drainage thereby breaking the 
‘closed system’. Patients must be able to manipu-
late the valve mechanism and empty the bladder 
regularly to avoid overfilling, with accompanying 
risks of back pressure on the upper urinary tract. 
Valves are generally inappropriate for patients with 
poor manual dexterity, poor bladder capacity, detru-
sor overactivity, ureteric reflux, renal impairment 
or cognitive impairment. There is relatively little 
research-based literature on catheter valves with 
much of the evidence supporting beneficial effects 
derived from the level of expert opinion. Concerns 
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over possible increased risk of infection associated 
with valves have not been realised although there is 
a paucity of research in this area. A lack of knowl-
edge on valves may interfere with their use in ap-
propriate situations; therefore, a full assessment is 
required to determine whether the person is a good 
candidate for a catheter valve using a systematic 
process, such as an algorithm [499].
The flushing mechanism resulting from bladder fill-
ing and emptying may be expected to contribute to 
reduction in problems of encrustation and blockage. 
One study was found that provides new evidence 
as to how a catheter valve might do this [500]. The 
laboratory study involved four experiments with a 
bladder model and artificial urine cultured with Pro-
teus mirabilis. Manual valves were opened every 
two or four hours with continuous drainage at night, 
followed by experiments with automatic valves 
timed to open for five minutes every two to four 
hours around the clock for seven days. All experi-
ments were compared with continuous drainage of 
urine. Analysis of variance showed that all models 
controlled by valves during the daytime (12 h) took 
significantly more time to block (62.6 versus 35.9 h, 
p=0.039) than 24 hour continuous drainage. Experi-
ments were done with automatic valves which ran 
24 hours day every two or four hours, and time to 
blockage extended to 119.8 h versus. 50.7 h, and 
159.8 hversus. 44.7 h, respectively. 
There is stronger evidence of benefits in terms of 
patient comfort and independence since this is a 
common finding in most studies. Five studies com-
paring a catheter valve with standard drainage (leg 
bag) were identified: three were cross-over designs, 
with 28, 16 and 18 subjects respectively [501] [502] 
[503] (Level of Evidence 3); two randomized their 
sample of 100 subjects to either catheter valve or 
standard drainage [504] [505] (Level of Evidence 2). 
None of the studies identified any significant differ-
ence in urinary tract infection and a majority found 
a high level of preference or acceptability of cath-
eter valves (>72%). There were no differences in 
reported incidence of bladder spasms or discomfort; 
however, there was a higher incidence of nocturnal 
frequency and episodes of bypassing with valves. It 
was suggested that a combination of a valve during 
the day and free drainage at night through an open 
valve connected to a drainage bag could be an ap-
propriate management strategy.
Several studies have evaluated a single valve de-
sign [506] [507] but only one has compared a broad 
range of valve designs [508]. Fader et al under-
took a comparative evaluation of the seven cath-
eter valves available on the UK market in 1996. 
Each valve type was tested for one week by be-
tween 19 and 36 subjects, followed by completion 
of a product evaluation questionnaire. Performance 
scores (and costs) varied widely between products 
but critical characteristics were: being easy to ma-
nipulate, leak-free, and inconspicuous. The authors 
concluded that prescribers need to be aware of the 
strengths and limitations of different valves for ap-
propriate product selection (Level of Evidence 3). 
A more recent development concerns the design of 
a prototype, novel, automatic valve system for LTC 
patients [509] which may be helpful for patients who 
lack sufficient dexterity to manage a manual valve. 
In summary:
 •  Catheter valves provide a well-accepted system 
of bladder emptying for suitable patients who 
are able to manipulate the valve mechanism 
and empty the bladder regularly to avoid over-
filling (Level of Evidence 2). 
 •  There is no evidence of increased risk of urinary 
tract infection with valves compared to conven-
tional drainage systems (Level of Evidence 2). 
 •  Valves may promote maintenance of bladder tone 
and capacity (Level of evidence 4). 
8. MAINTAINING EFFECTIVE CATHETER DRAINAGE
Use of urinary catheters is rarely completely trou-
ble-free. Catheter drainage can be compromised 
by a variety of factors from simple causes such as 
kinked tubing or the position of the drainage bag, 
to bladder spasm, pressure of a constipated bowel 
on the adjacent urethra, suction of bladder mucosa 
into the catheter eye, or blockage by blood clots, 
mucous or encrustations formed by deposits of min-
eral salts. The algorithms in Figures XII -10 to XII-
12 combine current evidence-based knowledge and 
expert opinion to provide some guidance on trouble-
shooting common problems. 
9. RECURRENT CATHETER ENCRUSTATION AND BLOCKAGE
Factors affecting persistent catheter encrustation 
leading to recurrent blockage have been discussed 
earlier in section XII.2.i. The day to day manage-
ment of recurrent catheter encrustation and block-
age is largely a nursing responsibility but there 
are few options available. Maintenance of dilute 
urine by a suitably high level of fluid intake has 
been shown to reduce encrustation in laboratory 
studies [438] and increased urinary citrate concen-
tration produced by drinking orange juice or other 
fruit juices may also be beneficial [438]. However 
the amounts required may be relatively high and 
clinical studies are needed to assess benefits and 
possible detrimental side effects e.g on bowel be-
haviour. Use of a catheter valve in suitable patients 
may also help reduce build up of encrustation by 
facilitating periodic flushing but clinical evidence 
is currently unavailable. In a majority of patients a 
characteristic pattern of ‘catheter life’ can be iden-
tified with careful record-keeping of three or more 
catheter episodes [424] [418] [510]. This may allow 
pro-active strategies of care designed to change 
the catheter before likely blockage. However, very 
frequent catheter changes can be unsuccessful or 
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Figure XII-10: Troubleshooting long-term catheter problems: urine does not drain (N = No; Y = Yes). (Al-
ways have a spare catheter available)
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Figure XII-11: Troubleshooting long-term catheter problems: urinary by-passing.
unacceptable for some patients, as well as being 
costly in terms of health service resources [420]. 
In a study of planned catheter changes [511], 
based on observation of the intervals for three 
changes,urinary pH, and visual encrustation, un-
planned changes decreased significantly from 46 
the year prior (n=39) to 30 during the 12 months 
post intervention (n=21, p<0.01). The major impact 
on quality of life related to catheter problems de-
creased from 39% to 5%, though satisfaction with 
care management did not change much. 
An alternative strategy is the regular prophylac-
tic instillation or irrigation of the catheter with 
an acidic ‘catheter maintenance’ solution to dis-
solve mineral deposits. In older literature the 
term ‘bladder washout’ appears but as the aim 
is to wash the catheter, rather than the bladder, 
‘catheter maintenance solution’ is a more appro-
priate term. A range of commercially available 
catheter-maintenance solutions is indicated in 
Table 12-6, although these are not necessar-
ily available in all countries. Support for irriga-
tions is strongly divided between those claiming 
benefit for specific patients who experience very 
frequent blockage and those who consider any 
break to the closed system to increase risks of 
infection. Research evidence is primarily de-
rived from laboratory models of the catheterised 
bladder. The few clinical studies which have ad-
dressed this issue have been limited by method-
ological deficits and small sample size.
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Figure XII-12: Troubleshooting long-term catheter problems: the inflation balloon does not deflate.
1745
l) Levels of evidence relating to catheter-associ-
ated risks and complications
•  All currently available catheter materials are subject 
to bacterial biofilm formation (Level of Evidence 1).
•  Silver alloy coated catheters are associated with a sta-
tistically significant reduction in incidence of asymp-
tomatic bacteriuria in short-term catheterised, hos-
pitalized adults (studies of varying quality included) 
(Level of Evidence 1). There is less robust data to 
show that silver-alloy catheters reduce symptomatic 
infection (Level of evidence 4). Silver oxide coated 
catheters are not associated with a statistically signifi-
cant reduction in bacteriuria (Level of Evidence 2). 
•  Antimicrobial catheters can prevent bacteriuria in 
hospitalized patients during short-term catheter-
ization (<14days) (Level of Evidence 1). Trial re-
sults are highly context dependent and the effec-
tiveness of specific antimicrobial preparations may 
be limited to specific groups of microorganisms. 
Potential toxicity and / or antimicrobial resistance 
is unknown (Level of Evidence 2).
•  There is little evidence to guide the precise tim-
ing of antibiotic cover (when required) for catheter 
change. One study has shown that clinical outcomes 
(i.e. reduction in polymicrobial counts in urine, time 
to achieve afebrile status and clinical status at 72 
hours) are significantly better among subjects ran-
domised to catheter change immediately before in-
stitution of antibiotics (Level of Evidence 2).
•  A majority of health services have clear policies on 
the use of antibiotics, designed to limit unneces-
sary use. Current evidence does not support rou-
tine use of antibiotic cover during catheter chang-
es unless the patient’s condition renders them 
particularly at risk (Level of evidence 4).
•  Meatal cleansing by simple washing with soap 
and water (i.e. not with antimicrobial agents) dur-
ing routine bathing or showering is recommended 
(Level of Evidence 1). 
•  Recurrent urinary catheter blockage caused by 
encrustation occurs in 40-50% of all long-term 
catheterised patients (Level of Evidence 2). In 
the majority a characteristic pattern of ‘catheter 
life’ can be identified (Level of Evidence 3).
•  Evidence from in vitro models of the catheterised 
bladder indicates that i) dilute urine; ii) high urine 
citrate content (> 1.5mg/mL) reduce risk of block-
age (Level of Evidence 2).
•  Evidence from in vitro models of the catheterised 
bladder indicates that acidic ‘catheter maintenance’ 
Suby G or Solution G 
 
3.23% citric acid solution, pH 4, containing magnesium 
oxide to minimise tissue irritation, aimed at reducing 
encrustation. Used where routine catheter maintenance is 
required to reduce build up of encrustations. 
Solution R1 
6% citric acid solution, pH 2, containing magnesium 
carbonate, aimed at dissolving encrustations. A stronger 
acid than Suby G and therefore not recommended for 
frequent, regular use. 
RenacidinR2 
A citric acid solution, pH 3.5-4.2, containing glucono-delta-
lactone to minimise tissue irritation and magnesium 
carbonate, aimed at reducing encrustation. 
Mandelic acid 1%1 
An acidic solution, pH 2, aimed at inhibiting the growth of 
urease-producers. A stronger acid which is not commonly 
used to reduce catheter encrustations    
Saline 0.9%1,3 
A neutral solution, pH 7, recommended for flushing of 
debris and small blood clots. Neutral pH solutions will not 
dissolve catheter encrustations. 
Chlorhexidine 0.02%1 
An antiseptic solution aimed at preventing or reducing 
bacterial growth, in particular E. coli and Klebsiella species 
(but will not prevent biofilm formation on long-term 
catheters) 
1 Available in the UK pre-packed in a sterile delivery devices designed for instillation into a 
urinary catheter.  
2 RenacidinR is approved in the USA for kidney stone disintegration only. Although it may 
be effective in certain situations for persistent catheter blockers, there are no supporting 
studies. 
•
 
Saline is widely available
 
1
Table XII-6: Catheter maintenance solutions
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solutions may have a role in dissolving encrusta-
tions in persistent blockers (Level of Evidence 2). 
There is insufficient evidence from RCTs to assign 
an in vivo level of evidence.
•  Suprapubic catheterisation (SPC) is an appropri-
ate alternative to urethral catheterization for many 
patients following appropriate risk assessment 
(Level of Evidence 1).
•  There is some evidence for a reduction in catheter-
associated infection in SPC use during short-term 
catheterisation (Level of Evidence 2), compared to 
urethral catheter insertion. However, there is no cor-
responding evidence for long-term catheterisation.
•  Patient comfort, quality of life and satisfaction with 
SPC is generally good compared to urethral cath-
eters (Level of Evidence 1).
•  Catheter valves provide a well-accepted system 
of bladder emptying for suitable patients who are 
able to manipulate the valve mechanism and emp-
ty the bladder regularly to avoid overfilling (Level 
of Evidence 2). 
•  There is no evidence of increased risk of urinary 
tract infection with valves compared to conven-
tional drainage systems (Level of Evidence 2).
m) Urinary catheters versus other care strategies
Very few studies have compared urinary catheteri-
sation with other strategies to manage urinary in-
continence, not least because of the difficulties in 
recruiting to and conducting robust trials. For male 
patients who do not have problems with retention 
of urine external urine collection systems are an 
option (See Sections VII, VIII and IX). One recent 
prospective, randomized, unblinded, controlled trial 
on men >40years in a US Veterans Affairs Medical 
Centre reported that the use of condom catheters 
was less likely to be associated with bacteriuria, 
symptomatic UTI or death than the use of indwell-
ing catheters [101]. Patients reported that condom 
catheters were more comfortable (P=0.02) and less 
painful (P=0.02) than indwelling catheters.
A small number of studies have attempted to 
examine preferences for different urinary incon-
tinence treatments in long-term care. In a de-
scriptive, comparative study of preferences for 
treatments for frail older adults, residents in long-
term care facilities were interviewed and groups 
likely to serve as proxy decision makers were sur-
veyed (family members of residents and nursing 
staff) [512]. Forced choice comparisons of conti-
nence treatments were measured. Although there 
was wide variation within and between groups, 
most preferred non-invasive strategies (diapers 
and prompted voiding) to invasive strategies in-
cluding indwelling catheterisation. Older adults 
stated they would choose a treatment based, in 
part, on feeling dry, being natural, not causing 
embarrassment, being easy, and not resulting 
in dependence. Similar results, showing urinary 
catheterisation as the least favoured choice, were 
found in a study of 117 medical inpatients aged 80 
years or over, their physicians, nurses and family 
members [513].
3. CATHETER-RELATED QUALITY OF LIFE
Use of a LTC is often a last choice for bladder 
management when other options such as CIC, for 
males a sheath (condom) catheter, or other void-
ing treatments like Credé procedure, are either un-
satisfactory or no longer practical. Catheter users 
must deal with a variety of problems that disrupt 
their daily activities and negatively affect QoL, 
such as CAUTI, blockage, leakage and catheter 
dislodgment. In addition, the visibility of a cath-
eter or drainage bag can contribute to shame or 
stigma, and urine odour can be embarrassing. A 
catheter can also be a reminder of vulnerability as-
sociated with illness / mortality and a symbol of a 
loss in control of bodily function. Yet catheter us-
ers also acknowledge catheter-associated benefits 
of freedom from wetness, convenience, and utility 
in promoting urine drainage. While this section fo-
cuses on long-term catheter use, even short-term 
catheters can have a detrimental impact on QoL. 
For instance in a study of short term catheter use 
prior to surgery for acute urinary retention, leaking, 
blocking, urgency, and pain at the penis or during 
erection were all reported [514].
Studies of QoL issues commonly utilise qualitative 
research methodologies, such as phenomenology 
or grounded theory approaches (see also Section 
XII.1.e). In-depth interviews with catheter-users and 
carers provide important insights into aspects of ‘liv-
ing with a catheter’ and contribute research based 
evidence to support development of effective care 
strategies. Measurement of QoL and the impact of 
factors which may affect it is complex. Most validated 
QoL instruments fall into one of two groups: i) generic 
measures designed to encompass domains includ-
ing physical, mental and social wellbeing; ii) disease 
specific measures designed to measure change 
in QoL resulting from treatment. For those people 
whose urinary symptoms are managed by products 
or devices, including catheter users, it is particularly 
difficult to assess the impact of the product on QoL. 
This is partially because changes are more likely 
to be related to improved management of ongoing 
symptoms rather than actual change in symptoms, 
and partially because QoL is also dependent on the 
underlying disease process. 
Much of the literature on LTC use involves people 
with neurogenic bladder, particularly those with 
spinal cord injury (SCI) or multiple sclerosis (MS). 
Thus, QoL in catheter users must be considered 
from a perspective of how the disease and the de-
vice affect the individual’s life. For instance, in one 
postal survey of 230 people with SCI, the factors 
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which had most impact on QoL were social activi-
ties and accomplishments, including employment, 
attending school, and other activities. There was 
no association between QoL and different blad-
der drainage methods [515]. A particular problem 
for people with spinal cord injury or disease is au-
tonomic dysreflexia (AD), an autonomic nervous 
system syndrome causing symptoms which include 
severe hypertension, headache and sweating. A 
blocked urinary catheter can be a common cause. 
AD can be a serious problem requiring emergency 
medical attention, but lack of knowledge and aware-
ness of the risks by some health care providers can 
cause high levels of anxiety for SCI patients [516] 
[305] (Level of Evidence 3). 
There is currently one instrument measuring qual-
ity of life in people with indwelling urinary catheters 
[269] though this measure was validated in two 
small samples. Further development and validation 
are ongoing in the US and in the UK (Level of Evi-
dence 3).
The published literature addressing QoL in cathe-
ter-users is small, and is commonly limited to re-
ports addressing levels of satisfaction with a device. 
Studies which include a broader perspective of QoL 
are discussed below under the following headings: 
changes in bladder management, embarrassment, 
sexuality, catheter-related pain, catheter adjust-
ment, and self-management.
a) Changes in Bladder Management
Changes in bladder management are often made 
to promote QoL but there are trade offs that require 
weighing up the pros and cons of various methods. 
People sometimes switch from CIC to an indwell-
ing catheter - despite the inherent problems with an 
indwelling catheter -because quality of life might be 
improved. In particular, women with cervical spinal 
cord injury (SCI) may need an indwelling catheter 
because of difficulties in transferring to the toilet, 
limited hand dexterity, or dependence on caregiv-
ers [517]. Moreover, many people have used dif-
ferent bladder drainage methods over time. In one 
study, of 30 long-term catheter users, 80% of the 
sample had used another form, and 33% had used 
two or three different types [518]. In another small 
study with a sample of 11, 100% had used another 
method, and 27% had used two or three other types 
[306]. Reasons for non-compliance with CIC in re-
lation to QoL or satisfaction have been addressed 
in Section XII.1.e and in some studies comparing 
drainage methods (Level of Evidence 3).
Two studies provided additional evidence of how 
changes in bladder drainage methods are made to 
improve their quality of life. In a retrospective study 
assessing compliance with bladder management, 
50 new spinal cord injury (SCI) patient records were 
reviewed after admission, discharge, and follow up 
from 1994-1997 [517]. Of 38 patients on IC at hospi-
tal discharge, 20 (52%) were back to UC at follow up. 
Six of 10 females on IC had resumed UC. Reasons 
for not continuing with IC were: the need to depend 
on caregivers, poor hand functioning, spasticity, in-
continence (despite anticholinergic drugs), and for 
females with cervical injury, toileting inconvenience 
(Level of Evidence 3). In contrast, a retrospective 
chart review and follow up questionnaire was used 
with 236 SCI injured people (at least 10 years post 
injury) between 1956-1990 [519]. An 85% response 
rate was achieved in the sample, with 82% males 
who had tetraplegia (47%) or paraplegia (53%). 
Although 46% changed their bladder management 
method over time and 28% considered the method 
a problem, in 58% of those who had tetraplegia, the 
use of CIC went up from 11% at discharge to 36%. 
Suprapubic tapping decreased from 57% to 31% 
and Crede increased from 5% to 19%. CIC alone, or 
with other methods, was the most common method 
(Level of Evidence 2).
b) Embarrassment
Embarrassment and a sense of lack of bladder con-
trol are two major catheter-related issues that are 
ongoing problems for many people. In one study 
at a US Veterans Affairs Medical Centre, 30% of 
catheterised patients surveyed found the indwelling 
catheter embarrassing, and 61% stated it restricted 
their activities of daily living [107]. The catheter is 
placed in a position in the body normally considered 
‘private’, yet health care providers frequently need 
access to the site to provide care. Also, the force 
of urine flow is something that catheter users must 
deal with on a daily basis. In a qualitative phenom-
enological study of 14 people with long-term cathe-
ters, people told stories of how getting wet in public 
was embarrassing and how the force of the urine 
was like water that had built up pressure [516]. They 
used the metaphor of “flowing water” to describe the 
force of urine flow, the weight of the drainage bag, 
and the sound of urine sloshing around in the bag. 
Living with the catheter was described in one quali-
tative study [305] as a swing back and forth between 
stigma, when it contributed to embarrassment or 
shame, and acceptance when it was working right 
and did not cause problems. The catheter became a 
source of embarrassment during catheter changes, 
bag emptying, and when it leaked or spilled in pub-
lic. Individuals used planning and great care when 
going out (e.g. mapping out the toilets) to prevent 
urine accidents. They were bothered also by their 
lack of bodily control, the monotonous care, and 
how it was a reminder of their condition and mortal-
ity (Level of Evidence 3).
Catheter related embarrassment is a common ex-
perience stemming from exposure to the opposite 
sex, the visibility of the urine bag, and unpredict-
ability of urine accidents [520] [521] [305]. Breech-
es in privacy were identified in two qualitative stud-
ies of the lived experience of catheter use [522] 
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[523] [305] [524]. To care providers, catheters may 
seem commonplace, but male / female sensitivities 
may occur during catheter care, particularly cath-
eter changes, including men who are embarrassed 
by a female care provider [520]. Embarrassment 
can be minimized by providing privacy during cath-
eter changes and same sex care providers when 
possible [522] [305] [523]. Acknowledging the em-
barrassment that exists if the nurse is of the oppo-
site sex paradoxically may diminish the vulnerabil-
ity [305]. Humour is often used by care providers, 
catheter users, and caregivers, and a professional 
approach by the health care provider may help the 
catheter user accept the situation [522] [305] [523] 
(Level of Evidence 3).
A few studies have examined QoL issues related 
to practical aspects of living with the catheter, such 
as managing the drainage bag (See Section VIII). 
While most people who are self-caring cope with 
the management of their catheter drainage system, 
many find them restrictive and report a negative 
impact on QoL. In a small pilot study based on a 
postal questionnaire to LTC catheter users (n=59) 
[525] almost 25% of respondents stated that wear-
ing a bag had a major negative affect on everyday 
living. Concealment of the bag was one of the most 
important concerns raised (89%). Keeping the urine 
drainage bag covered and its visibility minimized 
can help reduce embarrassment and the stigma re-
lated to using a catheter. The visibility of the bag 
can be considered demeaning and it exemplifies a 
loss of bladder control [305] [523]. Moreover, if a 
bag is unreliable, and springs a leak for instance, 
it contributes to vulnerability. Even using a catheter 
for a short time can be an assault to one’s dignity. 
In a study in post-operative short-term catheter use, 
people complained about feeling “on display” and 
objectified [522] (Level of Evidence 3).
c) Sexuality
In a study of experiences of 25 men with prostate 
cancer, many of whom were treated with a urinary 
catheter, subjects reported the catheter contribut-
ed to feelings of shame, excess hospital visits for 
complications, and with other treatments for can-
cer, an end to sexual activity [526]. Men viewed 
healthcare professionals as having responsibility 
for medical decisions and they alone felt respon-
sible for the catheter, micturition, and sexual life 
(Level of Evidence 3).
Issues related to sexuality were dominant in sev-
eral other studies. Using a catheter compounded 
changes in sexual life caused by illness or injury 
[521] [524]. In one study, catheter users com-
plained that care providers did not provide enough 
information about sexuality and how to adapt to a 
catheter [524]. Despite some care provider’s re-
luctance to address these issues, sexual health 
should be a part of assessments [527], and infor-
mation about sexual activity should be provided 
proactively, while recognizing that some catheter 
users will wish to engage in sexual intercourse and 
others will not (Level of Evidence 3-4).
In a study of 20 men in Nigeria with prostate-related 
obstruction, who used an indwelling catheter from 
1-36 months, [528], negative changes in self-es-
teem and sexuality (manhood) were reported. How-
ever, family and friends were instrumental in provid-
ing support and encouragement, including financial 
help and transportation to the hospital. The underly-
ing disease may also impact on sexuality. For in-
stance, a urinary catheter complicates sexual activ-
ity in people with spinal cord injury (SCI). Moreover, 
men may have changes in sexual performance re-
lated to ejaculation, erectile function, and arousal 
[529]. For females with SCI, experimenting with 
positions, lubrication, and preventing spasticity may 
be helpful in sexual activity [529] (Level of Evidence 
2). For people with SCI, sex-related autonomic 
dysreflexia (AD) occurs most often in people who 
suffer from AD during bladder or bowel care [530] 
(Level of Evidence 2). Autonomic dysreflexia is an 
autonomic nervous system syndrome that occurs in 
people with spinal cord injury or disease. Symptoms 
include severe hypertension and excruciating head-
ache as well as sweating and goosebumps. It can 
be a serious problem—even life-threatening--re-
quiring emergency medical attention, yet it is some-
times ignored or disregarded by health care pro-
viders [516]. A blocked catheter is also a frequent 
cause of AD. In a qualitative study [524], several 
people complained that care providers did not know 
much about AD and often dismissed their anxiety 
and concerns (Level of Evidence 3). 
Promoting sexual health for persons with catheters 
[531] requires awareness of self (especially in rela-
tion to sexuality), training for health care providers, 
open communication, and advocacy for and valida-
tion of patients’experiences. 
d) Catheter-related Pain
Pain related to catheter use is not always recog-
nized although anecdotal information suggests that 
many people find a urethral catheter uncomfortable 
(see also Section XII.2 k.3 on catheter comfort and 
catheter change procedures). In Saint et al’s study 
[107] 90% of catheterised patients surveyed report-
ed they found the indwelling catheter uncomfortable 
or painful, and in a study of 43 community dwelling 
persons [126] 54% reported catheter-associated 
pain, and in a sample of 20 men who used a cath-
eter for prostate obstruction, 35% had pain [528]. 
Sometimes women complained about the pain 
because of sitting on the catheter or sores in the 
vaginal area [516], however it is unclear whether 
sores or skin irritation are related to latex sensitiv-
ity, friction, or wetness or a combination. Bladder 
spasms, CAUTIs, blockage, and dislodgement can 
all contribute to catheter-associated pain, as well as 
insertion and removal procedures [532] [523] [516] 
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(Level of Evidence 3). Pain arising from AD in SCI 
patients can result from catheter blockage and has 
been discussed above.
e) Adjustment to a Catheter
Adjusting to living with a catheter may take a con-
siderable time. In Roe’s study [533] participants 
reported it had taken them up to a year. Similar 
lengths of time are commonly reported in anecdotal 
evidence. An educational booklet for catheter wear-
ers has been shown to significantly improve knowl-
edge and acceptance of the catheter [534]. Though 
the implications for this type of intervention are posi-
tive (Level of Evidence 1-2), the sample was small 
(n=45) and the study has not been replicated. The 
core category identified in a study using a grounded 
theory approach to examine older people’s expe-
riences of living with a LTC was ‘all about accep-
tance’. Two further categories defined as ‘at ease’ 
and ‘unease’ reflected the extremes of their experi-
ence and these were mediated by ‘interaction with 
others’ [535]. The presence of a catheter can affect 
the individual’s view of their own body and such 
shifts in body image can cause some people to ex-
clude themselves socially. New catheter users (both 
urethral and suprapubic) may resist the “intrusion 
of the catheter” prior to acknowledging the need 
for it [536]. Qualitative studies have shown that al-
though some people felt ill prepared for a catheter, 
and even viewed it as distasteful, most learned to 
accept the device over time [536] [523]. Catheter-
users have described their changed perceptions of 
the body and of how they learned to pay attention 
to urine flow to prevent catheter related problems. 
Though most acknowledged feeling vulnerable be-
cause of disruptions caused by the catheter, they 
noted also that keeping urine flowing was critical to 
their wellbeing [537] (Level of Evidence 3).
Health care providers need to provide proactive 
support and education about the catheter and its 
care, particularly since some catheter users are 
uncomfortable in asking for help or support. Male 
/ female sensitivities can interfere; for example, a 
woman might be disinclined to talk about her cath-
eter with her son [536] [523] (Level of Evidence 3).
Guiding and supporting an individual’s adjustment 
to living with a catheter involves promoting dignity, 
supporting the changed body image so that the 
catheter becomes a part of self (and almost not no-
ticed), and learning self-management and self-care, 
and in planning for active life in the community. It 
is essential that catheter users know how to select 
suitable equipment. Simple advice such as not us-
ing a coloured catheter in the summer when white 
clothing would allow it to show can be very help-
ful. Knowing where toilets are and planning for out-
ings (rehearsing) can prevent urine accidents [516] 
(Level of Evidence 3). Ambulatory females who use 
a belly bag need to face the toilet when emptying 
the bag. Since this position is associated with male 
toileting rather than female it can sometimes cause 
embarrassment. Some women may prefer to use a 
unisex toilet where possible.
While adjustment takes time, emotional distress with 
the catheter can swing back into the picture at any 
time if problems develop. Depending on whether 
the device is working well or not, people can move 
back and forth between acceptance and estrange-
ment from the catheter [305] when the problem in 
the background emerges and brings the issue once 
again to the foreground [538] (Level of Evidence 3). 
Learning to live with a catheter involves recognizing 
that the benefits can outweigh the problems [524], 
watching for signs of problems, and adjusting to the 
interpersonal and sexual changes [536] (Level of 
Evidence 3).
f) Self-management
Self-monitoring, a component of self-management, 
involves awareness of what to notice and related 
measurements or observations [539]. Self-monitor-
ing urine flow was found to be helpful in preventing 
or minimizing catheter-related problems in a pilot 
study with 11 community-based individuals over a 
six months’ time [306]. In this study, a 3-day urinary 
diary of intake and output was combined with an ed-
ucational program, individualized to the interests of 
participants. Most participants said they learned to 
pay attention to urine flow, through observing con-
tinuous drainage into the drainage bag, increased 
awareness of the urine colour, position of the cath-
eter, and by monitoring the consistency of their fluid 
intake [306]. Health care providers can help cath-
eter users to learn to manage their catheter them-
selves, (i.e. self-care) by identifying where they are 
in the process of learning self-care and by working 
with them [536] (Level of Evidence 3).
g) Summary
Most published studies of patients with indwelling 
catheters have focussed on short-term catheters (< 
14 days) in hospitalised patients and relatively few 
have compared different modes of catheterisation 
(urethral, suprapubic, intermittent). The main sub-
ject of research on catheter use has been the risk 
of catheter-associated infection and the surrogate 
outcome measure of bacteriuria (asymptomatic) is 
commonly employed. However, there are important 
questions over the appropriateness of this as an 
outcome measure. Although there is clear evidence 
to support a small proportion of catheter care proce-
dures (indicated below) the majority of procedures 
are based on clinical experience and expert opin-
ion. Long-term studies are difficult to carry out for 
a variety of reasons (not least the frailty of many 
long-term catheterised patients) and there are rela-
tively fewer studies based on community dwelling 
patients. RCTs may not be the most appropriate or 
pragmatic design for these groups. Although there 
are now a number of Cochrane reviews relating to 
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long-term catheter use it is clear that the quality of 
studies available frequently precludes drawing ro-
bust conclusions. 
The published literature on SPC use is still relatively 
small, with much of it based on single centre co-
hort or case studies, or on short-term post-operative 
care following surgical procedures (not necessarily 
related to lower urinary tract symptoms). The major-
ity of reports on SPC for long-term bladder drain-
age focus on the management of neurogenic blad-
der. Robust conclusions are often difficult to reach 
given the relatively short follow-up time frame of 
many studies and the lack of precise definitions of 
key outcome measures such as measurement of 
infection. Overall the risks associated with short 
and long-term use of indwelling catheters are com-
mon to both urethral and SPC insertions, including 
CAUTI, tissue trauma, catheter encrustation leading 
to blockage, formation of bladder calculi and histo-
logical changes.
Quality of life measures, including evaluation of 
psychometrics, need to be developed further and 
tested in this population, which may have different 
needs than others with incontinence. Studies of in-
continent people that include catheter users should 
present data in ways that give the reader informa-
tion about this sub-population. Sensitivity and a 
proactive stance from care providers could prevent 
or minimize some of the stigmatizing effects of the 
catheter, including those related to privacy needs, 
dignity, and sexuality. Further product development 
may help catheter users attain a higher quality of 
life. Additional research on the effects of self-man-
agement/self-care may provide direction for teach-
ing that could contribute to a higher quality of life for 
catheter users.
4.  OVERALL RECOMMENDATIONS RELAT-
ING TO CATHETERS
a)  Intermittent catheters
 • Clean intermittent catheterisation (CIC) is a 
treatment of choice for those with ongoing 
bladder emptying problems and residual urine 
> 100ml who are able to manage the tech-
nique (Grade of Recommendation A).
 •  CIC technique can be taught to all ages of 
people with appropriate motivation and man-
ual dexterity (or to a carer where this is ac-
ceptable to both parties). Appropriate educa-
tion and ongoing support is needed (Grade of 
Recommendation C/D).
 •  Frequency of catheterisation needs to be based 
on individual need, to prevent over-filling of 
bladder (Grade of Recommendation C).
 •  An external lubricant or lubricant-coated cath-
eter is recommended to minimise urethral 
trauma (Grade of Recommendation C).
 •  CIC users may benefit from access to differ-
ent catheters or catheter-packs for different 
purposes (eg ease of use may be particular 
important when at work or in public) (Grade 
of Recommendation C)
b) Indwelling catheters
 •  Indwelling catheters should only be used af-
ter alternative management strategies have 
been considered and rejected as unsatisfac-
tory (Grade of Recommendation A).
 •  Duration of catheterisation should be minimal 
(Grade of Recommendation A). 
 •  A closed drainage system should be main-
tained to reduce risk of catheter-associated 
infection (Grade of Recommendation A).
 •  Asymptomatic bacteriuria should NOT be 
treated with antibiotics (unless urologi-
cal instrumentation is planned) (Grade of 
Recommendation B).
 •  Routine urine culture in an asymptomatic 
patient is not recommended (Grade of 
Recommendation C).
 •  Silver-alloy catheters should be considered 
for short-term catheterised patients to re-
duce the risk of catheter-associated infection 
(Grade of Recommendation A) but further 
economic evaluations are required to deter-
mine cost-benefit to institutions.
 •  Catheter materials designed for long-term 
use (all-silicone, silicone or hydrogel-coating) 
should be used where a catheter is expected 
to be used long-term (i.e. >14days) (Grade of 
Recommendation B).
 •  Meatal cleansing with plain soap and water 
(not with antimicrobial agents) is recommend-
ed (Grade of Recommendation A).
 •  Addition of disinfectants to drainage bags, 
bladder irrigation and antibiotic prophylaxis are 
NOT recommended as routine infection-control 
measure (Grade of Recommendation A).
 •  If an indwelling catheter is being considered, 
SPC should be considered alongside UC, fol-
lowing appropriate risk assessment (Grade of 
Recommendation B).
 •  UC and SPC insertion should be carried out 
only by appropriately trained and skilled prac-
titioners using aseptic technique (Grade of 
Recommendation C).
 •  UC and SPC catheters and drainage bags 
should be adequately supported to prevent 
meatal or cystostomy damage from traction 
(Grade of Recommendation C).
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 •  In patients with recurrent catheter encrusta-
tion and blockage, careful monitoring should 
be undertaken to identify a characteristic pat-
tern of ‘catheter life’ and instigate pre-emptive 
catheter changes prior to likely blockage 
(Grade of Recommendation C).
c) Catheter valves
 •  A catheter valve can provide an effective means 
of catheter drainage following appropriate patient 
assessment (Grade of Recommendation B).
 •  A combination of a valve during the day and 
free drainage at night through an open valve 
connected to a drainage bag could be an ap-
propriate management strategy (Grade of 
Recommendation D). 
5. PRIORITIES FOR RESEARCH
a) General
 •  Despite much published research (primarily 
on short-term catheter use in acute care set-
tings), catheter studies have been hampered 
by methodological weaknesses. There is a 
need for agreement on key criteria to per-
mit robust comparisons between studies: (i) 
criteria for symptomatic UTI, (ii) significant 
bacteriuria in a catheterised patient and its 
clinical/research usefulness (iii) standardised 
time frames for following patients in studies of 
catheter-associated infection eg 48h, 5 days, 
7 days, 14 days 21 days etc (iv) documenta-
tion of the use of antibiotics prior to and during 
a study eg preoperatively in surgery or com-
mencement of antibiotics for other conditions 
during the study, (v) patient follow-up to in-
clude post catheter removal.
 •  A standardised definition of UTI should be 
adopted as the primary outcome variable. At 
present the most recent CDC/NHSN surveil-
lance definition of health care-associated UTI 
is an example [379]. Although criteria for both 
symptomatic UTI and asymptomatic bacteri-
uria are defined by the CDC/NHSN, it should 
be recognised that definitions are applicable 
to non-catheterised populations and specific 
to acute care settings and additional defini-
tions apply to catheterized patients [342].
 •  Moreover, definitions which distinguish be-
tween asymptomatic and symptomatic infec-
tion in catheterized patients can be prone to 
coding errors. Inappropriately treated asymp-
tomatic bacteriuria confounds the errors [540] 
and contributes to a lack in knowledge of effec-
tive ways to treat symptomatic CAUTI [541].
 •  Better adherence to CONSORT guidelines 
[542] eg double blind randomization with ap-
propriate power calculations, intention to treat 
analysis with inclusion of study drop-outs
 •  Need for clinical studies which are adequately 
powered to detect differences in clinically and 
economically important endpoints in prefer-
ence to (or in addition to) more easily mea-
sured surrogate endpoints such as bacteriuria.
 •  Comparative studies of different patient 
groups eg. males and females, different age 
groups, patients at home and those in institu-
tional care, including patients’ comfort, satis-
faction and quality of life measures.
 •  Further research on the development of bio-
materials that resist microbial adherence and 
biofilm formation and /or prevent catheter-
associated bacteriuria in both long-term and 
short-term catheter users.
 •  Further efforts aimed at reduction of short and 
LTC use, particularly acute care and nursing 
home populations. Targeted areas to include 
evaluation and management of skin prob-
lems, and alternative measures for people 
with diabetes mellitus, obesity and communi-
cation problems. 
b) Intermittent catheters
There is lack of evidence demonstrating the effec-
tiveness of any particular catheter type, technique 
or strategy. Variations in clinical practice and growth 
in the use of single-use catheters (particularly coat-
ed catheters) with associated increased costs mean 
that large, well-designed, parallel group RCTs are 
needed. RCTs are difficult to conduct in this area 
and must focus on the most important pragmatic 
questions, for both clinical and cost-effective rea-
sons. Key issues are identified below.
 •  What evidence is there that coated (single-
use) catheters are superior to uncoated 
(multi-use) catheters and in what ways (e.g 
infection, comfort, convenience)? Further 
studies are needed on the risks / benefits of 
single use catheterisation (new catheter used 
at each insertion) versus single patient use 
(patient cleans, stores and re-uses the same 
catheter for several days) for patients whose 
long-term bladder management is by CIC.
 •  To assist assessment of cost-effectiveness, 
it is recommended that patient acceptability / 
satisfaction with procedure and a measure of 
health state utility are measured for different 
situations (e.g. at home and when away from 
home) as a secondary outcome variable.
c) Indwelling catheters
 •  Epidemiological studies of CAUTI in LTC use 
in community care settings. 
 •  Better prospective data on long-term sequa-
lae of indwelling catheter use, eg ongoing 
symptoms, strictures, calculi, bladder cancer. 
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 •  Studies comparing catheterisation techniques 
eg CIC, suprapubic and urethral catheters, on 
CAUTI and other risks or potential benefits
 •  Studies to determine whether the frequency of 
regular re-catheterisation make a difference 
to CAUTI and other complications
 •  Studies to ascertain if there are detrimental effects 
on bladder tissue from persistent asymptomatic 
bacteriuria in long-term catheterised patients.
 •  Clinical evaluation of strategies to reduce re-
current catheter encrustation and blockage, 
including maintaining a dilute urine, increased 
level of urinary citrate, role of acidic ‘catheter 
maintenance’ solutions.
 •  Further development of catheter materials 
resistant to microbial biofilm formation, new 
approaches to disruption of the biofilm, or al-
ternatives to catheterisation.
d) Catheter valves
 •  Clinical investigation of effect of catheter 
valves on incidence and frequency of catheter 
encrustation and blockage.
 •  Cost-effectiveness studies of disposable ver-
sus re-useable valves.
 •  Studies designed to demonstrate if catheter 
valves promote maintenance of bladder tone 
and capacity.
 •  Further examination of combination manage-
ment strategies such as valve during the day 
and free drainage overnight.
e) Quality of life
 •  Identification of appropriate quality of life indicators/
criteria and measures for catheterised patients. 
 •  Development of a quality of life measurement 
instrument including both subjective mea-
sures and objective measures, including fac-
tors such as: frequency of catheter blockage, 
catheter-associated infection, hospitalization, 
unplanned catheter changes, adequacy of 
equipment, knowledge about self care, interac-
tion with caregivers in catheter management.
 •  Case study analyses to maximise evidence 
gained through clinical experience and expert 
opinion, particularly where opportunities for 
formal research are likely to be unrealistic.
 
The broader issues of conservative management of 
faecal incontinence are dealt with comprehensively 
in chapter 16 while this chapter deals with products 
for preventing or managing faecal incontinence. 
They fall into three main categories:
 •  Products that aim either to prevent or contain 
leaked stool.
 •  Products that seek to prevent or mask the offen-
sive odour that occurs from leaked stool or flatus.
 •  Products for preventing or treating perianal 
skin damage associated with faecal inconti-
nence (one of the primary complications of fae-
cal incontinence and an important part of care).
Products dealing with skin health and odour are 
covered in Sections XIV and XV, respectively, while 
products for preventing or containing faecal inconti-
nence are covered in this section (apart from absor-
bent pads, which are included in Section VI).
1.  PRODUCTS TO PREVENT OR CONTAIN 
LEAKED STOOL
There is little knowledge about product manage-
ment for people suffering with faecal incontinence. 
Peden-McAlpine et al. (2008) [543] show in their 
study the experiences of ten women with faecal in-
continence. They show how a number of strategies, 
such as: bathroom rituals, eating habits or fiber sup-
plements belong to the management strategies of 
the affected, so that they may actively participate in 
a normal public life. The use of aids is also a major 
strategy as Bliss et al. (2011) [544] also show. More 
than 1/3 of those questioned (189 participants) 
would no longer pursue their activities, when they 
had no aids at their disposal. Thereby, those who 
suffer seriously with faecal incontinence resort to 
absorbent aids, particularly to pantiliners from the 
range of feminine hygiene products. First and fore-
most of importance for the study participants was 
odour control, however, when asked about their sat-
isfaction with various aspects of the product, they 
ranked odour control as the worst.
Products fall into three groups:
 • Plugs to prevent leakage of faeces.
 •  Devices to channel faeces from the rectum 
into a storage container.
 •  Absorbent pads to contain leaked faeces (see 
Section 6).
An anal plug (Figure XIII-1) consists of a foam, cup-
shaped plug that is collapsed and held by a film for 
insertion; the plug opens when the film comes in 
contact with the moist rectal mucosa [545] [546]. It 
is inserted like a suppository using a lubricant gel. 
It has a string for removal or it can be expelled by 
raising intra-abdominal pressure and pushing like 
during normal defaecation. The anal plug has been 
used mainly by community living people, both adults 
and children, who are independent in managing 
faecal incontinence and toileting. Another type 
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of experimental anal plug consists of a balloon 
at the end of a catheter connected to a notification 
device. The catheter is intended to be inserted into 
the rectum by the user and the inflated balloon acts 
as the anal plug; there are also vent holes on the 
distal tip of the catheter (Figure XIII-2). The dispos-
able, double lumen, balloon-cuffed rubber catheter 
has an infra-red photo-interrupter sensor that is 
connected to a pager [547]. When faeces enter the 
rectum, a photosensor signal is sent to the pager 
which then notifies the person to inflate the balloon. 
Before a bowel movement, the balloon is deflated 
and the catheter is withdrawn. To prevent ischemic 
bowel damage, patients are advised to deflate the 
balloon for 10-15 min every 3-4 hours.
By contrast, devices for channelling faeces from the 
rectum to a storage container are used primarily by 
people who are acutely ill, critically ill, confined to 
bed, or in long-term care institutions and receive as-
sistance in incontinence management and toileting 
by caregivers [548] [549] [550] [551] [552]. These 
devices do not prevent faecal incontinence and are 
used primarily for preventing or treating skin damage 
associated with faecal incontinence. They include 
rectal tubes, catheters, trumpets, and pouches.
Rectal tubes and catheters are inserted into the 
rectum and drain faeces through openings at their 
proximal end into a collection bag (Figure XIII-3). 
Sometimes a balloon slightly distal to the proximal 
tip is inflated with the aim of preventing leakage of 
faeces around the catheter and to retard inadver-
tent expulsion of the tube during defaecation [549]. 
This arrangement works best with liquid stool which 
is most likely to be able to flow without blocking the 
drainage lumen [553] [552]. Bowel management pro-
grams often include daily saline irrigations through 
the rectal catheter to maintain liquid consistency of 
stool and catheter patency. Differing amounts and 
frequency of irrigation have been reported (300 to 
900 ml). Cutting the tip of the catheter off at an angle 
to facilitate drainage of stool of thicker consistency 
has been reported [554]. A rectal tube / catheter is 
contraindicated in patients who have intestinal mu-
cosal disease, immunosuppression, gastrointestinal 
bleeding or bleeding tendencies, recent myocardial 
infarction or prostate surgery [555] [554]. Use of a 
rectal tube with or without inflating the balloon is 
controversial because of concerns of perforating 
the rectum, damaging the anal sphincter or rectal 
mucosa, stimulating intestinal secretion worsening 
diarrhoea and thus incontinence [553] [554] [556]. 
Critically ill patients, who often receive a rectal tube, 
may be at greater risk for intestinal ischemia and 
rectal damage because they experience shunting of 
blood from the gastrointestinal tract during shock or 
low perfusion states.
A rectal trumpet is a nasopharyngeal airway that 
is inserted into the rectum and connected to a col-
lection bag at its distal end. The flange end of the 
trumpet is inserted into the rectum [557] (Figure 
XIII-4). A possible advantage of the rectal trumpet 
over a rectal tube is that it is shorter and has less 
contact with the rectal mucosa, so limiting the area 
of possible damage. Other limitations are similar to 
those for the rectal tube / catheter regarding risk 
of expulsion from forceful valsalva movements and 
dislodging during linen changes or from tugging on 
the collection bag [557]. Nasopharyngeal airways 
that can be used as a rectal trumpet are produced 
by several manufacturers.
An external anal pouch consists of a pliable wafer, 
which has an opening at its centre, an adhesive on 
the body side, and a collection bag on the other. The 
wafer adheres to the perianal skin (Figure XIII-5). 
 Figure XIII-1: Anal plugs.
Figure XIII-2: Procon anal plug with infra-red photo- 
interrupter sensor and pager. (Reproduced with the 
permission of Wiley-Blackwell Publishing)
a:  infrared photo-interrupter sensor and flatus vent 
holes incorporated into the catheter
b: 20 cc air cuff (similar to a regular bladder catheter)
c: flatus venting charcoal filter
d: cuff fill valve
e: monitor connector
f: monitor that resembles a “beeper” or pager
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The bag has a resealable port at its distal end through 
which faeces can be drained without the need to re-
move the wafer from the skin. The port can also be 
connected to a larger, gravity drainage bag. Some 
pouches have a small folded flap that allows flatus 
to escape so that it doesn’t inflate and rupture the 
bag. The pouch avoids the risks of rectal or sphincter 
damage associated with the rectal tube or trumpet. If 
used without the additional drainage bag, it can col-
lect leaked stool of any consistency without clogging. 
A limitation of the rectal pouch is difficulty in apply-
ing it on people who have a small space or severe 
oedema between the anus and vagina or scrotum. 
Other reported disadvantages include difficulties in 
maintaining the seal (especially when the perianal 
skin is already damaged); break of the seal when re-
positioning the patient; and skin tears by traumatic 
removal of the adhesive [557] [551].
An intra-anal stool bag is composed of a latex bag 
(20cm non-extended, to 26cm extended) that is in-
serted into the anus and an adhesive attachment 
(10 cm in diameter) applied perianally [558] (Figure 
XIII-6). There is a cut-out on the ventral urinary side 
of the adhesive wafer.
Aspects of patient assessment that are relevant to 
products to prevent or contain leaked stool include 
the following: a) physical characteristics (e.g. some 
anal plugs may be too large to fit smaller sized chil-
dren), b) dexterity (e.g. some degree is needed to 
insert or remove an anal plug), c) mobility (e.g. rectal 
catheters are mainly used for patients who are in bed 
versus ambulatory), d) nature of incontinence (e.g. 
bowel catheters will require irrigation when stool con-
sistency is not loose or liquid in order to remain pat-
ent; and e) personal priority and lifestyle (e.g., some 
persons will wear an anal plug on certain occasions 
such as when swimming, despite discomfort).
2. QUALITY OF DATA
Since the previous review there have been two 
observational studies in which the anal plug has 
been evaluated. One study was of adults [559] and 
Figure XIII-3: Rectal catheters; Flexiseal Fecal Man-
agement System, Convatec (Nordic Capital Fund 
VII and Avista Capital Partners); Princeton, NJ 
(top); and Zassi Bowel Management System, Hol-
lister, Inc. Libertyville, IL (bottom).
Figure XIII-4: A rectal trumpet.
Figure XIII-5: An anal pouch.
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the other of children [560] bringing the total num-
ber of published evaluations of anal plugs for con-
trolling faecal incontinence to ten. There was one 
study of the anal catheter plug (Procon, AnaTech, 
El Paso, TX). Six reports included children of which 
two studied children exclusively [561] [562]. The 
study designs were one randomized clinical trial, 
four repeated measures (cross-over), one pre-post 
design, two prospective cohort studies, one cross-
sectional survey, one case series, and one case 
report. One study did not specify the manufactur-
er of the anal plug studied [560], one study [561] 
compared plugs of two manufacturers (Coloplast, 
Denmark and Med.SSE-System, Germany) and all 
other studies of anal plugs evaluated products from 
the same manufacturer (Coloplast). There has also 
been one published evaluation of a rectal trumpet 
using a case series design [557] and one each of 
an external anal pouch and an intra-anal stool bag 
in which no comparison group or pre-post measures 
were included.
3. RESULTS
a) Anal Plugs
Most evaluations of anal plugs have involved rela-
tively small cohorts of ambulatory subjects. The 
largest sample had 48 subjects and 26 of 31 per-
sons in the intervention group who wore the anal 
plug completed the study [563]. The aetiologies of 
faecal incontinence varied across studies and in-
cluded spina bifida, imperforate anus, spinal injury, 
post-surgical incontinence, sphincteric injury, and 
obstetric trauma. Faecal incontinence was mea-
sured by self-report using a daily stool diary in six 
studies [563] [562] [547] [545] [546] [564]. A ques-
tionnaire /survey was used in one descriptive [565] 
and one repeated measures study [561]. The main 
reported outcome measures were: the number of 
episodes of faecal incontinence per number of anal 
plugs used due to self removal or need for defeca-
tion [545]; the number of patients experiencing no 
faecal incontinence [564] [562] [561] [546] [560] or 
improved faecal incontinence [546] while using the 
plug; score on a 10-point visual analogue scale for 
control of faecal leakage, [559]; the number of pa-
tients able to retain 150 ml of viscous fluid while us-
ing the plug [564]; and the change in a faecal incon-
tinence severity score [563] [547]. The percentage 
of participants lost to follow-up ranged from 10% 
[545] to 80% [564]. 
The effectiveness of the plug in preventing faecal 
incontinence in adults ranged from 83% [564] to 
38% [562] (Level of Evidence 3). Bond et al [563] 
conducted a randomized clinical trial of the effec-
tiveness of an anal plug that included 31 adults and 
children with spina bifida in the treatment group 
and 17 adults and children in a control group; 84% 
of the treatment group and 100% of the control 
group completed 12 months of follow-up. There 
was no statistical difference in the faecal inconti-
nence severity score between the group wearing 
an anal plug and the one that did not; however, 
the study was determined to be underpowered to 
detect differences. Norton and Kamm [546] com-
pared two anal plugs for two weeks each in ran-
dom order in a cross-over design. Of the 20 adults 
(16 female) participating, 10 (50%) were continent, 
and 9 (45%) withdrew after trying the first plug. 
Three anal plugs were compared by 10 adults for 
one week each in a cross-over design in an earlier 
study by Mortensen and Humphreys [545]. Con-
tinence was achieved in 83% of anal plug uses 
overall. Faecal incontinence occurred in 18%, 19% 
and 15% of uses when Plug 1, 2 or 3 were worn, 
respectively. Only one subject withdrew from the 
study. In a pre-post comparison of an anal catheter 
plug, seven of 18 adults (39%) with various aetiolo-
gies of faecal incontinence and a Cleveland Clinic 
FI severity score >7 completed a 14-day wear 
period [547]. The mean (standard deviation (sd)) 
faecal incontinence score during wear of the anal 
plug (5.2 (3.0)) was less than half that before its 
use (12.7 (3.6)). Thirty middle-aged patients (aged 
63 (52-70) years (mean (range)) with intractable 
FI of various aetiologies tested the anal plug for 
three weeks; the score for control of faecal leak-
age on a visual analogue scale (1= very poor to 
10= extremely good) was 9 (median) after 1 and 
3 weeks of using the plug [559]. Christiansen & 
Roed-Petersen [564] reported that 86% of persons 
were able to retain 150 ml of viscous fluid while an 
anal plug was inserted. 
Figure XIII-6: Interanal stool bag (left) and Outer attach-
ment wafer of Interanal stool bag (right). (Reproduced 
with the permission of Wiley- Blackwell Publishing)
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In the study of children only, 38 children (ages six to 
15 years) after anorectal malformation repair com-
pared two anal plugs (one made of polyurethane 
and one of polyvinyl alcohol) for three weeks each in 
random order in a cross-over design. Approximately 
two-thirds (61%) completed the study. Twelve chil-
dren (32%) were completely continent using either 
plug and five (13%) reported “total failure.” Two or 
fewer soiling accidents occurred in 74% using the 
polyurethane plug, and in 65% using the polyvinyl 
alcohol plug [561]. 
In a study of 20 children and adults with spina bi-
fida, average age 12 years (range = 4-29 years), the 
weekly number of episodes of FI soiling decreased 
from 4 (0-28) to 0 (0-8) (median (range)) after us-
ing the anal plug [560].A survey of adults and chil-
dren showed that a higher percentage of children 
tolerated using an anal plug over a longer period 
of time [565]. Five of eight (63%) adult survey re-
spondents who had faecal incontinence of various 
aetiologies stopped using an anal plug immediately 
while three used it periodically for 12 to 20 months. 
Two of seven child respondents stopped anal plug 
use immediately while five (71%) used it weekly for 
an average of 2.5 years. 
The most common reported problems associated 
with wearing an anal plug included discomfort and 
failure to retain the plug. Despite efficacy, approxi-
mately two-thirds of the subjects in two studies 
[564] [546] said they would not continue to wear the 
plug due to discomfort. Discomfort occurred in 10% 
to 12% of the times that one of the three anal plugs 
were worn in another study [545]. In more recent 
studies, 23% and 33% of subjects reported discom-
fort [563] [560]and 23-25% withdrewfrom studies 
because of pain [562] or discomfort[560]. More men 
than women withdrew from one study because of 
discomfort [559]. Adults who experience discomfort 
do not seem to adapt over time [559]. After three 
weeks of wear, adults reported a score on a ten-
point visual analogue scale for comfort while insert-
ing the anal plug was 7 (5-9) and while removing 
it was 8 (7-10) (median (range)). There was no 
association between comfort of the plug and ano-
rectal sensitivity during anal-rectal physiology tests 
in adults [546]. Children seem to experience less 
discomfort than adults while wearing the anal plug. 
[561] [559]. Approximately 20% of children reported 
that insertion of the polyvinyl alcohol plug was pain-
ful while 17% found removal of the polyurethane 
plug to be painful; one child experienced bleeding 
on removal of this second plug. Rectal bleeding also 
occurred in adults but infrequently [545]. 
Failure to retain the anal plug was reported by 13% 
of subjects in two studies [563] [562] and was noted 
by one child in the paediatric study as a reason for 
withdrawal [561]. The size of any plug tested was 
too large for six children in one study [561]. Twenty-
seven of 30 adult subjects preferred a small size 
anal plug [559]. Other tolerance problems were 
fairly uncommon. In one study, adults rated all three 
anal plugs that were evaluated as relatively easy to 
insert. Two plugs were difficult to remove in only 5% 
and 6% of uses, respectively, while the third was dif-
ficult to remove in 23% of uses [545]. Other reported 
problems were feeling a need to defecate [546], in-
convenience or difficulty in managing [546] [547], 
and local irritation [565].
b) Rectal Trumpet
One case series study evaluated the use of a rectal 
trumpet in 22 acutely or critically ill patients with fae-
cal incontinence and perineal skin damage [557]. 
For 90% of the subjects, the skin damage had been 
caused by wearing a rectal pouch immediately prior 
to the study. Subjects used the trumpet for periods 
varying between 36 hours and 16 days (mean 6.5 
days; sd 4.4 days). The reasons for any discontinua-
tion of use were reported. Outcome was determined 
using a daily questionnaire completed by patients’ 
nurses and the health of the perianal skin was noted 
by subjective assessment. No standardised defini-
tions or criteria for restoration of skin integrity or 
healing of skin damage were reported. Two subjects 
were lost to follow up. Faeces were successfully di-
verted to and contained by the collection bag in all 
patients. Recovery from skin damage was reported 
in 7 (39%) patients and partial healing of skin in the 
remaining 11 (61%). Discomfort on insertion was 
noted for 41% of subjects (Level of Evidence 3).
c) Rectal Catheter Systems
Closed rectal catheter and collection bag systems 
specifically designed for extended use and diversion 
of faeces are commercially available, primarily for 
acutely-ill or bed-ridden patients (Flexi-Seal™ and 
Flexi-Seal™ Signal™ Faecal Management System, 
Convatec A Bristol Myers Squibb Company; Prince-
ton, NJ; Actiflo Indwellling Bowel Catheter (formerly 
Zassi® Bowel Management System); Hollister, Inc., 
Libertyville, IL; Dignicare® and Dignishield™ Stool 
Management Systems, Bard Medical). The cath-
eters of these systems typically contain a retention 
cuff that collapses to assist with insertion (US FDA 
approved for up to 29 days) and a port for irrigation. 
In one system (Acti-flo) there is also a collapsible 
zone below the cuff that resides in the anus to al-
low normal anal sphincter function during use and 
a second port for sampling intestinal fluid. A third 
catheter has an inner balloon that can be inflated 
to serve as an anal plug to promote retention of an 
enema, for instance (Kim, US Patent 5 569 216, ap-
parently not currently commercially available).
Six studies evaluated use of a rectal catheter sys-
tem. Three studies used one type of catheter while 
the other three studies used three different types 
of systems. One study was of children [566]. The 
designs included a prospective single cohort in four 
studies [548] [567] [549] [566], a pre-post descrip-
tive design[568], and a retrospective case-matched 
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pre-post design [569]. The largest sample size was 
106 in the retrospective chart review whereas sam-
ple sizes in the prospective studies were relatively 
small, ranging from 20 to 42 subjects. In the studies 
of adults, subjects were burn patients in two stud-
ies [567] [569] and acutely or critically-ill patients 
in three studies [548] [568] [549]. In three studies, 
irrigation of the catheter with saline, a combination 
of lactulose and saline irrigation or use of an en-
ema was used to keep the stool liquid and the rectal 
catheter patent [567] [569] [549].
In only two studies was the effectiveness of the rec-
tal catheter system in reducing faecal incontinence 
reported (Level of Evidence 3). In the one paediatric 
study, 31 children (11 females) participated. Eight 
families refused to stop using the rectal catheter 
to complete an incontinence diary without use of a 
catheter. Two children had balloon extrusions and 
three were noncompliant resulting in their study 
withdrawal. The mean number of daily faecal incon-
tinence episodes as reported on a daily diary de-
creased from 3 to 1.5 in males and from 1.6 to 1.1 in 
females (p<0.05 for both) [566]. Three children ex-
perienced no improvement of faecal incontinence. 
In the one adult study, 39 of 42 subjects (62% fe-
male) with diarrhoea in intensive care units in seven 
hospitals completed the study. There was up to 29 
days of follow-up. Varying degrees and types of 
leakage around the rectal catheter were reported in 
71% of 198 assessments; 35% of these leakages 
extended to pads on the bed or beyond [548]. Sev-
en (17%) of subjects had difficulty retaining the rec-
tal catheter. Section 6.11 discusses use of a small 
gauze dressing for absorbing small amounts of 
stool leakage and a moisture barrier as skin protec-
tive strategies that might also help prevent damage 
from stool leakage around a rectal catheter. Skin 
damage from the tape holding the catheter in place 
and rectal bleeding are other reported but uncom-
mon complications [567] [548]. 
The effect of a rectal catheter on various outcomes 
associated with stool leakage has also been stud-
ied. Two studies reported costs savings in terms of 
reducing laundering of soiled bed linens. One study 
reported that the number of bed linen changes in 
burn patients with diarrhoea decreased eight-fold 
and dressing changes in hospitalized or burn pa-
tients decreased in half after a bowel system was 
introduced [567]. A multi-site study of 146 bedridden 
patients in the U.S. showed that one catheter (Hol-
lister, Inc) reduced the rate of bed linen changes 
(1.2 changes per day) more than another (1.7 per 
day) (Convatec). Estimates of cost savings based 
on staff time and laundry costs was almost $14 USD 
per patient per day [570].
Other outcome measures of rectal catheter use 
included urinary tract infections, incidence of skin 
/ soft tissue damage or infections, prevalence of 
pressure ulcers, and number of linen changes 
(Level of Evidence 3/4). In a retrospective review 
of medical records, approximately twice as many 
burn patients had skin / soft tissue or urinary tract 
infections before a bowel catheter system was in-
troduced than after (p<0.01) [569]. A prospective 
study of acutely and critically-ill patients showed 
that 41% who had normal skin in the perineum or 
buttocks at baseline maintained normal skin during 
use of the bowel catheter, 44% with some degree 
of skin damage improved, and 8% had worsened 
skin condition [548]. The percentage of intensive 
care unit patients with a stage II or greater pres-
sure ulcer was observed to be less at nine months 
after use of a bowel catheter was introduced. The 
total number of patients observed was not report-
ed. The length of time during which the prevalence 
of pressure ulcers was determined prior to catheter 
use was also not reported [568]. 
The condition of the rectal mucosa was observed 
endoscopically in 40 patients total across three 
studies; the evaluations were not blinded or inde-
pendent and did not use a rating scale [548] [567] 
[549]. All endoscopic observations were reported as 
being normal after rectal catheter use. Few com-
plications associated with use of the rectal cath-
eter system were reported in one study. Leakage 
around the rectal catheter seemed to be the most 
frequent problem. Catheter expulsion occurred in 
a small number of patients and skin damage from 
trying to secure the tube occurred only in one pa-
tient. Altered rectal sphincter function occurred us-
ing one of the catheters [549]. As the catheters are 
used more widely in clinical practice, there are more 
case reports of complications including rectal or 
lower gastrointestinal bleeding and need for blood 
replacement, mucosal pressure necrosis, fistula, 
and autonomic dysreflexia [571] [572] [573] MAUDE 
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/
cfmaude/search.cfm. (Level of Evidence 3).
d) Anal Pouch
One case series study evaluated the use of an ex-
ternal anal pouch (Technoline, Concordia, Moderna, 
Italy) in 120 nursing home or hospitalized patients 
(65 men, 55 women, ages 45-96 years) [574]. The 
nursing home residents (n = 92) were bedridden and 
had faecal and urinary incontinence or were treated 
for constipation for rectal enemas that drained into 
the pouch. Ten had a pressure ulcer. They used the 
pouch for four weeks or more. Acute care patients (n 
= 28, of which 10 were in the intensive care unit) had 
diarrhoea and were temporarily bedridden. Forty-
five patients who had surgery of the perineal area 
received a pouch to collect post-surgical drainage 
for up to three days. In the nursing home residents 
free of pressure ulcers, no new ulcers developed. 
In those with a pressure ulcer, healing occurred in 
five residents, ulcer diameter was reduced by 50% in 
three residents, and there was less than 50% reduc-
tion in two residents. Of the nursing home and acute 
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care participants, 77% found the pouch comfortable 
and 75% thought it was better than a sanitary nap-
kin. Seventy-seven percent of the nurses thought 
the anal pouch was easy to apply and 78% thought 
is easy to remove. Reported complications included 
moderate pain on removal in 18 (15%) patients in the 
nursing home or acute care (Level of Evidence 3).
An internal anal stool bag (Terumo Corp., Tokyo, 
Japan) was applied to five bedridden patients (3 
female, 2 male) aged 68-90 years [558]. Persons 
were administered a biscodyl suppository prior to 
insertion of the stool bag into the anus to control ex-
cretion of faeces. The bag was successful in collect-
ing stool 50% of the time (Level of Evidence 3). The 
bag was removed after each stool was collected.
Bliss and Savik (2008) [88] carried out a study, to 
examine the use of a surgical dressing to absorb a 
small leak of feces. These anorectal dressings can be 
placed between the buttocks. Of 28 people who had 
faecal incontinence, 27 had used the dressing and 23 
of them wanted to continue to use it. 79% reported no 
skin complications, and 80% of the participants rated 
their confidence in its effectiveness as very good to 
good. Use of the dressing lessened anxiety about fae-
cal soiling in 81% and was thought to improve quality 
of life in 76%. The authors stated that new types of 
absorbent products will become available.
4. SUMMARY
 •  An anal plug can successfully prevent fae-
cal incontinence but it is associated with high 
levels of discomfort, more so in adults than 
children (Level of Evidence 3).
 •  A rectal catheter system diverts faeces to a 
collection bag and promotes healing of dam-
aged perineal skin but requires liquid stool 
consistency to remain patent. Some catheter 
systems enable irrigation of the rectum to 
maintain liquid stool consistency.
 •  Non-blinded and non-independent endoscopic 
observations suggest the rectal catheter does 
not cause rectal mucosal damage during the rec-
ommended length of use (≤ 29 d in the US). As 
rectal catheter usage increases in clinical prac-
tice, case reports of complications have become 
evident; among the common ones reported are 
perianal skin damage, rectal bleeding, and mu-
cosal pressure necrosis. (Level of Evidence 3).
 •  A rectal trumpet can successfully channel 
faeces to a collection bag and there is some 
evidence that it can thereby enable damaged 
perianal skin to recover but it has been asso-
ciated with discomfort and its safety has not 
been determined (Level of Evidence 3). 
 •  An external anal pouch and an internal anal 
bag can be used to collect stool (Level of 
Evidence 3) but the adhesive wafers used to 
adhere them can cause skin damage upon re-
moval. The internal anal bag has been primar-
ily used when a bowel movement is induced 
using a suppository.
5. RECOMMENDATIONS
 •  Anal plugs may be tried but many patients are 
likely to use them on a limited basis or reject them 
due to discomfort (Grade of Recommendation C). 
  •  The use of a rectal trumpet (i.e. a nasopharyn-
gel tube inserted into the rectum) in patients with 
loose / liquid stool consistency offers an alterna-
tive to the rectal pouch when pouch adherence is 
a problem and may preserve perianal skin integ-
rity or facilitate healing (Grade of Recommenda-
tion C). The safety of the rectal trumpet has not 
been determined, but it suggests a lower risk due 
to its shorter length than a standard, longer rectal 
tube (Grade of Recommendation C).
 •  Use of a standard rectal tube with and without 
an inflatable balloon for faecal diversion is indi-
cated primarily for non-ambulatory patients with 
liquid stools (Grade of Recommendation C). 
 •  Use of an anal pouch attached to a drainage 
catheter to divert liquid stool is recommended, 
but there is a risk of skin damage. For this 
reason it is not recommended in cases where 
skin is already damaged or the need for fae-
cal diversion is less acute (e.g. where stool is 
more formed) (Grade of Recommendation C).
6. PRIORITIES FOR RESEARCH
 •  Development of an anal plug that is more 
comfortable and tolerable.
 •  More rigorous evaluation of anal plugs using 
larger subject cohorts and more objective out-
come measures over longer periods of use.
 •  More rigorous evaluation of rectal tubes / 
catheters and trumpets using larger subject 
cohorts and more objective outcome mea-
sures (e.g. for assessing health of the rectal 
mucosa) over longer periods of use.
 •  Development and evaluation of an external anal 
pouch that is easy to apply and remove, adheres 
to skin better and, perhaps, even promotes heal-
ing of damaged skin to which it would be applied. 
Further evaluation of an internal stool bag with 
similar adherent properties (as recommended 
for the external anal pouch) is needed.
1. BACKGROUND
The skin of an incontinent individual will be regu-
larly exposed to contact with urine and / or fae-
XIV. SKIN HEALTH AND CONTI-
NENCE PRODUCTS
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ces and damage to the skin is the main physical 
health consequence of urinary and faecal incon-
tinence. The majority of current knowledge about 
the effects of urine and faeces on skin has been 
obtained from studies with pads or pad materials 
on animals, healthy infants, and on body areas 
such as the forearm or back of adults. Where clini-
cal trials have been conducted, they have usually 
been on infants and rarely on adults using pads. 
Skin irritation within the pad occlusion area is usu-
ally termed diaper dermatitis in infants. In adults 
the term perineal dermatitis (PD) has commonly 
been used, but more recently it has been proposed 
that incontinence-associated dermatitis (IAD) is a 
better term because affected skin areas are not 
confined to the perineum [575] [576]. A consen-
sus panel in 2005 defined IAD as ‘erythema and 
oedema of the surface of the skin, sometimes ac-
companied by bullae with serous exudate, erosion, 
or secondary cutaneous infection [577] and this 
term and definition has been widely used since 
then [578] [575] [579]. More recently IAD has been 
classed as a sub-category of ‘moisture-associated 
skin damage’ (MASD) which includes intertriginous 
dermatitis and peristomal and periwound moisture-
associated dermatitis [579] [580]. 
Literature reviews and consensus papers
There has been considerable interest in IAD over 
the last few years, particularly with regard to its 
definition and aetiology and there have been three 
review/consensus papers on the subject [578] [575] 
[579] and one focusing on the prevention and treat-
ment of IAD [581]. 
a) The role of urine and faeces in skin irritation
Prolonged exposure to water alone has been shown 
to cause hydration dermatitis [582] [583] and pro-
longed occlusion of the skin (as within a continence 
product) has been demonstrated to reduce skin bar-
rier function [584] and significantly raise microbial 
counts and pH [585] [586]. Repeated wetting and 
drying makes the skin more vulnerable to substances 
that are usually innocuous, e.g., bile salts [587] [588]. 
A product that simply maintains wet and occluded 
skin (even without the additional constituents of urine 
and faeces) is therefore likely to cause skin irritation 
and increase skin permeability to other irritants.
Using a hairless mouse model Buckingham and Berg 
[589] examined the role of faeces in the aetiology 
of diaper dermatitis. They identified proteases and 
lipases as the major irritants and noted that these 
faecal enzymes not only irritated the skin directly but 
also increased the susceptibility of the skin to other 
irritants such as bile salts. The irritant effect of faeces 
was virtually eliminated by heating, which destroys 
enzymes, and was restored by the replacement of 
specific enzymes [e.g. lipase and protease). Skin 
damage appeared dependent on the concentration 
and length of exposure to enzymes in faeces [590].
A similar mouse model was used by the same re-
searchers to examine the role of urine in the ae-
tiology of diaper dermatitis [588]. They found that 
the irritant potential of urine by itself was minimal 
over short periods (48 hours) but after continuous 
exposure (10 days), skin damage became appar-
ent. The researchers also measured skin perme-
ability and found that continuous exposure to urine 
greatly increased skin permeability (more than 15 
fold) compared to occluded skin or skin exposed 
only to water. 
However, the combination of urine and faeces 
caused significantly higher levels of irritation than 
urine or faeces alone. The authors concluded that 
the presence of faecal urease results in the break 
down of urinary urea causing an increase in pH, 
which increases the activities of faecal proteases 
and lipases leading to skin irritation. The role of 
microorganisms - which comprise approximately 
50% of the solid component of faeces - in skin dam-
age is unresolved. Microorganisms on the skin of 
infants with and without diaper dermatitis were simi-
lar [591]. Zimmerer [592] sampled the microflora of 
the skin after pre-loading with pre-wetted patches 
containing urine and found that the microbial counts 
were significantly higher for wet patches relative to 
the dry patch controls. It was nearly impossible to 
establish infection with the opportunistic organism, 
Candida albicans, on normal skin without complete 
occlusion of the site [593]. Therefore, it is thought 
that bacterial or fungal infection is secondary to al-
terations in the skin barrier that allow penetration of 
the microorganisms [594].
Zimmerer et al. [592] examined the role of skin wet-
ness in the development of diaper dermatitis by 
using the volar forearms of adult volunteers. They 
aimed to determine the effects of wet and dry di-
aper materials on skin health with respect to fric-
tion, abrasion damage, permeability and microbial 
growth. Pre-wetted patches of baby diapers were 
placed on the volar forearms of adults for two hours 
and then the skin was subjected to friction and abra-
sion. The coefficient of friction for the ‘wet’ skin was 
significantly higher than for ‘dry’ skin although in-
creased fluid loading of wet patches did not further 
increase skin friction. Similarly, skin hydrated with 
a wet patch showed a significant increase in skin 
abrasion damage relative to a dry patch. Again, 
variations in the fluid loading of the patch did not 
produce significant changes in abrasion damage.
Although the volar forearm is most commonly used 
for skin experimentation, it has not been shown to 
be a valid model for the skin exposed to an incon-
tinence pad, i.e. buttocks and groins. Schnetz and 
colleagues [595] demonstrated that trans-epidermal 
water loss (TEWL) measurements (used to mea-
sure both skin barrier function and excess water in 
the skin) from the volar forearm did not correlate 
with those taken from the face, although the left and 
1760
right side of the face showed good correlation. The 
researchers concluded that TEWL measurements 
for the study of facial cosmetics should be taken 
from the face rather than the forearm. Similarly, 
studies using the volar forearm may not be valid 
for the buttocks and groin. Skin in the perianal area 
was shown to be more sensitive to faecal irritation 
than that on the inner arm [596].
Recently Fader and colleagues (2010, 2011) [597] 
[598] reviewed the literature on measurement of 
TEWL for assessment of overhydrated skin and 
found that there was a lack of standardization in all 
components of the method including the analysis 
and interpretation of findings [597] and they de-
scribe the development and testing of a more valid 
and robust method and compare measurements 
made on younger and older women and on volar 
forearm and hip skin. The authors conclude that age 
did not significantly affect measurements but those 
made on the hip were consistently higher and more 
variable than those made on the forearm. It is rec-
ommended that the forearm is used for future work.
Berg [588] analysed the aetiological factors contrib-
uting to infant diaper dermatitis and developed a 
model (Figure XIV-1) to show its development and 
resolution. However, the applicability of this model 
to adults with incontinence has not been tested, and 
other factors such as low mobility and prolonged 
pressure - which are common in frail, older adults - 
are not accounted for in this model. In addition, this 
model assumes the presence of urinary and faecal 
incontinence, which is much less common in adult 
populations than urinary incontinence alone.
b) Prevalence of incontinence-associated der-
matitis / perineal dermatitis
Incontinence-associated dermatitis (IAD) has been 
defined most recently as “an inflammation of the 
skin occurring with or without erosian or secondary 
cutaneous infection”. Perineal dermatitis (PD) is an 
inflammation of the skin characterized by redness, 
tissue breakdown or denudement, vesiculation, 
oozing, crusting, soreness, itching, and in its more 
severe form, pain and fungal patches [599] [600] 
[575] within the pad area. In the largest study of as-
sessment records of more than 59,000 residents in 
510 nursing homes located in 31 US states, Bliss et 
al. [601] reported a prevalence of perineal dermati-
tis of nearly 6%. In studies with smaller sample siz-
es and other populations, perineal dermatitis (Table 
XIV-1) has been shown to affect about a quarter to 
a half of patients. 
Recently there has been further clinical evidence 
supporting the role of faeces in the development of 
IAD. Bliss et al (2011) [544] studied the develop-
ment of IAD in 45 criticially ill adults in three critical 
care units. Most (76%) were male and all were free 
of IAD at the start of the study. IAD developed in 
36% of patients and the median time to onset was 
4 days (range 1-6). Severe IAD (denudement) oc-
curred in 9% of the observed time. Frequent incon-
tinence of loose or liquid stools and diminished cog-
nitive awareness were significant independent risk 
factors for development of IAD sooner.
Shigeta and colleagues (2011) [610] studied the 
skin of 100 older Japanese patients in a nursing 
Figure XIV-1: Berg’s model of diaper dermatitis (1987).
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home who had faecal and/or urinary incontinence 
and wore absorbent products. Multivariate logistic 
regression analysis showed that the presence of di-
arrhea was an independent risk factor. 
Bliss et al. [611] prospectively investigated the de-
velopment of IAD using assessment data of 1,850 
elders who were free of IAD at admission to a nurs-
ing home. The preliminary report showed that at 
three months after admission, faecal incontinence 
alone and double incontinence were significant pre-
dictors of IAD, but urinary incontinence alone was 
not a significant risk. The prevalence of IAD ap-
pears to be influenced not only by the type of patient 
(nursing home versus hospitalized) but also by the 
type of incontinence and whether or not a skin dam-
age prevention program is followed.
Measurement of IAD
There is no widely available valid or reliable tool 
for the assessment of PD / IAD although four in-
struments have been published [614] [615] [601] 
[617]. One of these tools, the Perineal Assessment 
Tool, despite its name, is an instrument primarily for 
assessing the risk of IAD (versus assessing skin 
health) and it has been described and used by its 
developer as such [616]. The most recently pub-
lished tool [617] has been subject to internal vali-
dation and determines degree of redness, amount 
of skin loss and presence of rash on 13 body loca-
tions; a revised version for dark-toned skin is also 
being tested. Most researchers have reported rat-
ings of colour changes (degree of erythema) based 
on visual inspection, which may be confounded 
by the presence of reactive hyperaemia on areas 
subject to pressure (particularly the buttocks, hips 
and sacrum). In some studies (mainly those finding 
higher proportions of IAD) trained staff or research-
ers have been utilised to carry out skin inspections 
at pre-specified times and in others (mainly those 
finding lower proportions of IAD) the usual care staff 
have been asked to report skin problems or written 
records have been used; this may explain the wide 
range of prevalence reported. 
Few studies report the severity of PD. In a prospec-
tive surveillance study of 981 nursing home resi-
dents with incontinence of urine and/or stool over 
six weeks, the most common anatomical locations 
of PD were the buttocks (73% of those with PD) 
and perianal area (70%) followed by the genitalia, 
scrotum and groin (36%) and thighs (24%) with the 
smallest percentage near the sacrum (9%). Approx-
imately one-third of residents had PD in more than 
one location. Mild PD was by far the most common 
(69% of residents); severe PD affected only 8% of 
residents [616].
c) Pressure ulcers and incontinence
The role of urinary and faecal incontinence in the de-
velopment of pressure ulcers is uncertain. Studies 
aiming to identify risk factors for the development of 
pressure ulcers have generally found that the pres-
ence of both urinary and faecal incontinence was a 
risk [617] [618] [619] [620], but some studies have 
only found faecal rather than urinary incontinence 
to be a risk factor [621] [622]. Pressure ulcer risk 
assessment scales all have a sub-scale of inconti-
nence or moisture-level, and the main mechanism 
for the development of pressure ulcers has been 
thought to be the increased friction and increased 
vulnerability to abrasion of wet skin.
Some researchers have used pressure ulcer clas-
sification systems, such as those published by the 
National Pressure Ulcer Advisory Panel (NPUAP) 
or the European Pressure Ulcer Advisory Panel 
(EPUAP), to measure skin health. The validity and 
reliability of most of these tools have not been es-
tablished. Doughty et al [623] and Bethell [624] 
described numerous other limitations of pressure 
ulcer staging systems and despite recent revisions 
of the NPAUP and EPUAP staging systems, many 
of the shortcomings still apply. The reliability of the 
EPUAP staging score (which is a modified version 
of the NPUAP score) has been tested recently in 
three studies using photographs of pressure ulcers. 
These photographs included ‘moisture lesions’ (de-
fined as lesions resulting from prolonged exposure 
of the skin to excessive fluid because of urinary or 
faecal incontinence, profuse sweating or wound 
exudate). A high degree of reliability for classifica-
tion of moisture lesions was found amongst 44 pres-
sure ulcer experts (Kappa =0.80) [625]. However, 
inter-rater reliability was found to be much worse 
(Kappa = 0.37) when photographs were viewed by 
473 non-expert nurses [626] and subsequently in 
Authors
 
Sample
 
Prevalence 
of dermatitis 
(%)
Lyder et al., 
1992 [602] 
15 older people: hospital 
psychogeriatric wards 
33 
Keller et al., 
1990 [603] 
95 older people: long stay 53 
Brown, 1994 
[22]
 166 adults (acute medical 
wards) 
35 
Bale et al., 2004 
[604] 
79 nursing home residents 25 
Zehrer et al., 
2005 
[605] 
398 nursing home residents 
on a skin damage 
prevention regimen 
4 
Bliss, Savik  et 
al., 2006 [601] 
59,558 nursing home 
residents 
5.7 
Bliss, Zehrer et 
al., 2006  [601] 
1,918 nursing home 
residents on a skin damage 
prevention program 
3.5 
Ehman et al., 
2006 [606] 
45 adult intensive care unit 
patients 
36 
Junkin et al., 
2008 [607] 
698 paediatric and adult 
hospitalized patients 
20 
Shigeta et al., 
2008[608] 
100 older Japanese patients 
in a nursing home 
36 
Beeckman et al., 
2011[609] 
141 long-term care patients 22.5 
Table XIV-1: Studies reporting the prevalence of 
incontinence-associated dermatitis
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a European study of 1,452 non-expert nurses from 
five European countries (Kappa = 0.36). The au-
thors concluded that better descriptors needed to 
be incorporated into the EPUAP system and more 
education was needed. 
An education tool aimed at improving skills in pres-
sure ulcer classification (the PUCLAS education 
tool) was developed by a workgroup of the EPUAP 
and was tested by Beeckman and colleagues [627] 
in a randomised controlled trial. 1217 nurses from 
Belgium, the Netherlands, UK and Portugal partici-
pated. At baseline 45% of skin photographs were 
classified correctly and results were significantly 
improved in the intervention group who received 
the PUCLAS education tool (63% classified cor-
rectly) compared to the control group (53% classi-
fied correctly). Furthermore the proportion of correct 
assessments for IAD was 71% in the intervention 
group and 36% in the control group. The authors 
conclude that the PUCLAS tool improved pressure 
ulcer classification. 
However there is still debate regarding the validity 
of separately classifying IAD from pressure ulcers 
particularly when skin damage occurs over bony 
prominences. To investigate the validity of classify-
ing moisture lesions, Houwing et al. [628] examined 
the histology of 14 biopsy samples of damaged 
patient skin. Skin damage was classified using the 
EPUAP system: 12 were moisture lesions, one was 
a grade 4 pressure ulcer (extensive tissue destruc-
tion / necrosis) and one was a combination of a 
moisture lesion and a grade 1 pressure lesion (non-
blanchable erythema). Both pressure ulcers had a 
histological pattern suggesting ischemic pathology; 
the histology of the moisture lesions, however, was 
either of an ischemic or irritation pattern. Because 
of the overlap in histology patterns of some of the 
moisture lesions and the pressure ulcers, the au-
thors concluded that there is no justification for clas-
sifying moisture lesions separately from pressure 
ulcer lesions.` This finding requires further study as 
there are several limitations of their study. First, the 
true aetiology of the skin damage and the veracity 
of the EPUAP classification were not determined; 
some moisture lesions seem to be partially over 
a bony prominence so that a mix of pressure and 
moisture damage cannot be ruled out, which might 
explain the mixed histology patterns. Secondly, the 
moisture lesions and the pressure ulcer were both 
described as having blanchable erythema. 
Identification of moisture lesions as distinct from 
pressure ulcers is sought as a way to solve the ten-
sion between inadequate prevention / treatment of a 
pressure ulcer and inappropriate use of costly pre-
vention relieving devices / measures. It is also of 
importance in determining care quality. Pressure ul-
cers are deemed as quality indicators in many coun-
tries and are considered to be preventable. Facili-
ties may not be allowed to charge for the care and 
treatment of patients who develop pressure ulcers 
and may also be fined. The ‘correct’ classification of 
IAD and pressure ulcers therefore has financial and 
reputational implications.
Fader et al. [629], examined the effects of absorbent 
continence pads on mattress interface pressures 
using an articulated model or “phantom” as the 
subject and found that the presence of a pad sig-
nificantly and substantially (around 20%) increased 
the peak pressures recorded between the buttocks 
and the pad / mattress. Peak pressures were fre-
quently found at the locations of pad creases and it 
was considered that pad folding and compression 
may contribute to raised interface pressures. It is 
therefore possible that continence product use con-
tributes to the formation of pressure ulcers by rais-
ing interface pressures. 
Black et al. (2011) [579] have categorized IAD as dis-
tinct from pressure ulcers as shown in Table XIV.2
2.  CLINICAL STUDIES OF THE IMPACT OF 
PRODUCTS AND PRODUCT MATERIALS 
ON SKIN HEALTH
In the 1980s, product manufacturers introduced dia-
pers with super-absorbent polymers (SAP), which 
were designed to reduce skin wetness, buffer pH 
and reduce urine / faecal contact in order to help 
prevent diaper dermatitis. This led to clinical and 
laboratory studies to evaluate the efficacy of dia-
pers with different materials, in particular, super-ab-
sorbent polymers (SAP) compared to those without, 
and compared to conventional washable diapers.
a) Quality of data
There are three types of studies testing the effects 
of different products or product materials on skin 
health: (i) clinical trials of normal infants wearing di-
apers; (ii) laboratory wet patch testing of adult fore-
arms with diaper or continence pad patches; and 
(iii) clinical trials of adult absorbent pads containing 
different materials. The infant diaper studies were 
randomised controlled trials with large samples and 
blind measurement of outcomes. It should be noted 
that these studies were carried out by industry-em-
ployed staff. The infant and laboratory studies used 
a probe comprising two hygrosensors and thermis-
tors (an evaporimeter) placed on the ‘wet’ skin to 
measure trans-epidermal water loss (TEWL), an 
indicator of skin hydration level. However, there is 
uncertainty about the optimum procedures for mea-
suring TEWL, and different procedures and out-
comes were used in the studies, making it difficult 
to compare results. Probably the most important 
threat to the validity of these studies is the selection 
of products or materials used in the study. None of 
the studies adequately described the products used 
- in particular, regarding their total absorbency. Thus 
it is possible that an alternative explanation for the 
fairly consistent findings that disposable pads with 
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SAP perform better on skin outcome measures may 
be that those with SAP simply had greater absor-
bency than those without.
b) Results
1. CLINICAL STUDIES OF INFANT DIAPERS
Campbell and colleagues [630] conducted four 
clinical studies involving 1,614 infants randomly 
assigned to either disposable diapers with SAP, 
disposable diapers without SAP or washable cloth 
diapers. Disposable diapers with SAP were asso-
ciated with significantly reduced skin wetness as 
measured by TEWL, lower pH and lower ratings of 
diaper dermatitis when compared to the two other 
diaper products (Level of Evidence 2).
Lane et al., [631] randomised disposable diapers 
without SAP and disposable diapers with SAP to 
149 newborn infants and assessed their skin condi-
tion seven times over a 14 week period. Skin rash 
ratings were significantly lower for infants wearing 
diapers with SAP at only one time period (14 weeks) 
(Level of Evidence 2).
Davis and colleagues [632] assessed 150 infants 
over 15 weeks in a cross-over study involving four 
different disposable diaper types, two with different 
levels of SAP and two with different levels of fluff pulp 
only. Both diapers containing SAP were associated 
with significantly less skin wetness and significantly 
lower pH. Clinical skin ratings showed significantly 
lower ratings for the SAP-containing pads compared 
to the lower weight fluff pulp pad, but not compared 
to the higher weight fluff pad (Level of Evidence 2).
2. LABORATORY STUDIES OF DIAPER PATCHES
Wilson and Dallas [633] used the adult normal volar 
forearm skin model to compare patches taken from 
16 different infant diapers. They found that disposable 
diapers containing SAP left the skin significantly drier 
than washable diapers and disposable diapers with-
out SAP (p<0.01). Disposable diapers without SAP did 
not differ significantly from reusable diapers and there 
were no significant differences between products with-
in any of the three groupings (Level of Evidence 2). 
However, in a subsequent study involving 20 dis-
posable and washable adult incontinence pads in-
corporating a similar range of materials to the baby 
diaper study Dallas and Wilson [634] found signifi-
cant differences between products within each of 
the three product groupings but not between group-
ings (Level of Evidence 2). Grove et al. [635] used 
a similar approach to compare three infant diapers 
and found a significant difference in skin wetness 
between two that contained similar quantities of 
SAP (p<0.001). The one in which the SAP was in a 
layer near the water-proof backing kept the skin dry-
er than that in which it was near the coverstock. The 
third diaper – which had a microporous (breathable) 
backing kept the skin significantly dryer than each 
of the other two (p<0.001) (Level of Evidence 2).
3. CLINICAL STUDIES OF ADULT ABSORBENT PRODUCTS
There has been one clinical study of adult inconti-
nent patients comparing underpads with and with-
out SAP, diapers with and without SAP and wash-
able cloth underpads and which used skin condition 
as the primary outcome variable [22]. This study 
included 166 incontinent patients (urine, faeces 
or both) from three acute care facilities who were 
divided into the five groups. It is unclear whether 
randomisation to group occurred by patient or by 
facility. One facility used the washable cloth under-
pads only for their patients. Other patients tested 
either diapers or underpads and crossed-over from 
without SAP to with SAP products after six weeks. 
Skin measurements were made for colour, integrity 
and symptoms using rating scales. Both blind and 
non-blind measurements were made. 
Findings were rather complex and difficult to in-
terpret and no corrections for multiple comparisons 
Factors IAD Stage I Pressure Ulcers Stage II Pressure Ulcers 
History of 
condition 
Exposure to urine or 
stool 
Exposure to pressure, shear and/or 
microclimate from immobility or inactivity 
Exposure to pressure, shear and/or 
microclimate from immobility or inactivity 
Location of 
affected skin 
Skin folds in areas 
where urine or stool can 
accumulate 
Skin usually over bony prominences or 
exposed to other external pressure (eg, 
medical device) 
Skin usually over bony prominences or exposed 
to other external pressure (eg, medical device) 
Colour of 
wound bed 
Shiny, red, glistening, 
no slough in wound bed 
Nonblanchable erythema of intact skin Shiny pink or red open wound, no slough in 
wound bed 
Colour of 
periwound 
tissue 
Red, irritated, 
edematous 
Normal for race/ethnicity, edema may be 
palpable  
Normal for race/ethnicity, edema may be 
palpable 
Characteristics 
of involved 
area 
Blotchy, not uniform in 
appearance 
Tend to be single areas of erythema Tend to be single ulcers with distinct ulcer 
wound margin 
Pain Burning, itching and 
tingling  
Sharp pain, usually no itching; pain may 
intensify when patient is initially moved off 
of injured areas  
Sharp pain, usually no itching; pain may 
intensify when patient is initially moved off of 
injured areas 
Odour Urine, faecal odour None None unless infected and then may have odour 
of infecting organism 
Other Candidiasis common 
(seen as satellite 
lesions) 
Redness tends to resolve with offloading or 
repositioning of device 
Ulcer bed is shallow and heals through 
epithelialization  
Table XIV-2: Differentiation of IAD Versus Stage I and II Pressure Ulcers
1764
appear to have been made. Overall there were no dif-
ferences in skin measurements between the diaper 
and underpad groups but - for some measurement 
sub-groups - differences were found with mean co-
lour scores being significantly higher (worse) in the 
without-SAP diaper group and the washable cloth 
underpad group. Blinded ‘worst’ skin colour scores 
were highest for without-SAP diapers and washable 
cloth underpads and lowest for with-SAP products. 
Overall the findings supported the favourable ef-
fects of SAP on skin health but, as with the infant 
diaper studies, total absorbency of the products was 
not reported (Level of Evidence 2).
Hu et al. [66] randomised an unnamed range of dis-
posable insert pads with mesh pants to 34 nursing 
home residents who were matched (based on incon-
tinence severity) with 34 residents who received the 
usual reusable cloth diaper product. Skin condition 
was rated at baseline and after the five week inter-
vention period by a blinded nurse researcher. Skin 
condition was reported to be significantly better in the 
disposable pad group (Level of Evidence 2).
More recently Beguin and colleagues (2010) [636] 
tested a modified diaper design (incorporating a 
top layer of specialised cellulose – beneath the 
top sheet – to maintain skin pH, and air-permeable 
side panels to minimise skin occlusion) in a small 
study of 12 patients using a pre-post test design. 
Skin pH was significantly lower when patients used 
the modified diaper and 8 out of 12 patients had 
resolution of pre-existing skin lesions. A larger more 
robust trial would be needed to establish any impor-
tant clinical benefit. 
3.  CLINICAL STUDIES OF SKIN-CARE PROD-
UCTS AND NURSING PRACTICES TO 
MAINTAIN OR IMPROVE SKIN HEALTH
The skin of incontinent people requires frequent 
cleansing to remove urine and / or faeces. Soap and 
water is in common use [637] but it is known that re-
peated exposure to anionic surfactants (common in 
soaps) results in skin irritation [638] [639]. In addition, 
the action of washing is also considered likely to con-
tribute to mechanical damage of the stratum corneum. 
Cleansing of skin soiled with urine and / or faeces 
should occur immediately if possible or promptly 
after episodes of incontinence [640] [641] [642] 
[643] [644] [579] [575]. In addition, an individual-
ized schedule for cleansing the perineum according 
to patients’ needs or preferences [645] [646] [575] 
[579] or at routine intervals, such as daily or at bath 
time [647] [576] [640] [642] [648] has been recom-
mended (Level of Evidence 3). 
The practice of cleansing or wiping the perineum 
front to back is recommended as standard practice 
in the literature - particularly for women [649] [650] 
[651] [652] [653]; this recommendation is based on 
the physiological rationale of lowering presumed 
risk of contaminating the urethra with faecal bac-
teria and subsequent urinary tract infection [653]. 
One retrospective study of pregnant women found a 
significantly higher association of urinary tract infec-
tions in women who self-reported they wiped back 
to front (25.8%) than among those who wiped front 
to back (18.5%) [654] (Level of Evidence 2). 
To minimize friction damage of the skin during the 
perineal cleansing process, gentle cleansing and 
patting dry the skin [655] [656] rather than rubbing 
or using a soft cloth is recommended by clinical ex-
perts [616] [657] [576] [643] [644] [658] [659] [659] 
(Level of evidence 4). 
However there is some evidence that drying the skin 
by patting may be less effective than gentle towel 
drying or drying with a hair dryer [660]. Damp skin 
is more vulnerable to friction damage and special 
care may therefore be needed to ensure that the 
skin is dry. For already damage skin, there are clini-
cal anecdotes of using a small hand-held hair-dryer 
set on a low and cool setting rather than drying with 
a cloth. Further research into cleaning and drying 
techniques and products is encouraged.
Alternative cleansers are available which have been 
formulated with the intention of overcoming some 
of the limitations of soap and water. Although over-
hydration of skin is detrimental, an excessively dry 
stratum corneum develops cracks and fissures and 
can be as ineffective a barrier as an over hydrated 
one [583]. Soap has a high pH (9.5-11) [661] and 
under laboratory conditions skin that has been ex-
posed to high pH solutions has been found to have 
increased stratum corneum swelling and other 
signs of skin damage. However, there is a lack of 
controlled clinical trials comparing standard (high 
pH) soap with pH neutral soap or cleansers. 
Many modern cleansers are designed to be used 
without water [i.e. ‘no-rinse’) and are designed to 
provide a less aggressive skin environment than 
soap (e.g. lower pH) but this may compromise their 
effectiveness in cleaning the skin of urine and fae-
ces. This question has been addressed by Ronner 
et al, (2010) [662] who compared soap and water 
and a no-rinse cleanser in terms of their ability to 
remove escherichia coli and staphylococcus aure-
us. This laboratory study employed volunteer volar 
forearms and found low level and comparable levels 
of residual bacteria on the skin. 
The use of topical products aiming to prevent or 
treat skin irritation is common but there is a lack 
of standardisation in definitions and descriptions 
of products, which makes comparisons difficult. 
Products such as ‘moisturisers’ or ‘barriers’ may 
be applied to the skin after cleansing, and some 
cleansers also incorporate moisturisers. The aim 
of moisturisers (also known as emollients) is to hy-
drate the skin by reducing trans-epidermal water 
loss through occlusion (e.g. petrolatum), by drawing 
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water into the stratum corneum by the addition of a 
humectant (a hygroscopic substance, e.g. glycerol) 
or by adding water in the applied water-miscible 
product. These modes of action are often combined 
in the same product, but there are exceptions - such 
as petrolatum - which only work by occlusion [663]. 
Some products are designed specifically to prevent 
penetration of water into the stratum corneum (‘bar-
rier’ products) such as liquid skin sealants contain-
ing polymers, and may allow trans-epidermal water 
loss whilst preventing external water penetration. 
Simple occlusive products such as petrolatum may 
also act as barrier products to water but also oc-
clude trans-epidermal water loss.
The application of skin barriers is recommended 
on areas that would come in contact with leaked 
urine and / or faeces. In general these areas in-
clude the buttocks and perianal area, groin, and 
inner thighs. Community-living persons report leak-
ing small amounts of faeces that remain between 
the buttocks. Clinically, nursing staff have observed 
seepage of faeces around a rectal catheter in hos-
pitalized patients. In both groups, perianal skin pro-
tection is important, and skin barriers are recom-
mended (Level of evidence 4).
Topical creams are commonly used to prevent 
and treat dermatitis but controlled experiments to 
assess efficacy on human and animal skin have 
produced equivocal results. Ghadially et al. [663] 
showed that barrier recovery (measured by TEWL) 
on experimentally irritated skin was accelerated by 
the application of petrolatum and De Paepe K et al. 
[664] showed similar results using a different mois-
turising cream. Hannuksela and Kinnunen [665] 
showed that treatment with moisturisers prevented 
the development of irritation in an experiment in-
volving frequent skin washing with liquid detergent. 
However, Gabard [666] was unable to demonstrate 
significant acceleration of barrier recovery to chroni-
cally irritated skin following application of different 
moisturisers using a chronic irritation model and 
also found that some creams enhanced irritation. 
The efficacy of barrier products in preventing water 
penetration of the skin has been tested in labora-
tory settings. Vinson and Proch [667] applied wet 
patches with a water-soluble marker to skin coated 
with three different barrier products and measured 
dye extracted from the skin by absorbance spectro-
photometry. One multiple barrier product performed 
significantly better than a petrolatum-based and an 
allantoin-based protectant. Waring and Hoggarth 
[668] used a Chromameter to measure skin colour 
change after staining skin with a water-soluble dye, 
covering it with a barrier product and washing the 
skin. Petrolatum products were found to be more 
effective barriers than dimethicone-based products. 
In a later study, Hoggarth et al. [669] investigated 
the barrier function and skin hydration properties 
of six skin protectants when applied to the volar 
forearms of 18 healthy volunteers. The researchers 
found that each had different performance proper-
ties with the water-in-oil products containing petro-
latum performing better than the oil-in-water prod-
ucts containing dimethicone for protection against 
irritation or maceration. However the dimethicone 
products had higher hydration properties compared 
to the petrolatum products. Overall the water-in-
oil petrolatum-based product was the only product 
to be efficacious for all performance variables. A 
limitation of some petrolatum-based moisture bar-
riers compared to a non-alcohol barrier film for in-
dividuals wearing absorbent pads or briefs is that 
the petrolatum-based products have been shown to 
transfer from the skin onto the absorbent product 
and reduce fluid update by 54% to 90%. [605]. How-
ever this has not been tested in clinical trials and the 
effects of different topical products on the leakage 
performance of absorbent pads is unknown.
Other practices that may affect skin health include 
frequency of pad changing. Increasing pad chang-
ing may reduce skin wetness by application of a 
dry pad and may therefore benefit skin health. In-
creased pad changing is commonly recommended 
to prevent or treat dermatitis particularly in infants 
[670] Level of Evidence 4.
a) Quality of data
Several studies of skin cleansing and / or moisturis-
ing / barrier products to prevent perineal dermatitis 
have been limited by being uncontrolled [614] [671] 
[604] [672] and of small size and lacking adequate 
power calculations [673] [674] [602], or not including 
any clinical outcome measures [673]. Measurement 
of dermatitis may also have been compromised by 
reactive hyperaemia on skin areas subject to pres-
sure. Only four randomised controlled trials of a skin 
cleansing regimes to prevent perineal dermatitis 
could be found, and two RCTs of products to treat 
dermatitis. Two trials focused on the costs of barrier 
products use. In addition there was one randomised 
crossover trial of pad changing frequency.
b) Results
1. SKIN CLEANSING / MOISTURISING PRODUCTS TO PREVENT 
DERMATITIS
Byers et al. [673] compared four different cleansing 
/ moisturising regimes including soap and water us-
ing a multiple cross-over design. Despite having a 
very small sample size (n = 12 elderly women) they 
found statistically significant differences in TEWL, 
pH and erythema between some of the regimes, 
and soap and water was found to be the least ef-
fective product for skin health. No clinical outcomes 
were measured and differences in outcomes were 
small (Level of Evidence 2).
Beeckman et al, 2011 [609] randomised 141 nurs-
ing home residents to receive standard cleansing 
with pH neutral soap and water with the use of a 
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3-in-1 perineal care washcloth impregnated with a 
3% dimethicone skin protectant over a period of 
120 days. Skin health was measured using the IAD 
skin condition assessment tool. Although no differ-
ences in the severity of IAD were found there were 
substantial differences in prevalence of IAD (ex-
perimental: 8.1% versus control: 27.1%, F = 3.1, 
p=0.003) (Level of Evidence 2).
Cleansing products
Cooper and Gray [657] randomised 93 long-term el-
derly subjects to skin cleansing with soap and water 
or with a foam cleanser over a 14 day period and 
blindly assessed perineal skin photographs at zero, 
seven and 14 days. The skin of 37% of subjects using 
soap and water remained ‘healthy’ compared to 66% 
of subjects using the foam cleanser. However, statisti-
cal analysis was not carried out (Level of Evidence 3).
Lewis-Byers et al. [658] randomised 32 nursing 
home residents with incontinence to a soap and 
water or no-rinse cleanser regime over a period of 
three weeks. No significant differences in skin con-
dition were found but no power calculations were 
included (Level of Evidence 3).
Taken together, the evidence from these trials indi-
cate that specialised cleansers may be better than 
soap and water for skin health, although there is 
still a need for further robust clinical trials. Reported 
staff opinion tends to favour specialised cleansers 
rather than soap and water and there may also be 
cost savings [614] [673] [674] [658] although the re-
liability and validity of the health economic analyses 
carried out to date has been questioned by Beeck-
man (2009) [581].
Costs of barrier products to prevent dermatitis
Zehrer et al. [605] compared the cost and efficacy 
of three incontinence skin barrier products in 250 
nursing home residents from four facilities. A poly-
mer-based barrier film was used either once daily or 
three times weekly, and one of two petrolatum oint-
ments was used after each episode of incontinence. 
Residents were monitored for skin damage for six 
months. There were no significant differences in ef-
fectiveness among the various barrier film and oint-
ment protocols of care. Time and motion measures 
were used to determine the costs of the products 
and associated nursing labour. Daily cost of barrier 
product ranged from $0.17 for the barrier film applied 
three times per week to $0.76 for a petrolatum oint-
ment applied after each incontinent episode. When 
nursing staff labour to apply the barrier products was 
included in the cost analysis, costs increased from 
$0.26 per day for the less frequently applied barrier 
film to $1.40 per day for the more frequently applied 
petrolatum ointments (Level of Evidence 3). 
Bliss et al. [616] randomly selected 16 nursing 
homes to compare the cost and effectiveness of 
four skin damage prevention regimens. In three of 
the four skin prevention regimens, a moisture barri-
er ointment or cream of different compositions (43% 
petrolatum; 98% petrolatum; and 12% zinc oxide + 
1% dimethicone) was applied after each episode of 
incontinence, while in the fourth, a polymer-based 
alcohol-free barrier film was applied three times per 
week. All regimens used a pH-balanced, moistur-
izing cleanser of the same manufacturer as the bar-
rier. Time and motion measures were documented 
for the amount of skin care products used, the 
number, type, and time of caregivers performing 
IAD prevention care, and the number and type of 
supplies used. Compared to the three regimens in 
which a barrier was applied after each episode of in-
continence, the use of a regimen in which a barrier 
film was applied three times weekly had significantly 
lower costs for the barrier product, labour associ-
ated with barrier application, and total cost which 
included products, labour, and supplies. There were 
also savings in total product (cleanser and barrier) 
and total labour costs. The total cost was lowest for 
the regimen using the barrier film compared to the 
other regimens in which a barrier needed to be ap-
plied after each episode of incontinence. The total 
cost savings ranged from $ 0.40 to $0.85 per epi-
sode of incontinence (Level of Evidence 2).
Although both these studies demonstrated cost sav-
ings when using barrier-film products such savings 
are dependent on relatively infrequent application 
of the barrier-film product. This may be achieved by 
assigning product application to care staff on par-
ticular shifts but uncontrolled use of such products 
may be expensive.
2. SKIN PRODUCTS TO TREAT DERMATITIS
In a double blind controlled trial of 64 subjects, An-
thony et al. [675] compared the efficacy of cream 
formulated to treat dermatitis (Sudocrem) with zinc 
cream BP. Thirty subjects showed inflammatory le-
sions of the buttocks and a significantly greater pro-
portion of subjects allocated to Sudocrem showed 
reduction in skin redness at both seven days and 14 
days. No differences were found in the prevention of 
inflammatory lesions between the two groups. Skin 
measurements were made over the ischial tuberosi-
ties but the effect of reactive hyperaemia was not 
accounted for. There was no control group receiving 
no skin treatment and therefore it was not possible 
to establish the efficacy of using cream as treatment 
per se (Level of Evidence 2).
Baatenburg de Jong & Admiraal [676] determined 
the cost of treating moderate to severe IAD in 39 
nursing home patients in the Netherlands randomly 
assigned to treatment with a non-stinging barrier 
film or zinc oxide oil. The barrier film was applied 
every 48 - 72 hours for less severe skin damage 
and 24 - 48 hours for more severe damage. Zinc ox-
ide oil was applied twice per day and after each epi-
sode of incontinence. Both barriers reduced IAD but 
the no-sting barrier film was significantly associated 
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with reduced severity of skin redness and skin loss, 
although skin assessments were not blinded. The 
cost per day of the nursing staff labour in the regi-
men using the barrier film was €68.58 (sd = € 23.61) 
compared to €88.20 (sd = €22.88) in the regimen 
using the zinc oxide oil The total cost (including bar-
rier, labor and supplies) per day of the regimen us-
ing the barrier film (€76.13, sd = €25.48) was also 
less than for the regimen using the zinc oxide oil 
(€102.96, sd = €23.25) (Level of Evidence 2).
3. PAD CHANGING FREQUENCY
Fader et al. [629] investigated the effect of different 
frequency of night-time pad changing on 81 incon-
tinent nursing / residential home subjects from 20 
homes. Following a two week baseline period, sub-
jects were randomised by home to pad changing at 
22.00 and 06.00 for four weeks followed by 22.00, 
02.00 and 06.00 for four weeks, or vice versa. 
Blinded skin measurements of instrumental erythe-
ma (using an erythema meter), visual rating, trans-
epidermal water loss and pH were made at baseline 
and during the last two weeks of each regime with 
instrumental erythema measurements used as the 
primary outcome variable. Trans-epidermal water 
loss measurements were significantly higher when 
pads were changed less frequently (22.00 and 
06.00) indicating that skin was wetter. No other sig-
nificant differences were found. However, five sub-
jects developed stage II pressure ulcers in the less 
frequent pad changing regime compared to none in 
the frequent pad changing regime. Although more 
frequent pad changing did not demonstrate less 
dermatitis / erythema, the pressure ulcer findings - 
though non-significant - make it unwise to conclude 
that less frequent pad changing does not damage 
skin health (Level of Evidence 2).
4. SUMMARY
 •  Incontinence-associated dermatitis is a com-
mon problem amongst absorbent product us-
ers (Level of Evidence 2).
 •  Skin wetness overhydrates skin and potenti-
ates the effects of other irritants (Level of 
Evidence 2).
 •  Faecal incontinence is more irritating than uri-
nary incontinence, but the combined effects of 
urine and faeces are particularly damaging to 
skin (Level of Evidence 2).
 •  Absorbent pads containing super absorbent 
polymers are associated with reduced skin 
wetness (Level of Evidence 3).
 •  Wet skin is more vulnerable to friction and 
abrasion injury (Level of Evidence 2).
 •  Pressure ulcers are associated with urinary and 
faecal incontinence (Level of Evidence 2).
 •  Bodyworn absorbent products may raise in-
terface pressures measured under the but-
tocks (Level of Evidence 3).
 •  There are indications that skin cleansers may 
be more cost-effective than soap and water 
(Level of Evidence 3) and may be better for 
skin health (Level of Evidence 2).
 •  Barrier skin products may impede water pen-
etration into the stratum corneum (Level of 
Evidence 3).
 •  A regular and structured skin care regimen using 
topical preparations such as moisturisers or bar-
rier creams is associated with a low incidence of 
perineal dermatitis (Level of evidence 4).
 •  More frequent pad changing has not been 
shown to prevent dermatitis, but less frequent 
pad changes may be associated with pres-
sure ulcers (Level of Evidence 3).
5. RECOMMENDATIONS
 •  Absorbent pads with SAP should be selected 
in preference to those without (Grade of Rec-
ommendation B).
 •  Absorbent pads should be changed regularly 
to minimise skin wetness (Grade of Recom-
mendation C).
 •  Patients with faecal or double incontinence 
should be changed as soon as possible after 
incontinence has occurred to prevent the de-
velopment of dermatitis from protease and li-
pase activity (Grade of Recommendation B).
 •  Patients should be washed gently at times 
of pad change with either soap and water or 
cleansers. Cleanser may be less time-con-
suming than soap and water (Grade of Rec-
ommendation C).
 •  Skin barrier products should be applied to 
areas that potentially come in contact with 
leaked urine and / or faeces (Grade of Rec-
ommendation D)
 •  Barrier products may be applied to skin within 
the pad area to reduce water penetration of 
the skin (Grade of Recommendation C).
 •  Buttock and sacral areas should be protected 
using topical skin barrier products, contain-
ment products or diversion devices in patients 
vulnerable to IAD or pressure ulcers (Grade 
of Recommendation C). 
6. PRIORITIES FOR RESEARCH
 •  Controlled randomized trials that investigate 
the effectiveness of skin care products or 
skin care regimes to prevent or treat peri-
neal skin damage due to urinary and faecal 
incontinence are recommended. Trials which 
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aim to test the comparative effects of different 
cleansing regimes, different barrier products 
and use of barrier products compared to care-
ful cleansing are needed in particular. Such 
studies should determine appropriate sample 
sizes using power analyses. Analyses need 
to be powered to distinguish effects on par-
ticipants with faecal or double incontinence. 
Objective measures from instruments, stan-
dardized clinical assessments, and patient 
symptom ratings should be included. 
 •  Laboratory-based studies on healthy volun-
teers are recommended to help select prod-
ucts and establish potential efficacy of prod-
ucts before undertaking RCTs.
 •  Further work is needed to examine the rela-
tionship between IAD and pressure ulcers, 
in particular the potential and/or methods to 
discriminate between them, including use of 
biomarkers and technology.
 •  Studies to identify markers or ways of dis-
criminating between pressure ulcers and IAD 
are required. Trials to test the comparative 
effectiveness of different skin cleansing re-
gimes are needed as are trials to determine 
whether skin barrier products deliver benefits 
over careful cleansing alone and, if they do, 
which work best.
Fear of smelling is a major concern that preoc-
cupies many people suffering from incontinence 
and it is an issue that has been raised in several 
qualitative studies that have explored the subjec-
tive opinion of the patient eg [677] [678] [5]. Ac-
cordingly, there is a demand for products which will 
mask odour or, preferably, prevent it.
1. PRODUCTS FOR URINARY INCONTINENCE
Fresh, infection-free urine smells only slightly but 
bacterial action on urea over time yields pungent 
smelling ammonia. 
A variety of anti-microbial solutions are available 
for washing such products as hand-held urinals 
or for treating urine spillage onto soft furnishings 
such as carpets. They aim to prevent smell by de-
stroying the bacteria responsible for break down 
of urea. There are no robust published studies 
that have sought to evaluate such products. An-
other approach is to mask the smell of stale urine 
using a strong but (hopefully) pleasant smelling 
liquid. There are no robust published studies on 
such products either but anecdotal evidence sug-
gests that, in time, the masking smell comes to be 
associated with the incontinence that it is intend-
ed to disguise. Several companies supply prod-
ucts (washable bedpads, carpets, chairs, clothing 
and bed linen) made with fabrics that have been 
treated with anti-microbial agents intended to re-
duce the smell of any urine on or in them. How-
ever, again, there have been no robust published 
studies to investigate efficacy. 
One of the 12 disposable bodyworn pads for 
lightly incontinent women evaluated by Clarke-
O’Neill et al. [18] was treated with a lavender 
scent but it was not found to perform significantly 
better than the other products in terms of pre-
venting smell. However, the scent was appreci-
ated by 18% of the 50 test subjects, who com-
mented favourably on it.
2. PRODUCTS FOR FAECAL INCONTINENCE
Odour associated with faecal incontinence may 
occur from involuntarily leaked stool or flatus. In 
a study with subjects eating a self-selected diet, 
Moore et al. [679] identified the volatile chemi-
cals primarily responsible for faecal odours as the 
methyl sulphides: methanethiol, dimethyl disul-
phide, and dimethyl trisulphide. Hydrogen sulphide 
was thought to make a smaller contribution. In a 
subsequent study with persons consuming a bo-
lus of pinto beans and lactulose (a non-absorbable 
carbohydrate) Suarez et al. [680] attributed the 
odour of flatus to the sulphur compounds, hydro-
gen sulphide, methanethiol, and dimethyl sulphide. 
The intensity of the odour in flatus was related to 
the concentration of the sulphur-containing com-
pounds: the ability of the human nose to recognise 
malodorous odour appears to be related to the 
amount of gas expelled [680]. Different states of 
health and gastrointestinal function, diet composi-
tion, relative concentrations of sulphide gases and, 
possibly, short chain fatty acids or ammonia are 
expected to contribute to the odour of faeces and 
flatus [679] and [680]. 
There are several commercially available devices 
that are designed to absorb the odour of flatus. 
One such product originally called the “Toot Trap-
per” and renamed the “Flatulence Filter” (UltraT-
ech products, Inc., Houston, TX, USA) is a cush-
ion or pad (which can be placed directly against 
the anus) that is lined with activated charcoal. 
Both the cushion and pad are encased in either a 
washable or a disposable cover. There are similar 
products by other manufacturers (e.g., Flat-D by 
Flat-D Innovations, Inc., Iowa, USA and GasMed-
ic and GasBGon by Dairiair and manufactured 
by ECVC, Greenville, NC, USA). Pads compris-
ing fabric covered activated charcoal that can be 
worn next to the anus or attached to a brief (Gas-
Medic underair pad by Dairiair and Flat-D, Flat-
D Innovations, Inc., Cedar Rapids, IA). There is 
also underwear (briefs) entirely made of covered 
activated carbon cloth (Underease protective un-
derwear (UltraTech Products, Inc., Houston, TX). 
Ohge at el. [681] compared the effectiveness of 
XV. ODOUR CONTROL PRODUCTS
1769
11 devices containing activated carbon in six nor-
mal adults (50% female) under controlled condi-
tions in absorbing odoriferous rectal gases. Five 
types of seat cushions, four types of pads, and 
two types of briefs (one that held a pad next to 
the anus and one made of activated carbon fiber 
fabric) were tested. A mixture gas comprising 100 
ml of nitrogen with traces of hydrogen sulphide 
(40 ppm), methylmercaptan (40 ppm) and hydro-
gen (5,000 ppm) was instilled into the rectum of 
the subjects via a rectal tube. Since hydrogen 
does not react with charcoal, the amount of un-
absorbed sulphide was determined from the ratio 
of sulphide to hydrogen collected from the panta-
loons relative to the ratio in the instilled gas. The 
subjects wore mylar pantaloons that were sealed 
at the thighs and waist with elastic bandages to 
reduce convection to the air.
The subjects’ clothing, apart from any device, 
absorbed approximately 22% of sulphide gas. 
The cushions absorbed an amount comparable 
to usual clothing, 20%. The various pads and the 
brief with an attached pad held near the anus ab-
sorbed 55-77% of the rectal gas. The underwear 
made of charcoal fabric was the most effective 
and removed nearly all (95-99%) of the sulphide 
gas. The charcoal fabric briefs are reusable and 
the charcoal is allegedly regenerable with heat. 
There are no reports of any odour absorbing 
devices being evaluated in persons with faecal 
incontinence. In vitro studies showed that each 
device had the capability of absorbing the rectal 
gases and that their performance efficiency de-
pended on contact between the charcoal element 
and gas. Briefs entirely made of activated char-
coal fabric appear to provide the greatest surface 
area for contact with malodorous rectal gas. The 
absorption of odorous gas by clothing suggests 
that washing outer clothing as well as underwear 
is important to reduce odour.
Some products aim to reduce the amount of mal-
odorous flatus that is produced. Administration 
of the probiotic, Lactobacillus plantarum, (5 x 
107 cfu/ml) in a randomized trial of 60 patients 
with IBS significantly reduced flatulence (by half 
in 44% of patients). Only 18% of the placebo 
group reported reductions of flatulence [682]. 
Although administration of charcoal, yucca and 
zinc acetate reduced the percentage of episodes 
of malodorous gas [683], there are inconsistent 
findings about reductions in flatulence from in-
gesting activated charcoal in humans [165] [684].
Two clinical trials involving small sample sizes 
(19 and eight persons, respectively ) showed that 
the over-the-counter product, Beano, which con-
tains α-galactosidase, reduced flatus frequency in 
normal persons following the ingestion of beans 
[685] [686]. A significant reduction in cumulative 
breath hydrogen excretion over an 8-hour period 
after α-galactosidase versus placebo suggests 
α-galactosidase reduces flatus production [686]. 
Although Ganiats et al., 1994 [685] reported a sig-
nificant decrease in flatus using 240 galactosidic 
units (GalU), Di Stefano reported that effects of 
1200 GalU but not 300 GalU were significantly dif-
ferent from placebo. One GalU is the amount of 
galactosidase that releases 1 μmol of galactose 
from its substrate in one minute [686]. Differenc-
es in the test diet or lack of adequate statistical 
power may explain these differences since nei-
ther study reported a power analysis. Although a 
reduction in the amount of intestinal gas produced 
may decrease the volume of odour, it may not de-
crease its potency or perceived odour.
A few products are available that aim to prevent, 
absorb, or control odour associated with involun-
tarily leaked stool or flatus associated with faecal 
incontinence. These include cushions and pads 
that absorb odour as well as probiotics and en-
zymes, which aim to reduce production of mal-
odorous gas.
3. RECOMMENDATIONS
 •  Briefs made of activated charcoal fabric are 
recommended over pads or cushions contain-
ing activated charcoal for absorbing odoriferous 
rectal gas (Grade of Recommendation C). 
 •  Since some pads absorb up to 75% of gas, 
there may be value in offering patients who 
have smaller amounts of gas the opportunity 
to compare pads and briefs for themselves. 
(Grade of Recommendation D). 
 •  For those persons experiencing stool 
leakage due to flatus, over-the-counter 
α-galactosidase containing products, which 
reduce flatus frequency, can be tried in an 
attempt to reduce FI frequency (Grade of 
Recommendation B). 
 •  Washing of outer as well as under clothing 
after flatus is recommended to reduce odour 
due to absorption of gas by clothing (Grade of 
recommendation of C).
4. PRIORITIES FOR RESEARCH
 •  Investigation of whether probiotics or changes 
in dietary intake can modulate or reduce the 
odour of flatulence or leaked faeces.
 •  Development of an absorbent product that 
can reduce the odour of leaked faeces while 
protecting the skin. 
 •  Investigation of the efficacy of anti-microbial 
agents in textile products (soft furnishings and 
bedding) for reducing odour associated with 
urinary and faecal incontinence.
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